assay,std_type,SMILES,std_value,std_units,standard_relation,molecule_chembl_id
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2cn3cc(Br)ccc3n2)cc1,10.3,nM,=,CHEMBL81260
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2nc3ccc(I)cc3s2)cc1,0.9,nM,=,CHEMBL55380
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CNc1ccc(-c2cn3cc(C)ccc3n2)cc1,2000.0,nM,>,CHEMBL78410
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CNc1ccc(-c2cn3ccccc3n2)cc1,1000.0,nM,>,CHEMBL81685
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,Cc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1,242.0,nM,=,CHEMBL78621
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2cn3ccccc3n2)cc1,2000.0,nM,>,CHEMBL312622
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2nc3ccc(I)cn3c2I)cc1,2000.0,nM,>,CHEMBL310444
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,Cc1ccc2nc(-c3ccc(Br)cc3)cn2c1,638.0,nM,=,CHEMBL78765
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc2nc(-c3ccc(Br)cc3)cn2c1,339.0,nM,=,CHEMBL309920
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,15.0,nM,=,CHEMBL78012
Inhibition constant against [125I]-7 (TZDM) binding to Amyloid beta 1-40 aggregates,Ki,CN(C)c1ccc(-c2nc3ccccn3c2I)cc1,2000.0,nM,>,CHEMBL311035
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC1(C)[C@H]2CC[C@](C)(C2)[C@H]1NS(=O)(=O)c1ccc(F)cc1,19.0,%,=,CHEMBL1089750
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,31.0,%,=,CHEMBL311039
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,5000.0,nM,=,CHEMBL311039
Observed stimulation of the production of soluble beta-amyloid precursor protein,Stimulation,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,20.0,%,=,CHEMBL311039
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,47.0,%,=,CHEMBL450926
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,2700.0,nM,=,CHEMBL450926
Observed stimulation of the production of soluble beta-amyloid precursor protein,Stimulation,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,32.0,%,=,CHEMBL450926
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,58.0,%,=,CHEMBL310242
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,1800.0,nM,=,CHEMBL310242
Observed stimulation of the production of soluble beta-amyloid precursor protein,Stimulation,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,23.0,%,=,CHEMBL310242
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,26.0,%,=,CHEMBL74874
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,11000.0,nM,=,CHEMBL74874
Observed stimulation of the production of soluble beta-amyloid precursor protein,Stimulation,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,0.0,%,=,CHEMBL74874
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,24.0,%,=,CHEMBL75183
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,10000.0,nM,=,CHEMBL75183
Observed stimulation of the production of soluble beta-amyloid precursor protein,Stimulation,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,0.0,%,=,CHEMBL75183
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC12CC[C@@H](C1)C(C)(C)[C@H]2NS(=O)(=O)c1ccc(F)cc1,0.0,%,=,CHEMBL432343
"Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L), at 2.5 uM concentration",Inhibition,CC1(C)[C@@H]2CC[C@@](C)(C2)[C@H]1NS(=O)(=O)c1ccc(F)cc1,0.0,%,=,CHEMBL2114129
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1cc(/C=C\c2ccc(/C=C\c3ccc(O)c(C(=O)O)c3)c(Br)c2)ccc1O,0.13,nM,=,CHEMBL76112
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1cc(/C=C\c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(Br)c2)ccc1O,0.27,nM,=,CHEMBL74348
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1cc(/C=C\c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)cc2Br)ccc1O,0.19,nM,=,CHEMBL305634
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,0.14,nM,=,CHEMBL300172
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1ccccc1O,1800.0,nM,>,CHEMBL424
Inhibitory activity against binding of [125I]IMSB to amyloid beta in brain,Ki,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(Br)c2)ccc1O,0.11,nM,=,CHEMBL74704
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN(C)c1ccc(-c2nc3ccc(I)cc3s2)cc1,2000.0,nM,>,CHEMBL55380
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN(C)c1ccc(-c2nc3ccc(I)cc3s2)cc1,0.9,nM,=,CHEMBL55380
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN(C)c1ccc(-c2nc3ccc(I)cc3s2)cc1,5000.0,nM,>,CHEMBL55380
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN(C)c1ccc(-c2nc3ccc(I)cc3s2)cc1,2.2,nM,=,CHEMBL55380
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN1CCN(c2ccc(-c3nc4ccc(I)cc4s3)cc2)CC1,2000.0,nM,>,CHEMBL58092
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN1CCN(c2ccc(-c3nc4ccc(I)cc4s3)cc2)CC1,5.4,nM,=,CHEMBL58092
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN1CCN(c2ccc(-c3nc4ccc(I)cc4s3)cc2)CC1,2000.0,nM,>,CHEMBL58092
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN1CCN(c2ccc(-c3nc4ccc(I)cc4s3)cc2)CC1,6.4,nM,=,CHEMBL58092
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,0.17,nM,=,CHEMBL292910
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,1000.0,nM,>,CHEMBL292910
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,0.8,nM,=,CHEMBL292910
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,1000.0,nM,>,CHEMBL292910
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,0.14,nM,=,CHEMBL300172
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,1000.0,nM,>,CHEMBL300172
Inhibition constant of compound on ligand binding to aggregates of Amyloid beta was measured by comparing with [125I]IMSB,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,0.4,nM,=,CHEMBL300172
Inhibition constant of compound on ligand binding to aggregates of Amyloid beta was measured by comparing with [125I]TZDM,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,2000.0,nM,>,CHEMBL300172
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN(C)c1ccc(-c2nc3ccc(Br)cc3s2)cc1,2000.0,nM,>,CHEMBL55401
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN(C)c1ccc(-c2nc3ccc(Br)cc3s2)cc1,1.9,nM,=,CHEMBL55401
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN(C)c1ccc(-c2nc3ccc(Br)cc3s2)cc1,3000.0,nM,>,CHEMBL55401
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN(C)c1ccc(-c2nc3ccc(Br)cc3s2)cc1,0.8,nM,=,CHEMBL55401
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C,9000.0,nM,>,CHEMBL57267
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C,116.0,nM,=,CHEMBL57267
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C,4000.0,nM,>,CHEMBL57267
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C,294.0,nM,=,CHEMBL57267
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN1CCN(c2ccc(-c3nc4ccc(Br)cc4s3)cc2)CC1,2000.0,nM,>,CHEMBL55536
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN1CCN(c2ccc(-c3nc4ccc(Br)cc4s3)cc2)CC1,1.6,nM,=,CHEMBL55536
Inhibition constant for aggregates of amyloid beta compared to [125I]IMSB,Ki,CN1CCN(c2ccc(-c3nc4ccc(Br)cc4s3)cc2)CC1,2400.0,nM,>,CHEMBL55536
Inhibition constant for amyloid beta compared to [125I]TZDM,Ki,CN1CCN(c2ccc(-c3nc4ccc(Br)cc4s3)cc2)CC1,5.0,nM,=,CHEMBL55536
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,COc1ccc2nc(-c3ccc(N(C)C)cc3)sc2c1,1.9,nM,=,CHEMBL328430
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccccc3s2)cc1,11.0,nM,=,CHEMBL93334
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,4.3,nM,=,CHEMBL93124
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccc(C#N)cc3s2)cc1,8.6,nM,=,CHEMBL92802
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,COc1ccc2nc(-c3ccc(N)cc3)sc2c1,7.0,nM,=,CHEMBL92390
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,Nc1ccc(-c2nc3ccccc3s2)cc1,37.0,nM,=,CHEMBL93118
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccc(Br)cc3s2)cc1,1.7,nM,=,CHEMBL328660
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,46.0,nM,=,CHEMBL93884
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CN(C)c1ccc(-c2nc3ccc(Br)cc3s2)cc1,2.9,nM,=,CHEMBL55401
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CN(C)c1ccc(-c2nc3ccccc3s2)cc1,4.0,nM,=,CHEMBL92816
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,N#Cc1ccc2nc(-c3ccc(N)cc3)sc2c1,64.0,nM,=,CHEMBL93270
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CN(C)c1ccc(-c2nc3ccc(C#N)cc3s2)cc1,11.0,nM,=,CHEMBL92801
Binding affinity for Amyloid beta 1-40 aggregates fibrils in competition with BTA-1,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C,580.0,nM,=,CHEMBL57267
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccc(C)cc3s2)cc1,10.0,nM,=,CHEMBL330529
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,Cc1ccc2nc(-c3ccc(N(C)C)cc3)sc2c1,64.0,nM,=,CHEMBL329640
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CN(C)c1ccc(-c2nc3ccc(O)cc3s2)cc1,4.4,nM,=,CHEMBL91449
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,Nc1ccc(-c2nc3ccc(Br)cc3s2)cc1,7.2,nM,=,CHEMBL92852
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,CNc1ccc(-c2nc3ccc(OC)cc3s2)cc1,4.9,nM,=,CHEMBL94230
Binding affinity for Amyloid beta 1-40 aggregates in competition with [N-methyl-3H] BTA-1.,Ki,Cc1ccc2nc(-c3ccc(N)cc3)sc2c1,9.5,nM,=,CHEMBL93109
In vitro effective concentration against beta amyloid protein 42 in ELISA,EC50,CCCNC(=O)OC[C@@H](C)N(c1cc(Cl)ccc1CO)S(=O)(=O)c1ccc(Cl)cc1,100.0,nM,<,CHEMBL181204
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(Cl)cc2)CC1,3500.0,nM,=,CHEMBL360473
In vitro effective concentration against beta amyloid protein 42 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(Cl)cc2)CC1,5000.0,nM,=,CHEMBL360473
In vitro inhibition of amyloid precursor protein 695 activity in CHO cells expressing human APP,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(Cl)cc2)CC1,1030.0,nM,=,CHEMBL360473
In vitro reduction of Swedish NL mutant amyloid precursor protein activity expressed in CHO cells,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(Cl)cc2)CC1,530.0,nM,=,CHEMBL360473
In vitro elevation of beta C-terminal fragment (Ct-99) in CHO cells expressing mutant Swedish NL human APP,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(Cl)cc2)CC1,640.0,nM,=,CHEMBL360473
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccc(Cl)cc2)CC1,12200.0,nM,=,CHEMBL180641
In vitro effective concentration against beta amyloid protein 42 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccc(Cl)cc2)CC1,20900.0,nM,=,CHEMBL180641
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccc(Cl)cc2)CC1,2700.0,nM,=,CHEMBL183805
In vitro effective concentration against beta amyloid protein 42 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccc(Cl)cc2)CC1,3700.0,nM,=,CHEMBL183805
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccccc2)CC1,62700.0,nM,=,CHEMBL183806
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccccc2)CC1,,nM,,CHEMBL183806
Percent inhibition of beta amyloid protein 40 activity in ELISA at 100 uM,Inhibition,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccccc2)CC1,84.0,%,=,CHEMBL182896
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccccc2)CC1,,nM,,CHEMBL182896
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccccc2)CC1,48600.0,nM,=,CHEMBL183815
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccccc2)CC1,,nM,,CHEMBL183815
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(OC)cc2)CC1,50600.0,nM,=,CHEMBL182768
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2OC)(S(=O)(=O)c2ccc(OC)cc2)CC1,,nM,,CHEMBL182768
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccc(OC)cc2)CC1,97000.0,nM,=,CHEMBL360740
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2)(S(=O)(=O)c2ccc(OC)cc2)CC1,,nM,,CHEMBL360740
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccc(OC)cc2)CC1,24500.0,nM,=,CHEMBL360341
In vitro effective concentration against beta amyloid protein 42 in ELISA; increase in presence of weak inhibitor,EC50,CCOC(=O)N1CCC(c2ccccc2C)(S(=O)(=O)c2ccc(OC)cc2)CC1,,nM,,CHEMBL360341
In vitro effective concentration against beta amyloid protein 40 in ELISA,EC50,CCCNC(=O)OC[C@@H](C)N(c1cc(Cl)ccc1CO)S(=O)(=O)c1ccc(Cl)cc1,100.0,nM,=,CHEMBL181204
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,30.0,%,=,CHEMBL563
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,305000.0,nM,=,CHEMBL563
Concentration required to inhibit A beta 40 peptide; nd is not determined,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,,%,,CHEMBL563
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,87.0,%,=,CHEMBL196279
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,75000.0,nM,=,CHEMBL196279
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,,nM,,CHEMBL196279
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,75.0,%,=,CHEMBL195970
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,77000.0,nM,=,CHEMBL195970
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,94000.0,nM,=,CHEMBL195970
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2Cl)c(F)c1,13.0,%,=,CHEMBL197456
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccccc2Cl)c(F)c1,,nM,,CHEMBL197456
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2cccc(Cl)c2)c(F)c1,58.0,%,=,CHEMBL194098
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2cccc(Cl)c2)c(F)c1,,nM,,CHEMBL194098
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(Cl)cc2)c(F)c1,55.0,%,=,CHEMBL193415
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(Cl)cc2)c(F)c1,,nM,,CHEMBL193415
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,79.0,%,=,CHEMBL264006
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,21000.0,nM,=,CHEMBL264006
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,46000.0,nM,=,CHEMBL264006
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,Cc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,44.0,%,=,CHEMBL195884
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,Cc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,,nM,,CHEMBL195884
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,60.0,%,=,CHEMBL193971
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,129000.0,nM,=,CHEMBL193971
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,,nM,,CHEMBL193971
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2C(F)(F)F)c(F)c1,25.0,%,=,CHEMBL194686
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccccc2C(F)(F)F)c(F)c1,,nM,,CHEMBL194686
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,96.0,%,=,CHEMBL194274
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,83000.0,nM,=,CHEMBL194274
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,,nM,,CHEMBL194274
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccsc2)c(F)c1,40.0,%,=,CHEMBL371875
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccsc2)c(F)c1,,nM,,CHEMBL371875
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccncc2)c(F)c1,11.0,%,=,CHEMBL194645
Concentration required to inhibit A beta 42 peptide b; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccncc2)c(F)c1,,nM,,CHEMBL194645
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,67.0,%,=,CHEMBL196321
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,67000.0,nM,=,CHEMBL196321
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,,nM,,CHEMBL196321
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,42.0,%,=,CHEMBL196322
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,210000.0,nM,=,CHEMBL196322
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(O)cc2)c(F)c1,27.0,%,=,CHEMBL1394
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(O)cc2)c(F)c1,,nM,,CHEMBL1394
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,76.0,%,=,CHEMBL380778
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,41000.0,nM,=,CHEMBL380778
Concentration required to inhibit A beta 40 peptide 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,25.0,%,=,CHEMBL380778
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,75.0,%,=,CHEMBL197202
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,35000.0,nM,=,CHEMBL197202
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,,nM,,CHEMBL197202
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1C(F)(F)F,57.0,%,=,CHEMBL426291
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1C(F)(F)F,,nM,,CHEMBL426291
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,2.0,%,=,CHEMBL196691
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,,nM,,CHEMBL196691
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccccc3)c(F)c2)CC1,40.0,%,=,CHEMBL194760
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccccc3)c(F)c2)CC1,,nM,,CHEMBL194760
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccccc3)c(F)c2)CC1,-1.0,%,=,CHEMBL194760
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,55.0,%,=,CHEMBL196246
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,111000.0,nM,=,CHEMBL196246
Concentration required to inhibit A beta 40 peptide 100 um,IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,22000.0,nM,=,CHEMBL196246
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,79.0,%,=,CHEMBL196945
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,41000.0,nM,=,CHEMBL196945
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,14000.0,nM,=,CHEMBL196945
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,49.0,%,=,CHEMBL196946
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,96300.0,nM,=,CHEMBL196946
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,-5.0,%,=,CHEMBL196946
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,75.0,%,=,CHEMBL372751
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,46000.0,nM,=,CHEMBL372751
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,101000.0,nM,=,CHEMBL372751
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(C4CCOCC4)cc3)c(F)c2)CC1,52.0,%,=,CHEMBL193634
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccc(C4CCOCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL193634
Concentration required to inhibit A beta 40 peptide 100 uM; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccc(C4CCOCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL193634
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,58.0,%,=,CHEMBL194692
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,70600.0,nM,=,CHEMBL194692
Concentration required to inhibit A beta 40 peptide 100 uM; nd is not determined,IC50,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,,nM,,CHEMBL194692
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C)(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,77.0,%,=,CHEMBL364738
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C)(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,,nM,,CHEMBL364738
Concentration required to inhibit A beta 40 peptide 100 um,Inhibition,CC(C)(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,47.0,%,=,CHEMBL364738
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(C4CCCCC4)cc3)c(F)c2)CC1,60.0,%,=,CHEMBL194838
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccc(C4CCCCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL194838
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccc(C4CCCCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL194838
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,99.0,%,=,CHEMBL196947
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,31600.0,nM,=,CHEMBL196947
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,409000.0,nM,=,CHEMBL196947
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,80.0,%,=,CHEMBL372846
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,33600.0,nM,=,CHEMBL372846
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,111000.0,nM,=,CHEMBL372846
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,75.0,%,=,CHEMBL427548
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,57900.0,nM,=,CHEMBL427548
Concentration required to inhibit A beta 40 peptide 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,32.0,%,=,CHEMBL427548
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,97.0,%,=,CHEMBL197140
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,11000.0,nM,=,CHEMBL197140
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,,nM,,CHEMBL197140
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,28.0,%,=,CHEMBL382721
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL382721
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,81000.0,nM,=,CHEMBL382721
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,,nM,,CHEMBL382721
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,70.0,%,=,CHEMBL436483
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,17700.0,nM,=,CHEMBL436483
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,43.0,%,=,CHEMBL196070
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,114000.0,nM,=,CHEMBL196070
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,,nM,,CHEMBL196070
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)NO)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,31.0,%,=,CHEMBL196244
Concentration required to inhibit A beta 42 peptide; nd is not determined,IC50,CC(C(=O)NO)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,,nM,,CHEMBL196244
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(=O)NS(C)(=O)=O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,34.0,%,=,CHEMBL197305
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)NS(C)(=O)=O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,,nM,,CHEMBL197305
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(C(=O)NS(C)(=O)=O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,,nM,,CHEMBL197305
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1noc(O)n1,46.0,%,=,CHEMBL382746
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1noc(O)n1,,nM,,CHEMBL382746
Concentration required to inhibit A beta 40 peptide; nd is not determined,IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1noc(O)n1,,nM,,CHEMBL382746
Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Inhibition,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,70.0,%,=,CHEMBL193900
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,64000.0,nM,=,CHEMBL193900
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,12000.0,nM,=,CHEMBL193900
Concentration required to inhibit A beta 40 peptide at 100 uM,Inhibition,COC(=O)C(C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,45.0,%,=,CHEMBL193956
Concentration required to inhibit A beta 42 peptide at 100 uM,Inhibition,COC(=O)C(C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,242.0,%,=,CHEMBL193956
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,20000.0,nM,=,CHEMBL194020
Concentration required to inhibit A beta 42 peptide 100 uM,Inhibition,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,259.0,%,=,CHEMBL194020
Concentration required to inhibit A beta 40 peptide 100 uM,Inhibition,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(Cl)c1,40.0,%,=,CHEMBL194824
Concentration required to inhibit amyloid beta 42 peptide; nd is not determined,IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(Cl)c1,,nM,,CHEMBL194824
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,280000.0,nM,=,CHEMBL190083
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,Nc1ccc(/C=C/c2ccc(O)cc2)cc1,95.0,nM,=,CHEMBL194754
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,Nc1ccc(/C=C/c2ccc(OCC(CO)CF)cc2)cc1,15.0,nM,=,CHEMBL198597
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CN(C)c1ccc(/C=C/c2ccc(O)cc2)cc1,1.1,nM,=,CHEMBL198598
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CN(C)c1ccc(/C=C/c2ccc(OCC3COC(C)(C)OC3)cc2)cc1,59.0,nM,=,CHEMBL371066
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CN(C)c1ccc(/C=C/c2ccc(OCC(CO)CO)cc2)cc1,38.0,nM,=,CHEMBL196407
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,COc1ccc(S(=O)(=O)OCC(CO)COc2ccc(/C=C/c3ccc(N(C)C)cc3)cc2)cc1,150.0,nM,=,CHEMBL196213
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CN(C)c1ccc(/C=C/c2ccc(OCC(CO)C[18F])cc2)cc1,15.0,nM,=,CHEMBL1169460
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CN(C)c1ccc(/C=C/c2ccc(OCC(CO)Cc3ccc(Br)cc3)cc2)cc1,80.0,nM,=,CHEMBL196387
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,1.2,nM,=,CHEMBL381642
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CNc1ccc(/C=C/c2ccc(OCC(CO)CO)cc2)cc1,32.5,nM,=,CHEMBL196941
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,CNc1ccc(/C=C/c2ccc(OCC(CO)C[18F])cc2)cc1,5.0,nM,=,CHEMBL567747
Inhibition constant for I-125-IMPY binding to amyloid plaques in Alzheimers disease brain homogenates,Ki,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],2.8,nM,=,CHEMBL1788111
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,6700.0,nM,>,CHEMBL200116
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,5.2,nM,=,CHEMBL199946
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,6000.0,nM,=,CHEMBL202877
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](O)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,20000.0,nM,>,CHEMBL425031
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,9900.0,nM,=,CHEMBL200014
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,740.0,nM,=,CHEMBL202507
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,180.0,nM,=,CHEMBL200077
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccccc1-c1ccc(-c2ccccc2OC)s1,625.0,nM,=,CHEMBL204873
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,CNc1ccc(-c2ccc(-c3ccc(O)cc3)s2)cc1,31.2,nM,=,CHEMBL205512
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,Oc1ccc(-c2ccc(-c3ccc(NCCF)cc3)s2)cc1,3.9,nM,=,CHEMBL206224
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc(NCCF)cc3)s2)cc1,21.5,nM,=,CHEMBL202938
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,CN(C)c1ccc(-c2ccc(-c3ccc(O)cc3)s2)cc1,7.5,nM,=,CHEMBL377279
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc(N(C)C)cc3)s2)cc1,500.0,nM,=,CHEMBL438972
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,Nc1ccc(-c2ccc(-c3ccc(O)cc3)s2)cc1,9.6,nM,=,CHEMBL205824
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc(N)cc3)s2)cc1,5.6,nM,=,CHEMBL203320
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc([N+](=O)[O-])cc3)s2)cc1,18.5,nM,=,CHEMBL205403
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,Nc1ccc(-c2ccc(-c3ccc(N)cc3)s2)cc1,6.1,nM,=,CHEMBL382007
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc(O)cc3)s2)cc1,6.1,nM,=,CHEMBL381991
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,Oc1ccc(-c2ccc(-c3ccc(O)cc3)s2)cc1,4.0,nM,=,CHEMBL204010
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,COc1ccc(-c2ccc(-c3ccc(OC)cc3)s2)cc1,108.0,nM,=,CHEMBL378797
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,CSc1ccc(-c2ccc(-c3ccc(SC)cc3)s2)cc1,1000.0,nM,>,CHEMBL424863
Displacement of [125I]IMPY from beta amyloid plaque in brain homogenates,Ki,O=[N+]([O-])c1ccc(-c2ccc(-c3ccc([N+](=O)[O-])cc3)s2)cc1,185.0,nM,=,CHEMBL202898
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,200.0,nM,=,CHEMBL204357
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1=O,6800.0,nM,=,CHEMBL206766
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC/C=C/Cc1ccccc1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL204443
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC1CCCC1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,6000.0,nM,=,CHEMBL381336
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NCc1ccco1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL205400
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCCCNC(=O)[C@@H](CCC)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,5000.0,nM,=,CHEMBL205714
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(NN3CCCCC3)c2)C1=O,74.0,nM,=,CHEMBL208230
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(C(F)(F)F)cc3)c2)C1=O,30.0,nM,=,CHEMBL424684
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(OC)cc3)c2)C1=O,160.0,nM,=,CHEMBL274414
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(F)c(Cl)c3)c2)C1=O,17.0,nM,=,CHEMBL208504
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc4c(c3)OCO4)c2)C1=O,152.0,nM,=,CHEMBL205970
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(OC)c3)c2)C1=O,54.0,nM,=,CHEMBL410532
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(C)c3)c2)C1=O,17.0,nM,=,CHEMBL208350
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3Cl)c2)C1=O,29.0,nM,=,CHEMBL382880
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3)c2)C1=O,15.0,nM,=,CHEMBL205907
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,COc1ccc2oc(-c3ccc(N)cc3)cc2c1,2.3,nM,=,CHEMBL205221
Binding affinity to beta amyloid in human corpse AD brain,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,4.3,nM,=,CHEMBL93124
Binding affinity to beta amyloid in human corpse AD brain,Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,6.0,nM,=,CHEMBL381642
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,CN(C)c1ccc(-c2cc3cc(O)ccc3o2)cc1,2.8,nM,=,CHEMBL204414
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,COc1ccc2oc(-c3ccc(N(C)C)cc3)cc2c1,12.0,nM,=,CHEMBL383116
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,CNc1ccc(-c2cc3cc(O)ccc3o2)cc1,0.7,nM,=,CHEMBL204829
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,CNc1ccc(-c2cc3cc(OC)ccc3o2)cc1,1.3,nM,=,CHEMBL208212
Displacement of [125I]IMPY from beta amyloid in human corpse AD brain,Ki,Nc1ccc(-c2cc3cc(O)ccc3o2)cc1,11.5,nM,=,CHEMBL380476
Labelling of accumulated amyloid plaque in Tg2576 transgenic mouse brain hippocampus expressing human APP after 30 mins,Activity,[11CH3]Nc1ccc(-c2cc3cc(O)ccc3o2)cc1,,,,CHEMBL205633
Labelling of accumulated amyloid plaque in Tg2576 transgenic mouse brain cerebral cortex expressing human APP after 30 mins,Activity,[11CH3]Nc1ccc(-c2cc3cc(O)ccc3o2)cc1,,,,CHEMBL205633
Ability for neuropathological staining of amyloid plaque in human corpse AD brain temporal cortex,Activity,CNc1ccc(-c2cc3cc(O)ccc3o2)cc1,,,,CHEMBL204829
Ability for neuropathological staining of neurofibrillary tangles in human corpse AD brain temporal cortex,Activity,CNc1ccc(-c2cc3cc(O)ccc3o2)cc1,,,,CHEMBL204829
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,COc1ccc(/C=C/C=C/C=C/c2ccc(OC)cc2)cc1,8000.0,nM,>,CHEMBL379363
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,8000.0,nM,>,CHEMBL207649
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,10000.0,nM,>,CHEMBL93124
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,3000.0,nM,>,CHEMBL381642
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,5000.0,nM,>,CHEMBL78012
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,5.1,nM,=,CHEMBL292910
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,Nc1ccc(/C=C/C=C/C=C/c2ccc(NCCF)cc2)cc1,217.0,nM,=,CHEMBL205332
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CN(C)c1ccc(/C=C/C=C/C=C/c2ccc(N(C)C)cc2)cc1,7000.0,nM,>,CHEMBL377929
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(/C=C/C=C/C=C/c2ccc(NC)cc2)cc1,122.0,nM,=,CHEMBL208457
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,Nc1ccc(/C=C/C=C/C=C/c2ccc(N)cc2)cc1,375.0,nM,=,CHEMBL208456
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,O=[N+]([O-])c1ccc(/C=C/C=C/C=C/c2ccc([N+](=O)[O-])cc2)cc1,4000.0,nM,>,CHEMBL205899
"Displacement of [125I](E,E)-1-iodo-2,5-bis-(3-hydroxycarbonyl-4-methoxy)styrylbenzene from beta amyloid peptide in brain tissue at 50 uL",Ki,Oc1ccc(/C=C/C=C/C=C/c2ccc(O)cc2)cc1,150.0,nM,=,CHEMBL381731
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,COc1ccc(/C=C/C=C/C=C/c2ccc(OC)cc2)cc1,4000.0,nM,>,CHEMBL379363
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,152.0,nM,=,CHEMBL207649
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,2.8,nM,=,CHEMBL93124
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,1.2,nM,=,CHEMBL381642
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,5.0,nM,=,CHEMBL78012
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(=O)O)c3)c(I)c2)cc1C(=O)O,1000.0,nM,>,CHEMBL292910
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,Nc1ccc(/C=C/C=C/C=C/c2ccc(NCCF)cc2)cc1,12.0,nM,=,CHEMBL205332
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CN(C)c1ccc(/C=C/C=C/C=C/c2ccc(N(C)C)cc2)cc1,837.0,nM,=,CHEMBL377929
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,CNc1ccc(/C=C/C=C/C=C/c2ccc(NC)cc2)cc1,7.5,nM,=,CHEMBL208457
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,Nc1ccc(/C=C/C=C/C=C/c2ccc(N)cc2)cc1,9.0,nM,=,CHEMBL208456
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,O=[N+]([O-])c1ccc(/C=C/C=C/C=C/c2ccc([N+](=O)[O-])cc2)cc1,500.0,nM,=,CHEMBL205899
"Displacement of [125I]2-(4'-dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine from beta amyloid peptide in brain tissue at 50 uL",Ki,Oc1ccc(/C=C/C=C/C=C/c2ccc(O)cc2)cc1,9.0,nM,=,CHEMBL381731
Ability for neuropathological staining of cerebrovascular amyloid plaque in human corpse AD brain,Activity,CNc1ccc(-c2cc3cc(O)ccc3o2)cc1,,,,CHEMBL204829
Displacement of [125I]IMPY from beta amyloid in human AD cortical tissue,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,10.3,nM,=,CHEMBL78012
Displacement of [125I]IMPY from beta amyloid in human AD cortical tissue,Ki,CN(C)c1ccc(-c2cn3cc(CCF)ccc3n2)cc1,177.0,nM,=,CHEMBL381708
Displacement of [125I]IMPY from beta amyloid in human AD cortical tissue,Ki,CN(C)c1ccc(-c2cn3cc(CCCF)ccc3n2)cc1,48.3,nM,=,CHEMBL382407
Displacement of [125I]IMPY from beta amyloid in human AD cortical tissue,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,7.8,nM,=,CHEMBL207456
Binding affinity to beta amyloid 42 at 10 uM to 100 uM by ELISA,Activity,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O,,,,CHEMBL412321
Binding affinity to beta amyloid 42 by ELISA,Activity,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,CHEMBL212081
Inhibition of self-aggregation of beta amyloid 42 by thioflavin T assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,,,CHEMBL411972
Inhibition of self-aggregation of beta amyloid 42 by thioflavin T assay,Activity,CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,CHEMBL439310
Binding affinity to beta amyloid 42 by ELISA,Activity,CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,CHEMBL439310
Inhibition of self-aggregation of beta amyloid 42 by thioflavin T assay,Activity,NCCCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,,,CHEMBL215711
Binding affinity to beta amyloid 42 by ELISA,Activity,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,,,CHEMBL411972
Binding affinity to beta amyloid 42 by ELISA,Activity,CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)O,,,,CHEMBL376681
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)ccc1O,55.9,nM,=,CHEMBL106509
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(O)=C/C(C)=O)cc(I)c1O,24.9,nM,=,CHEMBL217923
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(O)=C/C(C)=O)ccc1OCCCF,316.3,nM,=,CHEMBL216864
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(O)=C/C(C)=O)ccc1OCCF,958.1,nM,=,CHEMBL216432
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)ccc1OCCCF,839.2,nM,=,CHEMBL386737
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)ccc1OCCF,232.7,nM,=,CHEMBL387276
Displacement of [125I]IMPY from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)cc(I)c1O,36.6,nM,=,CHEMBL216553
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)ccc1O,54.24,nM,=,CHEMBL106509
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,0.16,nM,=,CHEMBL300172
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OCCCF)c(OC)c2)ccc1O,0.07,nM,=,CHEMBL384465
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2cc(I)c(O)c(OC)c2)ccc1O,9.37,nM,=,CHEMBL215110
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,COc1cc(/C=C/C(C)=O)cc(I)c1O,19.97,nM,=,CHEMBL216553
Displacement of [125I]IMSB from beta amyloid protein 40,Ki,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,0.208,nM,=,CHEMBL116438
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,CNc1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,22.6,nM,=,CHEMBL224643
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,CNc1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,30.0,nM,=,CHEMBL224643
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1000.0,nM,>,CHEMBL429694
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],1000.0,nM,>,CHEMBL224392
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,O=c1cc(-c2ccc(O)cc2)oc2ccc(I)cc12,72.5,nM,=,CHEMBL388844
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,COc1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,29.0,nM,=,CHEMBL224064
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-40) protein aggregates,Ki,CN(C)c1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,13.2,nM,=,CHEMBL375934
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1000.0,nM,>,CHEMBL429694
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],1000.0,nM,>,CHEMBL224392
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,O=c1cc(-c2ccc(O)cc2)oc2ccc(I)cc12,77.2,nM,=,CHEMBL388844
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,COc1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,38.3,nM,=,CHEMBL224064
Displacement of [125I]6-iodo-4'-dimethyaminofl avone from beta amyloid (1-42) protein aggregates,Ki,CN(C)c1ccc(-c2cc(=O)c3cc(I)ccc3o2)cc1,15.6,nM,=,CHEMBL375934
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CN(C)c1ccc(/C=C/c2cnc(OCCOCCOCCF)c(Br)c2)cc1,6.8,nM,=,CHEMBL227869
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,OCCOc1ncc(/C=C/c2ccc(O)cc2)cc1I,15.5,nM,=,CHEMBL227923
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CNc1ccc(/C=C/c2cnc(OCCO)c(I)c2)cc1,8.5,nM,=,CHEMBL224149
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CN(C)c1ccc(/C=C/c2cnc(OCCO)c(I)c2)cc1,7.5,nM,=,CHEMBL224148
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,OCCOc1ncc(/C=C\c2ccc(O)cc2)cc1Br,6.8,nM,=,CHEMBL1162947
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CNc1ccc(/C=C/c2cnc(OCCO)c(Br)c2)cc1,5.0,nM,=,CHEMBL227817
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CN(C)c1ccc(/C=C/c2cnc(OCCO)c(Br)c2)cc1,3.6,nM,=,CHEMBL390561
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,Oc1ccc(/C=C/c2cnc(OCCOCCOCCF)c(I)c2)cc1,21.0,nM,=,CHEMBL228094
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CNc1ccc(/C=C/c2cnc(OCCOCCOCCF)c(I)c2)cc1,9.0,nM,=,CHEMBL224147
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CN(C)c1ccc(/C=C/c2cnc(OCCOCCOCCF)c(I)c2)cc1,7.5,nM,=,CHEMBL227750
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,Oc1ccc(/C=C/c2cnc(OCCOCCOCCF)c(Br)c2)cc1,14.2,nM,=,CHEMBL226662
Displacement of [15I]IMPY from Abeta peptide plaques in Alzheimer's disease patient brain,Ki,CNc1ccc(/C=C/c2cnc(OCCOCCOCCF)c(Br)c2)cc1,4.5,nM,=,CHEMBL227921
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,C(#Cc1ccccc1)c1ccccc1,175.0,nM,=,CHEMBL223309
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CN(C)c1ccc(C#Cc2ccc(OCCOCCOCCO)cc2)cc1,3.4,nM,=,CHEMBL413436
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CNc1ccc(C#Cc2ccc(OCCOCCOCCO)cc2)cc1,4.5,nM,=,CHEMBL227674
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Nc1ccc(C#Cc2ccc(OCCOCCOCCO)cc2)cc1,67.58,nM,=,CHEMBL227752
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Oc1ccc(C#Cc2ccc(OCCOCCOCCF)cc2)cc1,16.5,nM,=,CHEMBL227751
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CN(C)c1ccc(C#Cc2ccc(OCCOCCOCCF)cc2)cc1,2.9,nM,=,CHEMBL224096
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CNc1ccc(C#Cc2ccc(OCCOCCOCCF)cc2)cc1,1.9,nM,=,CHEMBL227495
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Nc1ccc(C#Cc2ccc(OCCOCCOCCF)cc2)cc1,21.5,nM,=,CHEMBL226610
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CN(C)c1ccc(C#Cc2ccc(OCCOCCO)cc2)cc1,3.8,nM,=,CHEMBL389671
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CNc1ccc(C#Cc2ccc(OCCOCCO)cc2)cc1,3.1,nM,=,CHEMBL227577
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CN(C)c1ccc(C#Cc2ccc(OCCOCCF)cc2)cc1,5.0,nM,=,CHEMBL227576
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CNc1ccc(C#Cc2ccc(OCCOCCF)cc2)cc1,1.2,nM,=,CHEMBL227521
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Nc1ccc(C#Cc2ccc(OCCOCCF)cc2)cc1,12.0,nM,=,CHEMBL373663
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,COc1ccc(C#Cc2ccc(N)cc2)cc1,2.9,nM,=,CHEMBL223285
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Nc1ccc(C#Cc2ccc(N)cc2)cc1,76.0,nM,=,CHEMBL227625
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,COc1ccc(C#Cc2ccc(O)cc2)cc1,2.9,nM,=,CHEMBL228034
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,CNc1ccc(C#Cc2ccc(O)cc2)cc1,1.5,nM,=,CHEMBL228033
Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates,Ki,Nc1ccc(C#Cc2ccc(O)cc2)cc1,106.0,nM,=,CHEMBL373548
Inhibition of beta amyloid protein formation assessed as reduction of turbidity,Activity,CC[C@H](C)N(CC(=O)N(CC(=O)N(CCO)CC(=O)N(CCO)CC(N)=O)CC(C)C)C(=O)CN(C)C(=O)CNC(=O)CN(Cc1ccccc1)C(=O)CN(CC(N)=O)C(=O)CN(CC(N)=O)C(=O)CNCCO,20.0,%,=,CHEMBL390357
Inhibition of beta amyloid protein formation assessed as reduction of turbidity,Activity,CC[C@H](C)N(CC(=O)N(C)CC(=O)NCC(=O)N(CC(=O)N(CC(N)=O)CC(=O)N(CC(N)=O)CC(=O)N(CCO)CC(N)=O)Cc1ccccc1)C(=O)CN(CC(C)C)C(=O)CN(CCO)C(=O)CNCCO,50.0,%,=,CHEMBL388461
Induction of amyloid type aggregate formation by thioflavin T assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C,,,,CHEMBL230666
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,530.0,nM,=,CHEMBL231446
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CCC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,16.0,nM,=,CHEMBL396543
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,180.0,nM,=,CHEMBL231548
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,140.0,nM,=,CHEMBL231547
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,120.0,nM,=,CHEMBL231449
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,540.0,nM,=,CHEMBL231448
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OC[C@H]2CC[C@@H](c3ccccc3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1,450.0,nM,=,CHEMBL396542
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,650.0,nM,=,CHEMBL231351
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,600.0,nM,=,CHEMBL395313
Inhibition of gamma-secretase,IC50,O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,73.0,nM,=,CHEMBL231250
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,60.0,nM,=,CHEMBL231248
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,360.0,nM,=,CHEMBL395312
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,190.0,nM,=,CHEMBL390889
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,900.0,nM,=,CHEMBL231647
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,180.0,nM,=,CHEMBL231545
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,1000.0,nM,=,CHEMBL231035
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,680.0,nM,=,CHEMBL230931
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,880.0,nM,=,CHEMBL425304
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,780.0,nM,=,CHEMBL231125
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,1900.0,nM,=,CHEMBL390478
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,86.0,nM,=,CHEMBL231544
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,280.0,nM,=,CHEMBL389549
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,220.0,nM,=,CHEMBL231447
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,8.9,nM,=,CHEMBL78012
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(CCCF)c1ccc(-c2cn3cc(I)ccc3n2)cc1,41.0,nM,=,CHEMBL69671
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(CCF)c1ccc(-c2cn3cc(I)ccc3n2)cc1,31.0,nM,=,CHEMBL70894
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(SCCO)ccc3n2)cc1,88.0,nM,=,CHEMBL244995
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,COc1ccc(CSc2ccc3nc(-c4ccc(N(C)C)cc4)cn3c2)cc1,8.3,nM,=,CHEMBL388460
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(SCC(N)=O)ccc3n2)cc1,391.0,nM,=,CHEMBL244994
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(SCCO)ccc3n2)cc1,645.0,nM,=,CHEMBL241986
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(SCC(N)=O)ccc3n2)cc1,1840.0,nM,=,CHEMBL241985
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,Cc1cc(-c2cn3cc(Br)ccc3n2)ccc1N,658.0,nM,=,CHEMBL245210
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(Br)ccc3n2)cc1Br,7.4,nM,=,CHEMBL245208
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(O)ccc3n2)cc1,177.0,nM,=,CHEMBL387998
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Br)cc(I)c3n2)cc1,183.0,nM,=,CHEMBL242410
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CCSc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1,8.3,nM,=,CHEMBL242194
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,COc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1,38.5,nM,=,CHEMBL243492
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc([N+](=O)[O-])ccc3n2)cc1,7.6,nM,=,CHEMBL244757
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(C#N)ccc3n2)cc1,8.2,nM,=,CHEMBL442269
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(F)ccc3n2)cc1,13.0,nM,=,CHEMBL241967
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Cl)ccc3n2)cc1,24.2,nM,=,CHEMBL394553
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Br)ccc3n2)cc1,5.9,nM,=,CHEMBL81260
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C(=O)C(F)(F)F)c1ccc(-c2cn3cc(Br)ccc3n2)cc1Br,1000.0,nM,>,CHEMBL388227
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Br)cc(C#N)c3n2)cc1,180.0,nM,>,CHEMBL242411
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(SCCO)ccc3n2)cc1C,1000.0,nM,>,CHEMBL245214
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(SCC(N)=O)ccc3n2)cc1C,1000.0,nM,>,CHEMBL244996
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CNc1ccc(-c2cn3cc(Br)ccc3n2)cc1C,1000.0,nM,>,CHEMBL241984
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CC(=O)N(C)c1ccc(-c2cn3cc(Br)ccc3n2)cc1C,1000.0,nM,>,CHEMBL243935
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,Cc1cc(-c2cn3cc(Br)ccc3n2)ccc1NC(=O)C(F)(F)F,1000.0,nM,>,CHEMBL388228
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1ccccc1CN(C)CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)Cc1ccccc1OC.Cl.Cl,20.3,%,=,CHEMBL557586
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],78.8,%,=,CHEMBL429694
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],61.1,%,=,CHEMBL345124
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,17.8,%,=,CHEMBL636
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,5.0,%,<,CHEMBL659
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccncc2)=CC1=O)Cc1ccncc1,22.5,%,=,CHEMBL241960
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccnc2)=CC1=O)Cc1cccnc1,13.1,%,=,CHEMBL241974
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccn2)=CC1=O)Cc1ccccn1,21.5,%,=,CHEMBL244762
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccs2)=CC1=O)Cc1cccs1,43.8,%,=,CHEMBL390247
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccco2)=CC1=O)Cc1ccco1,42.7,%,=,CHEMBL276444
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2[N+](=O)[O-])=CC1=O)Cc1ccccc1[N+](=O)[O-],46.7,%,=,CHEMBL395815
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2Cl)=CC1=O)Cc1ccccc1Cl,22.7,%,=,CHEMBL243057
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2C)=CC1=O)Cc1ccccc1C,46.9,%,=,CHEMBL243274
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2cccc(OC)c2)=CC1=O)Cc1cccc(OC)c1,70.9,%,=,CHEMBL394865
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccc(OC)cc2)=CC1=O)Cc1ccc(OC)cc1,68.8,%,=,CHEMBL242661
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2)=CC1=O)Cc1ccccc1,54.6,%,=,CHEMBL218443
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1ccccc1CN(CCCCCCNC1=CC(=O)C(NCCCCCCN(Cc2ccccc2OC)C(C)C)=CC1=O)C(C)C,58.5,%,=,CHEMBL242836
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1ccccc1CN(C)CCCCCCNC1=CC(=O)C(NCCCCCCN(C)Cc2ccccc2OC)=CC1=O,70.4,%,=,CHEMBL242191
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,COc1ccccc1CNCCCCCCNC1=CC(=O)C(NCCCCCCNCc2ccccc2OC)=CC1=O,69.9,%,=,CHEMBL243044
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(Cc1ccccc1OC)C(=O)CCCCCNC1=CC(=O)C(NCCCCCC(=O)N(CC)Cc2ccccc2OC)=CC1=O,28.7,%,=,CHEMBL242190
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)CCc2ccccc2OC)=CC1=O)CCc1ccccc1OC,71.4,%,=,CHEMBL394348
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCCNC1=CC(=O)C(NCCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,70.5,%,=,CHEMBL243273
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCNC1=CC(=O)C(NCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,50.5,%,=,CHEMBL230702
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCNC1=CC(=O)C(NCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,39.3,%,=,CHEMBL243272
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCNC1=CC(=O)C(NCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,32.4,%,=,CHEMBL243271
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCNC1=CC(=O)C(NCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,24.3,%,=,CHEMBL243270
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNc1ccc(NCCCCCCN(CC)Cc2ccccc2OC)cc1)Cc1ccccc1OC,56.5,%,=,CHEMBL230434
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=C(c2ccccc2)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(c2ccccc2)C1=O)Cc1ccccc1OC,68.2,%,=,CHEMBL396050
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=C(C)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(C)C1=O)Cc1ccccc1OC,68.0,%,=,CHEMBL243269
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=C(Br)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(Br)C1=O)Cc1ccccc1OC,63.9,%,=,CHEMBL243062
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=C(Cl)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(Cl)C1=O)Cc1ccccc1OC,68.2,%,=,CHEMBL243056
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=C(F)C(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=C(F)C1=O)Cc1ccccc1OC,52.1,%,=,CHEMBL243055
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,66.8,%,=,CHEMBL231160
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Cl)ncc3n2)cc1,88.0,nM,=,CHEMBL244747
Binding affinity to human beta amyloid plaque in alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(Cl)cnc3n2)cc1,147.0,nM,=,CHEMBL394626
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,19.0,nM,=,CHEMBL207456
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,Nc1ccc(-c2nc3ccc(-c4nc5ccccc5s4)cc3s2)cc1I,21.0,nM,=,CHEMBL242347
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,CN(C)c1ccc(-c2nc3ccc(-c4nc5ccc(F)cc5s4)cc3s2)cc1,23.0,nM,=,CHEMBL242132
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,CNc1ccc(-c2nc3ccc(-c4nc5ccc(F)cc5s4)cc3s2)cc1,27.0,nM,=,CHEMBL396212
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,CNc1ccc(-c2nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3s2)cc1,6.8,nM,=,CHEMBL242130
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,CNc1ccc(-c2nc3ccc(-c4nc5ccccc5s4)cc3s2)cc1,22.0,nM,=,CHEMBL394523
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,COc1ccc2nc(-c3ccc4nc(-c5ccc(N)cc5)sc4c3)sc2c1,25.0,nM,=,CHEMBL398155
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,Nc1ccc(-c2nc3ccc(-c4nc5ccc(F)cc5s4)cc3s2)cc1,36.0,nM,=,CHEMBL241917
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,Nc1ccc(-c2nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3s2)cc1,34.0,nM,=,CHEMBL243838
Displacement of [3H]PIB from beta amyloid in brain homogenate from Alzheimer's patient,Ki,Nc1ccc(-c2nc3ccc(-c4nc5ccccc5s4)cc3s2)cc1,25.0,nM,=,CHEMBL243630
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CN(C)c1ccc(C#Cc2cnc(OCCOCCOCCF)c(I)c2)cc1,16.8,nM,=,CHEMBL231915
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,OCCOc1ncc(C#Cc2ccc(O)cc2)cc1I,6.2,nM,=,CHEMBL232114
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CNc1ccc(C#Cc2cnc(OCCO)c(I)c2)cc1,12.5,nM,=,CHEMBL232113
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CNc1ccc(C#Cc2cnc(OCCO)c(Br)c2)cc1,1.6,nM,=,CHEMBL232112
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CNc1ccc(C#Cc2cnc(OCCOCCOCCF)c(Br)c2)cc1,13.1,nM,=,CHEMBL231918
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CN(C)c1ccc(C#Cc2cnc(OCCO)c(Br)c2)cc1,6.7,nM,=,CHEMBL231917
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CN(C)c1ccc(C#Cc2cnc(OCCOCCOCCF)c(Br)c2)cc1,11.2,nM,=,CHEMBL398059
Displacement of [125I]IMPY from beta amyloid plaque in human brain homogenates,Ki,CN(C)c1ccc(C#Cc2cnc(OCCO)c(I)c2)cc1,9.2,nM,=,CHEMBL231916
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,0.3,nM,=,CHEMBL240055
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,56.0,nM,=,CHEMBL240286
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,47.0,nM,=,CHEMBL240285
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,46.0,nM,=,CHEMBL398395
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,17.0,nM,=,CHEMBL240284
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,14.0,nM,=,CHEMBL240071
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL240070
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,27.0,nM,=,CHEMBL240069
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,3.5,nM,=,CHEMBL442801
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL239859
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,2.5,nM,=,CHEMBL239858
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,2.8,nM,=,CHEMBL400420
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,2.4,nM,=,CHEMBL239629
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,12.0,nM,=,CHEMBL393941
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,16.0,nM,=,CHEMBL236192
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,29.0,nM,=,CHEMBL429448
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,81.0,nM,=,CHEMBL236191
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,6.9,nM,=,CHEMBL236190
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,27.0,nM,=,CHEMBL236189
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,9.6,nM,=,CHEMBL236188
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,16.0,nM,=,CHEMBL236187
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236186
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,10.0,nM,=,CHEMBL236185
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL392060
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,6.9,nM,=,CHEMBL236184
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,17.0,nM,=,CHEMBL236183
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL392059
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,13.0,nM,=,CHEMBL236182
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,9.0,nM,=,CHEMBL394132
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,28.0,nM,=,CHEMBL238271
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.2,nM,=,CHEMBL392144
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC1(O)CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,104.0,nM,=,CHEMBL236196
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,57.0,nM,=,CHEMBL429449
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,2425.0,nM,=,CHEMBL236195
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,15.0,nM,=,CHEMBL236193
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,4.3,nM,=,CHEMBL392144
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,39.0,nM,=,CHEMBL393941
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,32.0,nM,=,CHEMBL236192
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,144.0,nM,=,CHEMBL429448
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,45.0,nM,=,CHEMBL236190
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,20.0,nM,=,CHEMBL236188
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,115.0,nM,=,CHEMBL236187
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236185
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,7.7,nM,=,CHEMBL392060
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,8.3,nM,=,CHEMBL236184
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,15.0,nM,=,CHEMBL236183
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,14.0,nM,=,CHEMBL392059
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,10.0,nM,=,CHEMBL236182
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,20.0,nM,=,CHEMBL394132
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,190.0,nM,=,CHEMBL238271
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)n2)cc1N,600.0,nM,=,CHEMBL392878
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,600.0,nM,=,CHEMBL81880
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,100.0,nM,=,CHEMBL245688
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cc(I)cc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000.0,nM,>,CHEMBL245479
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000.0,nM,>,CHEMBL245478
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000.0,nM,>,CHEMBL245477
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(OC)c(OC)c3)c2)cc1OC,20000.0,nM,=,CHEMBL245476
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,1800.0,nM,=,CHEMBL396917
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N4CCCC4)c(OC)c3)c2)ccc1N1CCCC1,20000.0,nM,>,CHEMBL248339
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,2700.0,nM,=,CHEMBL248338
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)c2)cc1N(C)C,1100.0,nM,=,CHEMBL248337
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)c2)ccc1OC,1300.0,nM,=,CHEMBL248133
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)c2)cc1N,300.0,nM,=,CHEMBL248132
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,700.0,nM,=,CHEMBL248131
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)c2)cc1OC,600.0,nM,=,CHEMBL247931
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,600.0,nM,=,CHEMBL247930
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(N(C)C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1900.0,nM,=,CHEMBL247728
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1400.0,nM,=,CHEMBL247727
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2ccc(O)c(OC)c2)nc(/C=C/c2ccc(O)c(OC)c2)c1,1700.0,nM,=,CHEMBL247726
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Cl)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL247530
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL427878
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,800.0,nM,=,CHEMBL247328
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,1100.0,nM,=,CHEMBL247929
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247927
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)n2)ccc1N(C)C,800.0,nM,=,CHEMBL391205
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247725
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)n2)cc1OC,500.0,nM,=,CHEMBL247674
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,700.0,nM,=,CHEMBL247524
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)n2)ccc1O,2300.0,nM,=,CHEMBL427877
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)n2)cc1N(C)C,900.0,nM,=,CHEMBL394713
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(NC)c3)n2)ccc1O,500.0,nM,=,CHEMBL248327
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)n2)ccc1OC,1100.0,nM,=,CHEMBL248122
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,8.95,nM,=,CHEMBL78012
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Kd,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,7.23,nM,=,CHEMBL93124
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Ki,CSc1ccc2nc(-c3ccc(N)cc3)cn2c1,377.0,nM,=,CHEMBL254850
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Ki,COC(=O)CCSc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1,205.0,nM,=,CHEMBL252969
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Ki,CSc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1,7.93,nM,=,CHEMBL252766
Binding affinity to beta amyloid plaque in human Alzheimer's disease brain tissue,Ki,CNc1ccc(-c2cn3cc(SC)ccc3n2)cc1,80.0,nM,=,CHEMBL252765
Displacement of [125I]IMPY from beta-amyloid plaques in brain homogenate of patient with Alzheimer's disease by gamma counting,Ki,CNc1ccc(-c2nc3c(O)cccc3s2)cc1,18.8,nM,=,CHEMBL524651
Displacement of [125I]IMPY from beta-amyloid plaques in brain homogenate of patient with Alzheimer's disease by gamma counting,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,2.8,nM,=,CHEMBL93124
Displacement of [125I]IMPY from beta-amyloid plaques in brain homogenate of patient with Alzheimer's disease by gamma counting,Ki,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,11.2,nM,=,CHEMBL486529
Displacement of [125I]IMPY from beta-amyloid plaques in brain homogenate of patient with Alzheimer's disease by gamma counting,Ki,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,11.5,nM,=,CHEMBL503833
Binding affinity to beta-amyloid plaques in subiculum of transgenic mouse overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3c(O)cccc3s2)cc1,,,,CHEMBL524651
Binding affinity to beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3c(O)cccc3s2)cc1,,,,CHEMBL524651
Binding affinity to beta-amyloid plaques in subiculum of transgenic mouse overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to beta-amyloid plaques in subiculum of transgenic mouse overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to core beta-amyloid plaques in vibratome section of transgenic mouse overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to vascular beta-amyloid plaques in vibratome section of transgenic mouse cortex overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to vascular beta-amyloid plaques in vibratome section of transgenic mouse cortex overexpressing human APP at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to vascular beta-amyloid plaques in vibratome section of transgenic mouse overexpressing human APP at 0.1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to vascular beta-amyloid plaques in cortex of patient with Alzheimer's disease at 0.1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Binding affinity to vascular beta-amyloid plaques in vibratome section of transgenic mouse overexpressing human APP at 0.1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to vascular beta-amyloid plaques in cortex of patient with Alzheimer's disease at 0.1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to fibrillar beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3c(O)cccc3s2)cc1,,,,CHEMBL524651
Binding affinity to fibrillar beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cccc(O)c3s2)cc1,,,,CHEMBL486529
Binding affinity to fibrillar beta-amyloid plaques in cortex of patient with Alzheimer's disease at 1 uM by fluorescence microscopy,Activity,CNc1ccc(-c2nc3cc(O)ccc3s2)cc1,,,,CHEMBL503833
Displacement of [125I]IMPY from beta-amyloid plaques in AD patient brain,Ki,FCCOCCOCCOc1ccc(C#Cc2ccc3c(c2)CCN3)cc1,4.0,nM,=,CHEMBL451807
Displacement of [125I]IMPY from beta-amyloid plaques in AD patient brain,Ki,FCCOCCOCCOc1ccc(C#Cc2ccc3[nH]ccc3c2)cc1,1.5,nM,=,CHEMBL519255
Binding affinity to beta-amyloid in gray matter of AD patent brain,Activity,[18F]CCOCCOCCOc1ccc(C#Cc2ccc3[nH]ccc3c2)cc1,,,,CHEMBL488695
Binding affinity to beta-amyloid in gray matter of AD patent brain,Activity,[18F]CCOCCOCCOc1ccc(C#Cc2ccc3c(c2)CCN3)cc1,,,,CHEMBL487843
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,54.5,%,=,CHEMBL450553
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCn1c(=O)c2cc3c(=O)n(CCCCCCN(CC)Cc4ccccc4OC)c(=O)c3cc2c1=O)Cc1ccccc1OC,5.0,%,<,CHEMBL507903
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCN1C(=O)c2ccc(-c3ccc4c(c3)C(=O)N(CCCCCCN(CC)Cc3ccccc3OC)C4=O)cc2C1=O)Cc1ccccc1OC,16.5,%,=,CHEMBL507304
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCN1CCN(CCCCCCN(CC)Cc2ccccc2OC)C1=O)Cc1ccccc1OC,5.0,%,<,CHEMBL449941
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCn1c(=O)c(=O)n(CCCCCCN(CC)Cc2ccccc2OC)c2ccccc21)Cc1ccccc1OC,8.8,%,=,CHEMBL452339
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCN1CC(=O)N(CCCCCCN(CC)Cc2ccccc2OC)CC1=O)Cc1ccccc1OC,4.8,%,=,CHEMBL449467
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,Cc1ccc2nc(-c3ccc(F)cc3)sc2c1,5.7,nM,=,CHEMBL510384
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,O=C(O)c1ccc2nc(-c3ccc(F)cc3)sc2c1,4000.0,nM,>,CHEMBL501127
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,COc1ccc2nc(-c3ccc(F)cc3)sc2c1,2.2,nM,=,CHEMBL490083
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,Oc1ccc2nc(-c3ccc(F)cc3)sc2c1,22.5,nM,=,CHEMBL490084
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,Oc1cc(O)c2sc(-c3ccc(F)cc3)nc2c1,776.0,nM,=,CHEMBL490085
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,2.8,nM,=,CHEMBL207456
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Activity,CCN(CCCCCCN1CCN(CCCCCCN(CC)Cc2ccccc2OC)C(=O)C1=O)Cc1ccccc1OC,,,,CHEMBL450990
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCC(=O)N1Cc2ccc3c4c(ccc(c24)C1)CN(C(=O)CCCCCN(CC)Cc1ccccc1OC)C3)Cc1ccccc1OC,12.7,%,=,CHEMBL507885
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Activity,CCN(CCCCCC(=O)N[C@H]1CC[C@H](NC(=O)CCCCCN(CC)Cc2ccccc2OC)CC1)Cc1ccccc1OC,,,,CHEMBL499722
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Activity,CCN(CCCCCC(=O)N[C@H]1CCCC[C@@H]1NC(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,,,,CHEMBL450506
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Activity,CCN(CCCCCC(=O)N[C@H]1CCCC[C@H]1NC(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,,,,CHEMBL499825
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCC(=O)N1CCN(C(=O)CCCCCN(CC)Cc2ccccc2OC)CC1)Cc1ccccc1OC,5.0,%,<,CHEMBL502877
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCC(=O)N1CCC(C2CCN(C(=O)CCCCCN(CC)Cc3ccccc3OC)CC2)CC1)Cc1ccccc1OC,13.7,%,=,CHEMBL254016
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Activity,CCN(CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(CC)Cc1ccccc1OC)Cc1ccccc1OC,,,,CHEMBL173309
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,COc1ccccc1CN(C)CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)Cc1ccccc1OC,20.3,%,=,CHEMBL11805
Inhibition of self-induced amyloid beta (1-40) aggregation by thioflavin T formation assay,IC50,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,9690.0,nM,=,CHEMBL450553
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CCN(CCCCCCN1C(=O)c2cccc3cccc(c23)C1=O)Cc1ccccc1OC,5.0,%,<,CHEMBL488590
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,5.0,%,<,CHEMBL659
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],61.1,%,=,CHEMBL345124
Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay,Inhibition,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],78.8,%,=,CHEMBL429694
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccccc3o2)cc1,2300.0,nM,=,CHEMBL492216
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,810.0,nM,=,CHEMBL492217
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,160.0,nM,=,CHEMBL491203
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,130.0,nM,=,CHEMBL509088
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(F)ccc3o2)cc1,1980.0,nM,=,CHEMBL489978
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Cl)ccc3o2)cc1,200.0,nM,=,CHEMBL446870
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Br)ccc3o2)cc1,470.0,nM,=,CHEMBL489979
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(I)ccc3o2)cc1,170.0,nM,=,CHEMBL524114
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,70.0,nM,=,CHEMBL524141
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(O)cc3o2)cc1,3620.0,nM,=,CHEMBL443097
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,3440.0,nM,=,CHEMBL491406
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(F)cc3o2)cc1,2190.0,nM,=,CHEMBL491407
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Cl)cc3o2)cc1,3210.0,nM,=,CHEMBL490798
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Br)cc3o2)cc1,1340.0,nM,=,CHEMBL490799
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(I)cc3o2)cc1,2800.0,nM,=,CHEMBL492023
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N)cc3)cc2c1,820.0,nM,=,CHEMBL492024
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3cc(OC)ccc3o2)cc1,80.0,nM,=,CHEMBL523824
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cl.Nc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,2950.0,nM,=,CHEMBL444393
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1.Cl,2160.0,nM,=,CHEMBL490808
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N)cc3)oc2c1,5440.0,nM,=,CHEMBL490806
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3ccc(OC)cc3o2)cc1,800.0,nM,=,CHEMBL489994
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)c(OC)c3)cc2c1,160.0,nM,=,CHEMBL489792
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)c(OC)c3)oc2c1,530.0,nM,=,CHEMBL521929
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455
Binding affinity to human APP expressed in transgenic mouse brain vibratome section at 1 uM by fluorescence microscopy,Activity,O=[N+]([O-])c1ccc(-c2nc3ccccc3s2)cc1,,,,CHEMBL477841
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,2.8,nM,=,CHEMBL207456
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,O=[N+]([O-])c1ccc(-c2nc3ccccc3s2)cc1,9.0,nM,=,CHEMBL477841
Inhibition of APP in human leukocytes,IC50,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,30000.0,nM,>,CHEMBL515387
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.Cl.O=C(NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,16.4,%,=,CHEMBL3216429
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.Cl.O=C(NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,28.6,%,=,CHEMBL3215572
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,21.5,%,=,CHEMBL3215768
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,,%,,CHEMBL3215769
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.Cl.O=C(NCCCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,20.5,%,=,CHEMBL3215770
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,45.3,%,=,CHEMBL3216018
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,12.2,%,=,CHEMBL2448076
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,30.8,%,=,CHEMBL3215573
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,49.1,%,=,CHEMBL3216221
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Cl.Cl.O=C(CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,47.3,%,=,CHEMBL3215574
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,COC(=O)CCc1ccc2nc(-c3ccccc3)c3c(c2c1)OCCC3.Cl,,%,,CHEMBL554901
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],89.8,%,=,CHEMBL345124
Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method,Inhibition,Cl.Nc1c2c(nc3cc(Cl)ccc13)CCCC2,7.1,%,=,CHEMBL486698
Inhibition of self-assembly of human amyloid beta (1-42) aggregation at 10 uM by thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,63.5,%,=,CHEMBL555300
Inhibition of self-assembly of human amyloid beta (1-42) aggregation at 10 uM by thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@@H](C)c2ccccc2OC)=CC1=O)[C@@H](C)c1ccccc1OC,62.3,%,=,CHEMBL556581
Inhibition of self-assembly of human amyloid beta (1-42) aggregation at 10 uM by thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)[C@H](C)c2ccccc2OC)=CC1=O)[C@H](C)c1ccccc1OC,63.9,%,=,CHEMBL540178
Inhibition of self-assembly of human amyloid beta (1-42) aggregation at 10 uM by thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,66.8,%,=,CHEMBL231160
Binding affinity to beta amyloid plaques in human Alzheimer's disease patient brain at 54 uCi/200 uL by autoradiography,Activity,CN(C)c1ccc(/C=C/C(=O)c2ccc(OCCOCCOCC[18F])cc2)cc1,,,,CHEMBL568297
Binding affinity to human recombinant APP695 K670N and M671L Swedish double mutant plaques expressed in Tg2576 mouse brain at 100 uM after 10 mins by amyloid beta-protein immunohistostaining,Activity,CN(C)c1ccc(/C=C/C(=O)c2ccc(OCCOCCOCCF)cc2)cc1,,,,CHEMBL566316
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,Cc1ccc2nc(-c3ccc(F)cc3)sc2c1,5.7,nM,=,CHEMBL510384
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,Nc1ccc2nc(-c3ccc(F)cc3)sc2c1,10.0,nM,=,CHEMBL568061
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,2.8,nM,=,CHEMBL93124
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,CN(C)c1ccc2nc(-c3ccc(F)cc3)sc2c1,3.8,nM,=,CHEMBL566354
Displacement of [125I]IMPY from beta-amyloid plaques in Alzheimer's disease patient brain homogenate,Ki,CNc1ccc2nc(-c3ccc(F)cc3)sc2c1,4.1,nM,=,CHEMBL578982
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O,1000.0,nM,>,CHEMBL300172
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],1000.0,nM,>,CHEMBL224392
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,172.0,nM,=,CHEMBL207649
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,0.87,nM,=,CHEMBL93124
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,1.7,nM,=,CHEMBL570378
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(-c2nc3ccccc3s2)cc1,1.28,nM,=,CHEMBL93334
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,1.29,nM,=,CHEMBL78012
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,0.74,nM,=,CHEMBL579205
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCF)cc2)cc1,2.22,nM,=,CHEMBL566723
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.87,nM,=,CHEMBL1774461
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(/C=C/c2nc3ccccc3s2)cc1,2.3,nM,=,CHEMBL565657
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(/C=C/c2ccccc2I)cc1,7.7,nM,=,CHEMBL565623
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(/C=C/c2cccc(I)c2)cc1,4.5,nM,=,CHEMBL567746
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(/C=C/c2ccc(I)cc2)cc1,2.0,nM,=,CHEMBL570610
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CN(C)c1ccc(/C=C/c2ccc(F)cc2)cc1,22.0,nM,=,CHEMBL81999
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,COc1ccc(/C=C/c2cccc(I)c2)cc1,22.0,nM,=,CHEMBL565281
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,Oc1ccc(/C=C/c2cccc(I)c2)cc1,32.0,nM,=,CHEMBL567614
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,2.4,nM,=,CHEMBL381642
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCC(CO)CF)cc2)cc1,5.0,nM,=,CHEMBL373236
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCF)cc2)cc1,2.9,nM,=,CHEMBL566709
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCF)cc2)cc1,4.4,nM,=,CHEMBL566296
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCF)cc2)cc1,6.0,nM,=,CHEMBL570606
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCF)cc2)cc1,7.5,nM,=,CHEMBL576655
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCCCF)cc2)cc1,8.2,nM,=,CHEMBL566917
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCCCCCF)cc2)cc1,9.0,nM,=,CHEMBL566711
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCCCCCCCF)cc2)cc1,18.5,nM,=,CHEMBL585301
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCCCCCCCCCF)cc2)cc1,12.2,nM,=,CHEMBL565658
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay,Ki,CNc1ccc(/C=C/c2ccc(OCCCCCCCCCCCCCCCCCCCCCCCCF)cc2)cc1,63.0,nM,=,CHEMBL570608
Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain,Kd,[3H]N(c1ccc(/C=C/c2ccc(O)cc2)cc1)C([3H])([3H])[3H],2.4,nM,=,CHEMBL1788117
Binding affinity to beta-amyloid plaques in Alzheimer's disease patient temporal cortex by immunohistochemical staining,Activity,CN(C)c1ccc2nc(C=C(C#N)C#N)sc2c1,,,,CHEMBL594555
Binding affinity to beta-amyloid plaques in Alzheimer's disease patient temporal cortex by immunohistochemical staining,Activity,CN(C)c1ccc2nc(/C=C/c3ccc(C=C(C#N)C#N)cc3)sc2c1,,,,CHEMBL594574
Binding affinity to beta-amyloid plaques in normal patient brain section by immunohistochemical staining,Activity,CN(C)c1ccc2nc(C=C(C#N)C#N)sc2c1,,,,CHEMBL594555
Binding affinity to beta-amyloid plaques in normal patient brain section by immunohistochemical staining,Activity,CN(C)c1ccc2nc(/C=C/c3ccc(C=C(C#N)C#N)cc3)sc2c1,,,,CHEMBL594574
Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,EC50,NC1=NC(c2ccccc2)(c2ccccc2)C2=NCCCN12,16000.0,nM,=,CHEMBL582044
Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,EC50,CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N,4170.0,nM,=,CHEMBL291784
Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,EC50,CN1C(=O)C(c2ccccc2)(C2CCCCC2)N=C1N,810.0,nM,=,CHEMBL599965
Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,EC50,CN1C(=O)C(C2CCCCC2)(C2CCCCC2)N=C1N,1030.0,nM,=,CHEMBL589163
Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,EC50,Cc1ccoc1C(=O)Nc1cccc(C2(C3CCCCC3)N=C(N)N(C)C2=O)c1,180.0,nM,=,CHEMBL590830
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN1C(=O)c2ccc(Nc3ccccc3)cc2C1=O,7.6,nM,=,CHEMBL610505
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,Cc1ccc(Nc2ccc3c(c2)C(=O)N(C)C3=O)cc1,4.1,nM,=,CHEMBL598288
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN1C(=O)c2ccc(Nc3ccc(Br)cc3)cc2C1=O,3.8,nM,=,CHEMBL598081
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN1C(=O)c2ccc(Nc3ccc(I)cc3)cc2C1=O,0.9,nM,=,CHEMBL610504
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,COc1ccc(Nc2ccc3c(c2)C(=O)N(C)C3=O)cc1,16.3,nM,=,CHEMBL598082
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN1C(=O)c2ccc(Nc3ccc(O)cc3)cc2C1=O,19.7,nM,=,CHEMBL598083
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21,1000.0,nM,>,CHEMBL268868
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN1C(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc2C1=O,1000.0,nM,>,CHEMBL8036
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1000.0,nM,>,CHEMBL429694
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],1000.0,nM,>,CHEMBL224392
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,1000.0,nM,>,CHEMBL93124
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,1000.0,nM,>,CHEMBL78012
Binding affinity to beta-amyloid plaques isolated from Alzheimer's disease patient brain at 50 uM by fluorescence micrography,Activity,CN1C(=O)c2ccc(Nc3ccc(I)cc3)cc2C1=O,,,,CHEMBL610504
Binding affinity to beta-amyloid plaques isolated from Alzheimer's disease patient brain at 50 uM by fluorescence micrography,Activity,Cc1ccc(Nc2ccc3c(c2)C(=O)N(C)C3=O)cc1,,,,CHEMBL598288
Binding affinity to beta-amyloid plaques isolated from Alzheimer's disease patient brain at 50 uM by fluorescence micrography,Activity,CN1C(=O)c2ccc(Nc3ccc(Br)cc3)cc2C1=O,,,,CHEMBL598081
Displacement of [125I-N-Methyl-4-(4-bromoanilino)phthalimide from beta-amyloid plaques isolated from Alzheimer's disease patient brain,Kd,CN1C(=O)c2ccc(Nc3ccc([125I])cc3)cc2C1=O,0.21,nM,=,CHEMBL607562
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],27.0,nM,=,CHEMBL1788111
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1788121
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1744459
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],19.0,nM,=,CHEMBL1744460
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2nc(-c3ccc(N(C)C)nc3)sc2c1,81.0,nM,=,CHEMBL1082545
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3cc(O)ccc3s2)cn1,74.0,nM,=,CHEMBL1082546
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ncc(-c2nc3ccc(O)cc3s2)cn1,41.0,nM,=,CHEMBL1088617
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cn1,267.0,nM,=,CHEMBL1077196
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(C(N)=O)cc3s2)cn1,85.0,nM,=,CHEMBL1087548
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc2nc(-c3ccc(C(N)=O)nc3)sc2c1,35.0,nM,=,CHEMBL1077208
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],182.0,nM,=,CHEMBL1744461
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],204.0,nM,=,CHEMBL1744462
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(OC)cc3o2)cn1,185.0,nM,=,CHEMBL1082889
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],85.0,nM,=,CHEMBL1744463
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ccc(-c2nc3cc(O)ccc3o2)cn1,137.0,nM,=,CHEMBL1083207
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ncc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],75.0,nM,=,CHEMBL1744464
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(O)cc3o2)cn1,45.0,nM,=,CHEMBL1084943
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(OC)cc3o2)cn1,66.0,nM,=,CHEMBL1084944
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)nc3)oc2c1,60.0,nM,=,CHEMBL1084945
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)cn3)oc2c1,33.0,nM,=,CHEMBL1084946
Binding affinity to Abeta (1 to 40) in brain cortex of patient with Alzheimer's disease by autoradiography relative to non-specific unlabelled PIB binding,Activity,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],,,,CHEMBL1788121
Binding affinity to Abeta (1 to 40) in brain cortex of patient with Alzheimer's disease by autoradiography relative to non-specific unlabelled PIB binding,Activity,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],,,,CHEMBL1744459
Binding affinity to Abeta (1 to 40) in brain cortex of patient with Alzheimer's disease by autoradiography relative to non-specific unlabelled PIB binding,Activity,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],,,,CHEMBL1744460
Binding affinity to Abeta (1 to 40) in brain cortex of patient with Alzheimer's disease by autoradiography relative to non-specific unlabelled PIB binding,Activity,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],,,,CHEMBL1744461
Binding affinity to Abeta (1 to 40) in brain cortex of patient with Alzheimer's disease by autoradiography relative to non-specific unlabelled PIB binding,Activity,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],,,,CHEMBL1744462
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1nc(Cn2c(-c3ccc(Oc4cncnc4)cc3)ccc2-c2ccccc2Cl)ccc1NCCO,190.0,nM,=,CHEMBL1090543
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1nc(Cn2c(-c3ccc(Oc4cncnc4)cc3)ccc2-c2ccccc2Cl)ccc1OCCO,440.0,nM,=,CHEMBL1090542
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,CCCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2ccc(NCCO)c(N)n2)cc1,3200.0,nM,=,CHEMBL1089186
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,CCCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2ccc(OCCO)c(N)n2)cc1,13600.0,nM,=,CHEMBL1093807
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Nc4cncnc4)cc3)ccc2-c2ccccc2Cl)n1,8600.0,nM,=,CHEMBL1093806
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Oc4cccs4)cc3)ccc2-c2ccccc2Cl)n1,11800.0,nM,=,CHEMBL1092913
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Oc4cnccn4)cc3)ccc2-c2ccccc2Cl)n1,13300.0,nM,=,CHEMBL1092000
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Oc4cncnc4)cc3)ccc2-c2ccccc2Cl)n1,2200.0,nM,=,CHEMBL1091999
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Oc4ccncc4)cc3)ccc2-c2ccccc2Cl)n1,4800.0,nM,=,CHEMBL1091219
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccc(Oc4ccccc4)cc3)ccc2-c2ccccc2Cl)n1,9200.0,nM,=,CHEMBL1091343
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,C=CCNC(=O)c1ccc(-c2ccc(-c3ccccc3)n2Cc2cccc(N)n2)cc1,4800.0,nM,=,CHEMBL1092227
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,N#CCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2cccc(N)n2)cc1,5200.0,nM,=,CHEMBL1089137
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,CCCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2cccc(N)n2)cc1,2100.0,nM,=,CHEMBL1093450
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,COc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2cccc(N)n2)cc1,16000.0,nM,=,CHEMBL1093152
Inhibition of human recombinant APP in CHO cells assessed as decrease in beta amyloid protein level by ELISA,EC50,Nc1cccc(Cn2c(-c3ccccc3)ccc2-c2ccccc2)n1,15400.0,nM,=,CHEMBL1092879
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3cn(CCCCNC(=O)CCNC(=O)CO[C@H]4CC[C@@]5(C)C(=CC[C@H]6[C@@H]7CC[C@H]([C@H](C)CCCC(C)C)[C@@]7(C)CC[C@@H]65)C4)nn3)c(OC)c2)ccc1O,,%,,CHEMBL1253566
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253574
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253573
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253572
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3cn(CCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]4CC[C@@]5(C)C(=CC[C@H]6[C@@H]7CC[C@H]([C@H](C)CCCC(C)C)[C@@]7(C)CC[C@@H]65)C4)nn3)c(OC)c2)ccc1O,,%,,CHEMBL1253568
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3cn(CCCCCCNC(=O)CCNC(=O)CO[C@H]4CC[C@@]5(C)C(=CC[C@H]6[C@@H]7CC[C@H]([C@H](C)CCCC(C)C)[C@@]7(C)CC[C@@H]65)C4)nn3)c(OC)c2)ccc1O,,%,,CHEMBL1253567
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253575
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,CCCCNC(=O)CCC(=O)NCCCCCCn1cc(C/C(C(=O)/C=C/c2ccc(O)c(OC)c2)=C(O)\C=C\c2ccc(O)c(OC)c2)nn1,,%,,CHEMBL1253577
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,CCCCNC(=O)CCC(=O)NCCCCCCn1cc(COc2ccc(/C=C/C(O)=C/C(=O)/C=C/c3ccc(O)c(OC)c3)cc2OC)nn1,,%,,CHEMBL1253576
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253571
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253570
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3cn(CCCCCCNC(=O)CO[C@H]4CC[C@@]5(C)C(=CC[C@H]6[C@@H]7CC[C@H]([C@H](C)CCCC(C)C)[C@@]7(C)CC[C@@H]65)C4)nn3)c(OC)c2)ccc1O,,%,,CHEMBL1253565
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3cn(CCCCNC(=O)CO[C@H]4CC[C@@]5(C)C(=CC[C@H]6[C@@H]7CC[C@H]([C@H](C)CCCC(C)C)[C@@]7(C)CC[C@@H]65)C4)nn3)c(OC)c2)ccc1O,,%,,CHEMBL1253564
Inhibition of APP expressed in human ML60 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by ELISA in presence of tetracycline,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253575
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta oligomer formation at 10 uM by Western blotting,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253575
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta 42 oligomerization by transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCCCNC(=O)CCNC(=O)CCNC(=O)CO[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6CC[C@H]([C@H](C)CCCC(C)C)[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL1253575
Inhibition of APP expressed in human MC65 cells assessed as inhibition of amyloid beta 42 oligomerization by transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Binding affinity to beta-amyloid plaque in brain of patient with Alzheimer's disease after 30 mins by fluorescence microscopy,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)cc2)cc1,,,,CHEMBL188635
Binding affinity to beta-amyloid plaque in brain of patient with Alzheimer's disease after 30 mins by fluorescence microscopy,Activity,Oc1cccc(/C=C/c2ccc(/C=C/c3cccc(O)c3)cc2)c1,,,,CHEMBL1272227
Binding affinity to beta-amyloid plaque in brain of patient with Alzheimer's disease after 30 mins by fluorescence microscopy,Activity,Oc1cc(O)cc(/C=C/c2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,,,CHEMBL1272278
Binding affinity to beta-amyloid plaque in normal human brain after 30 mins by fluorescence microscopy,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)cc2)cc1,,,,CHEMBL188635
Binding affinity to beta-amyloid plaque in normal human brain after 30 mins by fluorescence microscopy,Activity,Oc1cccc(/C=C/c2ccc(/C=C/c3cccc(O)c3)cc2)c1,,,,CHEMBL1272227
Binding affinity to beta-amyloid plaque in normal human brain after 30 mins by fluorescence microscopy,Activity,Oc1cc(O)cc(/C=C/c2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,,,CHEMBL1272278
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,Nc1scc2c(C(=O)O)nn(-c3ccccc3)c(=O)c12,35481.3,nM,=,CHEMBL461622
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12,7943.3,nM,=,CHEMBL460366
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccc(Cl)cc2)c(=O)c2c(N)scc12,10000.0,nM,=,CHEMBL1098087
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCN(CC)C(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12,3548.1,nM,=,CHEMBL1360508
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(NC(=O)Cc3ccccc3)scc12,39810.7,nM,=,CHEMBL1451257
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2cccc(C(F)(F)F)c2)c(=O)c2c(N)scc12,39810.7,nM,=,CHEMBL461646
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(NC(=O)c3ccccc3)scc12,3162.3,nM,=,CHEMBL1515094
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,Cc1sc(N)c2c(=O)n(-c3ccccc3)ncc12,28183.8,nM,=,CHEMBL1323951
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(N)sc(C)c12,17782.8,nM,=,CHEMBL1593147
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccc(F)cc2)c(=O)c2c(N)scc12,12589.3,nM,=,CHEMBL1448371
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(NC(C)=O)scc12,44668.4,nM,=,CHEMBL1324177
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,Nc1scc2c(C(=O)NCc3ccccc3)nn(-c3ccccc3)c(=O)c12,7079.5,nM,=,CHEMBL1593746
"PUBCHEM_BIOASSAY: Assay for Inhibitors of the fibrillation of the Beta-Amyloid Protein Fragment, A-beta 1-42. (Class of assay: confirmatory) [Related pubchem assays: 1460, 1468 ]",Potency,CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12,25118.9,nM,=,CHEMBL460366
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,COc1ccc2c(c1)C(=NO)c1cc(OC)ccc1-2,4070.0,nM,=,CHEMBL1594514
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CCCCCCOC(=O)C(C#N)c1nc2ccccc2nc1N1CCN(C)CC1,790.0,nM,=,CHEMBL1411318
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,O=C1c2ccccc2-c2onc3ccc(NCCCn4ccnc4)c1c23,2210.0,nM,=,CHEMBL1379677
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)O)c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)O)c2ccccc12,2350.0,nM,=,CHEMBL116955
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CCN1CCN(c2nc3ccccc3nc2C(C#N)C(=O)OC2CCCCC2)CC1,1400.0,nM,=,CHEMBL1476741
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,O=C(Nc1ccc(N2CCOCC2)cc1)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1,1230.0,nM,=,CHEMBL1565212
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Oc1ccc(O)c2c(O)cccc12,4520.0,nM,=,CHEMBL1331245
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,C=CCOC(=O)C(C#N)c1nc2ccccc2nc1N1CCN(c2ccccc2OC)CC1,1130.0,nM,=,CHEMBL1411120
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Cc1cc(NC(=O)c2cc3nc(C4CC4)cc(C(F)(F)F)n3n2)no1,23670.0,nM,=,CHEMBL1527194
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CC(=O)c1ccc2c(c1)Nc1ccccc1S2,9020.0,nM,=,CHEMBL407734
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1,670.0,nM,=,CHEMBL296455
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Nc1ccc(O)c(-c2nc3ccccc3s2)c1,9180.0,nM,=,CHEMBL1422046
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CCOc1ccc(CNc2ccc(N3CCCC3)cc2)cc1,4300.0,nM,=,CHEMBL1566068
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,N=C1C=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=C1,510.0,nM,=,CHEMBL1368322
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CCOCCCn1c(=N)c(C(=O)NCc2ccc3c(c2)OCO3)cc2c(=O)n3cccc(C)c3nc21,3040.0,nM,=,CHEMBL1570435
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,,2750.0,nM,=,CHEMBL1449184
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Nc1ccc(Nc2ccccc2N)cc1,2050.0,nM,=,CHEMBL1597827
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,N=C(N)c1ccc(/N=N\c2c(O)ccc3c2[nH]c2ccccc23)cc1,1030.0,nM,=,CHEMBL1436467
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CN1c2cccc3cccc(c23)N(C)C1(C)C,62830.0,nM,=,CHEMBL1598356
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Cc1ccc2nc(-c3ccc(/N=N/c4cc(S(=O)(=O)O)c5ccccc5c4O)cc3)sc2c1S(=O)(=O)O,13440.0,nM,=,CHEMBL1398678
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,COc1cccc2c1C(=N)c1c(O)c3c(c(O)c1C2=O)C[C@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,680.0,nM,=,CHEMBL1417445
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Oc1ccccc1C1Nc2cccc3cccc(c23)N1,3810.0,nM,=,CHEMBL1568684
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],150.0,nM,=,CHEMBL64894
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CC(=O)OCCNc1cc(N2CCN(C)CC2)c2noc3c2c1C(=O)c1ccccc1-3,1300.0,nM,=,CHEMBL1427520
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CN(C)c1ccc(N/C=C/C(=O)c2ccc(F)cc2)cc1,3380.0,nM,=,CHEMBL1325549
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,COc1ccc2nc(N=Nc3ccc(N(C)C)cc3)sc2c1,100.0,nM,=,CHEMBL1378812
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,N=c1c(C(=O)NCc2ccc3c(c2)OCO3)cc2c(=O)n3ccccc3nc2n1Cc1cccnc1,10330.0,nM,=,CHEMBL1378869
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Nc1ccc2[nH]c(-c3ccc(Cl)cc3)nc2c1,55560.0,nM,=,CHEMBL1457311
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Cc1ccccc1Cn1ccc(NC(=O)c2cnn3c(C(F)(F)F)cc(-c4ccco4)nc23)n1,6740.0,nM,=,CHEMBL1457503
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,Cc1cc(-c2ccc(/N=N\c3ccc4c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c4c3O)c(C)c2)ccc1/N=N\c1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O,920.0,nM,=,CHEMBL1607905
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,c1cc2c3c(cccc3c1)NC1(CCCCCC1)N2,2240.0,nM,=,CHEMBL1391342
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CN(C)c1ccc(NC(=S)c2ccccn2)cc1,6240.0,nM,=,CHEMBL1393129
PUBCHEM_BIOASSAY: Beta amyloid ThS binding assay. (Class of assay: confirmatory) [Related pubchem assays: 596 ],Potency,CC(C)c1cc(Nc2cccc(O)c2)cc(C(C)C)c1O,3450.0,nM,=,CHEMBL1531620
Displacement of [125I]DMIC from Amyloid beta (1 to 42) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(C#CC(=O)c2ccc(I)cc2)cc1,6.0,nM,=,CHEMBL1643335
Displacement of [125I]DMIC from Amyloid beta (1 to 42) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(C#CC(=O)c2ccc(F)cc2)cc1,20.4,nM,=,CHEMBL1643337
Displacement of [125I]DMIC from Amyloid beta (1 to 42) after 3 hrs by gamma counting,Ki,COc1ccc(C#CC(=O)c2ccc(I)cc2)cc1,13.7,nM,=,CHEMBL1643338
Displacement of [125I]DMIC from Amyloid beta (1 to 42) after 3 hrs by gamma counting,Ki,O=C(C#Cc1ccc(O)cc1)c1ccc(I)cc1,325.8,nM,=,CHEMBL1643339
Displacement of [125I]DMIC from Amyloid beta (1 to 42) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,45.6,nM,=,CHEMBL78012
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,6.0,nM,=,CHEMBL93124
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N4CCCC4)cc3)cn12,91.0,%,=,CHEMBL1672888
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CCN(CC)c1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,79.0,%,=,CHEMBL1672889
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,88.0,%,=,CHEMBL93124
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N(C)C)cc3)cn12,89.0,%,=,CHEMBL1672890
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(NC(C)=O)cc3)cn12,44.0,%,=,CHEMBL1672891
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,Oc1ccc2c(c1)sc1nc(-c3ccc(N4CCCC4)cc3)cn12,91.0,%,=,CHEMBL1672892
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CCN(CC)c1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,79.0,%,=,CHEMBL1672893
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CN(C)c1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,85.0,%,=,CHEMBL1672894
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N)cc3)cn12,57.0,%,=,CHEMBL1672895
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,95.0,%,=,CHEMBL1671878
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Ki,CNc1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,3.5,nM,=,CHEMBL1671878
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,Nc1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,48.0,%,=,CHEMBL1672896
Displacement of [3H]PiB from human amyloid beta (1-40) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,46.0,%,=,CHEMBL1672897
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,83.0,%,=,CHEMBL93124
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,13.0,nM,=,CHEMBL93124
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N4CCCC4)cc3)cn12,82.0,%,=,CHEMBL1672888
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CCN(CC)c1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,91.0,%,=,CHEMBL1672889
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N(C)C)cc3)cn12,91.0,%,=,CHEMBL1672890
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(NC(C)=O)cc3)cn12,64.0,%,=,CHEMBL1672891
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,Oc1ccc2c(c1)sc1nc(-c3ccc(N4CCCC4)cc3)cn12,91.0,%,=,CHEMBL1672892
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CCN(CC)c1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,91.0,%,=,CHEMBL1672893
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CN(C)c1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,86.0,%,=,CHEMBL1672894
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,COc1ccc2c(c1)sc1nc(-c3ccc(N)cc3)cn12,74.0,%,=,CHEMBL1672895
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,97.0,%,=,CHEMBL1671878
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Ki,CNc1ccc(-c2cn3c(n2)sc2cc(OC)ccc23)cc1,5.8,nM,=,CHEMBL1671878
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,Nc1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,48.0,%,=,CHEMBL1672896
Displacement of [3H]PiB from human amyloid beta (1-42) at 100 nM after 180 mins by liquid scintillation counter,Inhibition,CNc1ccc(-c2cn3c(n2)sc2cc(O)ccc23)cc1,73.0,%,=,CHEMBL1672897
Binding affinity to amyloid beta (1 to 42) aggregate in cortex of Alzheimer disease patient brain by autoradiography,Activity,CN(C)c1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767206
Binding affinity to amyloid beta (1 to 42) aggregate in white matter of Alzheimer disease patient brain by autoradiography,Activity,CN(C)c1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767206
Binding affinity to amyloid beta (1 to 42) aggregate in cortex of Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody BC05,Activity,CN(C)c1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767206
Binding affinity to amyloid beta (1 to 42) aggregate in white matter of Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody BC05,Activity,CN(C)c1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767206
Binding affinity to amyloid beta (1 to 42) aggregate in cortex of Alzheimer disease patient brain by autoradiography,Activity,CNc1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767207
Binding affinity to amyloid beta (1 to 42) aggregate in white matter of Alzheimer disease patient brain by autoradiography,Activity,CNc1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767207
Binding affinity to amyloid beta (1 to 42) aggregate in cortex of Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody BC05,Activity,CNc1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767207
Binding affinity to amyloid beta (1 to 42) aggregate in white matter of Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody BC05,Activity,CNc1ccc(/C=C/C(=O)/C=C/c2ccc([125I])cc2)cc1,,,,CHEMBL1767207
Binding affinity to amyloid beta (1 to 42) aggregate in Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody,Activity,CN(C)c1ccc(/C=C/C(=O)/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,,,,CHEMBL1767209
Binding affinity to amyloid beta (1 to 42) aggregate in Alzheimer disease patient brain by immunohistochemical staining using amyloid beta antibody,Activity,CNc1ccc(/C=C/C(=O)/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,,,,CHEMBL1767210
Binding affinity to beta amyloid plaques in human Alzheimer's disease brain at 444 kBq/50 uL after 1 hr by autoradiography,Activity,CNc1ccc(-c2cc3cc(OCCOCCOCC[18F])ccc3o2)cn1,,,,CHEMBL1774458
Binding affinity to beta amyloid plaques in normal human brain at 444 kBq/50 uL after 1 hr by autoradiography,Activity,CNc1ccc(-c2cc3cc(OCCOCCOCC[18F])ccc3o2)cc1,,,,CHEMBL1774459
Displacement of [125I]TZDM from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,Nc1ccc(-c2nc3ccc(F)cc3s2)cc1,26.2,nM,=,CHEMBL284575
Displacement of [125I]TZDM from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(F)cc3s2)cc1,5.5,nM,=,CHEMBL1774642
Displacement of [125I]TZDM from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2nc3ccc(F)cc3s2)cc1,5.9,nM,=,CHEMBL1774643
Displacement of [125I]TZDM from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,5.8,nM,=,CHEMBL93124
Displacement of [3H]PIB from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(F)cc3s2)cc1,0.2,nM,=,CHEMBL1774642
Displacement of [3H]PIB from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2nc3ccc(F)cc3s2)cc1,0.3,nM,=,CHEMBL1774643
Displacement of [3H]PIB from amyloid beta (1 to 42) aggregates in Alzheimer's disease-human brain homogenate after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,1.6,nM,=,CHEMBL93124
Binding affinity to amyloid beta (1-42) plaque in brain of patient with Alzheimer's disease at 185 KBq/100ul after 1 hr by immunofluorescence staining method,Activity,CN(C)c1ccc(-c2cnc3cc([125I])ccc3n2)cc1,,,,CHEMBL1800540
Binding affinity to beta-amyloid plaque in brain of patient with Alzheimers disease at 1.6 uCi after 1 hr by autoradiography,Activity,O=C1/C(=C/c2ccc(OCCF)cc2)Oc2ccc([125I])cc21,,,,CHEMBL1915344
Binding affinity to beta-amyloid plaque in normal human brain sections at 1.6 uCi after 1 hr by autoradiography,Activity,O=C1/C(=C/c2ccc(OCCF)cc2)Oc2ccc([125I])cc21,,,,CHEMBL1915344
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3s2)cc1,,,,CHEMBL1926768
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3s2)cc1,,,,CHEMBL1926769
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3o2)cc1,,,,CHEMBL1926770
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3o2)cc1,,,,CHEMBL1926771
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3[nH]2)cc1,,,,CHEMBL1926772
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3[nH]2)cc1,,,,CHEMBL1926773
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3n2C)cc1,,,,CHEMBL1926774
Binding affinity to human amyloid beta (1 to 42) fibril assessed as intrinsic fluorescence intensity,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3n2C)cc1,,,,CHEMBL1926775
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C\c2nc3ccccc3s2)cc1,11.3,,=,CHEMBL1926768
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C/c2nc3ccccc3s2)cc1,7.41,,=,CHEMBL1926769
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C\c2nc3ccccc3o2)cc1,1.28,,=,CHEMBL1926770
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C/c2nc3ccccc3o2)cc1,2.69,,=,CHEMBL1926771
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C/c2nc3ccccc3[nH]2)cc1,2.71,,=,CHEMBL1926773
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C\c2nc3ccccc3n2C)cc1,5.9,,=,CHEMBL1926774
Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie,FC,CN(CCF)c1ccc(/C=C/c2nc3ccccc3n2C)cc1,5.17,,=,CHEMBL1926775
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C\c2nc3ccccc3s2)cc1,23.96,/uM,=,CHEMBL1926768
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C/c2nc3ccccc3s2)cc1,10.67,/uM,=,CHEMBL1926769
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C\c2nc3ccccc3o2)cc1,5.99,/uM,=,CHEMBL1926770
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C/c2nc3ccccc3o2)cc1,4.48,/uM,=,CHEMBL1926771
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C/c2nc3ccccc3[nH]2)cc1,3.63,/uM,=,CHEMBL1926773
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C\c2nc3ccccc3n2C)cc1,3.52,/uM,=,CHEMBL1926774
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,CN(CCF)c1ccc(/C=C/c2nc3ccccc3n2C)cc1,5.19,/uM,=,CHEMBL1926775
Binding affinity to human amyloid beta (1 to 42) fibril by fluorescence intensity assay,Kd,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],2.56,/uM,=,CHEMBL224392
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3s2)cc1,,,,CHEMBL1926768
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3s2)cc1,,,,CHEMBL1926769
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3o2)cc1,,,,CHEMBL1926770
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3o2)cc1,,,,CHEMBL1926771
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3[nH]2)cc1,,,,CHEMBL1926772
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3[nH]2)cc1,,,,CHEMBL1926773
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C\c2nc3ccccc3n2C)cc1,,,,CHEMBL1926774
Binding affinity to human amyloid beta (1 to 42) monomer by fluorescence intensity assay,Activity,CN(CCF)c1ccc(/C=C/c2nc3ccccc3n2C)cc1,,,,CHEMBL1926775
Binding affinity to amyloid beta aggregates in postmortem human Alzheimer's disease brain homogenates after 2 hrs by gamma counting,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.87,nM,=,CHEMBL1774461
Displacement of [3H]Pittsburgh compound B from human Abeta1-42 after 3 hrs by liquid scintillation counting,Ki,CNc1ccc(-c2cn3c(n2)sc2cc(OCC[18F])ccc23)cc1,3.2,nM,=,CHEMBL2017621
Displacement of [3H]Pittsburgh compound B from human Abeta1-40 after 3 hrs by liquid scintillation counting,Ki,CNc1ccc(-c2cn3c(n2)sc2cc(OCC[18F])ccc23)cc1,2.1,nM,=,CHEMBL2017621
Displacement of [3H]Pittsburgh compound B from human Abeta1-40 after 3 hrs by liquid scintillation counting,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,12.0,nM,=,CHEMBL207456
Displacement of [3H]Pittsburgh compound B from human Abeta1-42 after 3 hrs by liquid scintillation counting,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,7.7,nM,=,CHEMBL207456
Binding affinity to FITC-labeled amyloid beta (1 to 42) expressed in human SH-SY5Y cells at 10 uM after 10 mins thioflavin staining-based by fluorescence microscopic analysis,Activity,CN(C)c1ccc(/C=C/n2ncc(Cl)c(Cl)c2=O)cc1,,,,CHEMBL2031421
Binding affinity to amyloid beta (1 to 42) aggregates in human alzheimer's disease patient brain white matter at 92.5 kBq after 2 hrs by immunohistological staining,Activity,CN(C)c1ccc(/N=N/c2nc3ccc(OCCOCCOCC[18F])cc3s2)cc1,,,,CHEMBL2036420
Binding affinity to amyloid-beta plaque in cerebral blood vessels of alzheimer's disease patient cerebral amyloid angiopathy region of brain after 1 hr by thioflavin S staining,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Binding affinity to amyloid-beta plaque in cerebral blood vessels of alzheimer's disease patient cerebral amyloid angiopathy region of brain after 1 hr by autoradiography,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Binding affinity to amyloid-beta plaque in parenchymal region of normal human brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Binding affinity to amyloid-beta plaque in cerebral blood vessels of normal human cerebral amyloid angiopathy region of brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Binding affinity to amyloid-beta plaque in parenchymal region of alzheimer's disease patient brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Binding affinity to amyloid-beta plaque in cerebral blood vessels of alzheimer's disease patient cerebral amyloid angiopathy region of brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCC[18F])nc2)cc1,,,,CHEMBL2042249
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCn3cc(COCC(COCCOCCOCCF)(COCc4cn(CCOCCOCCOCCOc5ccc(/C=C/c6ccc(NC)cc6)cn5)nn4)COCc4cn(CCOCCOCCOCCOc5ccc(/C=C/c6ccc(NC)cc6)cn5)nn4)nn3)nc2)cc1,468.0,nM,=,CHEMBL2042247
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCNC(=O)CN(CC(=O)NCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)C(=O)COCCOCCOCCF)nc2)cc1,71.2,nM,=,CHEMBL2042246
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,0.87,nM,=,CHEMBL207456
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,3.18,nM,=,CHEMBL381642
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CN(C(=O)OC(C)(C)C)c1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(N(C)C(=O)OC(C)(C)C)cc4)cn3)OCCF)nc2)cc1,1000.0,nM,>,CHEMBL2042248
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,1.29,nM,=,CHEMBL78012
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,2.22,nM,=,CHEMBL566752
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.87,nM,=,CHEMBL1774461
Binding affinity to amyloid-beta plaque in cerebral blood vessels of alzheimer's disease patient cerebral amyloid angiopathy region of brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,,,,CHEMBL1774461
Binding affinity to amyloid-beta plaque in parenchymal region of alzheimer's disease patient brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,,,,CHEMBL1774461
Binding affinity to amyloid-beta plaque in cerebral blood vessels of normal human cerebral amyloid angiopathy region of brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,,,,CHEMBL1774461
Binding affinity to amyloid-beta plaque in parenchymal region of normal human brain after 1 hr,Activity,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,,,,CHEMBL1774461
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1[18F],0.74,nM,=,CHEMBL2042122
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)c([18F])n1,2.3,nM,=,CHEMBL2042123
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCC(COCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCCF)nc2)cc1,3.24,nM,=,CHEMBL2042124
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCCOCC(COCCOCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCCF)nc2)cc1,7.71,nM,=,CHEMBL2042125
Displacement of [18F]-amyvid from amyloid-beta aggregates in alzheimer's disease patient brain homogenates after 1 hr,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCOCCOCCOCCOCC(COCCOCCOCCOCCOCCOCCOc3ccc(/C=C/c4ccc(NC)cc4)cn3)OCCF)nc2)cc1,3.86,nM,=,CHEMBL2042245
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,19.0,nM,=,CHEMBL93124
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,22.0,nM,=,CHEMBL570378
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,158.0,nM,=,CHEMBL2048299
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,35.0,nM,=,CHEMBL2048300
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)oc2c1,395.0,nM,=,CHEMBL2048301
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)sc2c1,33.0,nM,=,CHEMBL2048302
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)sc2c1,66.0,nM,=,CHEMBL2048303
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,24.0,nM,=,CHEMBL579205
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)nc1F,44.0,nM,=,CHEMBL2048304
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(OC)cc3s2)c(F)n1,14.0,nM,=,CHEMBL2048305
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)c(F)n1,124.0,nM,=,CHEMBL2048306
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cc1F,98.0,nM,=,CHEMBL2048307
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,24.0,nM,=,CHEMBL2048308
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)c(F)n1,19.0,nM,=,CHEMBL2048309
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2cc3cc(O)ccc3o2)cc1F,30.0,nM,=,CHEMBL2048310
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2oc(-c3ccc(C(N)=O)nc3F)cc2c1,32.0,nM,=,CHEMBL2048311
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,NC(=O)c1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,44.0,nM,=,CHEMBL2048312
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)nc1F,35.0,nM,=,CHEMBL2048313
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)nc1F,32.0,nM,=,CHEMBL2048314
Binding affinity to amyloid beta(1 to 40) in cortical section isolated from Alzheimer disease patient at 1 nM by autoradiographic analysis,Activity,[3H]C([3H])([3H])Nc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,,,,CHEMBL2048315
Binding affinity to amyloid beta(1 to 40) in cortical section isolated from Alzheimer disease patient at 1 nM by autoradiographic analysis,Activity,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,,,,CHEMBL579205
Binding affinity to amyloid beta(1 to 40) in cortical section isolated from Alzheimer disease patient by autoradiographic analysis,Activity,[3H]C([3H])([3H])Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,,,,CHEMBL2092905
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1ccc(/C=C/c2cc(/C=C/c3ccc(O)cc3)ncn2)cc1,64.3,%,=,CHEMBL2059201
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1cccc(/C=C/c2cc(/C=C/c3cccc(O)c3)ncn2)c1,14.1,%,=,CHEMBL2059202
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,79.3,%,=,CHEMBL2059203
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,80.9,%,=,CHEMBL2059204
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,83.5,%,=,CHEMBL2059205
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,93.7,%,=,CHEMBL2059206
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccc(O)cc2)cc(/C=C/c2ccc(O)cc2)n1,67.4,%,=,CHEMBL2059207
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2cccc(O)c2)cc(/C=C/c2cccc(O)c2)n1,-28.7,%,=,CHEMBL2059208
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccc(O)c(OC)c2)cc(/C=C/c2ccc(O)c(OC)c2)n1,68.0,%,=,CHEMBL2059209
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccc(OC)c(O)c2)cc(/C=C/c2ccc(OC)c(O)c2)n1,55.0,%,=,CHEMBL2059210
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccc(O)c(N(C)C)c2)cc(/C=C/c2ccc(O)c(N(C)C)c2)n1,74.1,%,=,CHEMBL2059211
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,90.4,%,=,CHEMBL2059212
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CSc1nc(/C=C/c2ccc(O)cc2)cc(/C=C/c2ccc(O)cc2)n1,67.4,%,=,CHEMBL2059213
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CSc1nc(/C=C/c2cccc(O)c2)cc(/C=C/c2cccc(O)c2)n1,-53.3,%,=,CHEMBL2059214
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)nc(SC)n2)ccc1O,67.6,%,=,CHEMBL2059215
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)nc(SC)n2)cc1O,75.2,%,=,CHEMBL2059216
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CSc1nc(/C=C/c2ccc(O)c(N(C)C)c2)cc(/C=C/c2ccc(O)c(N(C)C)c2)n1,78.6,%,=,CHEMBL2059217
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,88.8,%,=,CHEMBL2059218
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1ccc(/C=C/c2cccc(/C=C/c3ccc(O)cc3)c2)cc1,58.4,%,=,CHEMBL1272225
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1cccc(/C=C/c2cccc(/C=C/c3cccc(O)c3)c2)c1,-28.7,%,=,CHEMBL2059219
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,71.5,%,=,CHEMBL2059386
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,67.9,%,=,CHEMBL2059387
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,63.9,%,=,CHEMBL248338
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,56.0,%,=,CHEMBL248131
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,80.7,%,=,CHEMBL2059388
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1cccc(/C=C/c2cc(O)cc(/C=C/c3cccc(O)c3)c2)c1,7.1,%,=,CHEMBL2059389
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1cc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,79.0,%,=,CHEMBL2059390
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,84.5,%,=,CHEMBL2059391
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1cc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,74.2,%,=,CHEMBL2059392
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,83.3,%,=,CHEMBL2059393
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,3200.0,nM,=,CHEMBL2059203
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,2100.0,nM,=,CHEMBL2059204
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,3700.0,nM,=,CHEMBL2059205
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,3400.0,nM,=,CHEMBL2059206
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,800.0,nM,=,CHEMBL2059212
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,1100.0,nM,=,CHEMBL2059218
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,1600.0,nM,=,CHEMBL2059388
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,1600.0,nM,=,CHEMBL2059391
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,3300.0,nM,=,CHEMBL2059393
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,103.0,%,=,CHEMBL2059203
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,91.8,%,=,CHEMBL2059204
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,85.3,%,=,CHEMBL2059205
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,76.6,%,=,CHEMBL2059206
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,COc1nc(/C=C/c2ccc(O)c(N(C)C)c2)cc(/C=C/c2ccc(O)c(N(C)C)c2)n1,59.0,%,=,CHEMBL2059211
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 10 uM after 18 hrs by MTT assay,Inhibition,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,67.4,%,=,CHEMBL2059212
Inhibition of amyloid beta (25 to 35)-induced cell death in mouse HT22 cells at 25 uM after 18 hrs by MTT assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC,56.0,%,=,CHEMBL2059394
Inhibition of amyloid beta (1 to 42) aggregation at 2 uM after 2 hrs by SDS-PAGE and PICUP technique,Inhibition,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,,%,,CHEMBL2059203
Inhibition of amyloid beta (1 to 42) aggregation at 2 uM after 2 hrs by SDS-PAGE and PICUP technique,Inhibition,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,,%,,CHEMBL2059204
Inhibition of amyloid beta (1 to 42) aggregation at 2 uM after 2 hrs by SDS-PAGE and PICUP technique,Inhibition,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,,%,,CHEMBL2059205
Inhibition of amyloid beta (1 to 42) aggregation at 2 uM after 2 hrs by SDS-PAGE and PICUP technique,Inhibition,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,,%,,CHEMBL2059206
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,C(=C/c1cc(/C=C/c2ccccc2)ncn1)\c1ccccc1,47.4,%,=,CHEMBL1585759
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,COc1nc(/C=C/c2ccccc2)cc(/C=C/c2ccccc2)n1,18.8,%,=,CHEMBL2059395
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,CSc1nc(/C=C/c2ccccc2)cc(/C=C/c2ccccc2)n1,11.6,%,=,CHEMBL2059396
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,C(=C/c1cccc(/C=C/c2ccccc2)c1)\c1ccccc1,19.8,%,=,CHEMBL2059397
Inhibition of amyloid beta (1 to 42) fibril formation at 10 uM after 1 hr by ThT spectrofluorometric analysis,Inhibition,Oc1cc(/C=C/c2ccccc2)cc(/C=C/c2ccccc2)c1,19.8,%,=,CHEMBL2059398
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,Inhibition,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,,%,,CHEMBL2063873
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,13000.0,nM,=,CHEMBL2063873
Inhibition of amyloid beta42 aggregation assessed as inhibition of fibril formation at 25 uM after 5 days by circular dichroism,Inhibition,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,,%,,CHEMBL2063873
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,Inhibition,O=Cc1cc(Cl)cc(Cl)c1O,,%,,CHEMBL2063877
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,Inhibition,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,,%,,CHEMBL2063874
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,62000.0,nM,=,CHEMBL2063873
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,30000.0,nM,=,CHEMBL2063874
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,23000.0,nM,=,CHEMBL2063874
Binding affinity to human amyloid beta plaque,Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,0.8,nM,=,CHEMBL207456
Binding affinity to human amyloid beta plaque,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1[18F],0.7,nM,=,CHEMBL2042122
Binding affinity to human amyloid beta plaque,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.9,nM,=,CHEMBL1774461
Binding affinity to human amyloid beta plaque,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,2.2,nM,=,CHEMBL566752
Binding affinity to amyloid beta(1 to 42) aggregates after 30 mins by Thioflavin-S-based fluorescence assay,Ki,CNc1ccc(C=C2C(=O)Nc3ccc(I)cc32)cc1,5057.0,nM,=,CHEMBL2069430
Binding affinity to amyloid beta(1 to 42) aggregates after 30 mins by Thioflavin-S-based fluorescence assay,Ki,CN(C)c1ccc(C=C2C(=O)Nc3ccc(I)cc32)cc1,4672.0,nM,=,CHEMBL2069431
Binding affinity to amyloid beta(1 to 42) aggregates after 30 mins by Thioflavin-S-based fluorescence assay,Ki,CNc1ccc(/C=C2\Nc3ccc(I)cc3C2=O)cc1,116.0,nM,=,CHEMBL2069432
Binding affinity to amyloid beta(1 to 42) aggregates after 30 mins by Thioflavin-S-based fluorescence assay,Ki,CN(C)c1ccc(/C=C2\Nc3ccc(I)cc3C2=O)cc1,31.0,nM,=,CHEMBL2069433
Binding affinity to beta-amyloid in Alzheimer's disease patient brain at 1.85 MBq/200 mL after 1 hr by thioflavin-S based autoradiography,Activity,CNc1ccc2nc(-c3ccc(OCC[18F])cc3)cnc2c1,,,,CHEMBL2087933
Binding affinity to beta-amyloid in normal human brain at 1.85 MBq/200 mL after 1 hr by thioflavin-S based autoradiography,Activity,CNc1ccc2nc(-c3ccc(OCC[18F])cc3)cnc2c1,,,,CHEMBL2087933
Binding affinity to beta-amyloid in Alzheimer's disease patient brain at 1.85 MBq/200 mL after 1 hr by thioflavin-S based autoradiography,Activity,CNc1ccc2nc(-c3ccc(OCCOCCOCC[18F])cc3)cnc2c1,,,,CHEMBL2087934
Binding affinity to beta-amyloid in normal human brain at 1.85 MBq/200 mL after 1 hr by thioflavin-S based autoradiography,Activity,CNc1ccc2nc(-c3ccc(OCCOCCOCC[18F])cc3)cnc2c1,,,,CHEMBL2087934
Inhibition of amyloid beta (1 to 42)-mediated neurotoxicity in human SH-SY5Y cells assessed as increase in cell viability after 48 hrs by MTT assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL177126
Inhibition of amyloid beta (1 to 42)-mediated neurotoxicity in human SH-SY5Y cells assessed as increase in cell viability after 48 hrs by MTT assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL499997
Inhibition of amyloid beta (1 to 42)-mediated neurotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 20 uM after 48 hrs by MTT assay,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,78.9,%,=,CHEMBL177126
Inhibition of amyloid beta (1 to 42)-mediated neurotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 20 uM after 48 hrs by MTT assay,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,96.1,%,=,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,100000.0,nM,>,CHEMBL465398
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,32800.0,nM,=,CHEMBL145
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(O)/C=C/c1ccccc1,100000.0,nM,>,CHEMBL27246
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,92900.0,nM,=,CHEMBL284616
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COC(=O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,100000.0,nM,>,CHEMBL416955
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,16400.0,nM,=,CHEMBL249447
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,4700.0,nM,=,CHEMBL249448
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,100.0,nM,=,CHEMBL177126
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,2200.0,nM,=,CHEMBL2146607
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,300.0,nM,=,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,3000.0,nM,=,CHEMBL2146608
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL145
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,,%,,CHEMBL284616
Inhibition of human amyloid beta (1 to 42) fibril formation at 50 uM after 24 hrs by transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL177126
Inhibition of human amyloid beta (1 to 42) fibril formation at 50 uM after 24 hrs by transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) oligomerization at 90 uM after 24 to 144 hrs by Dot blot analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) oligomerization assessed as decrease in trimer formation at 50 uM after 2 hrs by Western blot analysis,Inhibition,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,100.3,%,=,CHEMBL465398
Inhibition of human amyloid beta (1 to 42) oligomerization assessed as decrease in trimer formation at 50 uM after 2 hrs by Western blot analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,63.1,%,=,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) aggregates by measuring monomer concentration at 20 uM after 48 hrs by thermodynamic stability assay,Activity,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,1.2,uM,=,CHEMBL465398
Inhibition of human amyloid beta (1 to 42) aggregates by measuring monomer concentration at 20 uM after 48 hrs by thermodynamic stability assay,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,10.0,uM,=,CHEMBL177126
Inhibition of human amyloid beta (1 to 42) aggregates by measuring monomer concentration at 20 uM after 48 hrs by thermodynamic stability assay,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,27.0,uM,=,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,,%,,CHEMBL465398
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(O)/C=C/c1ccccc1,,%,,CHEMBL27246
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,COC(=O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,,%,,CHEMBL416955
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,,%,,CHEMBL249447
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL249448
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL177126
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL2146607
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Inhibition,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,,%,,CHEMBL2146608
Inhibition of human amyloid beta (1 to 42) beta-sheet formation at 50 uM after 12 to 24 hrs by CD-spectra analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) oligomerization assessed as decrease in trimer formation at 25 uM after 2 hrs by Western blot analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,87.6,%,=,CHEMBL499997
Inhibition of human amyloid beta (1 to 42) beta-sheet formation at 50 uM after 12 to 24 hrs by CD-spectra analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL177126
Inhibition of amyloid beta (25 to 35) binding to plasma membrane surface of human Sh-SY5Y cells at 30 uM after 30 mins by congo red-based spectrophotometry,Inhibition,CN(CCCCCCCOc1cccc(-c2oc3ccccc3c2C(=O)c2ccccc2)c1)Cc1ccccc1,,%,,CHEMBL2160227
Inhibition of amyloid beta (25 to 35) binding to plasma membrane surface of human Sh-SY5Y cells at 30 uM after 30 mins by congo red-based spectrophotometry,Inhibition,Cc1cccc(C(=O)c2c(-c3cccc(OCCCCCCCN(C)Cc4ccccc4)c3)oc3ccccc23)c1,,%,,CHEMBL2160228
Inhibition of amyloid beta (25 to 35) binding to plasma membrane surface of human Sh-SY5Y cells at 30 uM after 30 mins by congo red-based spectrophotometry,Inhibition,CN(CCCCCCCOc1ccc(-c2oc3ccccc3c2C(=O)c2ccccc2)cc1)Cc1ccccc1,,%,,CHEMBL511575
Binding affinity to amyloid beta (1-42) aggregates in human Alzheimer's disease brain sections,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,2.22,nM,=,CHEMBL566752
Binding affinity to amyloid beta (1-42) aggregates in human Alzheimer's disease brain sections,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.87,nM,=,CHEMBL1774461
Binding affinity to amyloid beta (1-42) aggregates in human Alzheimer's disease brain sections,Ki,CNc1ccc(/C=C/c2ccc(O)cc2)cc1,1.2,nM,=,CHEMBL381642
Binding affinity to amyloid beta plaques in Alzheimer patient brain at 370 KBq/100 ul after 1 hr by autoradiographic analysis,Activity,CNc1ccc(-c2nc3ccc(OCC[18F])cc3s2)cn1,,,,CHEMBL2179569
Binding affinity to amyloid beta plaques in Alzheimer patient brain at 370 KBq/100 ul after 1 hr by autoradiographic analysis,Activity,CNc1ccc(-c2nc3ccc(OCCOCCOCC[18F])cc3s2)cn1,,,,CHEMBL2179567
Binding affinity to amyloid beta plaques in Alzheimer patient brain at 370 KBq/100 ul after 1 hr by autoradiographic analysis,Activity,CNc1ccc(-c2nc3cc(OCC[18F])ccc3o2)cn1,,,,CHEMBL2179565
Binding affinity to amyloid beta plaques in Alzheimer patient brain at 370 KBq/100 ul after 1 hr by autoradiographic analysis,Activity,CNc1ccc(-c2nc3cc(OCCOCCOCC[18F])ccc3o2)cn1,,,,CHEMBL2179563
Binding affinity to intravascular amyloid beta angiopathies in Alzheimer patient brain by fluorescence microscopic analysis,Activity,CN(C)c1ccc(/C=C/c2cnc(/C=C/c3ccc(N(C)C)cc3)cn2)cc1,,,,CHEMBL2181037
Binding affinity to extracellular amyloid beta plaques in Alzheimer patient brain by fluorescence microscopic analysis,Activity,CN(C)c1ccc(/C=C/c2cnc(/C=C/c3ccc(N(C)C)cc3)cn2)cc1,,,,CHEMBL2181037
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Nc1c(S(=O)(=O)c2ccc(Cl)cc2)cnc2cc(-c3ccccc3)nn12,2300.0,nM,=,CHEMBL2179241
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],900.0,nM,=,CHEMBL2179242
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,700.0,nM,=,CHEMBL2179243
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Cc1nc2sc3c(c2c(=O)o1)CCCC3,1200.0,nM,=,CHEMBL1458517
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,Inhibition,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,,%,,CHEMBL2179243
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,Inhibition,Cc1nc2sc3c(c2c(=O)o1)CCCC3,,%,,CHEMBL1458517
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability at 10 uM measured up to 20 hrs in presence of MTX,Inhibition,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],,%,,CHEMBL2179242
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability at 10 uM measured up to 20 hrs in presence of MTX,Inhibition,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,,%,,CHEMBL2179243
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability at 10 uM measured up to 20 hrs in presence of MTX,Inhibition,Cc1nc2sc3c(c2c(=O)o1)CCCC3,,%,,CHEMBL1458517
Binding affinity to amyloid beta plaques in transgenic Alzheimer patient brain at 370 kBq/100 ul after 1 hr by immunohistochemical staining method,Activity,CN(C)c1ccc(-c2nc3cc(OCCOCCOCC[18F])ccc3o2)cc1,,,,CHEMBL2178556
Binding affinity to amyloid beta plaques in transgenic Alzheimer patient brain at 370 kBq/100 ul after 1 hr by immunohistochemical staining method,Activity,CNc1ccc(-c2nc3cc(OCCOCCOCC[18F])ccc3o2)cc1,,,,CHEMBL2178555
Binding affinity to amyloid beta plaques in transgenic Alzheimer patient brain at 370 kBq/100 ul after 1 hr by autoradiographic analysis,Activity,CN(C)c1ccc(-c2nc3cc(OCCOCCOCC[18F])ccc3o2)cc1,,,,CHEMBL2178556
Binding affinity to amyloid beta plaques in transgenic Alzheimer patient brain at 370 kBq/100 ul after 1 hr by autoradiographic analysis,Activity,CNc1ccc(-c2nc3cc(OCCOCCOCC[18F])ccc3o2)cc1,,,,CHEMBL2178555
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Bmax,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,1100.0,nM,=,CHEMBL2203395
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Bmax,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,1454.0,nM,=,CHEMBL2203394
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Bmax,[3H]C([3H])([3H])N(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,2088.0,nM,=,CHEMBL2203393
Binding affinity to amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 5 nM after 90 mins by autoradiography,Activity,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,,,,CHEMBL2203395
Binding affinity to amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 5 nM after 90 mins by autoradiography,Activity,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,,,,CHEMBL2203394
Binding affinity to amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 5 nM after 90 mins by autoradiography,Activity,[3H]C([3H])([3H])N(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,,,,CHEMBL2203393
"Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 9.6 nM after 90 mins by scintillation counting in presence of 5-Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine",Activity,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,35.0,%,=,CHEMBL2203395
"Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 6.4 nM after 90 mins by scintillation counting in presence of 5-Fluoro-2-(1-methyl-1H-indol-5-yl)-oxazolo[5,4-b]pyridine",Activity,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,50.0,%,=,CHEMBL2203394
"Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient at 4.2 nM after 90 mins by scintillation counting in presence of [4-(5-Fluoro-oxazolo[5,4-b]pyridin-2-yl)-phenyl]-dimethyl-amine",Activity,[3H]C([3H])([3H])N(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,50.0,%,=,CHEMBL2203393
Ratio of Bmax to Kd for amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient,Ratio,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,117.0,,=,CHEMBL2203395
Ratio of Bmax to Kd for amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient,Ratio,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,232.0,,=,CHEMBL2203394
Ratio of Bmax to Kd for amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient,Ratio,[3H]C([3H])([3H])N(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,464.0,,=,CHEMBL2203393
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Kd,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,9.6,nM,=,CHEMBL2203395
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Kd,[3H]C([3H])([3H])n1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,6.4,nM,=,CHEMBL2203394
Displacement of [3H]DMAB from amyloid beta plaque in cortex homogenate isolated from Alzheimer disease patient after 90 mins by scintillation counting,Kd,[3H]C([3H])([3H])N(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,4.5,nM,=,CHEMBL2203393
Binding affinity to human amyloid beta plaque,IC50,Cn1cnc2cc(-c3nc4ccc(F)nc4o3)ccc21,1000.0,nM,>,CHEMBL2203392
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ncc21,1000.0,nM,>,CHEMBL2203391
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)ccc21,48.7,nM,=,CHEMBL2203390
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4cc[nH]c4c3)oc2n1,45.3,nM,=,CHEMBL2203389
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4ncsc4c3)oc2n1,35.8,nM,=,CHEMBL2203388
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)cnc21,30.2,nM,=,CHEMBL2203387
Binding affinity to human amyloid beta plaque,IC50,CN1CCc2cc(-c3nc4ccc(F)nc4o3)cnc21,47.0,nM,=,CHEMBL2203386
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,10.5,nM,=,CHEMBL2203385
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3cnc4[nH]ccc4c3)oc2n1,25.7,nM,=,CHEMBL2203384
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,8.0,nM,=,CHEMBL2203383
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4[nH]ccc4c3)oc2n1,13.8,nM,=,CHEMBL2203382
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cn1,41.8,nM,=,CHEMBL2203381
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cn1,102.0,nM,=,CHEMBL2203380
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,4.0,nM,=,CHEMBL2203379
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cc1,23.1,nM,=,CHEMBL2203378
Binding affinity to human amyloid beta plaque,IC50,COc1ccc(-c2nc3ccc(F)nc3o2)cc1,32.5,nM,=,CHEMBL2203288
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,CCCC[N+]1=C(/C=C/c2ccc(N(CC)CC)cc2)C(C)(C)c2ccccc21.[I-],,,,CHEMBL2203332
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,CN1CCN(c2ccc(/C=C/C3=[N+](C)c4ccccc4C3(C)C)cc2)CC1.[I-],,,,CHEMBL2207757
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,C[N+]1=C(/C=C/c2ccc(N3CCCC3)cc2)C(C)(C)c2ccccc21.[I-],,,,CHEMBL2207756
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,COc1ccc(/C=C/C2=[N+](C)c3ccccc3C2(C)C)cc1.[I-],,,,CHEMBL2207755
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,C[N+]1=C(/C=C/c2ccc(O)cc2)C(C)(C)c2ccccc21.[I-],,,,CHEMBL2207754
Binding affinity to amyloid beta aggregates in Alzheimer patient hippocampus by fluorescence microscopy,Activity,CCN(CC)c1ccc(/C=C/C2=[N+](C)c3ccccc3C2(C)C)cc1.[I-],,,,CHEMBL2207753
Binding affinity to beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates at 50 uM after 20 min by fluorescence microscopic analysis relative to thioflavin S-treated control,Activity,COc1ccc2nc(/N=C/c3ccc(N(C)C)cc3)sc2c1,,,,CHEMBL2296467
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,5.3,nM,=,CHEMBL78012
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc2nc(/N=C/c3ccc(O)cc3)sc2c1,34.72,nM,=,CHEMBL2296463
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc2nc(/N=C/c3ccc(I)cc3)sc2c1,102.74,nM,=,CHEMBL2296462
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc2nc(/N=C/c3ccc(Br)cc3)sc2c1,106.46,nM,=,CHEMBL2296464
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc(/C=N/c2nc3ccc(OC)cc3s2)cc1,10.82,nM,=,CHEMBL2296466
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc2nc(/N=C/c3ccc([N+](=O)[O-])cc3)sc2c1,514.65,nM,=,CHEMBL2296465
Displacement of [3H]IMPY from beta amyloid (unknown origin) isolated from alzheimer's patient brain homogenates after 2 hr by gamma counting analysis,Ki,COc1ccc2nc(/N=C/c3ccc(N(C)C)cc3)sc2c1,4.38,nM,=,CHEMBL2296467
Induction of amyloid beta (1-42) (unknown origin) oligomer formation after 48 hr by silver staining,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Inhibition of amyloid beta (1-42) (unknown origin) oligomer formation after 48 hr by silver staining,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298386
Inhibition of amyloid beta (1-42) (unknown origin) oligomer formation after 48 hr by silver staining,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298384
Stabilization of random coil conformation of amyloid beta (1-42) (unknown origin) after 3 days by CD spectroscopy,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298386
Stabilization of random coil conformation of amyloid beta (1-42) (unknown origin) after 3 days by CD spectroscopy,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Stabilization of random coil conformation of amyloid beta (1-42) (unknown origin) after 3 days by CD spectroscopy,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298384
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:5 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298386
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:5 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:5 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298384
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:1 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298386
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:1 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Binding affinity to amyloid beta (1-42) (unknown origin) assessed as increase in hydrophobic site exposure at Abeta42/compound molar ratio of 1:1 after 3 days by ANS fluorescence analysis,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298384
Induction of amyloid beta (1-42) (unknown origin) assembly assessed as mixed fibril and spherical aggregate formation after 3 days by ThT stain based fluorescence microscopy,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298386
Inhibition of amyloid beta (1-42) (unknown origin) assembly assessed as decrease in fibril formation after 3 days by ThT stain based fluorescence microscopy,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298385
Inhibition of amyloid beta (1-42) (unknown origin) assembly assessed as decrease in fibril formation after 3 days by ThT stain based fluorescence microscopy,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298384
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:5 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298386
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:5 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298385
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:5 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298384
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:1 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298386
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:1 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298385
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at Abeta42/compound molar ratio of 1:1 after 3 days by thioflavin T fluorescence method,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298384
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:5 after 3 days by turbidity based assay,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298386
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:1 after 3 days by turbidity based assay,Inhibition,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL2298386
Induction of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:5 after 3 days by turbidity based assay,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Induction of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:5 after 3 days by turbidity based assay,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298384
Induction of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:1 after 3 days by turbidity based assay,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298385
Induction of amyloid beta (1-42) (unknown origin) aggregation at Abeta42/compound molar ratio of 1:1 after 3 days by turbidity based assay,Activity,CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,,,CHEMBL2298384
Inhibition of beta amyloid (25 to 35) (unknown origin) disaggregation after 4 days by thioflavin-T fluorescence analysis,Activity,OB(O)/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL2315705
Inhibition of beta amyloid (25 to 35) (unknown origin) disaggregation after 4 days by thioflavin-T fluorescence analysis,Activity,OB(O)/C=C/c1ccccc1,,,,CHEMBL559289
Inhibition of beta amyloid (25 to 35) (unknown origin) aggregation after 4 days by thioflavin-T fluorescence analysis,Activity,OB(O)/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL2315705
Inhibition of beta amyloid (25 to 35) (unknown origin) aggregation after 4 days by thioflavin-T fluorescence analysis,Activity,OB(O)/C=C/c1ccccc1,,,,CHEMBL559289
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,8.0,nM,=,CHEMBL78012
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,COc1c2ccccc2nc2cc(I)ccc12,10000.0,nM,>,CHEMBL2326887
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,COc1c2ccc(I)cc2nc2ccc(N(C)C)cc12,39.2,nM,=,CHEMBL2326888
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc2nc3cc(I)ccc3c(OC)c2c1,28.9,nM,=,CHEMBL2326889
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc2nc3cc(I)ccc3c(N)c2c1,83.5,nM,=,CHEMBL2326890
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CNc1c2ccc(I)cc2nc2ccc(OC)cc12,13.8,nM,=,CHEMBL2326891
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc2nc3cc(I)ccc3c(N(C)C)c2c1,121.0,nM,=,CHEMBL2326892
Neuroprotectivie activity against amyloid beta (25 to 35)-induced toxicity in human SH-SY5Y cells assessed as increase in cell viability at 10 uM incubated for 2 hrs prior to amyloid beta (25 to 35)-challenge measured after 24 hrs by MTT assay relative to control,Activity,C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,16.6,%,=,CHEMBL2322191
Neuroprotectivie activity against amyloid beta (25 to 35)-induced toxicity in human SH-SY5Y cells assessed as increase in cell viability at 10 uM incubated for 2 hrs prior to amyloid beta (25 to 35)-challenge measured after 24 hrs by MTT assay relative to control,Activity,C=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)C[C@H](O)[C@@H]1[C@@]3(C)CC[C@H](O)[C@@H](C)[C@@H]3CC[C@@]21O)C(C)C,20.1,%,=,CHEMBL2322190
Binding affinity to amyloid beta (1 to 42) (unknown origin) at 0.5 uM by fluorescence analysis,Activity,Cc1ccc2nc(/C=C/c3ccc(N)cc3)ccc2c1.Cl,,,,CHEMBL2323025
Displacement of Thioflavin-T from pre-aggregated amyloid beta (1 to 42) (unknown origin) at >25 nM by fluorometric assay,Activity,Cc1ccc2nc(/C=C/c3ccc(N)cc3)ccc2c1,,,,CHEMBL2323024
Binding affinity to pre-aggregated amyloid beta (1 to 42) (unknown origin) at 25 nM by Thioflavin T-based fluorometric assay,Activity,Cc1ccc2nc(/C=C/c3ccc(N)cc3)ccc2c1,,,,CHEMBL2323024
Binding affinity to pre-aggregated amyloid beta (1 to 42) (unknown origin) assessed as hyperchromic effect at 5 uM by fluorescence analysis,Activity,Cc1ccc2nc(/C=C/c3ccc(N)cc3)ccc2c1,,,,CHEMBL2323024
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 1:1 compound to amyloid beta ratio after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,73.0,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 1:1 compound to amyloid beta ratio after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc2nc(/C=C/c3ccc(N)cc3)ccc2c1,42.4,%,=,CHEMBL2323024
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 1:1 compound to amyloid beta ratio after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc2nc(/C=C/c3ccccc3)ccc2c1,,%,,CHEMBL2323026
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 1:1 compound to amyloid beta ratio after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc2nc(/C=C/c3ccccc3)ccc2c1,,%,,CHEMBL2323027
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323356
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323355
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323354
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323353
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323352
Inhibition of amyloid beta (1 to 40_1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323351
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323356
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323355
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323354
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323353
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323352
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323351
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323356
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323355
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCC(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323354
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,CCOc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323353
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1,69.0,%,=,CHEMBL2323352
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence method relative to rifampicin,Inhibition,COc1ccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1OC,69.0,%,=,CHEMBL2323351
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CCN(CC)CCCC(C)Nc1c2ccc(I)cc2nc2ccc(OC)cc12,353.0,nM,=,CHEMBL2326893
Binding affinity to amyloid beta aggregate (unknown origin) by centrifugation method,Kd,CCN(CC)CCCC(C)Nc1c2ccc([125I])cc2nc2ccc(OC)cc12,48.4,nM,=,CHEMBL2326894
Displacement of congo red from amyloid-beta40 (unknown origin) assessed as reduction of congo red-amyloid beta40 complex level,Activity,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,2.6,%,=,CHEMBL2337291
Displacement of congo red from amyloid-beta40 (unknown origin) assessed as reduction of congo red-amyloid beta40 complex level,Activity,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,2.6,%,=,CHEMBL2337290
Displacement of congo red from amyloid-beta40 (unknown origin) assessed as reduction of congo red-amyloid beta40 complex level,Activity,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,2.6,%,=,CHEMBL2337293
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,1000.0,nM,=,CHEMBL2337291
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,2700.0,nM,=,CHEMBL2337290
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,3700.0,nM,=,CHEMBL2337293
Inhibition of amyloid-beta40 (unknown origin) aggregation at 250 uM by congo red spectral-shift assay,Activity,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,,,,CHEMBL2337290
Inhibition of amyloid-beta40 (unknown origin) aggregation at 250 uM by congo red spectral-shift assay,Activity,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,,,,CHEMBL2337293
Inhibition of amyloid-beta40 (unknown origin) aggregation at 250 uM by congo red spectral-shift assay,Activity,Oc1ccc(-c2ccc(-c3ccc(O)c(O)c3)cc2)cc1O,,,,CHEMBL2337292
Binding affinity to ordered beta sheet of amyloid beta (1 to 42) (unknown origin) assessed as fluorescence enhancement at 0.5 uM by fluorescence spectra analysis relative to control,FC,F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2NC2C(c3ccccc3)=CC(c3ccccc3)=[N+]21,16.0,,=,CHEMBL2334673
Binding affinity to unordered beta sheet of amyloid beta (1 to 42) (unknown origin) assessed as fluorescence enhancement at 0.5 uM by fluorescence spectra analysis relative to control,FC,F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2NC2C(c3ccccc3)=CC(c3ccccc3)=[N+]21,6.0,,=,CHEMBL2334673
Binding affinity to ordered beta sheet of amyloid beta (1 to 42) (unknown origin) by circular dichroism spectroscopic analysis,Activity,F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2NC2C(c3ccccc3)=CC(c3ccccc3)=[N+]21,,,,CHEMBL2334673
Binding affinity to unordered beta sheet of amyloid beta (1 to 42) (unknown origin) by circular dichroism spectroscopic analysis,Activity,F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2NC2C(c3ccccc3)=CC(c3ccccc3)=[N+]21,,,,CHEMBL2334673
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],,,,CHEMBL429694
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],,,,CHEMBL345124
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,Nc1c2c(nc3ccccc13)CCCC2,,,,CHEMBL95
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,50.2,%,=,CHEMBL116438
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCCc1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,49.2,%,=,CHEMBL2375939
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCCN1CCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,45.6,%,=,CHEMBL2375938
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,Cn1cc[n+](CCCC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)c1,55.1,%,=,CHEMBL2375937
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCC[n+]1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,60.3,%,=,CHEMBL2375936
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,C[N+]1(CCC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)CCCC1,44.9,%,=,CHEMBL2375935
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,C[N+](C)(C)CCC(=O)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,38.3,%,=,CHEMBL2375934
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCc1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,47.1,%,=,CHEMBL2375933
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCNc1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,20.6,%,=,CHEMBL2375932
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCOc1cccnc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,48.7,%,=,CHEMBL2375931
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CN1CCN(CCC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)CC1,49.7,%,=,CHEMBL2375930
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCN1CCOCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,19.9,%,=,CHEMBL2375929
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCN1CCCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,41.2,%,=,CHEMBL2375928
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CCN1CCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,50.0,%,=,CHEMBL2375927
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CCN(CC)CCC(=O)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,49.3,%,=,CHEMBL2375926
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CN(C)CCC(=O)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,51.8,%,=,CHEMBL2375925
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,Cn1cc[n+](CCC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)c1,44.9,%,=,CHEMBL2375924
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CC[n+]1cccc(F)c1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,53.7,%,=,CHEMBL2375923
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CC[n+]1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,61.4,%,=,CHEMBL2375922
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(Cc1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,42.4,%,=,CHEMBL2375921
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CNc1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,25.3,%,=,CHEMBL2375920
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(COc1cccnc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,43.9,%,=,CHEMBL2375919
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CN1CCN(CC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)CC1,49.5,%,=,CHEMBL2375945
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CN1CCOCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,12.1,%,=,CHEMBL2375944
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CN1CCCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,38.9,%,=,CHEMBL1098308
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(CN1CCCC1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,35.3,%,=,CHEMBL1096953
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CCN(CC)CC(=O)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,36.9,%,=,CHEMBL1096952
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,CN(C)CC(=O)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,47.0,%,=,CHEMBL2375943
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,Cn1cc[n+](CC(=O)Nc2ccc3nc4c5[nH]c6ccccc6c5ccn4c(=O)c3c2)c1,51.4,%,=,CHEMBL2375942
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(C[n+]1cccc(F)c1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,45.9,%,=,CHEMBL2375941
Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control,Imax,O=C(C[n+]1ccccc1)Nc1ccc2nc3c4[nH]c5ccccc5c4ccn3c(=O)c2c1,43.7,%,=,CHEMBL2375940
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation assessed as shorter assemblies at 10 uM after 6 days by atomic force microscopy relative to control,Inhibition,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,,%,,CHEMBL2381401
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,O=C(/C=C/c1ccccc1)c1cccc(CN2CCN(Cc3ccccc3)CC2)c1,30.0,%,=,CHEMBL2381388
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc3ccccc3c2)c1,30.0,%,=,CHEMBL2381389
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(OC)c(OC)c2)c1,30.0,%,=,CHEMBL2381390
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc(/C=C/C(=O)c2cccc(CN3CCN(Cc4ccccc4)CC3)c2)cc1OC,30.0,%,=,CHEMBL2381391
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(OC)cc2)c1,30.0,%,=,CHEMBL2380323
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc(/C=C/C(=O)c2cccc(CN3CCC(c4ccccc4)CC3)c2)cc1,30.0,%,=,CHEMBL2381392
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc(/C=C/C(=O)c2cccc(CN3CCN(Cc4ccccc4)CC3)c2)cc1,30.0,%,=,CHEMBL2381393
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2cccc(OC)c2)c1,30.0,%,=,CHEMBL2381394
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1cccc(/C=C/C(=O)c2cccc(CN3CCC(c4ccccc4)CC3)c2)c1,30.0,%,=,CHEMBL2381395
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1cccc(/C=C/C(=O)c2cccc(CN3CCN(Cc4ccccc4)CC3)c2)c1,30.0,%,=,CHEMBL2381396
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(F)cc2)c1,30.0,%,=,CHEMBL2381397
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(Cl)cc2)c1,30.0,%,=,CHEMBL2381398
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(Br)cc2)c1,30.0,%,=,CHEMBL2381399
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccc(-c3ccccc3)cc2)c1,30.0,%,=,CHEMBL2381400
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381401
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381402
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381403
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccn4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381383
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381384
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381385
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,30.0,%,=,CHEMBL2381386
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 100 uM after 4 to 6 days by Thioflavin-T fluorescence microscopy,Inhibition,CCN(CC)Cc1cccc(C(=O)/C=C/c2ccccc2)c1,30.0,%,=,CHEMBL2381387
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,6500.0,nM,=,CHEMBL2381403
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,4000.0,nM,=,CHEMBL2381384
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,5000.0,nM,=,CHEMBL2381385
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,14000.0,nM,=,CHEMBL2381402
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,21000.0,nM,=,CHEMBL2381403
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381402
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,1000.0,nM,=,CHEMBL2381384
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381385
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381386
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381401
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381402
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381403
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccn4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381383
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381384
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381385
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381386
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381402
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381403
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ccccn4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381383
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381384
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381385
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381386
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation at 50 uM after 16 to 18 hrs by ELISA,Inhibition,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,95.0,%,<=,CHEMBL2381401
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer assembly at 50 uM after 30 mins by biotinyl-streptavidin assay,Inhibition,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,65.0,%,>,CHEMBL2381401
Inhibition of amyloid beta (1-42) fibril aggregation (unknown origin) at 100 uM after 20 hrs by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of amyloid beta (1-42) fibril aggregation (unknown origin) at 100 uM after 20 hrs by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,,%,,CHEMBL247932
Inhibition of amyloid beta fibril aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932
Binding affinity to amyloid beta (1 to 42) (unknown origin) aggregates assessed as apparent dissociation constant after 30 mins by fluorescence spectroscopic analysis,Kd,Nc1ccc(/C=C/c2nc3ccc(I)cc3[nH]2)cc1,900.0,nM,=,CHEMBL2385163
Binding affinity to amyloid beta (1 to 42) (unknown origin) aggregates assessed as apparent dissociation constant after 30 mins by fluorescence spectroscopic analysis,Kd,CNc1ccc(/C=C/c2nc3ccc(I)cc3[nH]2)cc1,420.0,nM,=,CHEMBL2385164
Binding affinity to amyloid beta (1 to 42) (unknown origin) aggregates assessed as apparent dissociation constant after 30 mins by fluorescence spectroscopic analysis,Kd,CN(C)c1ccc(/C=C/c2nc3ccc(I)cc3[nH]2)cc1,820.0,nM,=,CHEMBL2385165
Binding affinity to amyloid beta (1 to 42) in alzheimer disease patient brain by immunohistochemical staining analysis,Activity,CN(C)c1ccc(/C=C/c2nc3ccc([125I])cc3[nH]2)cc1,,,,CHEMBL2385168
Binding affinity to amyloid beta (1 to 40) (unknown origin),Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,20.0,nM,=,CHEMBL207456
Binding affinity to amyloid beta (1 to 40) (unknown origin),Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],890.0,nM,=,CHEMBL224392
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation after 18 hrs by DELFIA,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,30000.0,nM,=,CHEMBL723
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1,100000.0,nM,=,CHEMBL2386874
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]4C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1,100000.0,nM,=,CHEMBL2386881
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,100000.0,nM,=,CHEMBL497
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,100000.0,nM,=,CHEMBL297453
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,100000.0,nM,=,CHEMBL468154
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,NCCCS(=O)(=O)O,100000.0,nM,=,CHEMBL149082
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,50.12,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCCN2CCCCC2C)ccc2c(=O)cc(-c3ccccc3)oc12,43.23,%,=,CHEMBL2393057
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCN2CCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,42.03,%,=,CHEMBL2392936
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,41.67,%,=,CHEMBL2393064
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCN2CCCCC2C)ccc2c(=O)cc(-c3ccccc3)oc12,41.67,%,=,CHEMBL2393054
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCCOc1ccc2c(=O)cc(-c3ccccc3)oc2c1C,40.87,%,=,CHEMBL2393068
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCN(C)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,39.94,%,=,CHEMBL2393066
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,39.29,%,=,CHEMBL2392939
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCCN2CCC(O)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,39.04,%,=,CHEMBL2393062
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCOc1ccc2c(=O)cc(-c3ccccc3)oc2c1C,38.95,%,=,CHEMBL2393067
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCCN2CCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,38.12,%,=,CHEMBL2392940
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN(C)C)ccc2c(=O)cc(-c3ccccc3)oc12,37.86,%,=,CHEMBL2393070
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,37.48,%,=,CHEMBL2393063
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCC(O)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,37.38,%,=,CHEMBL2393061
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCCCC2C)ccc2c(=O)cc(-c3ccccc3)oc12,37.32,%,=,CHEMBL2393055
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCCCC2C)ccc2c(=O)cc(-c3ccccc3)oc12,36.74,%,=,CHEMBL2393056
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN(C)C)ccc2c(=O)cc(-c3ccccc3)oc12,34.29,%,=,CHEMBL2393069
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCN(C)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,31.14,%,=,CHEMBL2393065
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCN2CCCCC2C)ccc2c(=O)cc(-c3ccccc3)oc12,30.54,%,=,CHEMBL2392941
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCN2CCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,27.12,%,=,CHEMBL2392937
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCN2CCC(O)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,26.89,%,=,CHEMBL2393058
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCCN2CCOCC2)ccc2c(=O)cc(-c3ccccc3)oc12,24.59,%,=,CHEMBL2393072
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCC(O)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,22.08,%,=,CHEMBL2393060
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCCC2)ccc2c(=O)cc(-c3ccccc3)oc12,21.83,%,=,CHEMBL2392938
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCN2CCC(O)CC2)ccc2c(=O)cc(-c3ccccc3)oc12,21.35,%,=,CHEMBL2393059
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM by thioflavin T based fluorometric assay,Inhibition,Cc1c(OCCCCN2CCOCC2)ccc2c(=O)cc(-c3ccccc3)oc12,20.42,%,=,CHEMBL2393071
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(OCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,67.8,%,=,CHEMBL2391486
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(OCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,67.5,%,=,CHEMBL2391487
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(OCCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,59.8,%,=,CHEMBL2391489
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,59.0,%,=,CHEMBL2391653
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(OCCCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,57.6,%,=,CHEMBL2391490
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCCCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,57.1,%,=,CHEMBL2391485
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,57.0,%,=,CHEMBL2391483
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,55.1,%,=,CHEMBL2391654
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(OCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,52.7,%,=,CHEMBL2391488
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCCOc2ccc3ccc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,52.7,%,=,CHEMBL2391484
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,42.4,%,=,CHEMBL116438
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(OCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,34.9,%,=,CHEMBL2391492
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(OCCCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,31.9,%,=,CHEMBL2391477
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=c1ccc2ccc(O)cc2o1,30.5,%,=,CHEMBL51628
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCNCC1)Nc1c2c(nc3ccccc13)CCCC2,30.3,%,=,CHEMBL2391652
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(OCCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,30.0,%,=,CHEMBL2391476
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCCOc2ccc3c(-c4ccccc4)cc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,29.5,%,=,CHEMBL2391481
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCOc2ccc3c(-c4ccccc4)cc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,28.6,%,=,CHEMBL2391480
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCOc2ccc3c(-c4ccccc4)cc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,28.2,%,=,CHEMBL2391479
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCCCCCOc2ccc3c(-c4ccccc4)cc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,27.5,%,=,CHEMBL2391482
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=C(CN1CCN(CCOc2ccc3c(-c4ccccc4)cc(=O)oc3c2)CC1)Nc1c2c(nc3ccccc13)CCCC2,27.2,%,=,CHEMBL2391478
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,O=c1cc(-c2ccccc2)c2ccc(O)cc2o1,27.1,%,=,CHEMBL325841
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(O)ccc12,22.4,%,=,CHEMBL2391651
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(OCCCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,22.1,%,=,CHEMBL2391475
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,COc1cc(=O)oc2cc(OCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,21.6,%,=,CHEMBL2391491
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,Inhibition,Cc1cc(=O)oc2cc(O)ccc12,21.5,%,=,CHEMBL12208
Displacement of [125I]IMPY from amyloid beta in brain homogenate of Alzheimer's disease patient after 2 hrs by gamma counting analysis,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,2.87,nM,=,CHEMBL1774461
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,10.5,nM,=,CHEMBL78012
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,Cn1c(-c2ccc(NCCCF)cc2)cc2ccccc21,1097.8,nM,=,CHEMBL2397726
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,Cn1c(-c2ccc(NCCF)cc2)cc2ccccc21,1030.1,nM,=,CHEMBL2397725
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(CCCF)c1ccc(-c2cc3ccccc3n2C)cc1,79.7,nM,=,CHEMBL2397724
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(CCF)c1ccc(-c2cc3ccccc3n2C)cc1,116.8,nM,=,CHEMBL2397723
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(CCCF)c1ccc(-c2cc3ccccc3[nH]2)cc1,31.5,nM,=,CHEMBL2397722
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(CCF)c1ccc(-c2cc3ccccc3[nH]2)cc1,28.4,nM,=,CHEMBL2397721
Displacement of [125I]IMPY from amyloid beta in brain homogenate of Alzheimer's disease patient after 2 hrs by gamma counting analysis,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1,2.22,nM,=,CHEMBL566752
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 3 hrs by gamma counting analysis,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,15.0,nM,=,CHEMBL78012
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,Oc1c(I)cc(Cl)c2cccnc12,40.95,%,=,CHEMBL497
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,Oc1c(I)cc(Cl)c2cccnc12,16.52,%,=,CHEMBL497
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by by transmission electron microscopic analysis,Activity,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,,,,CHEMBL2402067
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by by transmission electron microscopic analysis,Activity,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,,,CHEMBL2402160
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,86.43,%,=,CHEMBL165
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,88.81,%,=,CHEMBL2402067
Induction of disaggregation of Cu2+-induced amyloid beta (1 to 42) fibril (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,85.87,%,=,CHEMBL2402160
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by transmission electron microscopic analysis,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,,CHEMBL165
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by transmission electron microscopic analysis,Activity,Oc1c(I)cc(Cl)c2cccnc12,,,,CHEMBL497
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by transmission electron microscopic analysis,Activity,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,,,,CHEMBL2402067
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by transmission electron microscopic analysis,Activity,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,,,CHEMBL2402160
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.0,%,=,CHEMBL165
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,67.0,%,=,CHEMBL2402067
Induction of disaggregation of self-mediated amyloid beta (1 to 42) fibril (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence assay relative to control,Activity,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,82.0,%,=,CHEMBL2402160
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,,%,,CHEMBL2402067
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by by transmission electron microscopic analysis,Inhibition,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,%,,CHEMBL2402160
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to untreated control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,78.92,%,=,CHEMBL165
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to untreated control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,70.94,%,=,CHEMBL497
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to untreated control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,87.51,%,=,CHEMBL2402067
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay relative to untreated control,Inhibition,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,94.23,%,=,CHEMBL2402160
Inhibition of amyloid beta (1 to 42) fibril formation (unknown origin) at 20 uM after 24 hrs by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,,%,,CHEMBL2402067
Inhibition of amyloid beta (1 to 42) fibril formation (unknown origin) at 20 uM after 24 hrs by transmission electron microscopic analysis,Inhibition,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,,%,,CHEMBL2402160
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15110.0,nM,=,CHEMBL165
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,12350.0,nM,=,CHEMBL116438
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,,,,CHEMBL497
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,18350.0,nM,=,CHEMBL2402063
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,10320.0,nM,=,CHEMBL2402075
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,13070.0,nM,=,CHEMBL2402074
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3c[nH]c4ccccc34)cc2)cc(OC)c1,,,,CHEMBL2402073
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc[nH]c3)cc2)cc(OC)c1,,,,CHEMBL2402072
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3ccccc3OC)cc2)cc(OC)c1,,,,CHEMBL2402071
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3ccccc3N(C)C)cc2)cc(OC)c1,,,,CHEMBL2402070
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3ccc(OC)cc3O)cc2)cc(OC)c1,,,,CHEMBL2402069
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(Cl)ccc3O)cc2)cc(OC)c1,,,,CHEMBL2402068
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,7560.0,nM,=,CHEMBL2402067
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc([N+](=O)[O-])ccc3O)cc2)cc(OC)c1,,,,CHEMBL2402066
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cccc(OC)c3O)cc2)cc(OC)c1,,,,CHEMBL2402065
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3ccccc3O)cc2)cc(OC)c1,,,,CHEMBL2402064
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,14160.0,nM,=,CHEMBL2402161
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,6510.0,nM,=,CHEMBL2402160
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,7060.0,nM,=,CHEMBL2402159
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,7870.0,nM,=,CHEMBL2402158
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,10220.0,nM,=,CHEMBL2402157
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,10660.0,nM,=,CHEMBL2402163
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,12200.0,nM,=,CHEMBL2402162
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,69.73,%,=,CHEMBL165
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.77,%,=,CHEMBL116438
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,37.77,%,=,CHEMBL497
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,50.23,%,=,CHEMBL2402063
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,67.0,%,=,CHEMBL2402075
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,62.5,%,=,CHEMBL2402074
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3c[nH]c4ccccc34)cc2)cc(OC)c1,24.09,%,=,CHEMBL2402073
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc[nH]c3)cc2)cc(OC)c1,13.55,%,=,CHEMBL2402072
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3ccccc3OC)cc2)cc(OC)c1,6.9,%,=,CHEMBL2402071
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3ccccc3N(C)C)cc2)cc(OC)c1,7.17,%,=,CHEMBL2402070
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3ccc(OC)cc3O)cc2)cc(OC)c1,3.98,%,=,CHEMBL2402069
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(Cl)ccc3O)cc2)cc(OC)c1,31.27,%,=,CHEMBL2402068
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,79.5,%,=,CHEMBL2402067
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cc([N+](=O)[O-])ccc3O)cc2)cc(OC)c1,46.48,%,=,CHEMBL2402066
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3cccc(OC)c3O)cc2)cc(OC)c1,18.12,%,=,CHEMBL2402065
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc(NCc3ccccc3O)cc2)cc(OC)c1,20.7,%,=,CHEMBL2402064
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,62.38,%,=,CHEMBL2402161
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,78.06,%,=,CHEMBL2402160
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,71.48,%,=,CHEMBL2402159
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,78.8,%,=,CHEMBL2402158
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,68.1,%,=,CHEMBL2402157
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,71.18,%,=,CHEMBL2402162
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,69.07,%,=,CHEMBL2402163
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,CN(C)c1ccc(-c2cnc3cc(OCC[18F])ccc3n2)cc1,0.895,nM,=,CHEMBL2407622
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,CNc1ccc(-c2cnc3cc(OCC[18F])ccc3n2)cc1,15.7,nM,=,CHEMBL2407621
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,Nc1ccc(-c2cnc3cc(OCC[18F])ccc3n2)cc1,242.0,nM,>,CHEMBL2407620
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,CNc1ccc(-c2cnc3ccc(OCC[18F])cc3n2)cc1,242.0,nM,>,CHEMBL2407618
Ratio of AV-45 Ki to compound Ki for amyloid beta (1 to 42) (unknown origin) after 2 hrs by gamma counting,Ratio Ki,CN(C)c1ccc(-c2cnc3cc(OCCF)ccc3n2)cc1,10.0,,=,CHEMBL2407616
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,7.21,nM,=,CHEMBL78012
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)nc2)cc1,12.8,nM,=,CHEMBL1908919
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cnc3cc(OCCF)ccc3n2)cc1,0.895,nM,=,CHEMBL2407616
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(-c2cnc3cc(OCCF)ccc3n2)cc1,15.7,nM,=,CHEMBL2407615
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccc(-c2cnc3cc(OCCF)ccc3n2)cc1,242.0,nM,=,CHEMBL2407624
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cnc3ccc(OCCF)cc3n2)cc1,111.0,nM,=,CHEMBL2407623
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(-c2cnc3ccc(OCCF)cc3n2)cc1,758.0,nM,=,CHEMBL2407625
Displacement of [125I]IMPY from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccc(-c2cnc3ccc(OCCF)cc3n2)cc1,1180.0,nM,=,CHEMBL2407626
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,CN(C)c1ccc(-c2cnc3ccc(OCC[18F])cc3n2)cc1,111.0,nM,=,CHEMBL2407619
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain cortex after 1 hr by thioflavin-S based autoradiography,Ki,Nc1ccc(-c2cnc3ccc(OCC[18F])cc3n2)cc1,242.0,nM,>,CHEMBL2407617
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in human SH-SY5Y cells at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCCCc1nc2ccccc2s1,,,,CHEMBL2407153
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in human SH-SY5Y cells at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCc1nc2ccccc2s1,,,,CHEMBL2407152
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in Alzheimer's disease patient platelet-SH-SY5Y cell cybrid at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCCCc1nc2ccccc2s1,,,,CHEMBL2407153
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in Alzheimer's disease patient platelet-SH-SY5Y cell cybrid at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCc1nc2ccccc2s1,,,,CHEMBL2407152
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in mild cognitive impairment patient platelet-SH-SY5Y cell cybrid at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCCCc1nc2ccccc2s1,,,,CHEMBL2407153
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in mild cognitive impairment patient platelet-SH-SY5Y cell cybrid at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCc1nc2ccccc2s1,,,,CHEMBL2407152
Neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in normal cognition human platelet-SH-SY5Y cell cybrid at 2.5 uM preincubated for 3 hrs by MTT assay,Activity,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1ccc(-c2nc3ccccc3s2)cc1,,,,CHEMBL2407149
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCCCc1nc2ccccc2s1,22.3,%,=,CHEMBL2407153
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCCCc1nc2ccccc2s1,35.0,%,=,CHEMBL2407152
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)NCc1ccc(-c2nc3ccccc3s2)cc1,29.9,%,=,CHEMBL2407151
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1ccc(Cc2nc3ccccc3s2)cc1,61.3,%,=,CHEMBL2407150
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T dye-based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3ccccc13)CCCC2)Nc1ccc(-c2nc3ccccc3s2)cc1,22.3,%,=,CHEMBL2407149
Inhibition of amyloid beta (1 to 42) fibrilation (unknown origin) at 20 uM after 4 days by transmission electron microscopic analysis,Inhibition,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,,%,,CHEMBL2408101
Inhibition of amyloid beta (1 to 42) fibrilation (unknown origin) assessed as reduction in alpha-sheet structure formation at 10 uM after 2 days by CD spectroscopy assay,Inhibition,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,,%,,CHEMBL2408101
Inhibition of amyloid beta (1 to 42) fibrilation (unknown origin) assessed as reduction in beta-sheet structure formation at 10 uM after 2 days by CD spectroscopy assay,Inhibition,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,,%,,CHEMBL2408101
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,19700.0,nM,=,CHEMBL129795
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15900.0,nM,=,CHEMBL165
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(O)c1,18500.0,nM,=,CHEMBL2408097
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,23800.0,nM,=,CHEMBL2408096
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(Br)c(OCc3ccccc3)c(OC)c2)c(O)c1,12500.0,nM,=,CHEMBL2408095
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,9700.0,nM,=,CHEMBL260867
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(O)c1,10200.0,nM,=,CHEMBL258752
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19100.0,nM,=,CHEMBL2408094
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,8400.0,nM,=,CHEMBL229907
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)c(O)c1,7800.0,nM,=,CHEMBL2408093
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,10500.0,nM,=,CHEMBL2408092
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCCCOc3ccccc3)c(OC)c2)c(O)c1,10900.0,nM,=,CHEMBL2408091
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1OC,5800.0,nM,=,CHEMBL2407101
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3cc([N+](=O)[O-])ccc3O)cc2)c(O)c1,13300.0,nM,=,CHEMBL2408265
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3O)cc2)c(O)c1,10100.0,nM,=,CHEMBL2408264
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3OC)cc2)c(O)c1,7300.0,nM,=,CHEMBL2408263
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccc(C)cc3C)cc2)c(O)c1,8300.0,nM,=,CHEMBL2408262
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N(C)c3ccccc3)cc2)c(O)c1,20100.0,nM,=,CHEMBL2408261
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCc3ccccc3)cc2)c(O)c1,18900.0,nM,=,CHEMBL2408106
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCCc3ccccc3)cc2)c(O)c1,19100.0,nM,=,CHEMBL2408105
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCCCCCCCCCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,15900.0,nM,=,CHEMBL2408104
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19900.0,nM,=,CHEMBL2408103
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NC(C)C)cc2)c(O)c1,17800.0,nM,=,CHEMBL2408102
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,3200.0,nM,=,CHEMBL2408101
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCCC3)cc2)c(O)c1,5900.0,nM,=,CHEMBL2408100
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(C)CC3)cc2)c(O)c1,2200.0,nM,=,CHEMBL2408099
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCC3)cc2)c(O)c1,14600.0,nM,=,CHEMBL2408098
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.3,%,=,CHEMBL116438
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.1,%,=,CHEMBL165
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],35.5,%,=,CHEMBL12089
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccccc1SCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],76.8,%,=,CHEMBL2418130
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1ccccc1F)CCc1cc2c(cc1-3)OCO2.[Br-],73.3,%,=,CHEMBL2418129
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,CCc1ccccc1SCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],74.8,%,=,CHEMBL2418128
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1ccccc1Cl)CCc1cc2c(cc1-3)OCO2.[Br-],65.1,%,=,CHEMBL2418125
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1ccc(C)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],70.0,%,=,CHEMBL2418124
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1cccc(C)c1)CCc1cc2c(cc1-3)OCO2.[Br-],72.3,%,=,CHEMBL2418123
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1ccccc1C)CCc1cc2c(cc1-3)OCO2.[Br-],73.4,%,=,CHEMBL2418122
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCCCSc1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],69.1,%,=,CHEMBL2418119
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCCSc1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],70.6,%,=,CHEMBL2418118
Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OCCSc1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],70.4,%,=,CHEMBL2418117
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)c1cccnc1,13100.0,nM,=,CHEMBL573
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,28400.0,nM,=,CHEMBL858
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,50000.0,nM,>,CHEMBL2425961
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,50000.0,nM,>,CHEMBL2425960
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,50000.0,nM,>,CHEMBL2425959
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,50000.0,nM,>,CHEMBL2425958
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,50000.0,nM,>,CHEMBL2425957
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2c(/C=C/C(=O)NO)cccc2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425956
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425955
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2ccc(/C=C/C(=O)NO)cc2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425954
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,Cc1nc2cccc(/C=C/C(=O)NO)c2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425953
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)c1cccnc1,43700.0,nM,=,CHEMBL573
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,7700.0,nM,=,CHEMBL858
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,6800.0,nM,=,CHEMBL2425961
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,5500.0,nM,=,CHEMBL2425960
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,7400.0,nM,=,CHEMBL2425959
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,9500.0,nM,=,CHEMBL2425958
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,18100.0,nM,=,CHEMBL2425957
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2c(/C=C/C(=O)NO)cccc2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425956
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,18400.0,nM,=,CHEMBL2425955
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2ccc(/C=C/C(=O)NO)cc2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425954
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cccc(/C=C/C(=O)NO)c2c(=O)n1-c1ccccc1,50000.0,nM,>,CHEMBL2425953
Displacement of [N-methyl-3H]BTA-1 from amyloid beta (1 to 40) fibrils (unknown origin),Ki,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,4.3,nM,=,CHEMBL207456
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 mol equiv measured at 12 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](N)CCCCN)[C@@H](C)O,69.0,%,=,CHEMBL2430975
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 mol equiv measured at 12 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](N)CCCCN,55.0,%,=,CHEMBL2430976
Binding affinity to human amyloid-beta plaques at 1 uM by fluorescence microscopy,Activity,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,,,,CHEMBL207456
Binding affinity to human amyloid-beta plaques at 10 uM by fluorescence microscopy,Activity,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,,,,CHEMBL207456
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1,,,,CHEMBL207456
Binding affinity to human amyloid-beta plaques at 1 uM by fluorescence microscopy,Activity,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,,,,CHEMBL207649
Binding affinity to human amyloid-beta plaques at 10 uM by fluorescence microscopy,Activity,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,,,,CHEMBL207649
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(=C(C#N)C#N)c1ccc2cc(N(C)CCF)ccc2c1,,,,CHEMBL207649
Binding affinity to human amyloid-beta plaques at 10 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc([N+](=O)[O-])cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431405
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc([N+](=O)[O-])cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431405
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)(C)OC(=O)c1nn(-c2ccc(OCCF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431401
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCCF)cc2)c(=O)c2c(NC(=O)OC(C)(C)C)scc12,,,,CHEMBL2431404
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCCCF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431402
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCC(O)CF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431403
Binding affinity to human amyloid-beta plaques at 1 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCCF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431406
Binding affinity to human amyloid-beta plaques at 10 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCCF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431406
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(OCCF)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2431406
Binding affinity to human amyloid-beta plaques at 1 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(F)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2058004
Binding affinity to human amyloid-beta plaques at 10 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(F)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2058004
Binding affinity to human amyloid-beta plaques at 100 uM by fluorescence microscopy,Activity,CC(C)NC(=O)c1nn(-c2ccc(F)cc2)c(=O)c2c(N)scc12,,,,CHEMBL2058004
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20300.0,nM,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,11500.0,nM,=,CHEMBL2436692
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,12600.0,nM,=,CHEMBL2436691
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,4800.0,nM,=,CHEMBL2436690
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14100.0,nM,=,CHEMBL2436710
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccc(Cl)cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,,,,CHEMBL2436709
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,,,,CHEMBL2436708
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Nc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,,,,CHEMBL2436707
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,,,,CHEMBL2436706
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Cc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,,,,CHEMBL2436705
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,9600.0,nM,=,CHEMBL2436704
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,6500.0,nM,=,CHEMBL2436703
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13500.0,nM,=,CHEMBL2436702
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13200.0,nM,=,CHEMBL2436701
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,17300.0,nM,=,CHEMBL2436700
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14900.0,nM,=,CHEMBL2436699
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,9800.0,nM,=,CHEMBL2436698
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14200.0,nM,=,CHEMBL2436697
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,12800.0,nM,=,CHEMBL2436696
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16400.0,nM,=,CHEMBL2436695
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13700.0,nM,=,CHEMBL2436694
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16800.0,nM,=,CHEMBL2436693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(O)ccc12,,,,CHEMBL276915
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.5,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,67.4,%,=,CHEMBL2436692
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,62.0,%,=,CHEMBL2436691
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,85.3,%,=,CHEMBL2436690
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,61.1,%,=,CHEMBL2436710
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccc(Cl)cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,48.9,%,=,CHEMBL2436709
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,12.2,%,=,CHEMBL2436708
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Nc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,9.0,%,=,CHEMBL2436707
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,10.9,%,=,CHEMBL2436706
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Cc1ccc(-c2cc(=O)c3ccc(OCCCN4CCN(CCCNc5c6c(nc7ccccc57)CCCC6)CC4)cc3o2)cc1,13.4,%,=,CHEMBL2436705
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,68.7,%,=,CHEMBL2436704
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,79.1,%,=,CHEMBL2436703
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,63.0,%,=,CHEMBL2436702
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,62.5,%,=,CHEMBL2436701
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,53.4,%,=,CHEMBL2436700
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,58.0,%,=,CHEMBL2436699
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,70.0,%,=,CHEMBL2436698
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,63.3,%,=,CHEMBL2436697
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,65.4,%,=,CHEMBL2436696
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,53.7,%,=,CHEMBL2436695
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,59.1,%,=,CHEMBL2436694
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,54.1,%,=,CHEMBL2436693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccccc2)oc2cc(O)ccc12,27.2,%,=,CHEMBL276915
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)ccc1N(C)C,,%,,CHEMBL2435496
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(N(C)C)c(F)c3)oc12,,%,,CHEMBL2435494
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(N(C)C)cc3)oc12,,%,,CHEMBL2435512
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,,%,,CHEMBL32749
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)ccc1N(C)C,,%,,CHEMBL2435531
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,CN(C)c1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1F,,%,,CHEMBL2435529
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization at 10 uM after 2 hrs by SDS-PAGE analysis,Inhibition,CN(C)c1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1,,%,,CHEMBL2435526
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1ccc(-c2cc3cc(/C=C/C(=O)O)ccc3o2)cc1,57.0,%,=,CHEMBL2435498
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)cc1N(C)C,11.7,%,=,CHEMBL2435497
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)ccc1N(C)C,50.2,%,=,CHEMBL2435496
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(F)c(N(C)C)c3)oc12,9.9,%,=,CHEMBL2435495
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(N(C)C)c(F)c3)oc12,57.5,%,=,CHEMBL2435494
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)ccc1O,28.4,%,=,CHEMBL2435514
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)cc1O,0.0,%,=,CHEMBL2435513
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(N(C)C)cc3)oc12,72.6,%,=,CHEMBL2435512
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3cccc(N(C)C)c3)oc12,34.8,%,=,CHEMBL2435511
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccccc3N(C)C)oc12,3.7,%,=,CHEMBL2435510
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)cc1,12.5,%,=,CHEMBL2435509
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cccc(-c2cc3cc(/C=C/C(=O)O)cc(OC)c3o2)c1,0.0,%,=,CHEMBL2435508
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccccc1-c1cc2cc(/C=C/C(=O)O)cc(OC)c2o1,0.0,%,=,CHEMBL2435507
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(O)cc3)oc12,14.8,%,=,CHEMBL2435506
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3cccc(O)c3)oc12,0.0,%,=,CHEMBL2435505
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccccc3O)oc12,18.1,%,=,CHEMBL2435504
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccc(F)cc3)oc12,2.7,%,=,CHEMBL2435503
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3cccc(F)c3)oc12,0.4,%,=,CHEMBL2435502
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccccc3F)oc12,7.0,%,=,CHEMBL2435501
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)cc2cc(-c3ccccc3)oc12,0.0,%,=,CHEMBL2435500
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,42.8,%,=,CHEMBL32749
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1N(C)C,32.5,%,=,CHEMBL2435499
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)ccc1N(C)C,45.9,%,=,CHEMBL2435531
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1cc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)ccc1F,16.8,%,=,CHEMBL2435530
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1F,49.8,%,=,CHEMBL2435529
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)ccc1O,42.6,%,=,CHEMBL2435528
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1O,43.3,%,=,CHEMBL2435527
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1,70.6,%,=,CHEMBL2435526
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1cccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)c1,33.3,%,=,CHEMBL2435525
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,CN(C)c1ccccc1-c1cc2cc(/C=C/C(=O)O)cc(O)c2o1,8.1,%,=,CHEMBL2435524
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)cc1,34.2,%,=,CHEMBL2435523
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1cccc(-c2cc3cc(/C=C/C(=O)O)cc(O)c3o2)c1,0.0,%,=,CHEMBL2435522
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,COc1ccccc1-c1cc2cc(/C=C/C(=O)O)cc(O)c2o1,0.0,%,=,CHEMBL2435521
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3ccc(O)cc3)cc2c1,22.4,%,=,CHEMBL2435520
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3cccc(O)c3)cc2c1,0.0,%,=,CHEMBL2435519
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3ccccc3O)cc2c1,28.3,%,=,CHEMBL2435518
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3ccc(F)cc3)cc2c1,26.7,%,=,CHEMBL2435517
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3ccccc3)cc2c1,16.8,%,=,CHEMBL2435532
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3cccc(F)c3)cc2c1,14.3,%,=,CHEMBL2435516
Inhibition of amyloid beta (unknown origin) fibril formation at 10 uM by thioflavin T fluorescent dye assay,Inhibition,O=C(O)/C=C/c1cc(O)c2oc(-c3ccccc3F)cc2c1,19.7,%,=,CHEMBL2435515
Neuroprotective activity in differentiated human SH-SY5Y cells assessed as decrease in amyloid beta (1 to 42)-induced neurotoxicity incubated overnight prior to amyloid beta (1 to 42)-stimulation measured after 48 hrs by WST-1 assay,Activity,COC1=C2CCCCCCCCCCCCCCCNC(=CC1=O)C2=O,,,,CHEMBL2441288
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM by thioflavin T fluorescence method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,6880.0,nM,=,CHEMBL3087683
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C(=O)NCCCNC1=CC(=O)C(NCCCNC(=O)C(C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,,,,CHEMBL3087682
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C(=O)NCCCCCCNC1=CC(=O)C(NCCCCCCNC(=O)C(C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,,,,CHEMBL3087681
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4430.0,nM,=,CHEMBL3087680
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4770.0,nM,=,CHEMBL3087679
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,6110.0,nM,=,CHEMBL3087677
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3150.0,nM,=,CHEMBL3087676
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,8180.0,nM,=,CHEMBL3087675
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,76.4,%,=,CHEMBL3087683
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC(C(=O)NCCCNC1=CC(=O)C(NCCCNC(=O)C(C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,12.7,%,=,CHEMBL3087682
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC(C(=O)NCCCCCCNC1=CC(=O)C(NCCCCCCNC(=O)C(C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,,%,,CHEMBL3087681
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,90.0,%,>,CHEMBL3087680
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,87.2,%,=,CHEMBL3087679
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC(C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)C(C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,90.0,%,>,CHEMBL3087678
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,80.1,%,=,CHEMBL3087677
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,74.9,%,=,CHEMBL3087676
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,55.0,%,=,CHEMBL3087675
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,82.6,%,=,CHEMBL3087674
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,66.8,%,=,CHEMBL231160
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 1:0.1 to 1:2 protein to compound molar ratio after 20 hrs by transmission electron microscopic analysis,Inhibition,O=C(O)c1cc(O)c(O)c(O)c1,,%,,CHEMBL288114
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 1:0.1 to 1:2 protein to compound molar ratio up to 10 hrs by thioflavin T fluorescence assay,Inhibition,O=C(O)c1cc(O)c(O)c(O)c1,,%,,CHEMBL288114
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.04,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(CCCCCCCCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1)Cc1ccccc1,48.13,%,=,CHEMBL3093845
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(CCCCCCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1)Cc1ccccc1,29.36,%,=,CHEMBL3093844
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCCCCCN4CCCCC4)cc3o2)cc1,40.73,%,=,CHEMBL3093843
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCCCCCN4CCCC4)cc3o2)cc1,38.6,%,=,CHEMBL3093842
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)CCCCCCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,33.37,%,=,CHEMBL3093841
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(CCCCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1)Cc1ccccc1,39.52,%,=,CHEMBL3093840
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCCCN4CCCCC4)cc3o2)cc1,34.81,%,=,CHEMBL3093839
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCCCN4CCCC4)cc3o2)cc1,42.15,%,=,CHEMBL3093838
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)CCCCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,45.8,%,=,CHEMBL3093837
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(CCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1)Cc1ccccc1,46.55,%,=,CHEMBL3093836
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCN4CCCCC4)cc3o2)cc1,25.37,%,=,CHEMBL3093835
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCCCN4CCCC4)cc3o2)cc1,32.61,%,=,CHEMBL3093834
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)CCCCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,38.12,%,=,CHEMBL3093833
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(CCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1)Cc1ccccc1,39.13,%,=,CHEMBL3093832
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCN4CCOCC4)cc3o2)cc1,44.67,%,=,CHEMBL3093831
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCN4CCCCC4)cc3o2)cc1,30.64,%,=,CHEMBL3093830
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCCCCN4CCCC4)cc3o2)cc1,36.56,%,=,CHEMBL3093847
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)CCCCOc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,33.23,%,=,CHEMBL3093846
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,CN(CCCCNc1c2c(nc3ccccc13)CCCC2)CCCNc1c2c(nc3c(NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)OCc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)OCc4ccccc4)cccc13)CCCC2,,%,,CHEMBL3099499
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099497
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,O=[N+]([O-])c1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099496
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,CN(CCCCNc1c2c(nc3ccccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL489454
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,c1ccc2c(NCCCCCCCCSc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,,%,,CHEMBL129108
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as inhibition of fibril formation by transmission electron microscopy,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8.4,%,=,CHEMBL32823
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by ThT-based fluorescence assay,IC50,CN(CCCCNc1c2c(nc3c(NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)OCc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)OCc4ccccc4)cccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,51000.0,nM,=,CHEMBL3099500
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM by ThT-based fluorescence assay,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,81.0,%,=,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as depletion of higher molecular weight oligomers formation at 200 to 500 uM by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as stable smaller oligomer formation at 500 uM after 24 hrs by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as inhibition of toxic aggregate formation at 500 uM after 24 hrs by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as amorphous aggregates formation at 50 to 500 uM by transmission electron microscopy,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as disaggregation of toxic oligomers and precipitation at 200 to 500 uM by transmission electron microscopy relative to control,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as oligomer stabilization at 200 uM after 2 days by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as oligomer stabilization at 200 uM after 6 hrs by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,87.2,%,=,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as oligomer stabilization at 200 uM measured immediately by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,82.5,%,=,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as depletion of higher molecular weight oligomers after 6 hrs to 2 days by capillary electrophoresis method,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta (1 to 42) oligomerization (unknown origin) assessed as inhibition of fibril formation by transmission electron microscopy,Inhibition,O=C(CC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)NCC(=O)Nc1cccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc12)CCCC3,,%,,CHEMBL3099498
Inhibition of amyloid beta-42 self-aggregation (unknown origin) after 1 hr by ThT fluorescence assay,Inhibition,CN(C)Cc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(CN(C)C)c2)ccc1O,,%,,CHEMBL3098591
Inhibition of amyloid beta-42 self-aggregation (unknown origin) after 1 hr by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 100 uM after 1 hr by ThT fluorescence assay relative to control,Inhibition,CN(C)Cc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(CN(C)C)c2)ccc1O,32.0,%,=,CHEMBL3098591
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 100 uM after 1 hr by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,29.0,%,=,CHEMBL116438
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 50 uM after 1 hr by ThT fluorescence assay relative to control,Inhibition,CN(C)Cc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(CN(C)C)c2)ccc1O,28.0,%,=,CHEMBL3098591
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 50 uM after 1 hr by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,24.0,%,=,CHEMBL116438
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 5 uM after 1 hr by ThT fluorescence assay,Inhibition,CN(C)Cc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(CN(C)C)c2)ccc1O,,%,,CHEMBL3098591
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 5 uM after 1 hr by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction of H2O2 production at 800 nM after 30 mins by HRP/Amplex red assay,Inhibition,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,90.0,%,>,CHEMBL858
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction of H2O2 production at 800 nM after 30 mins by HRP/Amplex red assay,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,75.0,%,=,CHEMBL497
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction of H2O2 production at 800 nM after 30 mins by HRP/Amplex red assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)cc1O,80.0,%,=,CHEMBL2064671
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,66.7,%,=,CHEMBL497
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,63.4,%,=,CHEMBL165
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)cc1O,68.1,%,=,CHEMBL2064671
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/N=C/c1cccc(F)c1,70.2,%,=,CHEMBL3098342
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)cc1,83.7,%,=,CHEMBL1966239
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.5,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,64.2,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1ccc(O)c(/C=N/c2ccccc2)c1,29.0,%,=,CHEMBL3098349
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(Cl)cc1/C=N/c1ccccc1,33.8,%,=,CHEMBL3098348
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/C=N/c1ccc(F)cc1,24.9,%,=,CHEMBL3098347
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/C=N/c1cccc(F)c1,31.3,%,=,CHEMBL3098346
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/C=N/c1ccccc1F,27.8,%,=,CHEMBL1797968
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/N=C/c2ccccc2O)cc1,71.2,%,=,CHEMBL2064676
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1cccc(/N=C/c2ccccc2O)c1,66.1,%,=,CHEMBL2064674
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/C=N/c1ccccc1,44.9,%,=,CHEMBL205927
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1ccc(/C=N/c2ccccc2O)cc1OC,39.4,%,=,CHEMBL3098345
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1ccc(/C=N/c2ccccc2O)cc1,35.7,%,=,CHEMBL2064673
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CN(C)c1ccc(/C=N/c2ccccc2O)cc1,55.8,%,=,CHEMBL2236145
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)cc1O,64.6,%,=,CHEMBL2064671
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)c(O)c1,63.1,%,=,CHEMBL3098344
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/N=C/c1ccc(F)cc1,67.8,%,=,CHEMBL3098343
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/N=C/c1cccc(F)c1,67.6,%,=,CHEMBL3098342
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/N=C/c1ccccc1F,69.4,%,=,CHEMBL1797961
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccc(/C=N/c2ccccc2O)cc1,70.9,%,=,CHEMBL1966239
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1cccc(/C=N/c2ccccc2O)c1,64.3,%,=,CHEMBL2064670
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/C=N/c1ccccc1O,67.2,%,=,CHEMBL2064669
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Oc1ccccc1/N=C/c1ccccc1,51.7,%,=,CHEMBL2064668
Destabilization of preformed amyloid beta (1 to 40) (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,5000.0,nM,=,CHEMBL541265
Inhibition of amyloid beta (1 to 40) aggregation (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1540.0,nM,=,CHEMBL541265
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCNCc1ccc2nc(-c3cccnc3)c3c(c2c1)NCCC3,16.0,%,<=,CHEMBL3122169
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,16.0,%,<=,CHEMBL3122168
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,16.0,%,<=,CHEMBL3122167
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)NCCC3,16.0,%,<=,CHEMBL3122166
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCNCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,16.0,%,<=,CHEMBL3122150
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,16.0,%,<=,CHEMBL3122149
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccc(OC)cc1)CCC3,16.0,%,<=,CHEMBL3122148
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,16.0,%,<=,CHEMBL3122147
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(C(=O)OC)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,16.0,%,<=,CHEMBL3122146
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)N(Cc1ccccc1)CCC3,16.0,%,<=,CHEMBL3122145
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,16.0,%,<=,CHEMBL3122172
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(C(=O)OC)cc3)c3c(c2c1)N(Cc1ccccc1)C(=O)CC3,16.0,%,<=,CHEMBL3120185
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3cccnc3)c3c(c2c1)N(Cc1ccccc1)C(=O)CC3,16.0,%,<=,CHEMBL3122171
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM relative to control,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)C(=O)CC3,16.0,%,<=,CHEMBL3122170
Induction of amyloid beta (1 to 42) (unknown origin) disaggregation assessed as reduction of Cu2+-induced amyloid beta fibril formation at 25 uM after 24 hrs by thioflavin T fluorescence method,Activity,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,72.1,%,=,CHEMBL3127003
Induction of amyloid beta (1 to 42) (unknown origin) disaggregation assessed as reduction of Cu2+-induced amyloid beta fibril formation at 25 uM after 24 hrs by thioflavin T fluorescence method,Activity,CCN(CCCCOc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1)Cc1ccccc1OC,39.2,%,=,CHEMBL3126996
Induction of amyloid beta (1 to 42) (unknown origin) disaggregation assessed as reduction of Cu2+-induced amyloid beta fibril formation at 25 uM after 24 hrs by thioflavin T fluorescence method,Activity,CCN(CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1)Cc1ccccc1,36.1,%,=,CHEMBL3127006
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,,%,,CHEMBL3127003
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,,%,,CHEMBL3127003
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,64.0,%,=,CHEMBL116438
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,77.8,%,=,CHEMBL3127003
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1)Cc1ccccc1OC,71.9,%,=,CHEMBL3126996
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1)Cc1ccccc1,72.1,%,=,CHEMBL3127006
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL116438
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,35.0,%,=,CHEMBL3127003
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1)Cc1ccccc1OC,24.6,%,=,CHEMBL3126996
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1)Cc1ccccc1,34.3,%,=,CHEMBL3127006
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 6 days by atomic force microscopic analysis,Inhibition,COc1ccc2c(c1)oc1cccc(CN(C(=O)CCO[N+](=O)[O-])C(C)C)c12,,%,,CHEMBL3127215
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 to 100 uM after 1 hr by thioflavin T fluorescence assay,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,%,,CHEMBL659
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) after 1 hr by thioflavin T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) after 1 hr by thioflavin T fluorescence assay,Inhibition,COc1ccc2c(c1)oc1cccc(CN(C(=O)CCO[N+](=O)[O-])C(C)C)c12,,%,,CHEMBL3127215
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 100 uM after 1 hr by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,29.0,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 100 uM after 1 hr by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc2c(c1)oc1cccc(CN(C(=O)CCO[N+](=O)[O-])C(C)C)c12,25.0,%,=,CHEMBL3127215
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 1 hr by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,24.0,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 1 hr by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc2c(c1)oc1cccc(CN(C(=O)CCO[N+](=O)[O-])C(C)C)c12,19.0,%,=,CHEMBL3127215
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM after 1 hr by thioflavin T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 5 uM after 1 hr by thioflavin T fluorescence assay,Inhibition,COc1ccc2c(c1)oc1cccc(CN(C(=O)CCO[N+](=O)[O-])C(C)C)c12,,%,,CHEMBL3127215
Binding affinity to beta amyloid-containing senile plaques of Alzheimer's disease patient at 50 uM after 20 mins by thioflavin-S staining-based fluorescence microscopic analysis,Activity,CN(C)c1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1,,,,CHEMBL3126514
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,CN(C)c1ccc(-c2cn3cc([125I])ccc3n2)cc1,13.65,nM,=,CHEMBL71696
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,COc1cc(/C=C2\COc3ccc(Br)cc3C2=O)cc(OC)c1,39.19,nM,=,CHEMBL3126522
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,COc1cc(/C=C2\COc3ccc(Br)cc3C2=O)ccc1O,432.03,nM,=,CHEMBL3126521
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,COc1cccc(/C=C2\COc3ccc(Br)cc3C2=O)c1,73.46,nM,=,CHEMBL3126520
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,COc1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1OC,54.22,nM,=,CHEMBL3126519
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,CN(C)c1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1Br,25.54,nM,=,CHEMBL3126518
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,O=C1/C(=C/c2ccc(Br)cc2)COc2ccc(Br)cc21,143.81,nM,=,CHEMBL3126517
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,Nc1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1,63.57,nM,=,CHEMBL3126516
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)COc2ccc(Br)cc21,107.6,nM,=,CHEMBL3126515
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,CN(C)c1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1,9.1,nM,=,CHEMBL3126514
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,O=C1/C(=C/c2ccccc2)COc2ccc(Br)cc21,103.62,nM,=,CHEMBL3126513
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,O=C1/C(=C/c2ccc(O)cc2)COc2ccc(Br)cc21,103.35,nM,=,CHEMBL3126512
Displacement of [125I]IMPY from amyloid beta (1 to 40) (unknown origin) after 2 hrs by gamma counting analysis,Ki,COc1ccc(/C=C2\COc3ccc(Br)cc3C2=O)cc1,9.98,nM,=,CHEMBL3126511
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Inhibition,CN(C)c1ccc(-c2nnc(-c3cccc(I)c3)o2)cn1,,%,,CHEMBL3134121
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Inhibition,CN(C)c1ccc(-c2nnc(-c3ccc(I)cc3)o2)cn1,,%,,CHEMBL3134120
In vitro binding affinity to amyloid beta plaques in human AD brain at 148 nBq after 1 hr incubation at room temperature by autoradiography analysis,Activity,CN(C)c1ccc(-c2nnc(-c3cccc([125I])c3)o2)cn1,,,,CHEMBL3134118
In vitro binding affinity to amyloid beta plaques in human AD brain at 148 nBq after 1 hr incubation at room temperature by autoradiography analysis,Activity,CN(C)c1ccc(-c2nnc(-c3ccc([125I])cc3)o2)cn1,,,,CHEMBL3134119
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,3.05,nM,=,CHEMBL78012
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Ki,CN(C)c1ccc(-c2nnc(-c3ccc(I)cc3)o2)cc1,3.91,nM,=,CHEMBL609015
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Ki,CN(C)c1ccc(-c2nnc(-c3cccc(I)c3)o2)cn1,13.6,nM,=,CHEMBL3134121
Inhibition of [125I]IMPY binding to amyloid beta (1 to 42) aggregates (unknown origin) by gamma counting,Ki,CN(C)c1ccc(-c2nnc(-c3ccc(I)cc3)o2)cn1,24.8,nM,=,CHEMBL3134120
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,68.51,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.21,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,%,,CHEMBL659
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN3CCOCC3)cc2)cc(OC)c1,42.16,%,=,CHEMBL3133248
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN3CCC(O)CC3)cc2)cc(OC)c1,42.55,%,=,CHEMBL3133247
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN3CCCCC3C)cc2)cc(OC)c1,52.1,%,=,CHEMBL3133246
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN3CCCCC3)cc2)cc(OC)c1,54.0,%,=,CHEMBL3133245
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN3CCCC3)cc2)cc(OC)c1,57.78,%,=,CHEMBL3133244
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCCN(CCC)CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1,41.45,%,=,CHEMBL3133243
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN(C)C)cc2)cc(OC)c1,42.85,%,=,CHEMBL3133242
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CC)CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1,40.33,%,=,CHEMBL3133241
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccc(F)cc1,37.28,%,=,CHEMBL3133240
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1cccc(F)c1,28.25,%,=,CHEMBL3133239
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1F,29.55,%,=,CHEMBL3133314
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccc(OC)cc1,53.25,%,=,CHEMBL3133313
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1cccc(OC)c1,55.17,%,=,CHEMBL3133312
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1OC,64.53,%,=,CHEMBL3133311
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1,53.49,%,=,CHEMBL3133310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,47.2,%,=,CHEMBL3133309
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,43.57,%,=,CHEMBL3133308
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,49.79,%,=,CHEMBL3132866
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,36.4,%,=,CHEMBL3133307
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,44.72,%,=,CHEMBL3133306
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,46.4,%,=,CHEMBL3133250
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavon T staining-based fluorescence assay,Inhibition,COc1cc(/C=C/c2ccc(OCCN(C)Cc3ccccc3)cc2)cc(OC)c1,26.14,%,=,CHEMBL3133249
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC1(C(=O)O)C2CCC(O2)C1(C)C(=O)O,20596.2,nM,,CHEMBL275516
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1,18356.4,nM,,CHEMBL1441661
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC[C@@H]1Cc2cc(O)ccc2C2=C1c1ccc(O)cc1C[C@H]2CC,29092.9,nM,,CHEMBL282489
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,20596.2,nM,,CHEMBL285629
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,N#CC(=C(\N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N,29092.9,nM,,CHEMBL95758
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(C)(C)c1cc(/C=C(\C#N)C(N)=S)cc(C(C)(C)C)c1O,5173.5,nM,,CHEMBL539947
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCOC(=O)N1CCN(/[N+]([O-])=N/Oc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])CC1,14581.0,nM,,CHEMBL455983
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O,2592.9,nM,,CHEMBL78150
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1,29092.9,nM,,CHEMBL480
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,4610.9,nM,,CHEMBL386389
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,29092.9,nM,,CHEMBL15192
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1,1158.2,nM,,CHEMBL270299
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,29092.9,nM,,CHEMBL305660
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,16360.1,nM,,CHEMBL60718
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,18356.4,nM,,CHEMBL596674
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CN(N=O)c1cc(O)ccc1O,29092.9,nM,,CHEMBL269733
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,COC1=C(OC)C(=O)c2ccccc2C1=O,29092.9,nM,,CHEMBL402468
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,2310.9,nM,,CHEMBL403183
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C(N[C@@H](Cc1ccccc1)C(=O)CCl)OCc1ccccc1,14581.0,nM,,CHEMBL303579
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,16360.1,nM,,CHEMBL129795
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2c(c1)N=C([S+]([O-])Cc1ncc(C)c(OC)c1C)C2.[MgH2],29092.9,nM,,CHEMBL4299164
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,29092.9,nM,,CHEMBL47940
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=Nc1c(-c2c(O)[nH]c3cc(Br)ccc23)[nH]c2ccccc12,18356.4,nM,,CHEMBL355496
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C1O/C(=C/Br)CCC1c1cccc2ccccc12,23109.3,nM,,CHEMBL6206
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,,20596.2,nM,,CHEMBL11359
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,,4610.9,nM,,CHEMBL575867
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=c1oc(Cl)c(Cl)c2ccccc12,23109.3,nM,,CHEMBL24983
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(O)c(O)c1,20596.2,nM,,CHEMBL250711
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(Br)c2)cc1,29092.9,nM,,CHEMBL1435579
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Nc1ccc(-c2nc3ccc(-c4nc5ccc(N)cc5[nH]4)cc3[nH]2)cc1,29092.9,nM,,CHEMBL578741
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,S=C(Nc1ccccc1)Nc1nccs1,9200.0,nM,,CHEMBL1256364
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=c1c2ccccc2[se]n1-c1ccccc1,16360.1,nM,,CHEMBL51085
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=c1[nH]cc(F)c(=O)[nH]1,18356.4,nM,,CHEMBL185
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC12C(=O)OC(=O)C1(C)C1CCC2O1,23109.3,nM,,CHEMBL8066
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=Nc1ccc2oc(=O)ccc2c1,16360.1,nM,,CHEMBL1255659
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,23109.3,nM,,CHEMBL58
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC[N+](CC)(CC)COc1ccc(/C=C/c2ccccc2)cc1,18356.4,nM,,CHEMBL1589699
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC[n+]1c(C=CC=C2N(C)c3ccccc3C2(C)C)sc2ccccc21,5173.5,nM,,CHEMBL601364
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(=O)/C=C1\C(=O)N(C)c2ccccc21,18356.4,nM,,CHEMBL1512503
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,S=C(S)OC1CC2CC1C1CCCC21,29092.9,nM,,CHEMBL1161894
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Cn1ncc(S(=O)(=O)Cc2ccccc2)c(Br)c1=O,5173.5,nM,,CHEMBL1525723
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCN(CC)C(=S)SSC(=S)N(CC)CC,5173.5,nM,,CHEMBL964
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,23109.3,nM,,CHEMBL1117
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)C2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O,231.1,nM,,CHEMBL295038
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,7307.8,nM,,CHEMBL157101
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,,29092.9,nM,,CHEMBL174271
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,18356.4,nM,,CHEMBL1368696
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,20596.2,nM,,CHEMBL1231533
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,C[Se]C[C@H](N)C(=O)O,18356.4,nM,,CHEMBL62382
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,C=CC(=O)c1ccc(CCCCCC)cc1,16360.1,nM,,CHEMBL237600
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,5804.8,nM,,CHEMBL3392056
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,8199.5,nM,,CHEMBL472940
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5,5173.5,nM,,CHEMBL485832
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O,1458.1,nM,,CHEMBL1256686
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,2059.6,nM,,CHEMBL596380
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]2O[C@H](n3cnc4c(N)ncnc43)[C@@H](O)[C@H]2O)[C@@H](O)[C@H]1O,8199.5,nM,,CHEMBL1162201
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)C=C2,5804.8,nM,,CHEMBL1337170
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC,29092.9,nM,,CHEMBL416753
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,S=C(S)N1CCCC1,29092.9,nM,,CHEMBL399491
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC,29092.9,nM,,CHEMBL107514
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,O=C1c2ccccc2C(=O)c2c(NCCc3ccc(O)cc3)ccc(NCCc3ccc(O)cc3)c21,18356.4,nM,,CHEMBL425294
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,COc1ccc(CCCOc2cc(CCn3ccnc3)ccc2OC)cc1,29092.9,nM,,CHEMBL1332270
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2.Cl,29092.9,nM,,CHEMBL1256028
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21,16360.1,nM,,CHEMBL333826
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,c1cnc2c(c1)ccc1cccnc12,18356.4,nM,,CHEMBL415879
PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ,Potency,CCCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,20596.2,nM,,CHEMBL301722
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(CO)CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O,94.8,%,=,CHEMBL3218429
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(COS(=O)(=O)[O-])CS(=O)(=O)[O-])C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O.[Na+].[Na+],93.8,%,=,CHEMBL3218430
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,51.8,%,=,CHEMBL510763
Inhibition of monomeric amyloid beta (unknown origin) aggregation at 1:20 protein to compound ratio relative to control,Inhibition,CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,50.0,%,=,CHEMBL510763
Inhibition of monomeric amyloid beta (unknown origin)-mediated cytotoxicity at 1:5 protein to compound ratio by cell-based assay relative to control,Inhibition,CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,50.0,%,=,CHEMBL510763
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,82.7,%,=,CHEMBL3218178
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],83.0,%,=,CHEMBL3218179
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,98.7,%,=,CHEMBL3218180
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],127.3,%,=,CHEMBL3218181
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,98.7,%,=,CHEMBL3218182
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],119.5,%,=,CHEMBL3218183
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,100.0,%,=,CHEMBL3218184
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],100.5,%,=,CHEMBL3218185
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,92.9,%,=,CHEMBL3218186
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],107.1,%,=,CHEMBL3218187
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,100.0,%,=,CHEMBL3218188
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],96.3,%,=,CHEMBL3218189
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,97.0,%,=,CHEMBL3218425
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],95.1,%,=,CHEMBL3218426
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(CO)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O,76.4,%,=,CHEMBL3218427
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(COS(=O)(=O)[O-])CS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O.[Na+].[Na+],90.1,%,=,CHEMBL3218428
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(CO)CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O,87.9,%,=,CHEMBL3218429
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(COS(=O)(=O)[O-])CS(=O)(=O)[O-])C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O.[Na+].[Na+],94.7,%,=,CHEMBL3218430
Inhibition of amyloid beta (1 to 42) aggregation in HBP assessed as beta sheet formation at 1:20 protein to compound ratio after 48 hrs by Th-T fluorescence assay relative to control,Activity,CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,51.9,%,=,CHEMBL510763
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,96.1,%,=,CHEMBL3218178
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],95.9,%,=,CHEMBL3218179
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,92.5,%,=,CHEMBL3218180
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],92.0,%,=,CHEMBL3218181
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,96.6,%,=,CHEMBL3218182
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NC[C@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],92.0,%,=,CHEMBL3218183
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,99.6,%,=,CHEMBL3218184
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)NCCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],96.5,%,=,CHEMBL3218185
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCCCO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,93.0,%,=,CHEMBL3218186
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCCCOS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+],106.7,%,=,CHEMBL3218187
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,91.6,%,=,CHEMBL3218188
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],95.9,%,=,CHEMBL3218189
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@@H](O)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O,89.7,%,=,CHEMBL3218425
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OC[C@H](COS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O.[Na+].[Na+],91.4,%,=,CHEMBL3218426
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(CO)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O,81.1,%,=,CHEMBL3218427
Inhibition of amyloid beta (1 to 42)-mediated cytotoxicity in HBP assessed as cell death at 1:5 protein to compound ratio after 6 days by fluorescence assay relative to control,Activity,CC(C)C[C@H](NC(=O)OCC(COS(=O)(=O)[O-])CS(=O)(=O)[O-])C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O.[Na+].[Na+],86.3,%,=,CHEMBL3218428
Inhibition of amyloid beta (unknown origin) aggregation at 10 uM,Inhibition,O=C(CCCOc1cccc2[nH]c3ccccc3c12)NCCCNc1c2c(nc3ccccc13)CCCC2,36.0,%,=,CHEMBL3235502
Inhibition of amyloid beta (unknown origin) aggregation,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503
Inhibition of amyloid beta (unknown origin) aggregation at 25 uM,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)ccc1O,100.0,%,=,CHEMBL2171309
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,,,,CHEMBL2181036
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,,,,CHEMBL3233650
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233651
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233652
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233653
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233654
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233655
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,,,,CHEMBL3233657
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,,,,CHEMBL3233658
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,,,,CHEMBL3233661
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 100 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,,,,CHEMBL3233662
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,,,,CHEMBL2181036
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,,,,CHEMBL3233650
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233651
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233652
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233653
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233654
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233655
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,,,,CHEMBL3233657
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,,,,CHEMBL3233658
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,,,,CHEMBL3233661
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 100 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,,,,CHEMBL3233662
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,,,,CHEMBL2181036
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,,,,CHEMBL3233650
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233651
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233652
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233653
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233654
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233655
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,,,,CHEMBL2181036
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,,,,CHEMBL3233650
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233651
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233652
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233653
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233654
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233655
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,,,,CHEMBL3233657
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,,,,CHEMBL3233658
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,,,,CHEMBL3233661
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,,,,CHEMBL3233662
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain homogenate at 1.92 mM by [19F]-NMR spectrometric analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)c(OC)cc1/C=C/c1ccc(O)cc1,,,,CHEMBL3233649
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,,,,CHEMBL3233657
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,,,,CHEMBL3233658
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCCCC(F)(F)F)c2)cc1,,,,CHEMBL3233659
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,,,,CHEMBL3233661
Binding affinity to beta-amyloid plaque in Alzheimer's disease patient brain at 10 uM by fluorescence microscopic analysis,Activity,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,,,,CHEMBL3233662
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,COc1cc(/C=C/c2ccc(O)cc2)c(OC)cc1/C=C/c1ccc(O)cc1,,,,CHEMBL3233649
Binding affinity to beta-amyloid plaque in APP/PS1 transgenic mouse brain at 1 uM by fluorescence microscopic analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCCCC(F)(F)F)c2)cc1,,,,CHEMBL3233659
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) at 1.92 mM by [19F]-NMR spectrometric analysis,Activity,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,,,,CHEMBL3233660
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(O)cc2)c(OC)cc1/C=C/c1ccc(O)cc1,,,,CHEMBL3233649
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,,,,CHEMBL3233650
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233651
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233652
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233653
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,,,,CHEMBL3233654
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,,,,CHEMBL3233655
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,,,,CHEMBL3233656
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,,,,CHEMBL3233661
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,,,,CHEMBL3233662
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,100.0,,=,CHEMBL2181036
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,26.0,,=,CHEMBL3233650
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,1.0,,=,CHEMBL3233651
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,38.7,%,=,CHEMBL3233826
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,40.8,%,=,CHEMBL3233827
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,40.6,%,=,CHEMBL3233828
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,33.1,%,=,CHEMBL3233829
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,38.0,%,=,CHEMBL3233830
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@@H](C1)C2.Cl,38.4,%,=,CHEMBL3233831
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@H](C1)C2.Cl,43.2,%,=,CHEMBL3233832
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,40.9,%,=,CHEMBL3234038
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,35.3,%,=,CHEMBL3234039
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCc4ccc(CNC(=O)c5cc(O)c6c(c5)C(=O)c5cccc(O)c5C6=O)cc4)c3C(C1)C2.Cl,32.4,%,=,CHEMBL3234040
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,,%,,CHEMBL418068
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,,%,,CHEMBL536047
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@@H](C1)C2.Cl,13.2,%,=,CHEMBL2011499
Inhibition of amyloid beta-42 (unknown origin) aggregation assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@H](C1)C2,11.5,%,=,CHEMBL2007996
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,68.0,%,=,CHEMBL3233826
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,68.4,%,=,CHEMBL3233827
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,63.2,%,=,CHEMBL3233828
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,50.2,%,=,CHEMBL3233829
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,47.9,%,=,CHEMBL3233830
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=C[C@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@@H](C1)C2.Cl,58.6,%,=,CHEMBL3233831
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3[C@H](C1)C2.Cl,47.2,%,=,CHEMBL3233832
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,43.3,%,=,CHEMBL3234038
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2.Cl,40.7,%,=,CHEMBL3234039
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCc4ccc(CNC(=O)c5cc(O)c6c(c5)C(=O)c5cccc(O)c5C6=O)cc4)c3C(C1)C2.Cl,57.9,%,=,CHEMBL3234040
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O,49.9,%,=,CHEMBL418068
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,,%,,CHEMBL536047
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,3.0,,=,CHEMBL3233652
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,1.0,,=,CHEMBL3233653
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,2.0,,=,CHEMBL3233654
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,13.0,,=,CHEMBL3233655
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,19.0,,=,CHEMBL3233657
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,7.0,,=,CHEMBL3233658
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCCCC(F)(F)F)c2)cc1,2.0,,=,CHEMBL3233659
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,38.0,,=,CHEMBL3233660
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,2.0,,=,CHEMBL3233661
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to Methoxy-X04,RFU,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,4.0,,=,CHEMBL3233662
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,9.8,,=,CHEMBL2181036
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1cc(/C=C/c2ccc(CO)cc2)ccc1/C=C/c1ccc(CO)cc1,4.1,,=,CHEMBL3233650
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,1.0,,=,CHEMBL3233651
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,1.0,,=,CHEMBL3233652
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1cc(/C=C/c2ccc(C(F)(F)C(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)C(F)F)cc1,1.0,,=,CHEMBL3233653
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1cc(/C=C/c2ccc(C(F)(F)F)cc2)ccc1/C=C/c1ccc(C(F)(F)F)cc1,3.6,,=,CHEMBL3233654
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1cc(/C=C/c2ccc(OC(F)(F)F)cc2)ccc1/C=C/c1ccc(OC(F)(F)F)cc1,7.4,,=,CHEMBL3233655
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,10.7,,=,CHEMBL3233657
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,4.1,,=,CHEMBL3233658
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCCCC(F)(F)F)c2)cc1,4.3,,=,CHEMBL3233659
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,17.8,,=,CHEMBL3233660
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2O)cc1,1.0,,=,CHEMBL3233661
Binding affinity to fibrillar amyloid beta (1 to 40) (unknown origin) assessed as fluorescence intensity relative to control,FC,COc1ccc(/C=C/c2ccc(/C=C/c3ccc(OC)c(C(F)(F)F)c3)cc2OC)cc1,1.0,,=,CHEMBL3233662
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,COc1cc(/C=C/c2ccc(O)cc2)ccc1/C=C/c1ccc(O)cc1,24.2,nM,=,CHEMBL2181036
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(C(F)(F)F)c2)cc1,244.0,nM,=,CHEMBL3233657
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCC(F)(F)F)c2)cc1,39.3,nM,=,CHEMBL3233658
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OCCCC(F)(F)F)c2)cc1,56.4,nM,=,CHEMBL3233659
Displacement of [3H]chrysamine G from fibrillar amyloid beta (1 to 40) (unknown origin) after 1 hr by liquid scintillation spectrophotometric analysis,Ki,Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(OC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c2)cc1,84.48,nM,=,CHEMBL3233660
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,41.1,%,=,CHEMBL3262655
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,47.3,%,=,CHEMBL3262656
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,34.3,%,=,CHEMBL3262657
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,56.4,%,=,CHEMBL3262658
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,43.9,%,=,CHEMBL3262659
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCN(CC)CCCCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,39.6,%,=,CHEMBL3262660
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN(C)C)cc1)NCC2,55.3,%,=,CHEMBL3262661
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCCN(CCC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,51.2,%,=,CHEMBL3262662
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,CCCCN(CCCC)CCCCCCOc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1,51.4,%,=,CHEMBL3262663
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCC3C)cc1)NCC2,72.3,%,=,CHEMBL3262664
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCCC3C)cc1)NCC2,78.4,%,=,CHEMBL3262665
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCCC3)cc1)NCC2,76.4,%,=,CHEMBL3262666
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCCC3)cc1)NCC2,69.0,%,=,CHEMBL3262667
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(O)CC3)cc1)NCC2,62.1,%,=,CHEMBL3262668
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCOCC3)cc1)NCC2,57.4,%,=,CHEMBL3262669
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(O)(Cc4ccccc4)CC3)cc1)NCC2,62.7,%,=,CHEMBL3262670
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCN(c4ccccc4)CC3)cc1)NCC2,65.8,%,=,CHEMBL3262671
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCN(Cc4ccccc4)CC3)cc1)NCC2,61.4,%,=,CHEMBL3262672
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(OCCCCCCN3CCC(c4ccccc4)CC3)cc1)NCC2,61.2,%,=,CHEMBL3262673
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(O)cc1)NCC2,36.0,%,=,CHEMBL510363
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 46 to 48 hrs by thioflavin T based fluorometric assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.5,%,=,CHEMBL165
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4)cn3c2=O)cc(OC)c1O,93.0,nM,=,CHEMBL3286981
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(OC)c1O,7.0,nM,=,CHEMBL3286982
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Cl)c1O,32.0,nM,=,CHEMBL3286983
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Br)c1O,18.0,nM,=,CHEMBL3286984
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(O)c1O,18.0,nM,=,CHEMBL3286985
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)ccc1O,10000.0,nM,>,CHEMBL3286986
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)cc(OC)c1O,32.0,nM,=,CHEMBL3286987
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(Cl)c4)cn3c2=O)cc(OC)c1O,6.0,nM,=,CHEMBL3286988
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(C(F)(F)F)c4)cn3c2=O)cc(Cl)c1O,123.0,nM,=,CHEMBL3286989
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(OC(F)(F)F)c4)cn3c2=O)cc(F)c1O,10000.0,nM,>,CHEMBL3286990
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C(=O)O[C@@H](c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,58.3,%,=,CHEMBL3290504
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H](OC(=O)c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,53.2,%,=,CHEMBL3290505
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,58.0,%,=,CHEMBL3290506
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,65.0,%,=,CHEMBL3290507
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc3c(c2)OCO3)cc1OC,58.1,%,=,CHEMBL3290508
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@@H](C)[C@@H](C)Cc2ccc(O)c(OC)c2)ccc1O,62.2,%,=,CHEMBL430464
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O,57.0,%,=,CHEMBL254071
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)cc1OC,57.4,%,=,CHEMBL3290509
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)ccc1O,57.7,%,=,CHEMBL428239
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@@H]2c3cc(OC)c(O)cc3C=C(C)[C@H]2C)ccc1O,58.6,%,=,CHEMBL3290510
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)ccc1O,55.4,%,=,CHEMBL3290511
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)cc1OC,58.2,%,=,CHEMBL559937
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,C[C@@H]1[C@H](C)[C@@H](c2ccc3c(c2)OCO3)O[C@@H]1c1ccc2c(c1)OCO2,60.0,%,=,CHEMBL2151191
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control,Activity,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,54.1,%,=,CHEMBL196
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C(=O)O[C@@H](c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,65.4,%,=,CHEMBL3290504
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H](OC(=O)c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,62.0,%,=,CHEMBL3290505
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,59.2,%,=,CHEMBL3290506
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,64.0,%,=,CHEMBL3290507
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc3c(c2)OCO3)cc1OC,62.2,%,=,CHEMBL3290508
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@@H](C)[C@@H](C)Cc2ccc(O)c(OC)c2)ccc1O,63.8,%,=,CHEMBL430464
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O,61.5,%,=,CHEMBL254071
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)cc1OC,58.2,%,=,CHEMBL3290509
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)ccc1O,59.9,%,=,CHEMBL428239
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@@H]2c3cc(OC)c(O)cc3C=C(C)[C@H]2C)ccc1O,60.7,%,=,CHEMBL3290510
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)ccc1O,63.1,%,=,CHEMBL3290511
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)cc1OC,58.1,%,=,CHEMBL559937
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,C[C@@H]1[C@H](C)[C@@H](c2ccc3c(c2)OCO3)O[C@@H]1c1ccc2c(c1)OCO2,59.2,%,=,CHEMBL2151191
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control,Activity,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,55.6,%,=,CHEMBL196
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C(=O)O[C@@H](c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,68.9,%,=,CHEMBL3290504
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H](OC(=O)c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,63.5,%,=,CHEMBL3290505
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,62.0,%,=,CHEMBL3290506
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,63.1,%,=,CHEMBL3290507
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc3c(c2)OCO3)cc1OC,61.1,%,=,CHEMBL3290508
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@@H](C)[C@@H](C)Cc2ccc(O)c(OC)c2)ccc1O,69.2,%,=,CHEMBL430464
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O,61.8,%,=,CHEMBL254071
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)cc1OC,59.8,%,=,CHEMBL3290509
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)ccc1O,60.5,%,=,CHEMBL428239
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@@H]2c3cc(OC)c(O)cc3C=C(C)[C@H]2C)ccc1O,62.1,%,=,CHEMBL3290510
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)ccc1O,68.6,%,=,CHEMBL3290511
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)cc1OC,58.6,%,=,CHEMBL559937
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,C[C@@H]1[C@H](C)[C@@H](c2ccc3c(c2)OCO3)O[C@@H]1c1ccc2c(c1)OCO2,60.3,%,=,CHEMBL2151191
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control,Activity,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,58.5,%,=,CHEMBL196
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C(=O)O[C@@H](c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,66.8,%,=,CHEMBL3290504
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H](OC(=O)c2ccc3c(c2)OCO3)[C@H](C)C(C)=O)cc1OC,63.4,%,=,CHEMBL3290505
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO[C@@H]2O[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,58.3,%,=,CHEMBL3290506
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,OC[C@H](Cc1ccc2c(c1)OCO2)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)Cc1ccc2c(c1)OCO2,65.2,%,=,CHEMBL3290507
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc3c(c2)OCO3)cc1OC,61.9,%,=,CHEMBL3290508
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@@H](C)[C@@H](C)Cc2ccc(O)c(OC)c2)ccc1O,68.3,%,=,CHEMBL430464
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O,64.4,%,=,CHEMBL254071
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)cc1OC,58.7,%,=,CHEMBL3290509
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2c3cc4c(cc3C[C@@H](C)[C@@H]2C)OCO4)ccc1O,60.5,%,=,CHEMBL428239
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@@H]2c3cc(OC)c(O)cc3C=C(C)[C@H]2C)ccc1O,65.2,%,=,CHEMBL3290510
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1cc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)ccc1O,73.3,%,=,CHEMBL3290511
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,COc1ccc([C@H]2O[C@H](c3ccc4c(c3)OCO4)[C@@H](C)[C@H]2C)cc1OC,60.4,%,=,CHEMBL559937
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,C[C@@H]1[C@H](C)[C@@H](c2ccc3c(c2)OCO3)O[C@@H]1c1ccc2c(c1)OCO2,60.1,%,=,CHEMBL2151191
Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Activity,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,58.0,%,=,CHEMBL196
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,Oc1cccc(/C=C/c2cc(/C=C/c3ccc(O)c(O)c3)n[nH]2)c1,,%,,CHEMBL3358801
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,Oc1ccc(/C=C/c2cc(/C=C/c3ccccc3O)[nH]n2)cc1O,47.0,%,=,CHEMBL3358800
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,Oc1ccc(/C=C/c2cc(/C=C/c3ccc(O)c(O)c3)[nH]n2)cc1O,90.0,%,=,CHEMBL3358799
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,51.0,%,=,CHEMBL180239
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)C(C)(C)C(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,30.0,%,=,CHEMBL1645488
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)cc1,75.0,%,=,CHEMBL105350
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1cccc(O)c1,79.0,%,=,CHEMBL3358798
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)/C=C/c1ccccc1O,80.0,%,=,CHEMBL1983366
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,N#Cc1cccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)c1,96.0,%,=,CHEMBL3358797
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1cccc([N+](=O)[O-])c1)CC(=O)/C=C/c1ccc(O)c(O)c1,97.0,%,=,CHEMBL3358796
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1cc(O)c(O)c(O)c1)CC(=O)/C=C/c1ccccc1O,73.0,%,=,CHEMBL3358366
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1cc(O)c(O)c(O)c1)CC(=O)/C=C/c1cc(O)c(O)c(O)c1,46.0,%,=,CHEMBL3358365
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1c(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)cc1O,100.0,%,=,CHEMBL3358364
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1cc(O)c(O)c(O)c1,100.0,%,=,CHEMBL3358363
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)cc(OC)c1OC,95.0,%,=,CHEMBL3358362
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)cc1,95.0,%,=,CHEMBL3358361
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1ccc(O)c(O)c1,89.0,%,=,CHEMBL1083516
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1cccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(O)c2)c1,95.0,%,=,CHEMBL3358360
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1ccc(O)c(O)c1,99.0,%,=,CHEMBL3358359
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1ccccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)c(O)c1,100.0,%,=,CHEMBL3358358
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1ccccc1O,100.0,%,=,CHEMBL3358357
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1ccc(O)c(O)c1,99.0,%,=,CHEMBL319488
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,0.0,%,=,CHEMBL128748
Inhibition of amyloid beta-42 self-aggregation (unknown origin) at 25 uM after 20 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,80.0,%,=,CHEMBL116438
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCCN1CCN(Cc2ccccc2)CC1,,%,,CHEMBL3361262
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,CCN(CC)CCCN1C(=O)c2ccccc2S1(=O)=O,54.0,%,<=,CHEMBL3361261
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCCN(CCO)CCO,54.0,%,<=,CHEMBL3361260
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,CCN(CC)CCN1C(=O)c2ccccc2S1(=O)=O,54.0,%,<=,CHEMBL3361259
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCO,54.0,%,<=,CHEMBL3360756
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C1NS(=O)(=O)c2ccccc21,54.0,%,<=,CHEMBL310671
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,NS(=O)(=O)c1ccccc1Br,54.0,%,<=,CHEMBL1946184
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,Cc1ccccc1S(N)(=O)=O,54.0,%,<=,CHEMBL176892
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,NS(=O)(=O)c1ccc([N+](=O)[O-])cc1,54.0,%,<=,CHEMBL282157
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,COc1ccc(S(N)(=O)=O)cc1,54.0,%,<=,CHEMBL176402
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by atomic force microscopy,Inhibition,O=S(=O)(CCCN1CCC(c2ccccc2)CC1)NCCNc1cccc2ccccc12,,%,,CHEMBL3361265
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:1 after 4 days by Thioflavin-T fluorescence assay,Inhibition,Cl.O=S(=O)(CCCNCCNc1cccc2ccccc12)NCCNc1cccc2ccccc12,45.0,%,=,CHEMBL3361277
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=C(NCCCCNC(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1,,%,,CHEMBL3361279
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=C(CCC(=O)NCCNc1cccc2ccccc12)NCCNc1cccc2ccccc12,,%,,CHEMBL3361278
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,Cl.O=S(=O)(CCCNCCc1c[nH]c2ccccc12)NCCNc1cccc2ccccc12,,%,,CHEMBL3361276
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,Cl.O=S(=O)(CCCN(CCO)CCO)NCCNc1cccc2ccccc12,,%,,CHEMBL3361275
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,CC(C(O)c1ccccc1)N(C)CCCS(=O)(=O)NCCNc1cccc2ccccc12.Cl,,%,,CHEMBL3361274
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,Cl.O=S(=O)(CCCN1CCN(c2ncccn2)CC1)NCCNc1cccc2ccccc12,,%,,CHEMBL3361273
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,Cl.O=S(=O)(CCCN1CCC(O)CC1)NCCNc1cccc2ccccc12,64.0,%,=,CHEMBL3361272
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,CC(NCCCS(=O)(=O)NCCNc1cccc2ccccc12)c1ccccc1.Cl,,%,,CHEMBL3361271
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCN(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12,43.0,%,=,CHEMBL3361270
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCC(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12,60.0,%,=,CHEMBL3361269
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCOCC1)NCCNc1cccc2ccccc12,,%,,CHEMBL3361268
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCN(c2ccccn2)CC1)NCCNc1cccc2ccccc12,,%,,CHEMBL3361267
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCN(c2ccccc2)CC1)NCCNc1cccc2ccccc12,,%,,CHEMBL3361266
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCN1CCC(c2ccccc2)CC1)NCCNc1cccc2ccccc12,87.0,%,=,CHEMBL3361265
Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Inhibition,O=S(=O)(CCCCl)NCCNc1cccc2ccccc12,,%,,CHEMBL3361264
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,O=C1c2ccccc2S(=O)(=O)N1CCCN1CCC(O)CC1,,,,CHEMBL3361263
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,O=C1c2ccccc2S(=O)(=O)N1CCCN1CCN(Cc2ccccc2)CC1,,,,CHEMBL3361262
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,CCN(CC)CCCN1C(=O)c2ccccc2S1(=O)=O,,,,CHEMBL3361261
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,O=C1c2ccccc2S(=O)(=O)N1CCCN(CCO)CCO,,,,CHEMBL3361260
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,CCN(CC)CCN1C(=O)c2ccccc2S1(=O)=O,,,,CHEMBL3361259
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,O=C1c2ccccc2S(=O)(=O)N1CCO,,,,CHEMBL3360756
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,O=C1NS(=O)(=O)c2ccccc21,,,,CHEMBL310671
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,NS(=O)(=O)c1ccccc1Br,,,,CHEMBL1946184
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,Cc1ccccc1S(N)(=O)=O,,,,CHEMBL176892
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,NS(=O)(=O)c1ccc([N+](=O)[O-])cc1,,,,CHEMBL282157
Stimulation of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay,Activity,COc1ccc(S(N)(=O)=O)cc1,,,,CHEMBL176402
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCCN1CCC(O)CC1,54.0,%,<=,CHEMBL3361263
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C(CCC(=O)NCCNc1cccc2ccccc12)NCCNc1cccc2ccccc12,50.0,%,=,CHEMBL3361278
Inhibition of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Inhibition,O=C(NCCCCNC(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1,99.0,%,=,CHEMBL3361279
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCCl)NCCNc1cccc2ccccc12,,,,CHEMBL3361264
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCC(c2ccccc2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361265
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCN(c2ccccc2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361266
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCN(c2ccccn2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361267
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCOCC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361268
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCC(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361269
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,O=S(=O)(CCCN1CCN(Cc2ccccc2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361270
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,CC(NCCCS(=O)(=O)NCCNc1cccc2ccccc12)c1ccccc1.Cl,,,,CHEMBL3361271
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,Cl.O=S(=O)(CCCN1CCC(O)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361272
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,Cl.O=S(=O)(CCCN1CCN(c2ncccn2)CC1)NCCNc1cccc2ccccc12,,,,CHEMBL3361273
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,CC(C(O)c1ccccc1)N(C)CCCS(=O)(=O)NCCNc1cccc2ccccc12.Cl,,,,CHEMBL3361274
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,Cl.O=S(=O)(CCCN(CCO)CCO)NCCNc1cccc2ccccc12,,,,CHEMBL3361275
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,Cl.O=S(=O)(CCCNCCc1c[nH]c2ccccc12)NCCNc1cccc2ccccc12,,,,CHEMBL3361276
Stimulation of Amyloid beta (1 to 42) (unknown origin) oligomer assembly at Abeta:compound ratio of 0.0002 after 30 mins by single-site ELISA assay,Activity,Cl.O=S(=O)(CCCNCCNc1cccc2ccccc12)NCCNc1cccc2ccccc12,,,,CHEMBL3361277
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,550.0,nM,=,CHEMBL191083
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(=O)O,410.0,nM,<,CHEMBL3330737
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,10000.0,nM,>,CHEMBL3330738
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,7100.0,nM,=,CHEMBL3330739
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(N)=O,1500.0,nM,=,CHEMBL3330740
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=C1NC(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N1,10000.0,nM,>,CHEMBL3330741
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CN1C(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N(C)C1=O,10000.0,nM,>,CHEMBL3330742
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,10000.0,nM,>,CHEMBL3330743
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,10000.0,nM,>,CHEMBL3330744
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1)C(N)=O,10000.0,nM,>,CHEMBL3330745
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=O)s3)cc21,10000.0,nM,>,CHEMBL3330746
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=C(C#N)C#N)s3)cc21,10000.0,nM,>,CHEMBL3330747
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(/C=C(\C#N)C(N)=O)s3)cc21,10000.0,nM,>,CHEMBL3330748
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2ccc(-c3ccc(C=O)s3)s2)cc1,10000.0,nM,>,CHEMBL3330749
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2ccc(-c3ccc(C=C(C#N)C#N)s3)s2)cc1,1000.0,nM,<,CHEMBL3330750
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=O)s4)cc2n3C(C)(C)C)cc1,380.0,nM,<,CHEMBL3330751
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=C(C#N)C#N)s4)cc2n3C(C)(C)C)cc1,10000.0,nM,>,CHEMBL3330752
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(/C=C(\C#N)C(N)=O)s4)cc2n3C(C)(C)C)cc1,550.0,nM,=,CHEMBL3330753
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=Cc1ccc(-c2ccc(-c3ccc4[nH]ccc4c3)s2)s1,10000.0,nM,>,CHEMBL3330754
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,43.0,%,=,CHEMBL3330738
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1NC(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N1,0.0,%,=,CHEMBL3330741
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CN1C(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N(C)C1=O,18.0,%,=,CHEMBL3330742
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,44.0,%,=,CHEMBL3330743
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,30.0,%,=,CHEMBL3330744
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1)C(N)=O,46.0,%,=,CHEMBL3330745
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=O)s3)cc21,36.0,%,=,CHEMBL3330746
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=C(C#N)C#N)s3)cc21,16.0,%,=,CHEMBL3330747
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(/C=C(\C#N)C(N)=O)s3)cc21,36.0,%,=,CHEMBL3330748
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(-c2ccc(-c3ccc(C=O)s3)s2)cc1,0.0,%,=,CHEMBL3330749
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=C(C#N)C#N)s4)cc2n3C(C)(C)C)cc1,18.0,%,=,CHEMBL3330752
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=Cc1ccc(-c2ccc(-c3ccc4[nH]ccc4c3)s2)s1,46.0,%,=,CHEMBL3330754
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 1 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(=O)O,82.0,%,=,CHEMBL3330737
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 1 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(-c2ccc(-c3ccc(C=C(C#N)C#N)s3)s2)cc1,78.0,%,=,CHEMBL3330750
Inhibition of amyloid beta (1-42) aggregation (unknown origin) at 1 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=O)s4)cc2n3C(C)(C)C)cc1,61.0,%,=,CHEMBL3330751
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CN(C)c1ccc2nc3ccc(N)cc3[s+]c2c1.[Cl-],3000.0,nM,<,CHEMBL3330735
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CNc1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],3000.0,nM,<,CHEMBL3330736
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,3000.0,nM,<,CHEMBL164
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,3000.0,nM,<,CHEMBL253570
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2oc1=O,100000.0,nM,>,CHEMBL3326698
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2oc1=O,100000.0,nM,>,CHEMBL3326704
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,5000.0,nM,=,CHEMBL3326707
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2cc(OC(F)(F)F)ccc2oc1=O,24200.0,nM,=,CHEMBL3326709
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,13400.0,nM,=,CHEMBL3327246
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,6100.0,nM,=,CHEMBL3327247
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11000.0,nM,=,CHEMBL116438
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,54.6,%,=,CHEMBL1196204
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,11.0,%,=,CHEMBL292314
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CCOC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)OCCC3,41.8,%,=,CHEMBL1194313
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,Cl.O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,77.5,%,=,CHEMBL3322231
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,Cl.O=C(NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,54.3,%,=,CHEMBL3322234
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,Cl.O=C(NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,55.8,%,=,CHEMBL3322233
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,Cl.O=C(NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,52.5,%,=,CHEMBL3322232
Inhibition of aggregation of amyloid beta-42 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as amyloid fibril formation at 10 uM after 24 hrs by thioflavin S fluorescence method,Inhibition,CCNC(=O)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,,%,,CHEMBL3122167
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested at 1:1 compound to peptide ratio after 17 hrs by thioflavin T fluorescence method,Activity,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,16.0,%,=,CHEMBL297453
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested at 1:1 compound to peptide ratio after 17 hrs by thioflavin T fluorescence method,Activity,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,18.5,%,=,CHEMBL3298066
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested at 1:1 compound to peptide ratio after 17 hrs by thioflavin T fluorescence method,Activity,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,14.4,%,=,CHEMBL151
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested at 1:1 compound to peptide ratio after 17 hrs by thioflavin T fluorescence method,Activity,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,21.0,%,=,CHEMBL3297746
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in amyloid fibril formation at 40 uM after 5 days by Transmission electron microscopy,Inhibition,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,,%,,CHEMBL297453
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in amyloid fibril formation at 40 uM after 5 days by Transmission electron microscopy,Inhibition,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,,%,,CHEMBL3298066
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in amyloid fibril formation at 40 uM after 5 days by Transmission electron microscopy,Inhibition,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL151
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in amyloid fibril formation at 40 uM after 5 days by Transmission electron microscopy,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,4600.0,nM,=,CHEMBL297453
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,2700.0,nM,=,CHEMBL3298066
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6400.0,nM,=,CHEMBL151
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,5400.0,nM,=,CHEMBL3297746
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in large aggregates at 100 uM after 20 mins and 24 hrs by dynamic light scattering method,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in large aggregates at 400 uM after 20 mins and 2 hrs by size exclusion chromatography test,Activity,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,,,CHEMBL3297746
Inhibition of amyloid beta1-40 (unknown origin) aggregation,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,3000.0,nM,=,CHEMBL297453
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,Oc1ccc(/C=C/c2cc(O)c3c(c2)O[C@H](c2ccc(O)cc2)[C@H]3c2cc(O)cc(O)c2)cc1,39.0,%,=,CHEMBL1086500
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,OC[C@H]1O[C@@H](Oc2ccc(/C=C/c3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)[C@H]4c3cc(O)cc(O)c3)cc2)[C@H](O)[C@@H](O)[C@@H]1O,54.0,%,=,CHEMBL3331579
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,OC[C@H]1O[C@@H](Oc2ccc([C@H]3Oc4cc(/C=C/c5ccc(O)cc5)cc(O)c4[C@@H]3c3cc(O)cc(O)c3)cc2)[C@H](O)[C@@H](O)[C@@H]1O,58.0,%,=,CHEMBL3331580
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,OC[C@H]1O[C@@H](Oc2ccc(/C=C/c3cc(O)c4c(c3)O[C@@H](c3ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc3)[C@@H]4c3cc(O)cc(O)c3)cc2)[C@H](O)[C@@H](O)[C@@H]1O,56.0,%,=,CHEMBL3331581
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,OC[C@H]1O[C@@H](Oc2ccc(/C=C/c3cc(O)c4c(c3)O[C@H](c3ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc3)[C@H]4c3cc(O)cc(O)c3)cc2)[C@H](O)[C@@H](O)[C@@H]1O,56.0,%,=,CHEMBL3331582
Inhibition of Amyloid beta (25 to 35) (unknown origin) polymerization assessed as reduction in beta-amyloid fibril formation at 10 uM after 6 hrs by UV-visible spectroscopy,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,53.0,%,=,CHEMBL116438
Inhibition of Amyloid beta (1 to 40) (unknown origin) assessed as self-mediated fibril formation at 50 uM incubated for 48 hrs by transmission electron microscopy,Inhibition,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,,%,,CHEMBL636
Inhibition of Amyloid beta (1 to 40) (unknown origin) assessed as self-mediated fibril formation at 50 uM incubated for 48 hrs by transmission electron microscopy,Inhibition,COc1ccc(CN2CCCCC2)cc1OC(=O)N(C)C,,%,,CHEMBL3321877
Inhibition of Amyloid beta (1 to 40) (unknown origin) assessed as self-mediated fibril formation at 50 uM incubated for 48 hrs by transmission electron microscopy,Inhibition,COc1cc(CN2CCCCC2)ccc1OC(=O)N(C)C,,%,,CHEMBL3321885
Inhibition of Amyloid beta (1 to 40) (unknown origin) assessed as self-mediated fibril formation at 50 uM incubated for 48 hrs by transmission electron microscopy,Inhibition,COc1cc(C(C)N2CCCCC2)ccc1OC(=O)N(C)C,,%,,CHEMBL3321889
Inhibition of Amyloid beta (1 to 40) (unknown origin) assessed as self-mediated fibril formation at 50 uM incubated for 48 hrs by transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL116438
Binding affinity to amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Kd,COc1ccc(OCc2ccc([125I])cc2)cc1,0.56,nM,=,CHEMBL3314344
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(OCc2ccc(I)cc2)cc1,24.3,nM,=,CHEMBL3314322
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1cccc(OCc2ccc(I)cc2)c1,130.6,nM,=,CHEMBL3314323
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccccc1OCc1ccc(I)cc1,5164.8,nM,=,CHEMBL3314324
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1ccc(OCc2ccc(I)cc2)cc1,113.4,nM,=,CHEMBL3314325
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1cccc(OCc2ccc(I)cc2)c1,385.6,nM,=,CHEMBL3314326
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1ccccc1OCc1ccc(I)cc1,2831.2,nM,=,CHEMBL3314327
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Fc1ccc(OCc2ccc(I)cc2)cc1,107.1,nM,=,CHEMBL3314328
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Clc1ccc(OCc2ccc(I)cc2)cc1,18.8,nM,=,CHEMBL3314329
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Brc1ccc(OCc2ccc(I)cc2)cc1,12.0,nM,=,CHEMBL3314330
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Ic1ccc(COc2ccc(I)cc2)cc1,21.9,nM,=,CHEMBL3314331
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Ic1ccc(COc2ccccc2)cc1,79.4,nM,=,CHEMBL3314332
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CC(C)(C)c1ccc(OCc2ccc(I)cc2)cc1,117.6,nM,=,CHEMBL3314333
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccc(OCc2ccc(I)cc2)cc1,409.2,nM,=,CHEMBL3314334
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1cccc(OCc2ccc(I)cc2)c1,1534.7,nM,=,CHEMBL3314335
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccccc1OCc1ccc(I)cc1,1028.0,nM,=,CHEMBL3314336
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(OCc2ccc(I)cc2)cc1,48.2,nM,=,CHEMBL3314337
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1cccc(OCc2ccc(I)cc2)c1,593.6,nM,=,CHEMBL3314338
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccccc1OCc1ccc(I)cc1,20662.0,nM,=,CHEMBL3314339
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(OCc2ccc(I)cc2)cc1,17.6,nM,=,CHEMBL3314340
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1cccc(OCc2ccc(I)cc2)c1,894.2,nM,=,CHEMBL3314341
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(COc2ccc(I)cc2)cc1,49.4,nM,=,CHEMBL3314342
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(SCc2ccc(I)cc2)cc1,530.2,nM,=,CHEMBL3314343
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,32.2,nM,=,CHEMBL78012
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,38.8,nM,=,CHEMBL93124
Binding affinity to amyloid beta plaques in Alzheimer disease patient brain by thioflavin-S staining method,Activity,COc1ccc(OCc2ccc([125I])cc2)cc1,,,,CHEMBL3314344
Binding affinity to amyloid beta plaques in Alzheimer disease patient brain by thioflavin-S staining method,Activity,COc1ccc(COc2ccc([125I])cc2)cc1,,,,CHEMBL3314345
Binding affinity to amyloid beta plaques in Alzheimer disease patient brain by thioflavin-S staining method,Activity,CN(C)c1ccc(OCc2ccc([125I])cc2)cc1,,,,CHEMBL3314346
Binding affinity to amyloid beta plaques in APPswe/PSEN1 mouse brain by thioflavin-S staining method,Activity,COc1ccc(OCc2ccc([125I])cc2)cc1,,,,CHEMBL3314344
Binding affinity to amyloid beta plaques in APPswe/PSEN1 mouse brain by thioflavin-S staining method,Activity,COc1ccc(COc2ccc([125I])cc2)cc1,,,,CHEMBL3314345
Binding affinity to amyloid beta plaques in APPswe/PSEN1 mouse brain by thioflavin-S staining method,Activity,CN(C)c1ccc(OCc2ccc([125I])cc2)cc1,,,,CHEMBL3314346
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(OCc2ccc(I)cc2)cc1,24.55,nM,=,CHEMBL3314322
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1cccc(OCc2ccc(I)cc2)c1,131.83,nM,=,CHEMBL3314323
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccccc1OCc1ccc(I)cc1,5128.61,nM,=,CHEMBL3314324
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1ccc(OCc2ccc(I)cc2)cc1,112.2,nM,=,CHEMBL3314325
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1cccc(OCc2ccc(I)cc2)c1,389.05,nM,=,CHEMBL3314326
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Oc1ccccc1OCc1ccc(I)cc1,2818.38,nM,=,CHEMBL3314327
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Fc1ccc(OCc2ccc(I)cc2)cc1,107.15,nM,=,CHEMBL3314328
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Clc1ccc(OCc2ccc(I)cc2)cc1,18.62,nM,=,CHEMBL3314329
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Brc1ccc(OCc2ccc(I)cc2)cc1,12.02,nM,=,CHEMBL3314330
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Ic1ccc(COc2ccc(I)cc2)cc1,21.88,nM,=,CHEMBL3314331
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Ic1ccc(COc2ccccc2)cc1,79.43,nM,=,CHEMBL3314332
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CC(C)(C)c1ccc(OCc2ccc(I)cc2)cc1,117.49,nM,=,CHEMBL3314333
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccc(OCc2ccc(I)cc2)cc1,407.38,nM,=,CHEMBL3314334
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1cccc(OCc2ccc(I)cc2)c1,1548.82,nM,=,CHEMBL3314335
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,Nc1ccccc1OCc1ccc(I)cc1,1023.29,nM,=,CHEMBL3314336
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(OCc2ccc(I)cc2)cc1,47.86,nM,=,CHEMBL3314337
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1cccc(OCc2ccc(I)cc2)c1,588.84,nM,=,CHEMBL3314338
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccccc1OCc1ccc(I)cc1,20892.96,nM,=,CHEMBL3314339
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(OCc2ccc(I)cc2)cc1,17.78,nM,=,CHEMBL3314340
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1cccc(OCc2ccc(I)cc2)c1,891.25,nM,=,CHEMBL3314341
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(COc2ccc(I)cc2)cc1,48.98,nM,=,CHEMBL3314342
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,COc1ccc(SCc2ccc(I)cc2)cc1,524.81,nM,=,CHEMBL3314343
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,32.36,nM,=,CHEMBL78012
Displacement of [125I]1-Iodo-4-((4-methoxyphenoxy)methyl)benzene from amyloid beta42 (unknown origin) after 3 hrs by gamma counting,Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,38.9,nM,=,CHEMBL93124
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in beta c-terminal fragments at 50 nM to 10 uM after 48 hrs by immunoblotting method,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in alpha c-terminal fragments at 50 nM to 10 uM after 48 hrs by immunoblotting method,Activity,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,80.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in alpha c-terminal fragments at 50 nM to 10 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in full length APP level at 50 nM to 10 uM after 48 hrs by immunoblotting method,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in secreted APPalpha at 50 nM to 10 uM after 48 hrs by immunoblotting method,Activity,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,40.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in secreted APPbeta at 50 nM to 10 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in secreted APPalpha at 50 nM to 10 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells assessed as increase in c-terminal fragments at 50 nM to 10 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 100 nM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,20.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 50 nM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,21.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 1 uM after 48 hrs by immunoblotting method,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,,%,,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 500 nM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,31.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 1 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,54.0,%,=,CHEMBL3326535
Reduction in wild type APP751 (unknown origin) expressed in CHO cells at 10 uM after 48 hrs by immunoblotting method relative to untreated control,Inhibition,NC(=O)c1ccc(N2CCN(c3nc(-c4cccc(O)c4)cs3)CC2)c(Nc2nc(-c3cccc(O)c3)cs2)c1,63.0,%,=,CHEMBL3326535
Inhibition of aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM after 24 hrs by thioflavin S fluorescence assay,Inhibition,COc1cc(CCC(=O)/C=C/CCCNc2c3c(nc4cc(Cl)ccc24)CC2CC(C)=CC3C2)ccc1O,39.3,%,=,CHEMBL3355579
Inhibition of aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM after 24 hrs by thioflavin S fluorescence assay,Inhibition,COc1cc(CCC(=O)/C=C/c2ccc(CNc3c4c(nc5cc(Cl)ccc35)CC3CC(C)=CC4C3)cc2)ccc1O,70.6,%,=,CHEMBL3355580
Inhibition of aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM after 24 hrs by thioflavin S fluorescence assay,Inhibition,COc1cc(CCC(=O)/C=C/c2ccc(CNc3c4c(nc5cc(Cl)ccc35)CC3CC(C)=CC4C3)cc2)cc(CN(C)C)c1O,53.9,%,=,CHEMBL3355581
Inhibition of aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM after 24 hrs by thioflavin S fluorescence assay,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,8.9,%,=,CHEMBL140476
Inhibition of aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM after 24 hrs by thioflavin S fluorescence assay,Inhibition,CCCCC/C=C/C(=O)CCc1ccc(O)c(OC)c1,10.5,%,=,CHEMBL25948
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C.O=C(O)C(F)(F)F,,,,CHEMBL3329414
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C,,,,CHEMBL3329413
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL3329412
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,,,CHEMBL3329408
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,,,CHEMBL3329407
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,56.0,%,=,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,,,CHEMBL3329405
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,37.0,%,=,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL1914469
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,29.0,%,=,CHEMBL1915454
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL1915455
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:5 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,2.1,,=,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL1222250
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C.O=C(O)C(F)(F)F,,,,CHEMBL3329414
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C,,,,CHEMBL3329413
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL3329412
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,0.8,,=,CHEMBL3329411
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,0.7,,=,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,0.8,,=,CHEMBL3329409
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,,,CHEMBL3329408
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,,,CHEMBL3329407
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,2.8,,=,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,,,CHEMBL3329405
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,1.9,,=,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL1914469
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,1.8,,=,CHEMBL1915454
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,FC,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL1915455
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL1222250
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:5 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,40.0,%,=,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as increase in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,38.0,%,=,CHEMBL3329409
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as increase in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,27.0,%,=,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as increase in intensity of experimental fluorescence plateau at 1:10 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,14.0,%,=,CHEMBL3329411
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915455
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915454
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1914469
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329405
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,%,,CHEMBL3329407
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,%,,CHEMBL3329408
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329409
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329411
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3329412
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C,,%,,CHEMBL3329413
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329414
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as fold change in half-life of aggregation extension/reduction at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL1222250
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915455
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915454
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1914469
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329405
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,%,,CHEMBL3329407
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)C(C)C,,%,,CHEMBL3329408
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329409
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329411
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3329412
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C,,%,,CHEMBL3329413
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329414
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as reduction in intensity of experimental fluorescence plateau at 1:1 Abeta:compound ratio by thioflavin T assay based fluorescence microscopy,Inhibition,OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL1222250
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 4 to 24 hrs by transmission electron microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 4 to 24 hrs by transmission electron microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 4 to 24 hrs by transmission electron microscopy,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 100 uM after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation assessed as monomer stabilization at 100 uM after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:10 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:10 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:1 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL1915453
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:1 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3329406
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:1 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329410
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer formation at 1:2 Abeta:compound ratio after 4 to 6 hrs by capillary electrophoresis,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C,,%,,CHEMBL3329410
Binding affinity to amyloid beta (1 to 42) (unknown origin) at 2 mM by 2D-NOESY spectroscopy,Activity,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,,,,CHEMBL1945734
Binding affinity to amyloid beta (1 to 42) (unknown origin) at 2 mM by saturation transfer difference NMR analysis,Activity,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12,,,,CHEMBL1945734
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCN(CC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,85.5,%,=,CHEMBL3343708
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,85.2,%,=,CHEMBL3343712
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,83.8,%,=,CHEMBL3343713
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OCCNC1CCCCC1)C(=O)/C(=C/c1ccc(N(C)C)cc1)C2,84.3,%,=,CHEMBL3343715
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,,%,,CHEMBL3343718
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at 20 uM after 24 hrs by transmission electron microscopy,Inhibition,CCN(CC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,,%,,CHEMBL3343708
Inhibition of amyloid beta (1-42) (unknown origin) fibril formation at 20 uM after 24 hrs by transmission electron microscopy,Inhibition,CCCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,,%,,CHEMBL3343713
Disaggregation of amyloid beta (1-42) fibrils (unknown origin) at 20 uM after 24 hrs by thioflavin T fluorescence method,Activity,CCN(CC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,65.0,%,=,CHEMBL3343708
Disaggregation of amyloid beta (1-42) fibrils (unknown origin) at 20 uM after 24 hrs by thioflavin T fluorescence method,Activity,CCCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,73.8,%,=,CHEMBL3343713
Disaggregation of amyloid beta (1-42) fibrils (unknown origin) at 20 uM after 24 hrs by transmission electron microscopy,Activity,CCN(CC)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,,,,CHEMBL3343708
Disaggregation of amyloid beta (1-42) fibrils (unknown origin) at 20 uM after 24 hrs by transmission electron microscopy,Activity,CCCN(C)c1ccc(/C=C2\Cc3cc(OC)c(OCCN4CCCCC4)cc3C2=O)cc1,,,,CHEMBL3343713
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as fibril length at 300 uM for 7 days at pH 7.4 by transmission electron microscopy (Rvb = > 2 micrometer),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,2.0,um,<,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as fibril width at 300 uM for 7 days at pH 7.4 by transmission electron microscopy (Rvb = 12.3 +/- 1.2 nanometer),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,8.7,nm,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 900 uM after 72 hrs by CD spectra analysis (Rvb = 82 to 85%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,17.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 180 uM after 72 hrs by CD spectra analysis (Rvb = 82 to 85%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,5.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 36 uM after 72 hrs by CD spectra analysis (Rvb = 82 to 85%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,15.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 150 uM after 72 hrs by CD spectra analysis (Rvb = 84 to 87%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,36.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 30 uM after 72 hrs by CD spectra analysis (Rvb = 84 to 87%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,18.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as unordered at 6 uM after 72 hrs by CD spectra analysis (Rvb = 84 to 87%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,17.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 900 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,29.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 180 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,33.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 36 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,30.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 150 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,26.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 30 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,30.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-turns at 6 uM after 72 hrs by CD spectra analysis (Rvb = 0%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,27.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 900 uM after 72 hrs by CD spectra analysis (Rvb = 2 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,36.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 180 uM after 72 hrs by CD spectra analysis (Rvb = 2 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,36.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 36 uM after 72 hrs by CD spectra analysis (Rvb = 2 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,36.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 150 uM after 72 hrs by CD spectra analysis (Rvb = 1 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,16.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation by ThT fluorescence assay,Inhibition,OC[C@H]1O[C@@H](n2cc(COCC(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)COCC(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)nn2)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3327019
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation by ThT fluorescence assay,Inhibition,OC[C@H]1O[C@@H](n2cc(COCC(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)COCC(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)nn2)[C@H](O)[C@@H](O)[C@H]1O,,%,,CHEMBL3327020
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation by ThT fluorescence assay,Inhibition,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](n3cc(COCC(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)COCC(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)nn3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O,,%,,CHEMBL3327021
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation by ThT fluorescence assay,Inhibition,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation at 100 uM by ThT fluorescence assay,Activity,OC[C@H]1O[C@@H](n2cc(COCC(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)COCC(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)COCc3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)nn3)nn2)[C@H](O)[C@@H](O)[C@@H]1O,28.0,%,=,CHEMBL3327019
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation at 100 uM by ThT fluorescence assay,Activity,OC[C@H]1O[C@@H](n2cc(COCC(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)COCC(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)(COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)COCc3cn([C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)nn3)nn2)[C@H](O)[C@@H](O)[C@H]1O,28.0,%,=,CHEMBL3327020
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation at 100 uM by ThT fluorescence assay,Activity,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](n3cc(COCC(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)COCC(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)(COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)COCc4cn([C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)nn3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O,28.0,%,=,CHEMBL3327021
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as extension of lag phase of Abeta40 aggregation at 100 uM by ThT fluorescence assay,Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,45.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 6 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,21.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 30 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,20.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 150 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,22.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 36 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,19.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 180 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,26.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as alpha-helix at 900 uM after 72 hrs by CD spectra analysis (Rvb = 11 to 15%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,18.0,%,=,CHEMBL1236395
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 6 uM after 72 hrs by CD spectra analysis (Rvb = 1 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,35.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as beta-sheet at 30 uM after 72 hrs by CD spectra analysis (Rvb = 1 to 3%),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](Cn3cc(COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCC(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)(COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)COCc4cn(C[C@H]5O[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)nn4)nn3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,32.0,%,=,CHEMBL3327022
Inhibition of amyloid beta-40 aggregation (unknown origin) assessed as fibril width at 1800 uM for 7 days at pH 7.4 by transmission electron microscopy (Rvb = 12.3 +/- 1.2 nanometer),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,11.8,nm,=,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COC(=O)c1cc2c(cn1)[nH]c1ccccc12,22.1,%,=,CHEMBL453066
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Cc1nc(C(=O)NCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,42.4,%,=,CHEMBL3343883
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Cc1nc(C(=O)NCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,39.3,%,=,CHEMBL3343884
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Cc1nc(C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,41.5,%,=,CHEMBL3343885
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Cc1nc(C(=O)NCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,36.6,%,=,CHEMBL3343920
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,Cc1nc(C(=O)NCCCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,38.8,%,=,CHEMBL3343921
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c(cn1)[nH]c1ccccc12,41.2,%,=,CHEMBL3343922
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CCc1nc(C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc2c1[nH]c1ccccc12,44.6,%,=,CHEMBL3343882
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1,26.1,%,=,CHEMBL3343923
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2c([nH]c3ccccc32)c(-c2ccc(F)cc2)n1,29.7,%,=,CHEMBL3343924
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1ccc(-c2nc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc3c2[nH]c2ccccc23)cc1,25.2,%,=,CHEMBL3343925
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1Cc2[nH]c3ccccc3c2C[C@H]1C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,52.4,%,=,CHEMBL3343926
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1,65.8,%,=,CHEMBL3343927
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CC1c2[nH]c3ccccc3c2C[C@@H](C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)N1C(=O)OC(C)(C)C,42.3,%,=,CHEMBL3343928
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CC1N[C@H](C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)Cc2c1[nH]c1ccccc21,48.6,%,=,CHEMBL3343929
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,62.1,%,=,CHEMBL3343930
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,66.3,%,=,CHEMBL3343931
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,61.4,%,=,CHEMBL3343932
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,42.3,%,=,CHEMBL116438
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)[C@@H]1Cc2c([nH]c3ccccc23)CN1,63.7,%,=,CHEMBL3343927
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,56.7,%,=,CHEMBL76
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,COCCN(C[C@H]1CCCN(C2Cc3ccccc3C2)C1)C(=O)c1ccc2ccccc2c1,57.5,%,=,CHEMBL3338395
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,COCCN(C[C@@H]1CCCN(C2Cc3ccccc3C2)C1)C(=O)c1ccc2ccccc2c1,60.3,%,=,CHEMBL3338394
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,CCn1nc(C(=O)N2CCCC2)c2c1CCC(NCCc1nc(-c3ccccc3)cs1)C2,,%,,CHEMBL3338393
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,CC(c1nc2ccccc2s1)N(C)C(=O)CN1CCCC1c1ccc2c(c1)OCCCO2,,%,,CHEMBL3338392
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 8 to 48 hrs by thioflavin T fluorescence method,Inhibition,COCCN(CC1CCCN(C2Cc3ccccc3C2)C1)C(=O)c1ccc2ccccc2c1,61.7,%,=,CHEMBL3338391
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCNC4=CC(=O)c5ccccc5C4=O)c2c1)CCCC3,22.4,%,=,CHEMBL3356528
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCCNC4=CC(=O)c5ccccc5C4=O)c2c1)CCCC3,32.9,%,=,CHEMBL3356529
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,28.0,%,=,CHEMBL3356530
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,31.1,%,=,CHEMBL3356531
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C=C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,22.6,%,=,CHEMBL3356532
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C=C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,41.2,%,=,CHEMBL3356533
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(NCCNc2c3c(nc4ccccc24)CCCC3)=CC(=O)c2c(O)cccc21,39.9,%,=,CHEMBL3356534
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(NCCCNc2c3c(nc4ccccc24)CCCC3)=CC(=O)c2c(O)cccc21,37.9,%,=,CHEMBL3356535
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)=CC(=O)c2c(O)cccc21,37.5,%,=,CHEMBL3356536
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)=CC(=O)c2c(O)cccc21,,%,,CHEMBL3356537
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCNC4=CC(=O)c5c(O)cccc5C4=O)c2c1)CCCC3,41.3,%,=,CHEMBL3356538
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCCNC4=CC(=O)c5c(O)cccc5C4=O)c2c1)CCCC3,41.6,%,=,CHEMBL3356539
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCNC4=C(Cl)C(=O)c5ccccc5C4=O)c2c1)CCCC3,29.3,%,=,CHEMBL3356540
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(NCCCNC4=C(Cl)C(=O)c5ccccc5C4=O)c2c1)CCCC3,40.6,%,=,CHEMBL3356950
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(Cl)=C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,33.2,%,=,CHEMBL3356951
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(Cl)=C(NCCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)C(=O)c2ccccc21,52.8,%,=,CHEMBL3356952
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(Cl)=C(NCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,26.6,%,=,CHEMBL3356953
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,O=C1C(Cl)=C(NCCCNc2c3c(nc4ccccc24)CCCC3)C(=O)c2ccccc21,34.8,%,=,CHEMBL3356954
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,5.0,%,<,CHEMBL292314
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc2nc3c(c(N)c2c1)CCCC3,,%,,CHEMBL1256415
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,87.1,%,=,CHEMBL231160
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,64.2,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,50.2,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,CC(C)NNC(=O)c1ccncc1,,%,,CHEMBL92401
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,C#CCN(C)Cc1ccccc1,,%,,CHEMBL673
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)[nH]c2cc(NCc3ccccc3O)ccc12,32.6,%,=,CHEMBL3394545
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(NCc3ccccc3O)ccc2c2c1CCC2,41.6,%,=,CHEMBL3394544
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(NCc3ccccc3O)ccc2c2c1CCCC2,43.7,%,=,CHEMBL3394543
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(Cl)c(=O)oc2cc(NCc3ccccc3O)ccc12,47.6,%,=,CHEMBL3394542
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(C)c2ccc(NCc3ccccc3O)cc2oc1=O,47.7,%,=,CHEMBL3394541
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)oc2cc(NCc3ccccc3O)ccc12,36.1,%,=,CHEMBL3394540
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(C)c2ccc(/N=C/c3ccccc3O)cc2[nH]c1=O,49.1,%,=,CHEMBL3394539
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)[nH]c2cc(/N=C/c3ccccc3O)ccc12,35.6,%,=,CHEMBL3394538
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(/N=C/c3ccc(O)cc3O)ccc2c2c1CCC2,56.4,%,=,CHEMBL3394537
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(/N=C/c3ccc(O)cc3O)ccc2c2c1CCCC2,58.5,%,=,CHEMBL3394536
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(Cl)c(=O)oc2cc(/N=C/c3ccc(O)cc3O)ccc12,60.2,%,=,CHEMBL3394535
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(C)c2ccc(/N=C/c3ccc(O)cc3O)cc2oc1=O,57.6,%,=,CHEMBL3394534
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(/N=C/c3ccccc3O)ccc2c2c1CCC2,52.9,%,=,CHEMBL3394533
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,O=c1oc2cc(/N=C/c3ccccc3O)ccc2c2c1CCCC2,53.7,%,=,CHEMBL3394532
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(Cl)c(=O)oc2cc(/N=C/c3ccccc3O)ccc12,49.3,%,=,CHEMBL3394531
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1c(C)c2ccc(/N=C/c3ccccc3O)cc2oc1=O,53.9,%,=,CHEMBL3394530
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)oc2cc(/N=C/c3ccc(Br)cc3O)ccc12,51.5,%,=,CHEMBL3394529
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1ccc(/C=N/c2ccc3c(C)cc(=O)oc3c2)c(O)c1,49.4,%,=,CHEMBL3394528
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc(/C=N/c2ccc3c(C)cc(=O)oc3c2)c(O)c1,50.2,%,=,CHEMBL3394527
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)oc2cc(/N=C/c3ccc(O)cc3O)ccc12,50.3,%,=,CHEMBL3394526
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence method,Inhibition,Cc1cc(=O)oc2cc(/N=C/c3ccccc3O)ccc12,44.8,%,=,CHEMBL574382
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 5 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCC(O)CNc1c2c(nc3ccccc13)CCCC2,12.8,%,=,CHEMBL3393735
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 5 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCC(O)CNc1c2c(nc3cc(Cl)ccc13)CCCC2,9.2,%,=,CHEMBL3393736
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 5 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCC(O)CNc2c3c(nc4ccccc24)CCCC3)ccc1O,8.4,%,=,CHEMBL3393737
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 5 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCC(O)CNc2c3c(nc4cc(Cl)ccc24)CCCC3)ccc1O,13.5,%,=,CHEMBL3393738
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 5 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],76.6,%,=,CHEMBL429694
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCC(O)CNc1c2c(nc3ccccc13)CCCC2,49.8,%,=,CHEMBL3393735
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCC(O)CNc1c2c(nc3cc(Cl)ccc13)CCCC2,53.2,%,=,CHEMBL3393736
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCC(O)CNc2c3c(nc4ccccc24)CCCC3)ccc1O,46.3,%,=,CHEMBL3393737
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCC(O)CNc2c3c(nc4cc(Cl)ccc24)CCCC3)ccc1O,48.9,%,=,CHEMBL3393738
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM pre-incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],93.2,%,=,CHEMBL429694
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCN(C)Cc3ccccc3)oc2c1,23.0,%,=,CHEMBL3398298
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,21.1,%,=,CHEMBL3398299
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCN(C)Cc3ccccc3OC)oc2c1,43.6,%,=,CHEMBL3398300
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,47.9,%,=,CHEMBL3398301
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN(C)Cc3ccccc3)oc2c1,24.4,%,=,CHEMBL3398302
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,39.0,%,=,CHEMBL3398303
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN(C)Cc3ccccc3OC)oc2c1,47.5,%,=,CHEMBL3398304
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,51.0,%,=,CHEMBL3398305
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1N(C)C,25.6,%,=,CHEMBL3398306
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccc(N(C)C)cc1,37.1,%,=,CHEMBL3398307
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,C#CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,22.4,%,=,CHEMBL3398308
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN3CCOc4ccccc4C3)oc2c1,40.9,%,=,CHEMBL3398309
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCN(C)Cc3ccccc3)oc2c1,33.5,%,=,CHEMBL3398310
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,28.6,%,=,CHEMBL3398311
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCN(C)Cc3ccccc3OC)oc2c1,43.9,%,=,CHEMBL3398312
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,58.2,%,=,CHEMBL3398313
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,35.1,%,=,CHEMBL3398314
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,37.8,%,=,CHEMBL3398315
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,39.4,%,=,CHEMBL3398316
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(N(C)C)cc2o1)Cc1ccccc1OC,41.1,%,=,CHEMBL3398317
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(N(C)C)cc2o1)Cc1ccccc1N(C)C,40.8,%,=,CHEMBL3398318
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CN(CCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1,43.9,%,=,CHEMBL3398319
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1ccccc1CN(C)CCCNC(=O)c1cc(=O)c2c(O)cccc2o1,50.6,%,=,CHEMBL3398320
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1ccccc1CN(C)CCCCNC(=O)c1cc(=O)c2c(O)cccc2o1,49.3,%,=,CHEMBL3398321
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,48.7,%,=,CHEMBL3398322
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,59.2,%,=,CHEMBL3398323
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,63.0,%,=,CHEMBL3398324
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL116438
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCN(C)Cc3ccccc3)oc2c1,24.3,%,=,CHEMBL3398298
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,31.5,%,=,CHEMBL3398299
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCN(C)Cc3ccccc3OC)oc2c1,28.7,%,=,CHEMBL3398300
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,27.2,%,=,CHEMBL3398301
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN(C)Cc3ccccc3)oc2c1,35.3,%,=,CHEMBL3398302
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,34.1,%,=,CHEMBL3398303
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN(C)Cc3ccccc3OC)oc2c1,36.3,%,=,CHEMBL3398304
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,38.9,%,=,CHEMBL3398305
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1N(C)C,20.0,%,=,CHEMBL3398306
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccc(N(C)C)cc1,28.8,%,=,CHEMBL3398307
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,C#CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,21.5,%,=,CHEMBL3398308
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCN3CCOc4ccccc4C3)oc2c1,35.0,%,=,CHEMBL3398309
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCN(C)Cc3ccccc3)oc2c1,37.1,%,=,CHEMBL3398310
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1,42.6,%,=,CHEMBL3398311
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(O)c2c(=O)cc(C(=O)NCCCCCCN(C)Cc3ccccc3OC)oc2c1,48.1,%,=,CHEMBL3398312
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(OC)cc2o1)Cc1ccccc1OC,52.0,%,=,CHEMBL3398313
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,18.1,%,=,CHEMBL3398314
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,32.1,%,=,CHEMBL3398315
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cc(O)cc2o1)Cc1ccccc1OC,28.7,%,=,CHEMBL3398316
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(N(C)C)cc2o1)Cc1ccccc1OC,36.9,%,=,CHEMBL3398317
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cc(N(C)C)cc2o1)Cc1ccccc1N(C)C,30.7,%,=,CHEMBL3398318
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CN(CCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1,25.8,%,=,CHEMBL3398319
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1ccccc1CN(C)CCCNC(=O)c1cc(=O)c2c(O)cccc2o1,23.8,%,=,CHEMBL3398320
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1ccccc1CN(C)CCCCNC(=O)c1cc(=O)c2c(O)cccc2o1,24.1,%,=,CHEMBL3398321
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,35.2,%,=,CHEMBL3398322
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,48.3,%,=,CHEMBL3398323
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,CCN(CCCCCCNC(=O)c1cc(=O)c2c(O)cccc2o1)Cc1ccccc1OC,55.6,%,=,CHEMBL3398324
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of Cu2+-mediated aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,58.0,%,=,CHEMBL116438
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCC(Cc3ccccc3)CC2)cc(OC)c1OC,74.99,%,=,CHEMBL3397872
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCC(Cc3ccccc3)CC2)cc(OC)c1OC,78.22,%,=,CHEMBL3397873
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCC(Cc3ccccc3)CC2)cc(OC)c1OC,85.41,%,=,CHEMBL3397874
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCN2CCC(Cc3ccccc3)CC2)cc1OC,54.68,%,=,CHEMBL3397875
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCN2CCC(Cc3ccccc3)CC2)cc1OC,84.37,%,=,CHEMBL3397054
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCCN2CCC(Cc3ccccc3)CC2)cc1OC,80.74,%,=,CHEMBL3397876
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCC(Cc3ccccc3)CC2)ccc1O,84.37,%,=,CHEMBL3397877
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCC(Cc3ccccc3)CC2)ccc1O,88.04,%,=,CHEMBL3397878
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCC(Cc3ccccc3)CC2)ccc1O,71.35,%,=,CHEMBL3397879
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CC2CCN(CCNCc3cccnc3)CC2)cc1,84.37,%,=,CHEMBL3397880
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CC2CCN(CCCNCc3cccnc3)CC2)cc1,88.81,%,=,CHEMBL3397881
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CC2CCN(CCCCNCc3cccnc3)CC2)cc1,78.64,%,=,CHEMBL3397882
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,75.51,%,=,CHEMBL3397883
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,79.68,%,=,CHEMBL3397884
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,80.42,%,=,CHEMBL3397885
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCN2CCN(Cc3ccccc3)CC2)cc1OC,80.72,%,=,CHEMBL3397886
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCN2CCN(Cc3ccccc3)CC2)cc1OC,79.68,%,=,CHEMBL3397887
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCCN2CCN(Cc3ccccc3)CC2)cc1OC,67.7,%,=,CHEMBL3397888
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCN(Cc3ccccc3)CC2)ccc1O,71.87,%,=,CHEMBL3397889
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCN(Cc3ccccc3)CC2)ccc1O,67.18,%,=,CHEMBL3397890
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCN(Cc3ccccc3)CC2)ccc1O,72.39,%,=,CHEMBL3397894
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CN2CCN(CCNCc3cccnc3)CC2)cc1,56.77,%,=,CHEMBL3397893
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CN2CCN(CCCNCc3cccnc3)CC2)cc1,63.01,%,=,CHEMBL3397891
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(CN2CCN(CCCCNCc3cccnc3)CC2)cc1,69.27,%,=,CHEMBL3397892
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1OC,68.74,%,=,CHEMBL3397895
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1OC,68.22,%,=,CHEMBL3397896
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1OC,57.29,%,=,CHEMBL3397897
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1OC,67.62,%,=,CHEMBL3397898
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1OC,65.62,%,=,CHEMBL3397899
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNCCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)cc1OC,57.81,%,=,CHEMBL3397900
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)ccc1O,43.54,%,=,CHEMBL3397901
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)ccc1O,54.16,%,=,CHEMBL3397902
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(CNCCCCN2CCN(CC(c3ccccc3)c3ccccc3)CC2)ccc1O,42.18,%,=,CHEMBL3397903
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(C(CN2CCN(CCNCc3cccnc3)CC2)c2ccccc2)cc1,60.41,%,=,CHEMBL3397904
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(C(CN2CCN(CCCNCc3cccnc3)CC2)c2ccccc2)cc1,55.41,%,=,CHEMBL3397905
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,c1ccc(C(CN2CCN(CCCCNCc3cccnc3)CC2)c2ccccc2)cc1,57.49,%,=,CHEMBL3397906
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCCN2CCC(Cc3ccccc3)CC2)cc(OC)c1OC,1.51,,=,CHEMBL3397873
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCCCN2CCC(Cc3ccccc3)CC2)cc(OC)c1OC,1.51,,=,CHEMBL3397874
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1ccc(CNCCCN2CCC(Cc3ccccc3)CC2)cc1OC,1.51,,=,CHEMBL3397054
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1ccc(CNCCCCN2CCC(Cc3ccccc3)CC2)cc1OC,1.51,,=,CHEMBL3397876
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCN2CCC(Cc3ccccc3)CC2)ccc1O,1.51,,=,CHEMBL3397877
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCCN2CCC(Cc3ccccc3)CC2)ccc1O,1.51,,=,CHEMBL3397878
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,c1ccc(CC2CCN(CCNCc3cccnc3)CC2)cc1,1.51,,=,CHEMBL3397880
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,c1ccc(CC2CCN(CCCNCc3cccnc3)CC2)cc1,1.51,,=,CHEMBL3397881
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,c1ccc(CC2CCN(CCCCNCc3cccnc3)CC2)cc1,1.51,,=,CHEMBL3397882
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCCN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,1.71,,=,CHEMBL3397884
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1cc(CNCCCCN2CCN(Cc3ccccc3)CC2)cc(OC)c1OC,1.71,,=,CHEMBL3397885
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1ccc(CNCCN2CCN(Cc3ccccc3)CC2)cc1OC,1.71,,=,CHEMBL3397886
Ratio of curcumin to compound for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Ratio,COc1ccc(CNCCCN2CCN(Cc3ccccc3)CC2)cc1OC,1.71,,=,CHEMBL3397887
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.8,%,=,CHEMBL116438
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)CC,5.0,%,<,CHEMBL3397151
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,20.0,%,=,CHEMBL3397150
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)[C@@H](C)CC)C(=O)O,5.0,%,<,CHEMBL3397149
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)cccc12)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)N[C@H](C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)C(C)C,7.0,%,=,CHEMBL3397158
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)cccc12)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)N[C@H](C(=O)O)C(C)C,13.0,%,=,CHEMBL3397157
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)cccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O,12.0,%,=,CHEMBL3397156
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)cccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)O,9.0,%,=,CHEMBL3397155
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,49.0,%,=,CHEMBL3397154
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC,56.0,%,=,CHEMBL3397153
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,5.0,%,<,CHEMBL3397152
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)CC,10.0,%,=,CHEMBL3397151
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,16.0,%,=,CHEMBL3397150
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)[C@@H](C)CC)C(=O)O,13.0,%,=,CHEMBL3397149
Inhibition of authentic Amyloid beta (1 to 42) (unknown origin) aggregation 6 to 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL3397160
Inhibition of authentic Amyloid beta (1 to 42) (unknown origin) aggregation 6 to 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(C)C,,%,,CHEMBL3397159
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,5.0,%,<,CHEMBL3397152
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC,56.0,%,=,CHEMBL3397153
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)C(C)C)cccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)[C@@H](C)CC,39.0,%,=,CHEMBL3397154
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)cccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)O,5.0,%,<,CHEMBL3397155
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)CCc1cccc2c1oc1c(CCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)cccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O,5.0,%,<,CHEMBL3397156
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN)cccc12)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)N[C@H](C(=O)O)C(C)C,5.0,%,<,CHEMBL3397157
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)CNC(=O)CCc1cccc2c1oc1c(CCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)cccc12)C(=O)N[C@@H](CC[S+](C)[O-])C(=O)N[C@H](C(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)C(C)C,5.0,%,<,CHEMBL3397158
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation 6 to 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(C)C,,%,,CHEMBL3397159
Inhibition of pH-click Amyloid beta (1 to 42) (unknown origin) aggregation 6 to 48 hrs by Thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)O)C(C)C,,%,,CHEMBL3397160
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,25.6,%,=,CHEMBL3403872
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,30.3,%,=,CHEMBL3403873
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,33.8,%,=,CHEMBL3403874
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)cc3)cc(=O)c2c(OC)c1OC,35.5,%,=,CHEMBL3400187
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3cccc(OCC(=O)NCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,30.6,%,=,CHEMBL3403875
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3cccc(OCC(=O)NCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,31.8,%,=,CHEMBL3403876
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3cccc(OCC(=O)NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,32.5,%,=,CHEMBL3403877
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3cccc(OCC(=O)NCCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)c3)cc(=O)c2c(OC)c1OC,34.3,%,=,CHEMBL3403878
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(OC)c1OC,11.2,%,=,CHEMBL74490
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3cccc(O)c3)cc(=O)c2c(OC)c1OC,17.4,%,=,CHEMBL3401031
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,,%,,CHEMBL292314
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,47.8,%,=,CHEMBL116438
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC(=O)N6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2206986
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C(=O)C(C)C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL2206995
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207065
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL2207043
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2207042
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CNCCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,91.0,nM,=,CHEMBL2207069
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206994
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCOC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207044
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCN6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL2207050
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6(C)COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,400.0,nM,=,CHEMBL2206992
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CNC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206993
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,140.0,nM,=,CHEMBL3403815
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403817
Inhibition of beta-sheet formation in amyloid beta-42 (unknown origin) assessed as decrease in ThT fluorescence after 1 hr by spectrophotometric plate reader,Inhibition,COc1ccc(/C=C/[C@H]2CCC=C[C@@H]2c2ccc(OC)c(OC)c2)cc1OC,,%,,CHEMBL1818725
Inhibition of beta-sheet formation in amyloid beta-42 (unknown origin) assessed as decrease in ThT fluorescence after 1 hr by spectrophotometric plate reader,Inhibition,COc1cc(/C=C/C(=O)C2(C(=O)/C=C/c3ccc(O)c(OC)c3)CCC=C[C@@H]2c2ccc(OC)c(OC)c2)ccc1O,,%,,CHEMBL3401337
Inhibition of beta-sheet formation in amyloid beta-42 (unknown origin) assessed as decrease in ThT fluorescence at 50 uM after 1 hr by spectrophotometric plate reader,Inhibition,COc1cc(/C=C/C(=O)C2(C(=O)/C=C/c3ccc(O)c(OC)c3)CCC=C[C@@H]2c2ccc(OC)c(OC)c2)ccc1O,18.9,%,=,CHEMBL3401337
Inhibition of beta-sheet formation in amyloid beta-42 (unknown origin) assessed as decrease in ThT fluorescence at 50 uM after 1 hr by spectrophotometric plate reader,Inhibition,COc1ccc(/C=C/[C@H]2CCC=C[C@@H]2c2ccc(OC)c(OC)c2)cc1OC,59.6,%,=,CHEMBL1818725
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,130.0,nM,=,CHEMBL3403818
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,68.0,nM,=,CHEMBL3403819
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403820
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,,,,CHEMBL3403821
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403822
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL3403823
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL3403824
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403825
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403826
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403827
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403816
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,5.0,%,<,CHEMBL3402706
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,5.0,%,<,CHEMBL3402707
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,5.0,%,<,CHEMBL3402708
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,5.0,%,<,CHEMBL3402709
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1.Cl,5.0,%,<,CHEMBL3402710
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,5.0,%,<,CHEMBL3402711
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,5.0,%,<,CHEMBL3402712
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,5.0,%,<,CHEMBL3402713
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,5.0,%,<,CHEMBL3402714
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1ccccc1F.Cl,5.0,%,<,CHEMBL3402715
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,5.0,%,<,CHEMBL3402716
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,5.0,%,<,CHEMBL3402717
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,5.0,%,<,CHEMBL3402718
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,5.0,%,<,CHEMBL3402719
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,CN(CCCCCCCCN1C(=O)c2ccccc2C1=O)Cc1cccc(Cl)c1.Cl,5.0,%,<,CHEMBL3402720
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,Cl.O=C1c2ccccc2C(=O)N1Cc1ccc(CNCc2ccccc2)cc1,5.0,%,<,CHEMBL3402721
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,Cl.O=C1c2ccccc2C(=O)N1Cc1ccc(CNCc2ccccc2F)cc1,5.0,%,<,CHEMBL3402722
Inhibition of recombinant human HFIP-pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay,Inhibition,Cl.O=C1c2ccccc2C(=O)N1Cc1ccc(CNCc2cccc(Cl)c2)cc1,5.0,%,<,CHEMBL3402723
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCNC1CCN(Cc2ccccc2)CC1,10.0,%,<,CHEMBL3402288
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNC1CCN(Cc2ccccc2)CC1,69.1,%,=,CHEMBL3402289
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCNC1CCN(Cc2ccccc2)CC1,10.0,%,<,CHEMBL3402290
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCCNC1CCN(Cc2ccccc2)CC1,54.6,%,=,CHEMBL3400171
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCCNC1CCN(Cc2cccc(Cl)c2)CC1,72.5,%,=,CHEMBL3402296
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,COc1ccc(CN2CCC(NCCCN3C(=O)c4ccccc4C3=O)CC2)cc1,10.0,%,<,CHEMBL3402300
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,c1ccc(CN2CCC(NCCCn3ccc4ccccc43)CC2)cc1,27.8,%,=,CHEMBL3402303
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,c1ccc(CN2CCC(NCCCCCn3ccc4ccccc43)CC2)cc1,10.0,%,<,CHEMBL3402304
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,c1ccc(CN2CCC(NCCCCCCn3ccc4ccccc43)CC2)cc1,56.0,%,=,CHEMBL3402305
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,c1ccc(CN2CCC(NCCCCCCCCn3ccc4ccccc43)CC2)cc1,76.5,%,=,CHEMBL3402306
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,Fc1ccccc1CN1CCC(NCCCCCCCCn2ccc3ccccc32)CC1,10.0,%,<,CHEMBL3402308
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) at 10 uM aggregation by thioflavin-T assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,13.8,%,=,CHEMBL502
Inhibition of self-induced beta-amyloid (1 to 42) (unknown origin) aggregation by thioflavin-T assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCCNC1CCN(Cc2cccc(Cl)c2)CC1,,%,,CHEMBL3402296
Inhibition of amyloid beta40 production in human IMR32 cell by ELISA,Inhibition,COc1cc(N2CCN(C(=O)Cn3cnc4cc(C(F)(F)F)ccc43)C[C@@H]2C)ccc1-c1cnc(C)o1,,%,,CHEMBL3402161
Inhibition of amyloid beta42 production in human IMR32 cell by ELISA,Inhibition,COc1cc(N2CCN(C(=O)Cn3cnc4cc(C(F)(F)F)ccc43)C[C@@H]2C)ccc1-c1cnc(C)o1,,%,,CHEMBL3402161
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,O=C(Cc1ccccc1)NC(CSSCC(NC(=O)Cc1ccccc1)C(=O)O)C(=O)O,1950.0,nM,=,CHEMBL576840
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,CNc1ccc(C(=O)NC(CCCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,2750.0,nM,=,CHEMBL3400292
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1,,%,,CHEMBL3409487
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) after 7 days by thioflavin T fluorescence method,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) at 0.78 to 3200 uM after 1.5 hrs using anti-amyloid beta antibody DE2B4 by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1,,%,,CHEMBL3409487
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 3200 uM after 1.5 hrs using anti-amyloid beta antibody DE2B4 by dot blot analysis,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 3200 uM after 1.5 hrs using anti-amyloid beta antibody DE2B4 by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) at 0.78 to 3200 uM after 1.5 hrs using anti-oligomer A11 antibody by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)OCc1ccccc1,,%,,CHEMBL359477
Inhibition of amyloid beta(42) aggregation (unknown origin) at 0.78 to 3200 uM after 1.5 hrs using anti-oligomer A11 antibody by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1,,%,,CHEMBL3409487
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 3200 uM after 1.5 hrs using anti-oligomer A11 antibody by dot blot analysis,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 3200 uM after 1.5 hrs using anti-oligomer A11 antibody by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,CNc1ccc(C(=O)N[C@@H](CCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,,%,,CHEMBL3409485
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)OCc1ccccc1,,%,,CHEMBL359477
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM after 0.5 to 70 hrs by kinetic study,Inhibition,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL468154
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM up to 1.5 hrs by kinetic study,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 0.78 to 3200 uM after 1.5 hrs using anti-amyloid beta antibody DE2B4 by dot blot analysis,Inhibition,O=C(NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)OCc1ccccc1,,%,,CHEMBL359477
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 7 days by thioflavin T fluorescence method,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 7 days by thioflavin T fluorescence method,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) at 3200 uM after 7 days by thioflavin T fluorescence method,Inhibition,CNc1ccc(C(=O)N[C@@H](CCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,,%,,CHEMBL3409485
Inhibition of amyloid beta(42) aggregation (unknown origin) at 0.75 to 100 uM after 7 days by thioflavin T fluorescence method,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1,,%,,CHEMBL3409487
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 7 days by transmission electron microscopy,Inhibition,O=C(NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)OCc1ccccc1,,%,,CHEMBL359477
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 7 days by transmission electron microscopy,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1,,%,,CHEMBL3409487
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 3200 uM after 7 days by transmission electron microscopy,Inhibition,CNc1ccc(C(=O)N[C@@H](CCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,,%,,CHEMBL3409485
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 to 200 uM after 7 days by transmission electron microscopy,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) after 7 days by thioflavin T fluorescence method,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) after 7 days by thioflavin T fluorescence method,Inhibition,CNc1ccc(C(=O)N[C@@H](CCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,,%,,CHEMBL3409485
Inhibition of amyloid beta(42) aggregation (unknown origin) assessed as A11-positive oligomer formation at 100 uM up to 1.5 hrs by kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM up to 1.5 hrs by thioflavin T fluorescence-based kinetic study,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM up to 1.5 hrs by thioflavin T fluorescence-based kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 5 hrs by thioflavin T fluorescence-based kinetic study,Inhibition,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O,,%,,CHEMBL3409486
Inhibition of amyloid beta(42) aggregation (unknown origin) at 100 uM after 5 hrs by thioflavin T fluorescence-based kinetic study,Inhibition,O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1,,%,,CHEMBL3409488
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCNCc1ccccc1,10.0,%,<,CHEMBL3415557
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1,10.0,%,<,CHEMBL3415558
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1,10.0,%,<,CHEMBL3415559
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1,10.0,%,<,CHEMBL3415560
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCCNCc1ccccc1,13.47,%,=,CHEMBL3415561
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccccc1F,13.74,%,=,CHEMBL3415563
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccccc1F,10.0,%,<,CHEMBL3415564
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccccc1F,17.12,%,=,CHEMBL3415565
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,65.96,%,=,CHEMBL3415568
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccc(F)cc1,10.0,%,<,CHEMBL3415570
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1F,31.6,%,=,CHEMBL3415573
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1F,62.09,%,=,CHEMBL3415574
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1ccc(F)cc1F,10.0,%,<,CHEMBL3415575
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1cccc(Cl)c1,10.0,%,<,CHEMBL3415578
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCNCc1cccc(Cl)c1,20.75,%,=,CHEMBL3415579
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCCCNCc1cccc(Cl)c1,10.0,%,<,CHEMBL3415580
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,13.8,%,=,CHEMBL502
Inhibition of human recombinant amyloid beta (1 to 42) self-induced aggregation after 24 hrs by thioflavin-T based fluorometric assay,Inhibition,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,,%,,CHEMBL3415568
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 1 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,84.55,%,=,CHEMBL3415568
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 1 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1F,80.3,%,=,CHEMBL3415574
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 3 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,76.25,%,=,CHEMBL3415568
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 3 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1F,66.55,%,=,CHEMBL3415574
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 10 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCNCc1ccc(F)cc1,,,,CHEMBL3415568
Neuroprotective activity in human SH-SY5Y cells assessed as inhibition amyloid beta (1 to 42)-induced cytotoxicity at 10 uM after 48 hrs,Activity,O=C1c2ccccc2C(=O)N1CCCCCCNCc1ccc(F)cc1F,,,,CHEMBL3415574
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,32.1,%,=,CHEMBL3577505
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2oc(-c3ccc(OCCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,35.4,%,=,CHEMBL3577508
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,31.3,%,=,CHEMBL3577509
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccccc1CN(C)CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,37.1,%,=,CHEMBL3577510
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,34.3,%,=,CHEMBL3577511
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,35.6,%,=,CHEMBL3577517
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,66.5,%,=,CHEMBL3577520
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,69.1,%,=,CHEMBL3577522
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,71.4,%,=,CHEMBL3577524
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL116438
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 12.5 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,43.5,%,=,CHEMBL3577522
Inhibition of self-induced Abeta(1 to 42) (unknown origin) aggregation at 50 uM after 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,87.2,%,=,CHEMBL3577522
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,44.7,%,=,CHEMBL3577505
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,COc1cc2oc(-c3ccc(OCCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,48.2,%,=,CHEMBL3577508
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,43.1,%,=,CHEMBL3577509
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,COc1ccccc1CN(C)CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,46.2,%,=,CHEMBL3577510
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,46.8,%,=,CHEMBL3577511
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,49.2,%,=,CHEMBL3577517
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,84.8,%,=,CHEMBL3577520
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,85.7,%,=,CHEMBL3577522
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,87.2,%,=,CHEMBL3577524
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,58.0,%,=,CHEMBL116438
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,46.5,%,=,CHEMBL3577522
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin-T based fluorescence assay,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,64.6,%,=,CHEMBL3577522
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,41.3,%,=,CHEMBL3577511
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,81.3,%,=,CHEMBL3577522
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.5,%,=,CHEMBL116438
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by transmission electron microscopy,Inhibition,CCN(CCCCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,,%,,CHEMBL3577522
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,95.1,%,=,CHEMBL297453
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,63.5,%,=,CHEMBL3582126
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,89.5,%,=,CHEMBL3582127
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,62.8,%,=,CHEMBL3582128
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,80.5,%,=,CHEMBL3582129
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,99.0,%,=,CHEMBL3582130
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@]12CC[C@H](O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,54.6,%,=,CHEMBL3582131
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,98.8,%,=,CHEMBL3582132
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,Inhibition,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,70.4,%,=,CHEMBL3582133
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,500.0,nM,=,CHEMBL297453
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,95900.0,nM,=,CHEMBL3582126
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,28000.0,nM,=,CHEMBL3582127
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,34300.0,nM,=,CHEMBL3582128
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,71900.0,nM,=,CHEMBL3582129
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,10100.0,nM,=,CHEMBL3582130
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,1200.0,nM,=,CHEMBL3582132
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,43500.0,nM,=,CHEMBL3582133
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)C(=O)C[C@H]2O)CCC4=O,13400.0,nM,=,CHEMBL549959
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorometric assay,Inhibition,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,,%,,CHEMBL589390
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorometric assay,Inhibition,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,35.6,%,=,CHEMBL3585374
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM after 24 hrs by thioflavin T fluorometric assay,Inhibition,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,35.2,%,=,CHEMBL3585375
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3110.0,nM,=,CHEMBL3087676
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay (Rvb = 100%),Activity,C#CCN(C)[C@H](C)Cc1ccc(NCc2ncccc2OC)cc1,69.1,%,=,CHEMBL3585846
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay (Rvb = 100%),Activity,C#CCN(C)[C@H](C)Cc1ccc(NCc2ccccc2O)cc1,40.37,%,=,CHEMBL3585848
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay (Rvb = 100%),Activity,C#CCN(C)[C@H](C)Cc1ccc(NCc2cc(O)ccc2O)cc1,63.09,%,=,CHEMBL3585856
Inhibition of Cu2+-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM after 24 hrs by thioflavin T fluorescence assay (Rvb = 100%),Activity,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,68.25,%,=,CHEMBL76
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1Nc2ccccc2/C1=C\C=C\c1ccc([N+](=O)[O-])cc1,60.0,nM,=,CHEMBL3593923
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1Nc2ccccc2/C1=C/C=C/c1ccc([N+](=O)[O-])cc1,36.2,nM,=,CHEMBL3593922
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccccc1,694.7,nM,=,CHEMBL3593921
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C\c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccccc1,459.5,nM,=,CHEMBL3593920
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1Nc2ccccc2/C1=C\c1ccc([N+](=O)[O-])cc1,439.2,nM,=,CHEMBL3593919
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1Nc2ccccc2/C1=C/c1ccc([N+](=O)[O-])cc1,325.2,nM,=,CHEMBL201986
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,Nc1ccc(/C=C/C=C2\C(=O)Nc3ccccc32)cc1,50.8,nM,=,CHEMBL3593918
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(c3ccccc3)c3ccccc32)cc1,286.8,nM,=,CHEMBL3593917
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(Cc3ccc(N)cc3)c3ccccc32)cc1,98.9,nM,=,CHEMBL3593916
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\C=C\c3ccc(N(C)C)cc3)c3cccnc32)cc1,107.0,nM,=,CHEMBL3593915
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(Cc3ccccc3)c3ncccc32)cc1,85.1,nM,=,CHEMBL3593914
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CCOC(=O)N1C(=O)/C(=C\C=C\c2ccc(N(C)C)cc2)c2ccccc21,84.0,nM,=,CHEMBL3593913
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(c3ccncc3)c3ccccc32)cc1,45.9,nM,=,CHEMBL3593912
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(Cc3ccc([N+](=O)[O-])cc3)c3ccccc32)cc1,92.4,nM,=,CHEMBL3593911
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\C=C\c3ccc(N(C)C)cc3)c3ccccc32)cc1,129.6,nM,=,CHEMBL3593910
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(Cc3ccccc3)c3ccccc32)cc1,357.9,nM,=,CHEMBL3593909
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)N(C)c3ccccc32)cc1,56.0,nM,=,CHEMBL3593908
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(/C=C/C=C2\C(=O)N(Cc3ccccc3)c3ccccc32)cc1,741.0,nM,=,CHEMBL3593907
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,91.6,nM,=,CHEMBL328710
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)Nc3ncccc32)cc1,40.0,nM,=,CHEMBL3593893
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)Nc3ccc(O)cc32)cc1,94.8,nM,=,CHEMBL3593894
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)N(C)c3ccccc32)cc1,155.1,nM,=,CHEMBL86921
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)N(Cc3ccccc3)c3ccccc32)cc1,260.4,nM,=,CHEMBL3593895
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\c3ccc(N(C)C)cc3)c3ccccc32)cc1,251.5,nM,=,CHEMBL3593896
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)N(c3ccncc3)c3ccccc32)cc1,87.1,nM,=,CHEMBL3593897
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CCOC(=O)N1C(=O)/C(=C\c2ccc(N(C)C)cc2)c2ccccc21,139.9,nM,=,CHEMBL3593898
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)N(Cc3ccccc3)c3ncccc32)cc1,190.2,nM,=,CHEMBL3593899
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C\C=C\c2ccccc2)c2ccccc2N1Cc1ccccc1,703.3,nM,=,CHEMBL3593906
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)Nc3ccc(O)cc32)cc1,37.1,nM,=,CHEMBL3593905
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)Nc3ncccc32)cc1,15.3,nM,=,CHEMBL3593904
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C/C=C2\C(=O)Nc3ccccc32)cc1,27.6,nM,=,CHEMBL3593903
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(/C=C/C=C2\C(=O)Nc3ccccc32)cc1,125.8,nM,=,CHEMBL3593902
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1Nc2ccccc2/C1=C/C=C/c1ccccc1,266.8,nM,=,CHEMBL3593901
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,CN(C)c1ccc(/C=C2\C(=O)N(c3ccccc3)c3ccccc32)cc1,179.2,nM,=,CHEMBL3593252
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\c3ccc(N(C)C)cc3)c3cccnc32)cc1,113.3,nM,=,CHEMBL3593900
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C\C=C\c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccccc1,214.2,nM,=,CHEMBL3593924
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C/C=C/c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccccc1,235.4,nM,=,CHEMBL3593925
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\C=C\c3ccc([N+](=O)[O-])cc3)c3ccccc32)cc1,130.8,nM,=,CHEMBL3593926
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C/C=C/c3ccc([N+](=O)[O-])cc3)c3ccccc32)cc1,138.5,nM,=,CHEMBL3593927
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1cccc(CN2C(=O)/C(=C\C=C\c3ccc([N+](=O)[O-])cc3)c3ccccc32)c1,109.7,nM,=,CHEMBL3593928
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1cccc(CN2C(=O)/C(=C/C=C/c3ccc([N+](=O)[O-])cc3)c3ccccc32)c1,264.8,nM,=,CHEMBL3593929
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C\C=C\c3ccc([N+](=O)[O-])cc3)c3ccccc32)cc1OC,73.6,nM,=,CHEMBL3593930
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,COc1ccc(CN2C(=O)/C(=C/C=C/c3ccc([N+](=O)[O-])cc3)c3ccccc32)cc1OC,129.5,nM,=,CHEMBL3593931
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C\C=C\c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccc(OCCF)cc1,142.4,nM,=,CHEMBL3593932
Displacement of Thio-T from amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assay,Ki,O=C1/C(=C/C=C/c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccc(OCCF)cc1,125.3,nM,=,CHEMBL3593933
Binding affinity to amyloid beta in alzheimer's diseased human brain tissue at 5 uM after 20 mins by fluorescence microscopic analysis,Activity,CN(C)c1ccc(/C=C/C=C2\C(=O)Nc3ccccc32)cc1,,,,CHEMBL3593903
Binding affinity amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli after 1 hr by scintillation counting,Kd,O=C1/C(=C\C=C\c2ccc([N+](=O)[O-])cc2)c2ccccc2N1Cc1ccc(OCC[18F])cc1,271.0,nM,=,CHEMBL3593934
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,4.5,%,=,CHEMBL191083
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-],3.1,%,=,CHEMBL81782
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCCOc1ccc2c(c1)N(CC)/C(=C/C=C/c1sc3ccc(OCCC)cc3[n+]1CC)S2.[I-],,%,,CHEMBL3593980
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.[I-],8.1,%,=,CHEMBL3593278
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(Oc3no[n+]([O-])c3-c3ccccc3)cc21.[I-],1.8,%,=,CHEMBL3593279
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc21.[I-],21.0,%,=,CHEMBL3593281
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Inhibition,CCCOc1ccc2c(c1)N(CC)/C(=C/C=C/c1sc3ccccc3[n+]1CC)S2.[I-],7.0,%,=,CHEMBL3593282
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCCCO[N+](=O)[O-])cc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.O=S(=O)([O-])C(F)(F)F,26000.0,nM,=,CHEMBL3593276
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCc4no[n+]([O-])c4C(N)=O)cc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.O=S(=O)([O-])C(F)(F)F,17000.0,nM,=,CHEMBL3593277
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.[I-],26000.0,nM,=,CHEMBL3593280
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-],3300.0,nM,=,CHEMBL81782
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.[I-],7700.0,nM,=,CHEMBL3593278
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(Oc3no[n+]([O-])c3-c3ccccc3)cc21.[I-],1600.0,nM,=,CHEMBL3593279
Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCCOc1ccc2c(c1)N(CC)/C(=C/C=C/c1sc3ccccc3[n+]1CC)S2.[I-],800.0,nM,=,CHEMBL3593282
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)ccc1O,4300.0,nM,=,CHEMBL3594076
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1,15800.0,nM,=,CHEMBL3594077
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,1300.0,nM,=,CHEMBL3594078
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc(OC)c1O,2900.0,nM,=,CHEMBL3594079
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3900.0,nM,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,70.0,%,=,CHEMBL116438
"Potency index, ratio of curcumin IC50 to compound IC50 for inhibition of amyloid beta (1 to 42) (unknown origin) aggregation",Ratio IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,3.0,,=,CHEMBL3594078
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,O=C(NCC1CCCN(C2Cc3ccccc3C2)C1)c1cc([N+](=O)[O-])c2cccnc2c1O,28.7,%,=,CHEMBL3593657
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,O=C(NCC1CCCN(c2nc3ccccc3o2)C1)c1cc([N+](=O)[O-])c2cccnc2c1O,35.5,%,=,CHEMBL3593656
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,O=C(NCC1CCCN(c2nc3ccccc3s2)C1)c1cc([N+](=O)[O-])c2cccnc2c1O,33.3,%,=,CHEMBL3593655
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,O=C(NCC1CCCN(Cc2nc3ccccc3s2)C1)c1cc([N+](=O)[O-])c2cccnc2c1O,53.4,%,=,CHEMBL3593654
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,COCCN(CC1CCN(Cc2nc3ccccc3o2)CC1)C(=O)c1cc([N+](=O)[O-])c2cccnc2c1O,34.9,%,=,CHEMBL3593653
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,COCCN(CC1CCN(Cc2nc3ccccc3s2)CC1)C(=O)c1cc([N+](=O)[O-])c2cccnc2c1O,44.2,%,=,CHEMBL3593652
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,COCCN(CC1CCCN(C2Cc3ccccc3C2)C1)C(=O)c1cc([N+](=O)[O-])c2cccnc2c1O,20.1,%,=,CHEMBL3593658
Inhibition of human recombinant amyloid beta (1 to 42) self aggregation at 10 uM after 12 hrs by dot-blot assay,Inhibition,COCCN(CC1CCCN(C2Cc3ccccc3C2)C1)C(=O)c1ccc2ccccc2c1,61.7,%,=,CHEMBL3338391
Inhibition of amyloid beta (1 to 42) (unknown origin)-mediated cytotoxicity in rat PC12 cells treated with 30 mins compound pre-treated Abeta (1 to 42) followed by UV irradiation for 10 mins before transfection and measured after 48 hrs by WST8 assay,Inhibition,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C(O)C(F)(F)F)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,%,,CHEMBL3597987
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 20 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method (Rvb = 10%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,10.0,%,=,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 60 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method (Rvb = 10%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,20.0,%,=,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 120 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method (Rvb = 10%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,36.0,%,=,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (17 to 28) adduct at 200 uM incubated for 20 to 120 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method (Rvb = 10%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (29 to 42) adduct at 200 uM incubated for 20 to 120 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method (Rvb = 10%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 10 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method,Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 10 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method,Activity,C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O,,,,CHEMBL3597988
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM incubated for 10 mins irradiated with UV light for 10 mins by MALDI-TOF-MS method,Activity,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(C2(C(F)(F)F)N=N2)cc1)C(=O)O,,,,CHEMBL3597989
Binding affinity to amyloid beta (1 to 16) (unknown origin) assessed as intensity of peak for compound-amyloid beta (1 to 16) adduct at 200 uM irradiated with UV light for 10 mins by MALDI-TOF-MS method,Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as compound-amyloid beta (4 to 11) adduct formation at Tyr10 residue at 200 uM incubated for 2 hrs irradiated with UV light for 10 mins by LC-MS/MS method,Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as fluorescence intensity at 50 uM by Thioflavin-T fluorescence assay (Rvb = 100%),Activity,CC(C)C[C@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@@H](C(C)C)NC1=O,68.0,%,=,CHEMBL3597985
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as fluorescence intensity at 50 uM by Thioflavin-T fluorescence assay (Rvb = 100%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,59.0,%,=,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as fluorescence intensity at 50 uM irradiated with UV light for 10 mins and measured after 60 mins by Thioflavin-T fluorescence assay (Rvb = 100%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C(O)C(F)(F)F)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,21.0,%,=,CHEMBL3597987
Inhibition of fibril formation of amyloid beta (1 to 42) (unknown origin) at 50 uM incubated for 20 mins followed by irradiation with UV light for 10 mins and measured after 12 hrs by atomic force microscopy,Inhibition,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,%,,CHEMBL3597986
Inhibition of amyloid beta (1 to 42) (unknown origin)-mediated cytotoxicity in rat PC12 cells treated with 20 mins compound pre-treated Abeta (1 to 42) followed by UV irradiation for 10 mins before transfection and measured after 48 hrs by WST8 assay,Inhibition,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,,%,,CHEMBL3597986
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as fluorescence intensity at 50 uM irradiated with UV light for 10 mins and measured up to 4 hrs by Thioflavin-T fluorescence assay (Rvb = 100%),Activity,CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(C3(C(F)(F)F)N=N3)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](C(C)C)NC1=O,21.0,%,=,CHEMBL3597986
Binding affinity to amyloid beta (1 to 40) (unknown origin) assessed as increase in fluorescence after 3 hrs by UV-spectra analysis,Activity,Cc1c(O)c(=O)ccn1-c1ccc(-c2nc3ccccc3s2)cc1,50.0,%,=,CHEMBL3604811
Binding affinity to amyloid beta (1 to 40) (unknown origin) assessed as increase in fluorescence after 3 hrs by UV-spectra analysis,Activity,Cc1c(O)c(=O)ccn1-c1ccc(-c2nc3ccccc3o2)cc1,3.0,%,=,CHEMBL3604810
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Brc1ccc(/C=C/CSSC/C=C/c2ccc(Br)cc2)cc1,37.49,%,=,CHEMBL3612619
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Brc1cccc(/C=C/CSSC/C=C/c2cccc(Br)c2)c1,39.41,%,=,CHEMBL3612618
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Clc1ccc(/C=C/CSSC/C=C/c2ccc(Cl)cc2)cc1,48.16,%,=,CHEMBL3612617
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Fc1cccc(F)c1/C=C/CSSC/C=C/c1c(F)cccc1F,39.54,%,=,CHEMBL3612616
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Clc1cc(Cl)cc(/C=C/CSSC/C=C/c2cc(Cl)cc(Cl)c2)c1,47.49,%,=,CHEMBL3612615
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Clc1cccc(/C=C/CSSC/C=C/c2cccc(Cl)c2)c1,52.41,%,=,CHEMBL3612614
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Fc1cccc(/C=C/CSSC/C=C/c2cccc(F)c2)c1,44.16,%,=,CHEMBL3612613
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Fc1ccccc1/C=C/CSSC/C=C/c1ccccc1F,33.54,%,=,CHEMBL3612612
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/CSSC/C=C/c2ccc(O)cc2)cc1,53.01,%,=,CHEMBL3612620
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/CSSC/C=C/c2ccc(OC)cc2)cc1,58.54,%,=,CHEMBL365207
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/CSSC/C=C/c2ccc(OC)c(OC)c2)cc1OC,61.21,%,=,CHEMBL3612621
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/CSSC/C=C/c2ccc(O)c(OC)c2)ccc1O,66.89,%,=,CHEMBL3612815
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(F)cc1)SSC(=O)/C=C/c1ccc(F)cc1,62.41,%,=,CHEMBL3612816
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(Cl)cc1)SSC(=O)/C=C/c1ccc(Cl)cc1,65.62,%,=,CHEMBL3612817
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(Br)c1)SSC(=O)/C=C/c1cccc(Br)c1,68.74,%,=,CHEMBL3612818
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(Br)cc1)SSC(=O)/C=C/c1ccc(Br)cc1,52.18,%,=,CHEMBL3612819
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)SSC(=O)/C=C/c1ccc(O)cc1,66.44,%,=,CHEMBL3612820
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)SSC(=O)/C=C/c2ccc(OC)cc2)cc1,63.54,%,=,CHEMBL3612821
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)SSC(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC,74.16,%,=,CHEMBL3612822
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)SSC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,71.41,%,=,CHEMBL3612823
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)SSC(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1,68.97,%,=,CHEMBL3612824
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin-T-based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.5,%,=,CHEMBL116438
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,IC50,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,15000.0,nM,=,CHEMBL3622510
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,Inhibition,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,,%,,CHEMBL3622510
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,50.0,%,=,CHEMBL116438
Inhibition of amyloid beta oligomerization in human MC65 cells assessed as small AbetaOs formation at 0.3 uM incubated for 48 hrs under tetracycline removal condition by Western blot method,Inhibition,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,,%,,CHEMBL3622510
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by ThT assay,IC50,Oc1ccc(/C=C/c2ccc(O)c3ncccc23)cc1,8500.0,nM,=,CHEMBL3621634
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL70488
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,70.6,%,=,CHEMBL116438
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(Cc2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNCc3ccc(O)c(O)c3)CCC[C@]21C,72.97,%,=,CHEMBL3622260
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1NC(=O)/C=C/c1ccc(O)c(O)c1)CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,93.3,%,=,CHEMBL3622259
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,91.95,%,=,CHEMBL3622258
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(N)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)c3ccc(O)c(O)c3)CCC[C@]21C,26.07,%,=,CHEMBL3622257
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(N)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL3622256
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/O)C[C@@H]12,,%,,CHEMBL3622255
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)/C(=N/NC(=O)c1ccncc1)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622254
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622253
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)/C(=N/O)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622252
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/OC(=O)c3ccc(Cl)cc3)C[C@@H]12,,%,,CHEMBL3622251
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/NC(=O)c3ccncc3)C[C@@H]12,,%,,CHEMBL3622250
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/NC(C)=O)C[C@@H]12,,%,,CHEMBL3622249
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N\NC(N)=S)C[C@@H]12,,%,,CHEMBL3622248
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N\NC(N)=O)C[C@@H]12,,%,,CHEMBL3622247
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL3622246
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C/N=C\c3ccc(O)cc3O)CCC[C@]21C,24.53,%,=,CHEMBL3622245
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)Oc1cc(/C=N\C[C@]2(C)CCC[C@]3(C)c4ccc(C(C)C)cc4CC[C@@H]23)cc(OC(C)=O)c1OC(C)=O,20.57,%,=,CHEMBL3622244
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)Oc1cc(C(=O)NC[C@]2(C)CCC[C@]3(C)c4ccc(C(C)C)cc4CC[C@@H]23)cc(OC(C)=O)c1OC(C)=O,55.26,%,=,CHEMBL3622243
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3cc(O)c(O)c(O)c3)CCC[C@]21C,74.63,%,=,CHEMBL3622242
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL70488
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3cc(O)c(O)c(O)c3)CCC[C@]21C,48.98,%,=,CHEMBL3622242
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)Oc1cc(C(=O)NC[C@]2(C)CCC[C@]3(C)c4ccc(C(C)C)cc4CC[C@@H]23)cc(OC(C)=O)c1OC(C)=O,37.63,%,=,CHEMBL3622243
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)Oc1cc(/C=N\C[C@]2(C)CCC[C@]3(C)c4ccc(C(C)C)cc4CC[C@@H]23)cc(OC(C)=O)c1OC(C)=O,8.93,%,=,CHEMBL3622244
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C/N=C\c3ccc(O)cc3O)CCC[C@]21C,10.72,%,=,CHEMBL3622245
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL3622246
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N\NC(N)=O)C[C@@H]12,,%,,CHEMBL3622247
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N\NC(N)=S)C[C@@H]12,,%,,CHEMBL3622248
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/NC(C)=O)C[C@@H]12,,%,,CHEMBL3622249
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/NC(=O)c3ccncc3)C[C@@H]12,,%,,CHEMBL3622250
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/OC(=O)c3ccc(Cl)cc3)C[C@@H]12,,%,,CHEMBL3622251
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)/C(=N/O)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622252
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622253
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1ccc2c(c1)/C(=N/NC(=O)c1ccncc1)C[C@H]1[C@](C)(CNC(=O)C(F)(F)F)CCC[C@]21C,,%,,CHEMBL3622254
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N/O)C[C@@H]12,,%,,CHEMBL3622255
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(N)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CN)CCC[C@]21C,,%,,CHEMBL3622256
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(N)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)c3ccc(O)c(O)c3)CCC[C@]21C,14.25,%,=,CHEMBL3622257
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,82.78,%,=,CHEMBL3622258
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1NC(=O)/C=C/c1ccc(O)c(O)c1)CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,82.46,%,=,CHEMBL3622259
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(Cc2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNCc3ccc(O)c(O)c3)CCC[C@]21C,48.92,%,=,CHEMBL3622260
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation at 50 uM by thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,48.74,%,=,CHEMBL116438
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation by thioflavin-T fluorescence assay,IC50,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,3960.0,nM,=,CHEMBL3622258
Inhibition of amyloid beta-42 (unknown origin) aging fibrils disaggregation by thioflavin-T fluorescence assay,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,,%,,CHEMBL3622258
Inhibition of amyloid beta-42 (unknown origin) beta sheets structure formation at 40 uM after 48 hrs by circular dichroism spectra analysis,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,,%,,CHEMBL3622258
Increase of alpha-helics formation in amyloid beta-42 (unknown origin) at 40 uM after 48 hrs by circular dichroism spectra analysis,Activity,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,,,,CHEMBL3622258
Inhibition of amyloid beta-42 (unknown origin) fibrils formation at 50 uM after 48 hrs by transmission electron microscopy analysis,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,,%,,CHEMBL3622258
Inhibition of fibrils formation in aggregated amyloid beta-42 (unknown origin) assessed as short fibril formation at 50 uM after 48 hrs by transmission electron microscopy analysis,Inhibition,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,,%,,CHEMBL3622258
Inhibition of swAPP-mediated amyloid beta-42 production in human HEK293 cells at 25 uM after 48 hrs by ELISA (Rvb = 100 +/-3.45%),Activity,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,10.4,%,=,CHEMBL3622258
Inhibition of swAPP-mediated amyloid beta-42 production in human HEK293 cells at 10 uM after 48 hrs by ELISA (Rvb = 100 +/-3.45%),Activity,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,45.6,%,=,CHEMBL3622258
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccccc1)C2,14.3,%,=,CHEMBL3633474
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccc(C)cc1)C2,26.8,%,=,CHEMBL3633475
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCc1ccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)cc1,32.1,%,=,CHEMBL3633476
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1ccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)cc1,34.5,%,=,CHEMBL3633477
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCOc1ccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)cc1,40.8,%,=,CHEMBL3633478
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccc(F)cc1)C2,45.4,%,=,CHEMBL3633479
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccc(Cl)cc1)C2,38.2,%,=,CHEMBL3633480
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccc(Br)cc1)C2,47.6,%,=,CHEMBL3633481
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1cccc(C)c1)C2,19.1,%,=,CHEMBL3633482
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCc1cccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)c1,27.4,%,=,CHEMBL3633483
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)c1,30.2,%,=,CHEMBL3633484
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCOc1cccc(NC(=O)C2Cc3cc(OC)c(OC)cc3C2=O)c1,28.3,%,=,CHEMBL3633485
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1cccc(F)c1)C2,38.7,%,=,CHEMBL3633486
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1cccc(Cl)c1)C2,37.4,%,=,CHEMBL3633487
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1cccc(Br)c1)C2,31.9,%,=,CHEMBL3633488
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccccc1C)C2,40.3,%,=,CHEMBL3633489
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCc1ccccc1NC(=O)C1Cc2cc(OC)c(OC)cc2C1=O,21.8,%,=,CHEMBL3633490
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1ccccc1NC(=O)C1Cc2cc(OC)c(OC)cc2C1=O,25.6,%,=,CHEMBL3633491
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,CCOc1ccccc1NC(=O)C1Cc2cc(OC)c(OC)cc2C1=O,38.1,%,=,CHEMBL3633492
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccccc1F)C2,55.3,%,=,CHEMBL3633493
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccccc1Cl)C2,40.4,%,=,CHEMBL3633494
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(C(=O)Nc1ccccc1Br)C2,52.8,%,=,CHEMBL3633495
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced amyloid beta (1-42) aggregation (unknown origin) at 25 uM after 48 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,42.3,%,=,CHEMBL116438
Binding affinity to amyloid beta in human MC65 cells assessed as inhibition of tetracycline deficiency-induced amyloid beta oligomerization after 48 hrs by Western blot analysis,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCC(=O)NCCOCCOCCOCC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CO8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL3634269
Binding affinity to amyloid beta in human MC65 cells assessed as inhibition of tetracycline deficiency-induced amyloid beta oligomerization after 48 hrs by Western blot analysis,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCOCCOCCNC(=O)CCC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CO8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL3634274
Inhibition of amyloid beta42 (unknown origin) aggregation after 48 hrs by ThT assay,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCCCC(=O)NCCOCCOCCOCC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CO8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL3634269
Inhibition of amyloid beta42 (unknown origin) aggregation after 48 hrs by ThT assay,Inhibition,COc1cc(/C=C/C(=O)/C(Cc2cn(CCOCCOCCNC(=O)CCC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@H]5[C@@H]6C[C@@H]7O[C@]8(CC[C@@H](C)CO8)[C@@H](C)[C@@H]7[C@@]6(C)CC[C@@H]54)C3)nn2)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL3634274
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2oc(-c3ccc(O)c4ncccc34)cc2c1,57.7,%,=,CHEMBL3736120
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2cc(-c3ccc(O)c4ncccc34)oc2c1,46.3,%,=,CHEMBL3736261
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc(-c2cc3cccc(O)c3o2)c2cccnc12,35.1,%,=,CHEMBL3735005
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc(-c2cc3ccccc3o2)c2cccnc12,12.4,%,=,CHEMBL3736076
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1cc(O)c2cc(-c3ccc(O)c4ncccc34)oc2c1,61.2,%,=,CHEMBL3735557
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Cc1c(-c2ccc(O)c3ncccc23)oc2ccc(O)cc12,53.1,%,=,CHEMBL3736439
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc(-c2cc3cc(I)cc(I)c3o2)c2cccnc12,13.2,%,=,CHEMBL3735115
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2cc(-c3ccc4cccc(O)c4n3)oc2c1,33.8,%,=,CHEMBL3734795
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1cc(O)c2cc(-c3ccc4cccc(O)c4n3)oc2c1,48.7,%,=,CHEMBL3735525
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1c(Cl)cc(-c2cc3ccccc3o2)c2cccnc12,19.2,%,=,CHEMBL3736059
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1c(Cl)cc(-c2cc3cccc(O)c3o2)c2cccnc12,48.1,%,=,CHEMBL3736003
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2cc(-c3cc(Cl)c(O)c4ncccc34)oc2c1,52.0,%,=,CHEMBL3735104
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2oc(-c3cc(Cl)c(O)c4ncccc34)cc2c1,59.1,%,=,CHEMBL3736201
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Cc1c(-c2cc(Cl)c(O)c3ncccc23)oc2ccc(O)cc12,51.6,%,=,CHEMBL3735108
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2cc(-c3cc(I)c(O)c4ncccc34)oc2c1,63.5,%,=,CHEMBL3735548
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2oc(-c3cc(I)c(O)c4ncccc34)cc2c1,67.5,%,=,CHEMBL3734974
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1cc(O)c2cc(-c3cc(I)c(O)c4ncccc34)oc2c1,69.2,%,=,CHEMBL3735540
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,,%,,CHEMBL63
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,43.1,%,=,CHEMBL512578
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,35.2,%,=,CHEMBL140
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,39.1,%,=,CHEMBL165
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,%,,CHEMBL71
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,%,,CHEMBL389621
Inhibition of recombinant human Amyloid beta (1 to 42) self-induced aggregation at 5 uM after 48 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,5.0,%,<,CHEMBL497
Binding affinity to 15N-labeled human recombinant Amyloid beta (1 to 42) at 2 to 5 equiv by 2-D NMR analysis,Activity,Oc1ccc2oc(-c3cc(I)c(O)c4ncccc34)cc2c1,,,,CHEMBL3734974
Inhibition of self-induced recombinant human Amyloid beta (1 to 42) aggregation at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1ccc2oc(-c3cc(I)c(O)c4ncccc34)cc2c1,86.3,%,=,CHEMBL3734974
Inhibition of self-induced recombinant human Amyloid beta (1 to 42) aggregation at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,62.3,%,=,CHEMBL512578
Inhibition of self-induced recombinant human Amyloid beta (1 to 42) aggregation at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,20.2,%,=,CHEMBL497
Induction of disassembly of self-induced recombinant human amyloid beta (1 to 42) aggregates at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Activity,Oc1ccc2oc(-c3cc(I)c(O)c4ncccc34)cc2c1,83.9,%,=,CHEMBL3734974
Induction of disassembly of self-induced recombinant human amyloid beta (1 to 42) aggregates at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Activity,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,60.4,%,=,CHEMBL512578
Induction of disassembly of self-induced recombinant human amyloid beta (1 to 42) aggregates at 50 uM after 24 hrs by thioflavin T-based fluorescence assay,Activity,Oc1c(I)cc(Cl)c2cccnc12,13.5,%,=,CHEMBL497
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,244300.0,nM,=,CHEMBL3740785
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1OC=CC(C)(C)O2,300000.0,nM,>,CHEMBL3741682
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,300000.0,nM,>,CHEMBL3742121
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1cc2c(cc15)OC(C)(C)C=CO2,300000.0,nM,>,CHEMBL3741529
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,68100.0,nM,=,CHEMBL324842
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,CC1(C)C=Cc2cc(C(=O)O)ccc2O1,251500.0,nM,=,CHEMBL469159
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC[C@]3(C)[C@H](CC=C(C)[C@@]34C[C@]3(OC(C)=C(C)C3=O)C(=O)O4)[C@@]12C,112600.0,nM,=,CHEMBL3742151
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,149600.0,nM,=,CHEMBL3740688
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,CC1=CC[C@@H]2[C@@]3(C)C=CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,65400.0,nM,=,CHEMBL3739499
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,CC1=CC[C@@H]2[C@@]3(C)[C@@H](O)CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,300000.0,nM,>,CHEMBL3741111
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,300000.0,nM,>,CHEMBL3741300
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,300000.0,nM,>,CHEMBL3739748
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,300000.0,nM,>,CHEMBL3740785
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1OC=CC(C)(C)O2,300000.0,nM,>,CHEMBL3741682
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,300000.0,nM,>,CHEMBL3742121
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells preincubated for 1 hr followed by amyloid beta challenge measured after 24 hrs by MTT assay,EC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1cc2c(cc15)OC(C)(C)C=CO2,300000.0,nM,>,CHEMBL3741529
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,269500.0,nM,=,CHEMBL3739748
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,203700.0,nM,=,CHEMBL3741300
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CC1=CC[C@@H]2[C@@]3(C)[C@@H](O)CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,300000.0,nM,>,CHEMBL3741111
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CC1=CC[C@@H]2[C@@]3(C)C=CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,300000.0,nM,>,CHEMBL3739499
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,186600.0,nM,=,CHEMBL3740688
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC[C@]3(C)[C@H](CC=C(C)[C@@]34C[C@]3(OC(C)=C(C)C3=O)C(=O)O4)[C@@]12C,300000.0,nM,>,CHEMBL3742151
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CC1(C)C=Cc2cc(C(=O)O)ccc2O1,300000.0,nM,>,CHEMBL469159
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,71900.0,nM,=,CHEMBL324842
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells assessed as cell viability at 4 to 100 ug/ml pre-incubated for 24 hrs with Abeta ( 1 to 42) followed by compound-Abeta (1 to 42) mixture addition to cells and measured after 24 hrs by MTT assay,EC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,97900.0,nM,=,CHEMBL3740785
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells assessed as cell viability at 4 to 100 ug/ml pre-incubated for 24 hrs with Abeta ( 1 to 42) followed by compound-Abeta (1 to 42) mixture addition to cells and measured after 24 hrs by MTT assay,EC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,105200.0,nM,=,CHEMBL3739748
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells assessed as cell viability at 4 to 100 ug/ml pre-incubated for 24 hrs with Abeta ( 1 to 42) followed by compound-Abeta (1 to 42) mixture addition to cells and measured after 24 hrs by MTT assay,EC50,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,89900.0,nM,=,CHEMBL3740688
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregate-induced toxicity in rat PC12 cells assessed as cell viability at 4 to 100 ug/ml pre-incubated for 24 hrs with Abeta ( 1 to 42) followed by compound-Abeta (1 to 42) mixture addition to cells and measured after 24 hrs by MTT assay,EC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,57200.0,nM,=,CHEMBL324842
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation at 100 uM after 24 hrs by thioflavin T assay,Inhibition,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,30.0,%,=,CHEMBL3740785
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation at 100 uM after 24 hrs by thioflavin T assay,Inhibition,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,30.0,%,=,CHEMBL3739748
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation at 100 uM after 24 hrs by thioflavin T assay,Inhibition,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,30.0,%,=,CHEMBL3741300
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation at 100 uM after 24 hrs by thioflavin T assay,Inhibition,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,30.0,%,=,CHEMBL3740688
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(C)c(F)c2)C(=O)C1,,,,CHEMBL3741408
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(C(F)(F)F)cc2)C(=O)C1,,,,CHEMBL3740346
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1cc(F)cc(N2N=C(C)CC2=O)c1,,,,CHEMBL3739947
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1cccc(N2N=C(C)CC2=O)c1,50000.0,nM,>,CHEMBL3740705
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,50000.0,nM,>,CHEMBL3739861
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,,,,CHEMBL3740581
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,26000.0,nM,=,CHEMBL3741643
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,27000.0,nM,=,CHEMBL3741680
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccnc2)C(=O)C1,,,,CHEMBL3740667
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1cc(N2N=C(C)CC2=O)nc(OC)n1,,,,CHEMBL3742036
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,5600.0,nM,=,CHEMBL3741909
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,3400.0,nM,=,CHEMBL3741268
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,14500.0,nM,=,CHEMBL3742091
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,19600.0,nM,=,CHEMBL3741747
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccccc2)C(=O)C1,17.2,%,=,CHEMBL290916
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccccc2C)C(=O)C1,22.7,%,=,CHEMBL1880288
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cccc(C)c2)C(=O)C1,30.9,%,=,CHEMBL3742311
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(C)cc2)C(=O)C1,16.3,%,=,CHEMBL3740157
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc3ccccc3c2)C(=O)C1,56.2,%,=,CHEMBL3739456
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CCc1ccccc1N1N=C(C)CC1=O,26.3,%,=,CHEMBL3740761
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cc(C)ccc2C)C(=O)C1,7.4,%,=,CHEMBL3740979
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cc(F)ccc2C)C(=O)C1,26.2,%,=,CHEMBL3742186
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(C)c(F)c2)C(=O)C1,49.0,%,=,CHEMBL3741408
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(C(F)(F)F)cc2)C(=O)C1,56.3,%,=,CHEMBL3740346
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,COc1cc(F)cc(N2N=C(C)CC2=O)c1,26.4,%,=,CHEMBL3739947
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,COc1cccc(N2N=C(C)CC2=O)c1,39.7,%,=,CHEMBL3740705
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,50.7,%,=,CHEMBL3739861
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,47.0,%,=,CHEMBL3740581
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,60.6,%,=,CHEMBL3741643
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,53.4,%,=,CHEMBL3741680
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2cccnc2)C(=O)C1,20.2,%,=,CHEMBL3740667
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,COc1cc(N2N=C(C)CC2=O)nc(OC)n1,48.2,%,=,CHEMBL3742036
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,78.7,%,=,CHEMBL3741909
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,69.6,%,=,CHEMBL3741268
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,53.2,%,=,CHEMBL3742091
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation at 25 uM incubated for 72 hrs by Thioflavin T assay,Inhibition,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,71.4,%,=,CHEMBL3741747
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccccc2)C(=O)C1,50000.0,nM,>,CHEMBL290916
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccccc2C)C(=O)C1,50000.0,nM,>,CHEMBL1880288
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(C)c2)C(=O)C1,50000.0,nM,>,CHEMBL3742311
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(C)cc2)C(=O)C1,50000.0,nM,>,CHEMBL3740157
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc3ccccc3c2)C(=O)C1,50000.0,nM,>,CHEMBL3739456
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CCc1ccccc1N1N=C(C)CC1=O,50000.0,nM,>,CHEMBL3740761
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cc(C)ccc2C)C(=O)C1,50000.0,nM,>,CHEMBL3740979
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,3500.0,nM,=,CHEMBL3741747
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,3900.0,nM,=,CHEMBL3742091
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,5100.0,nM,=,CHEMBL3741268
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,19500.0,nM,=,CHEMBL3741909
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1cc(N2N=C(C)CC2=O)nc(OC)n1,50000.0,nM,>,CHEMBL3742036
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccnc2)C(=O)C1,50000.0,nM,>,CHEMBL3740667
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,2900.0,nM,=,CHEMBL3741680
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3741643
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,16800.0,nM,=,CHEMBL3740581
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3739861
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1cccc(N2N=C(C)CC2=O)c1,50000.0,nM,>,CHEMBL3740705
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1cc(F)cc(N2N=C(C)CC2=O)c1,50000.0,nM,>,CHEMBL3739947
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(C(F)(F)F)cc2)C(=O)C1,50000.0,nM,>,CHEMBL3740346
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(C)c(F)c2)C(=O)C1,50000.0,nM,>,CHEMBL3741408
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cc(F)ccc2C)C(=O)C1,50000.0,nM,>,CHEMBL3742186
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cc(F)ccc2C)C(=O)C1,,,,CHEMBL3742186
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cc(C)ccc2C)C(=O)C1,,,,CHEMBL3740979
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CCc1ccccc1N1N=C(C)CC1=O,,,,CHEMBL3740761
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc3ccccc3c2)C(=O)C1,,,,CHEMBL3739456
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(C)cc2)C(=O)C1,,,,CHEMBL3740157
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccc(C)c2)C(=O)C1,,,,CHEMBL3742311
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccccc2C)C(=O)C1,,,,CHEMBL1880288
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccccc2)C(=O)C1,,,,CHEMBL290916
Binding affinity to 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as change in chemical shifts after 1 hr by NMR analysis,Activity,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,,,CHEMBL28626
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,30300.0,nM,=,CHEMBL28626
"Inhibition of Amyloid beta (1 to 42) 13,14 A2 mutant (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay",Inhibition,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL503168
"Inhibition of Amyloid beta (1 to 42) 13,14 A2 mutant (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay",Inhibition,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL28626
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1c(OOc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,,,CHEMBL3747225
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,,,CHEMBL28
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C1C(=O)C(O)(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,,,,CHEMBL3747615
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C1Oc2cc(O)cc(O)c2C1=O,,,,CHEMBL3746361
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C(O)c1ccc(O)cc1,,,,CHEMBL441343
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C(O)c1c(O)cc(O)cc1O,,,,CHEMBL3747578
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C(O)C(=O)c1c(O)cc(O)cc1O,,,,CHEMBL3746374
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=Cc1c(O)cc(O)cc1O,,,,CHEMBL2403487
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=C(O)C(=O)c1ccc(O)cc1,,,,CHEMBL129918
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,,,,CHEMBL309490
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,,,CHEMBL150
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,,,CHEMBL503168
Binding affinity to HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) monomer (unknown origin) assessed as change in chemical shifts at 500 uM after 1 hr by NMR analysis,Activity,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,,,CHEMBL28626
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM after 48 hrs by TEM analysis,Inhibition,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL503168
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 to 100 uM under anaerobic condition after 5 days by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,%,,CHEMBL150
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 to 100 uM under anaerobic condition after 5 days by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL503168
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 to 100 uM under anaerobic condition after 5 days by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL28626
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM under ambient condition by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,%,,CHEMBL150
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM under ambient condition by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL503168
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM under ambient condition by Thioflavin-T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL28626
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,33000.0,nM,=,CHEMBL66
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,15300.0,nM,=,CHEMBL50
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,15100.0,nM,=,CHEMBL164
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,500000.0,nM,>,CHEMBL309490
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,55400.0,nM,=,CHEMBL503168
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,10.0,hr,=,CHEMBL28626
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,6.0,hr,=,CHEMBL503168
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,3.0,hr,=,CHEMBL150
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C(O)C(=O)c1ccc(O)cc1,3.0,hr,=,CHEMBL129918
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=Cc1c(O)cc(O)cc1O,3.0,hr,=,CHEMBL2403487
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C(O)C(=O)c1c(O)cc(O)cc1O,3.0,hr,=,CHEMBL3746374
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C(O)c1c(O)cc(O)cc1O,3.0,hr,=,CHEMBL3747578
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C(O)c1ccc(O)cc1,3.0,hr,=,CHEMBL441343
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C1Oc2cc(O)cc(O)c2C1=O,3.0,hr,=,CHEMBL3746361
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=C1C(=O)C(O)(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,3.0,hr,=,CHEMBL3747615
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,3.0,hr,=,CHEMBL28
Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs),TIME,O=c1c(OOc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,3.0,hr,=,CHEMBL3747225
Inhibition of elongation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed,Inhibition,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL28626
Inhibition of elongation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed,Inhibition,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL503168
Inhibition of elongation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) at 500 uM by Thioflavin-T fluorescence assay in presence of fibril seed,Inhibition,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,%,,CHEMBL150
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C(O)C(=O)c1ccc(O)cc1,,%,,CHEMBL129918
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=Cc1c(O)cc(O)cc1O,,%,,CHEMBL2403487
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C(O)C(=O)c1c(O)cc(O)cc1O,,%,,CHEMBL3746374
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C(O)c1c(O)cc(O)cc1O,,%,,CHEMBL3747578
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C(O)c1ccc(O)cc1,,%,,CHEMBL441343
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C1Oc2cc(O)cc(O)c2C1=O,,%,,CHEMBL3746361
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=C1C(=O)C(O)(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,,%,,CHEMBL3747615
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,%,,CHEMBL28
Inhibition of wild type amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by Thioflavin-T fluorescence assay,Inhibition,O=c1c(OOc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,,%,,CHEMBL3747225
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1,18.7,%,=,CHEMBL3752555
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1,13.7,%,=,CHEMBL3752451
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1,24.2,%,=,CHEMBL3753706
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,32.6,%,=,CHEMBL3753508
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,40.2,%,=,CHEMBL3753850
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,18.7,%,=,CHEMBL3752119
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCC2)c1cc2ccccc2o1,10.2,%,=,CHEMBL3754291
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2o1,26.2,%,=,CHEMBL3751866
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NCCCCCCCNc1c2c(nc3ccccc13)CCCCC2)c1cc2ccccc2o1,17.3,%,=,CHEMBL3754480
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,19.6,%,=,CHEMBL3754739
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,42.5,%,=,CHEMBL3752926
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,17.7,%,=,CHEMBL3754146
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1,9.3,%,=,CHEMBL3751941
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CNCCCCCCNc3c4c(nc5ccccc35)CCC4)oc12,64.1,%,=,CHEMBL3752356
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CNCCCCCCNc3c4c(nc5ccccc35)CCCC4)oc12,52.0,%,=,CHEMBL3752969
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCC4)cc2c1,76.2,%,=,CHEMBL3752543
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,61.3,%,=,CHEMBL3752467
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CNCCCCCCCNc3c4c(nc5ccccc35)CCCCC4)oc12,31.9,%,=,CHEMBL3753405
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1,62.2,%,=,CHEMBL3754341
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4cccc(OC)c4o3)oc12,38.5,%,=,CHEMBL3754694
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4cccc(OC)c4o3)oc12,44.6,%,=,CHEMBL3753957
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CN(CCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4cccc(OC)c4o3)oc12,25.0,%,=,CHEMBL3754778
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCC4)Cc3cc4ccccc4o3)cc2c1,30.7,%,=,CHEMBL3752384
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCC4)Cc3cc4ccccc4o3)cc2c1,44.5,%,=,CHEMBL3753360
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,c1ccc2oc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4ccccc4o3)cc2c1,39.8,%,=,CHEMBL3754672
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc2cc(CN(CCCCCCCNc3c4c(nc5ccccc35)CCCCC4)Cc3cc4cccc(OC)c4o3)oc12,37.3,%,=,CHEMBL3754005
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of HFIP pretreated Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cl.Cl.c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,50.1,%,=,CHEMBL3752685
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T-based fluorometric assay,IC50,Cl.Cl.c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400.0,nM,=,CHEMBL3752685
Inhibition of Amyloid beta42 (unknown origin) self aggregation assessed as Abeta fibril formation at 50 uM for 24 hrs by ThT-based fluorometric assay,Inhibition,CCN(CCCCCCCCc1cccc(OC)c1)Cc1ccccc1OC,,%,,CHEMBL3752227
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1ccc(CC(=O)Nc2nc(-c3ccccc3)cs2)cc1,10600.0,nM,=,CHEMBL3751854
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11300.0,nM,=,CHEMBL140
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CN(C)c1ccc(COc2ccc(OCCF)cc2)cc1,25.7,nM,=,CHEMBL3758709
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CN(C)c1ccc(COc2ccc(OCCOCCF)cc2)cc1,191.1,nM,=,CHEMBL3758630
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CN(C)c1ccc(COc2ccc(OCCOCCOCCF)cc2)cc1,357.7,nM,=,CHEMBL3759510
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,COc1ccc(COc2ccc(OCCF)cc2)cc1,118.5,nM,=,CHEMBL3759263
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,COc1ccc(COc2ccc(OCCOCCF)cc2)cc1,437.9,nM,=,CHEMBL3759176
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,COc1ccc(COc2ccc(OCCOCCOCCF)cc2)cc1,770.1,nM,=,CHEMBL3759854
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CN(C)c1ccc(OCc2ccc(OCCF)cc2)cc1,21.0,nM,=,CHEMBL3760007
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,COc1ccc(OCc2ccc(OCCF)cc2)cc1,152.6,nM,=,CHEMBL3758500
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,32.2,nM,=,CHEMBL78012
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,38.8,nM,=,CHEMBL93124
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Ki,CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)nc2)cc1,11.4,nM,=,CHEMBL1908919
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CN(C)c1ccc(COc2ccc(OCCF)cc2)cc1,,%,,CHEMBL3758709
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CN(C)c1ccc(COc2ccc(OCCOCCF)cc2)cc1,,%,,CHEMBL3758630
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CN(C)c1ccc(COc2ccc(OCCOCCOCCF)cc2)cc1,,%,,CHEMBL3759510
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,COc1ccc(COc2ccc(OCCF)cc2)cc1,,%,,CHEMBL3759263
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,COc1ccc(COc2ccc(OCCOCCF)cc2)cc1,,%,,CHEMBL3759176
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,COc1ccc(COc2ccc(OCCOCCOCCF)cc2)cc1,,%,,CHEMBL3759854
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CN(C)c1ccc(OCc2ccc(OCCF)cc2)cc1,,%,,CHEMBL3760007
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,COc1ccc(OCc2ccc(OCCF)cc2)cc1,,%,,CHEMBL3758500
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CN(C)c1ccc(-c2cn3cc(I)ccc3n2)cc1,,%,,CHEMBL78012
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,,%,,CHEMBL93124
Displacement of [125I]BOB-4 from Amyloid beta (1 to 42) (unknown origin),Inhibition,CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)nc2)cc1,,%,,CHEMBL1908919
Binding affinity to amyloid beta plaques in alzheimer's disease patient cerebral cortex by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(COc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3758381
Binding affinity to amyloid beta plaques in alzheimer's disease patient cerebral cortex by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(OCc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3759398
Binding affinity to amyloid beta plaques in healthy human brain by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(COc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3758381
Binding affinity to amyloid beta plaques in healthy human brain by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(OCc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3759398
Binding affinity to amyloid beta plaques in white matter of alzheimer's disease patient brain by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(COc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3758381
Binding affinity to amyloid beta plaques in white matter of alzheimer's disease patient brain by DANIR 3b staining based autoradiographic analysis,Activity,CN(C)c1ccc(OCc2ccc(OCC[18F])cc2)cc1,,,,CHEMBL3759398
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 80 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc2c(c1)OCO2)NCCNc1c2c(nc3ccccc13)CCCC2,30.9,%,=,CHEMBL3771349
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 80 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/c1ccc2c(c1)OCO2)NCCCNc1c2c(nc3ccccc13)CCCC2,8.27,%,=,CHEMBL3770451
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 80 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(/C=C/C=C/c1ccc2c(c1)OCO2)NCCCNc1c2c(nc3ccccc13)CCCC2,72.2,%,=,CHEMBL3769659
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 80 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(/C=C/C(=O)NCCNc2c3c(nc4ccccc24)CCCC3)cc1OC,19.6,%,=,CHEMBL3770818
Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 80 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(/C=C/C(=O)NCCCNc2c3c(nc4ccccc24)CCCC3)cc1OC,56.5,%,=,CHEMBL3770635
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1S2,18.3,%,=,CHEMBL828
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1OC,,%,,CHEMBL3770356
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1S2,10.3,%,=,CHEMBL1411769
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1OC,6.2,%,=,CHEMBL3770071
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1[Se]2,16.3,%,=,CHEMBL3769834
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1OC,6.3,%,=,CHEMBL3770978
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1[Se]2,14.5,%,=,CHEMBL3769862
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1OC,8.4,%,=,CHEMBL3769555
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 1 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],8.6,%,=,CHEMBL410263
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1S2,37.2,%,=,CHEMBL828
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1OC,,%,,CHEMBL3770356
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1S2,22.0,%,=,CHEMBL1411769
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1OC,4.5,%,=,CHEMBL3770071
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1[Se]2,24.1,%,=,CHEMBL3769834
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1OC,5.7,%,=,CHEMBL3770978
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1[Se]2,18.5,%,=,CHEMBL3769862
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1OC,7.9,%,=,CHEMBL3769555
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 5 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],20.4,%,=,CHEMBL410263
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1S2,59.1,%,=,CHEMBL828
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1OC,,%,,CHEMBL3770356
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1S2,33.7,%,=,CHEMBL1411769
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1OC,6.5,%,=,CHEMBL3770071
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1[Se]2,30.7,%,=,CHEMBL3769834
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1OC,8.7,%,=,CHEMBL3770978
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1[Se]2,25.1,%,=,CHEMBL3769862
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1OC,9.1,%,=,CHEMBL3769555
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 10 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],31.0,%,=,CHEMBL410263
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1S2,62.0,%,=,CHEMBL828
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccccc32)cc1OC,,%,,CHEMBL3770356
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1S2,60.8,%,=,CHEMBL1411769
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3Sc3ccc(Cl)cc32)cc1OC,5.9,%,=,CHEMBL3770071
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,c1ccc2c(c1)Nc1ccccc1[Se]2,45.6,%,=,CHEMBL3769834
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccccc32)cc1OC,11.1,%,=,CHEMBL3770978
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,Clc1ccc2c(c1)Nc1ccccc1[Se]2,45.0,%,=,CHEMBL3769862
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1ccc(C(=O)N2c3ccccc3[Se]c3ccc(Cl)cc32)cc1OC,5.9,%,=,CHEMBL3769555
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) at 25 uM measured every 5 mins for 16 hrs by thioflavin T fluorescence method relative to control,Inhibition,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],57.2,%,=,CHEMBL410263
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) measured every 5 mins for 16 hrs by thioflavin T fluorescence method,Inhibition,c1ccc2c(c1)Nc1ccccc1S2,,%,,CHEMBL828
Inhibition of amyloid beta (1-42) self-induced aggregation (unknown origin) measured every 5 mins for 16 hrs by thioflavin T fluorescence method,Inhibition,c1ccc2c(c1)Nc1ccccc1[Se]2,,%,,CHEMBL3769834
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(OC)cc([C@@H]2CC(=O)N(Cc3ccc(OC)c(OC)c3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])c1,,%,,CHEMBL3775928
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1cccnc1,,%,,CHEMBL3775088
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,46.59,%,=,CHEMBL140
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc([C@@H]2[C@@H]([N+](=O)[O-])[C@H](c3ccccc3Cl)CC(=O)N2Cc2ccccc2)ccc1O,11.78,%,=,CHEMBL3775929
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(OC)cc([C@@H]2CC(=O)N(Cc3ccc(OC)c(OC)c3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])c1,59.11,%,=,CHEMBL3775928
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc(CN2C(=O)C[C@@H](c3cc(OC)cc(OC)c3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)c1,56.85,%,=,CHEMBL3775246
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(OC)cc([C@@H]2CC(=O)N(Cc3ccccc3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])c1,54.98,%,=,CHEMBL3774795
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc(CN2C(=O)C[C@@H](c3ccc(C)cc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)c1,48.85,%,=,CHEMBL3775551
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(CN2C(=O)C[C@@H](c3ccc(C)cc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,30.6,%,=,CHEMBL3775695
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc(CN2C(=O)C[C@@H](c3ccc(C)cc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,42.06,%,=,CHEMBL3774990
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc([C@@H]2CC(=O)N(Cc3ccccc3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])cc1,44.1,%,=,CHEMBL3775523
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc(CN2C(=O)C[C@@H](c3ccccc3Cl)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)c1,50.03,%,=,CHEMBL3774789
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(CN2C(=O)C[C@@H](c3ccccc3Cl)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,28.73,%,=,CHEMBL3775359
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc(CN2C(=O)C[C@@H](c3ccccc3Cl)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,46.1,%,=,CHEMBL3774837
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2Cl)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1ccccc1,11.25,%,=,CHEMBL3775010
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(CN2C(=O)C[C@@H](c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1OC,49.22,%,=,CHEMBL3775593
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cccc(CN2C(=O)C[C@@H](c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)c1,51.67,%,=,CHEMBL3775381
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1ccc(CN2C(=O)C[C@@H](c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,46.08,%,=,CHEMBL3775185
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,Cc1ccc(CN2C(=O)C[C@@H](c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,39.87,%,=,CHEMBL3774627
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1ccc(F)cc1,6.39,%,=,CHEMBL3775629
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1ccccc1,43.56,%,=,CHEMBL3775649
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COC(=O)c1ccc(CN2C(=O)C[C@@H](c3ccccc3Cl)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,33.07,%,=,CHEMBL3774597
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COC(=O)c1ccc(CN2C(=O)C[C@@H](c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2c2ccc(O)cc2)cc1,36.29,%,=,CHEMBL3774711
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(OC)cc([C@@H]2CC(=O)N(Cc3cccnc3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])c1,54.01,%,=,CHEMBL3775259
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2Cl)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1cccnc1,41.56,%,=,CHEMBL3775870
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM for 24 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@@H](c2ccc(O)cc2)N1Cc1cccnc1,43.3,%,=,CHEMBL3775088
Inhibition of Amyloid beta (1 to 42 residues) (unknown origin) assessed as no fibril formation at 50 uM after 4 days by atomic force microscopic analysis,Inhibition,COc1cc(OC)cc([C@@H]2CC(=O)N(Cc3ccc(OC)c(OC)c3)[C@H](c3ccc(O)cc3)[C@H]2[N+](=O)[O-])c1,,%,,CHEMBL3775928
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM measured after 72 hrs by by Thioflavin T-based fluorometric assay,Inhibition,C[N+](C)(C)CCOC(=O)c1ccc(Oc2nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)nc(Oc3ccc(C(=O)OCC[N+](C)(C)C)cc3)n2)cc1,50.9,%,=,CHEMBL3781564
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM measured after 72 hrs by by Thioflavin T-based fluorometric assay,Inhibition,CC(COC(=O)c1ccc(Oc2nc(Oc3ccc(C(=O)OCC(C)N(C)C)cc3)nc(Oc3ccc(C(=O)OCC(C)N(C)C)cc3)n2)cc1)N(C)C,68.5,%,=,CHEMBL3780448
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM measured after 72 hrs by by Thioflavin T-based fluorometric assay,Inhibition,COc1nc(Oc2ccc(C(=O)OCC(C)N(C)C)cc2)nc(Oc2ccc(C(=O)OCC(C)N(C)C)cc2)n1,58.4,%,=,CHEMBL3780131
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Cc1ccc(-c2cc(NCCNc3cc(-c4cccs4)[nH]n3)n[nH]2)cc1,29000.0,nM,=,CHEMBL3781419
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,CN(C)c1ccc(-c2cc(NCCNc3cc(-c4ccc(N(C)C)cc4)[nH]n3)n[nH]2)cc1,7500.0,nM,=,CHEMBL3781022
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Fc1ccc(-c2cc(NCCNc3cc(-c4ccc(F)cc4)[nH]n3)n[nH]2)cc1,40500.0,nM,=,CHEMBL3781026
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 3 hrs by Thioflavin T-based fluorometric assay,Inhibition,O=C(NC1C2CC3CC(C2)CC1C3)c1nc(Cc2ccccc2)cc(Oc2ccccc2)n1,47.0,%,=,CHEMBL3781942
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 3 hrs by Thioflavin T-based fluorometric assay,Inhibition,CC(C)CCNC(=O)c1cc(Cc2ccccc2)cc(Oc2ccccc2)n1,71.0,%,=,CHEMBL3781135
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCN(C)Cc3ccccc3)cc2)cc(OC)c1,36.3,%,=,CHEMBL3786642
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1,21.9,%,=,CHEMBL3786194
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCN(C)Cc3ccccc3OC)cc2)cc(OC)c1,11.2,%,=,CHEMBL3786004
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1OC,25.8,%,=,CHEMBL3785365
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,21.2,%,=,CHEMBL3785337
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1,11.8,%,=,CHEMBL3787450
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCN(C)Cc3ccccc3OC)cc2)cc(OC)c1,20.3,%,=,CHEMBL3786423
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1OC,18.3,%,=,CHEMBL3786817
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,17.9,%,=,CHEMBL3786615
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1,14.3,%,=,CHEMBL3785308
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCCN(C)Cc3ccccc3OC)cc2)cc(OC)c1,29.6,%,=,CHEMBL3787251
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1OC,28.9,%,=,CHEMBL3786787
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCCCCN(C)Cc3ccccc3)cc2)cc(OC)c1,12.6,%,=,CHEMBL3787426
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1,14.6,%,=,CHEMBL3786464
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/c2ccc(OCC(=O)NCCCCCCN(C)Cc3ccccc3OC)cc2)cc(OC)c1,22.4,%,=,CHEMBL3786968
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,CCN(CCCCCCNC(=O)COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1)Cc1ccccc1OC,32.4,%,=,CHEMBL3785633
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,49.8,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,97.4,%,=,CHEMBL2288402
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CCN(C)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,95.3,%,=,CHEMBL3786785
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CCN(CC)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,91.7,%,=,CHEMBL3786747
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCCC3)cc2)Oc2cc(O)cc(O)c21,99.8,%,=,CHEMBL3786282
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCCCC3)cc2)Oc2cc(O)cc(O)c21,99.2,%,=,CHEMBL3263556
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCOCC3)cc2)Oc2cc(O)cc(O)c21,80.7,%,=,CHEMBL1814450
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN1CCN(c2ccc(/C=C3\Oc4cc(O)cc(O)c4C3=O)cc2)CC1,77.7,%,=,CHEMBL3787128
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccccc1/C=C1\Oc2cc(O)cc(O)c2C1=O,98.2,%,=,CHEMBL3786694
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N(C)C)cc1)C2=O,53.7,%,=,CHEMBL3785406
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N3CCCCC3)cc1)C2=O,40.3,%,=,CHEMBL3786378
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N3CCOCC3)cc1)C2=O,44.1,%,=,CHEMBL3786723
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(CC2Oc3cc(O)cc(O)c3C2=O)cc1,42.7,%,=,CHEMBL3785418
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1c2c(O)cc(O)cc2OC1Cc1ccc(N2CCOCC2)cc1,38.0,%,=,CHEMBL3787591
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(/C=C2\Oc3cc(N(C)C)cc(O)c3C2=O)cc1,22.3,%,=,CHEMBL3785241
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,61.4,%,=,CHEMBL2288402
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CCN(C)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,86.6,%,=,CHEMBL3786785
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CCN(CC)c1ccc(/C=C2\Oc3cc(O)cc(O)c3C2=O)cc1,88.9,%,=,CHEMBL3786747
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCCC3)cc2)Oc2cc(O)cc(O)c21,84.8,%,=,CHEMBL3786282
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCCCC3)cc2)Oc2cc(O)cc(O)c21,84.0,%,=,CHEMBL3263556
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1/C(=C/c2ccc(N3CCOCC3)cc2)Oc2cc(O)cc(O)c21,50.1,%,=,CHEMBL1814450
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN1CCN(c2ccc(/C=C3\Oc4cc(O)cc(O)c4C3=O)cc2)CC1,52.0,%,=,CHEMBL3787128
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccccc1/C=C1\Oc2cc(O)cc(O)c2C1=O,90.1,%,=,CHEMBL3786694
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N(C)C)cc1)C2=O,75.7,%,=,CHEMBL3785406
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N3CCCCC3)cc1)C2=O,46.0,%,=,CHEMBL3786378
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(O)c2c(c1)O/C(=C\c1ccc(N3CCOCC3)cc1)C2=O,47.5,%,=,CHEMBL3786723
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(CC2Oc3cc(O)cc(O)c3C2=O)cc1,40.5,%,=,CHEMBL3785418
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C1c2c(O)cc(O)cc2OC1Cc1ccc(N2CCOCC2)cc1,20.9,%,=,CHEMBL3787591
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,CN(C)c1ccc(/C=C2\Oc3cc(N(C)C)cc(O)c3C2=O)cc1,71.6,%,=,CHEMBL3785241
Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,67.2,%,=,CHEMBL140
Displacement of [125I]-2-[(4-Aminophenyl)methylene]-5-iodo-3(2H)-benzofuranone from amyloid beta (1 to 42) (unknown origin) after 3 hrs by gamma counting method,Ki,CN(C)c1ccc(/C=C2\Oc3ccc([125I])cc3C2=O)cc1,6.82,nM,=,CHEMBL3785292
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CCC/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,52.4,%,=,CHEMBL3786095
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CCC/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,37.5,%,=,CHEMBL3786643
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CCC/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,69.5,%,=,CHEMBL3785268
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CC(C)C/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,46.7,%,=,CHEMBL3786205
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CC(C)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,56.5,%,=,CHEMBL3785504
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CC(C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,28.6,%,=,CHEMBL3786129
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CC(C(C)C)C/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,32.7,%,=,CHEMBL3787274
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CC(C(C)C)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,57.5,%,=,CHEMBL3787250
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CC(C(C)C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,61.2,%,=,CHEMBL3785402
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CNC/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,47.7,%,=,CHEMBL3785522
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CNC/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,27.9,%,=,CHEMBL3787626
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CNC/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,39.3,%,=,CHEMBL3786742
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CN(C)C/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,57.6,%,=,CHEMBL3787510
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CN(C)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,60.4,%,=,CHEMBL3787299
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CN(C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,76.6,%,=,CHEMBL3785375
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\CN(Cc3ccccc3)C/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,49.0,%,=,CHEMBL3786212
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\CN(Cc3ccccc3)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,31.1,%,=,CHEMBL3787471
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\CN(Cc3ccccc3)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,45.3,%,=,CHEMBL3786242
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cccc(/C=C2\COC/C(=C\c3cccc(OC)c3Cl)C2=O)c1Cl,37.5,%,=,CHEMBL3786918
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1ccc(/C=C2\COC/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,42.7,%,=,CHEMBL3785460
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc(/C=C2\COC/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,55.3,%,=,CHEMBL3787119
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation at 10 uM after 2 days by thioflavin T fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,14.5,%,=,CHEMBL502
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation after 2 days by thioflavin T fluorometric assay,Inhibition,COc1cc(/C=C2\CCC/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,,%,,CHEMBL3785268
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation after 2 days by thioflavin T fluorometric assay,Inhibition,COc1ccc(/C=C2\CC(C(C)C)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,,%,,CHEMBL3787250
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation after 2 days by thioflavin T fluorometric assay,Inhibition,COc1cc(/C=C2\CC(C(C)C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,,%,,CHEMBL3785402
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation after 2 days by thioflavin T fluorometric assay,Inhibition,COc1ccc(/C=C2\CN(C)C/C(=C\c3ccc(OC)c(OC)c3Cl)C2=O)c(Cl)c1OC,,%,,CHEMBL3787299
Inhibition of amyloid beta (1-42) (unknown origin) self-induced aggregation after 2 days by thioflavin T fluorometric assay,Inhibition,COc1cc(/C=C2\CN(C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=O)c(Br)c(OC)c1OC,,%,,CHEMBL3785375
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 42 hrs by uranyl acetate staining-based transmission electron microscopy,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1.O=C(O)C(F)(F)F,,%,,CHEMBL3793216
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 42 hrs by uranyl acetate staining-based transmission electron microscopy,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3792894
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 42 hrs by uranyl acetate staining-based transmission electron microscopy,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1,,%,,CHEMBL3793747
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 42 hrs by ThT fluorescence assay,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1.O=C(O)C(F)(F)F,,%,,CHEMBL3793216
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 42 hrs by ThT fluorescence assay,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(C)C.O=C(O)C(F)(F)F,,%,,CHEMBL3792894
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 42 hrs by ThT fluorescence assay,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1,,%,,CHEMBL3793747
"Binding affinity to synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as negative nuclear overhauser effect at 0.4 mM after 2.5 weeks by 2D NOESY method",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Binding affinity to monomeric synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation up to 90 uM at 5 degC by 2D 1H-1H NMR spectroscopy",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Binding affinity to monomeric synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation up to 90 uM at 5 degC by 1D 1H NMR spectroscopy",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Binding affinity to monomeric synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation at 0.4 mM at 5 degC by 1D 1H NMR spectroscopy",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at compound/protein ratio of 10/1, 1/1, 0.1/1 after 4 hrs by ThT fluorescence assay",Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
Binding affinity to amyloid beta (1 to 42) (unknown origin) by SPR analysis,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
Binding affinity to amyloid beta (1 to 42) (unknown origin) by SPR analysis,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3793081
Binding affinity to amyloid beta (1 to 42) (unknown origin) by SPR analysis,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,,,CHEMBL3545685
"Binding affinity to synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as negative nuclear overhauser effect at 0.4 mM after 2.5 weeks by 1D 1H water LOGSY method",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Binding affinity to synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) at 0.4 mM after 2.5 weeks by saturation transfer difference method",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
"Binding affinity to monomeric synthetic 15N,13C-labelled recombinant amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation at 0.4 mM at 5 degC by 2D 1H-1H NMR spectroscopy",Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as remaining monomer level at compound/protein ratio of 1/1 after 12 hrs by capillary electrophoresis (Rvb = 19%),Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,52.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as formation of larger than dodecamers at compound/protein ratio of 1/1 at 12 hrs by capillary electrophoresis,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as appearance of glubular aggregation at compound/protein ratio of 1/1 after 42 hrs by transmission electron microscopy,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as appearance of less dense fiber at compound/protein ratio of 1/1 after 42 hrs by uranyl acetate staining-based transmission electron microscopy,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
"Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as scattered, short and scarce fiber formation at compound/protein ratio of 10/1 after 42 hrs by uranyl acetate staining-based transmission electron microscopy",Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 0.1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,16.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,26.0,%,=,CHEMBL3793248
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3794068
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,34.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,29.0,%,=,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3793622
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3545685
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,84.0,%,=,CHEMBL3793248
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,41.0,%,=,CHEMBL3794068
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,90.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,87.0,%,=,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,31.0,%,=,CHEMBL3793622
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,56.0,%,=,CHEMBL3545685
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 0.1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,129.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 0.1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,154.0,%,=,CHEMBL3793248
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,138.0,%,=,CHEMBL3794068
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,165.0,%,=,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,148.0,%,=,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,155.0,%,=,CHEMBL3793622
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,,%,,CHEMBL3545685
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793248
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,379.0,%,=,CHEMBL3794068
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3792618
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@@H](NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,325.0,%,=,CHEMBL3793622
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Activity,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCOC[C@H]1O[C@@H](OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O)C(C)C,280.0,%,=,CHEMBL3545685
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as extension of aggregation half life at compound/protein ratio of 10/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL3793081
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound/protein ratio of 0.1/1 after 42 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)CCOC[C@H]1OC(OCCCNC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)[C@H](O)[C@@H](O)[C@@H]1O,23.0,%,=,CHEMBL3793081
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,68.9,%,=,CHEMBL140
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,O=C1/C(=C/c2ccccc2)C(c2ccccc2)n2cccc21,1.4,%,=,CHEMBL3793189
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(C2/C(=C\c3ccc(OCc4ccccc4)c(OCc4ccccc4)c3)C(=O)c3cccn32)ccc1OCc1ccccc1,4.2,%,=,CHEMBL3793694
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,O=C1/C(=C/c2ccc(O)c(O)c2)C(c2ccccc2)n2cccc21,28.7,%,=,CHEMBL3794066
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C2/C(=O)c3cccn3C2c2ccccc2)ccc1O,14.5,%,=,CHEMBL3792740
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(C2/C(=C\c3ccc(O)c(O)c3)C(=O)c3cccn32)cc1O,24.9,%,=,CHEMBL3793919
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(/C=C2/C(=O)c3cccn3C2c2ccc(OC)c(O)c2)cc1O,8.4,%,=,CHEMBL3793444
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(C2/C(=C\c3ccc(O)c(OC)c3)C(=O)c3cccn32)cc1O,12.8,%,=,CHEMBL3792543
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(C2/C(=C\c3ccc(O)c(O)c3)C(=O)c3cccn32)ccc1O,26.1,%,=,CHEMBL3792514
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(/C=C2/C(=O)c3cccn3C2c2ccc(O)c(OC)c2)cc1O,15.9,%,=,CHEMBL3793743
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C2/C(=O)c3cccn3C2c2ccc(O)c(OC)c2)ccc1O,10.4,%,=,CHEMBL3793926
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(/C=C2/C(=O)c3cccn3C2c2ccc(O)c(OC)c2)c(OC)c1,6.0,%,=,CHEMBL3793963
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(C2/C(=C\c3cc(OC)c(OC)c(OC)c3)C(=O)c3cccn32)ccc1O,23.6,%,=,CHEMBL3792595
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,COc1cc(C2/C(=C\c3cc(OC)c(O)c(OC)c3)C(=O)c3cccn32)ccc1O,30.1,%,=,CHEMBL3793449
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM measured every 5 mins with shake for 15 secs by ThT fluorescence assay relative to control,Inhibition,O=C1/C(=C/c2ccc(O)c(O)c2)C(c2ccc(O)c(O)c2)n2cccc21,27.0,%,=,CHEMBL3793566
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCN(C)Cc2ccccc2)ccc1O,39.1,%,=,CHEMBL3793476
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,33.3,%,=,CHEMBL3793017
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCN(C)Cc2ccccc2OC)ccc1O,30.8,%,=,CHEMBL3794260
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,35.2,%,=,CHEMBL3794062
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCN(C)Cc2ccccc2)ccc1O,31.6,%,=,CHEMBL3792591
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,33.8,%,=,CHEMBL3792466
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCN(C)Cc2ccccc2OC)ccc1O,32.5,%,=,CHEMBL3793187
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,38.3,%,=,CHEMBL3792769
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCN(C)Cc2ccccc2)ccc1O,31.2,%,=,CHEMBL3792814
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,37.4,%,=,CHEMBL3793666
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCN(C)Cc2ccccc2OC)ccc1O,36.6,%,=,CHEMBL3792478
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,38.1,%,=,CHEMBL3792491
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,28.3,%,=,CHEMBL32749
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,72.7,%,=,CHEMBL231160
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 25 uM by Thioflavin T-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.2,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 50 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,49.3,%,=,CHEMBL3792491
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) at 10 uM by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,26.8,%,=,CHEMBL3792491
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCN(C)Cc2ccccc2)ccc1O,,,,CHEMBL3793476
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,,,,CHEMBL3793017
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCN(C)Cc2ccccc2OC)ccc1O,,,,CHEMBL3794260
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,,,,CHEMBL3794062
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCCN(C)Cc2ccccc2)ccc1O,,,,CHEMBL3792591
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,,,,CHEMBL3792466
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCCN(C)Cc2ccccc2OC)ccc1O,,,,CHEMBL3793187
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,,,,CHEMBL3792769
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCCCCN(C)Cc2ccccc2)ccc1O,,,,CHEMBL3792814
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1,,,,CHEMBL3793666
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)NCCCCCCN(C)Cc2ccccc2OC)ccc1O,,,,CHEMBL3792478
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,45.5,%,=,CHEMBL3792491
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)O)ccc1O,,,,CHEMBL32749
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,,,,CHEMBL231160
Induction of disaggregation of self-induced amyloid beta (1 to 42) fibril formation (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T-based fluorometric assay,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,57.6,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) aggregation (unknown origin) by Thioflavin T-based fluorometric assay,Inhibition,CCN(CCCCCCNC(=O)/C=C/c1ccc(O)c(OC)c1)Cc1ccccc1OC,,%,,CHEMBL3792491
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1,71.28,nM,=,CHEMBL3797646
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,22.54,nM,=,CHEMBL3797706
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,51.81,nM,=,CHEMBL3799558
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(O)cc1)Nc1c2c(nc3ccccc13)CCCC2,45.29,nM,=,CHEMBL3798857
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,77.45,nM,=,CHEMBL3797623
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OC)cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c1,55.86,nM,=,CHEMBL3798989
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,30.74,nM,=,CHEMBL3797363
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,65.5,nM,=,CHEMBL3799703
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)ccc1O,37.36,nM,=,CHEMBL3797381
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)c1ccc(O)c(O)c1)Nc1c2c(nc3ccccc13)CCCC2,17.36,nM,=,CHEMBL3800453
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,49.14,nM,=,CHEMBL3800317
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,45.88,nM,=,CHEMBL3799950
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1O,46.12,nM,=,CHEMBL3798813
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,51.77,nM,=,CHEMBL3799175
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1c[nH]c2ccccc12)Nc1c2c(nc3ccccc13)CCCC2,38.96,nM,=,CHEMBL3799641
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,Nc1c2c(nc3ccccc13)CCCC2,12.21,nM,=,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 50 uM after 24 hrs by phosphomolybdic acid staining-based transmission electron microscopic analysis,Inhibition,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,,%,,CHEMBL3797706
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 50 uM after 24 hrs by phosphomolybdic acid staining-based transmission electron microscopic analysis,Inhibition,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,,%,,CHEMBL3799558
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 50 uM after 24 hrs by phosphomolybdic acid staining-based transmission electron microscopic analysis,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,44.6,%,=,CHEMBL435734
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,CNC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,29.8,%,=,CHEMBL3809851
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,CCNC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,36.3,%,=,CHEMBL3809166
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,CCCNC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,20.3,%,=,CHEMBL3809439
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)NC(C)C)c(OC)c2)cc1OC,21.4,%,=,CHEMBL3810176
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)NC3CCCCC3)c(OC)c2)cc1OC,35.4,%,=,CHEMBL3808488
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)N(C)C)c(OC)c2)cc1OC,28.5,%,=,CHEMBL3809456
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,CCN(CC)C(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,11.9,%,=,CHEMBL3809269
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(N3CCCCC3)c(OC)c2)cc1OC,26.2,%,=,CHEMBL3808507
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccccc3)c(OC)c2)cc1OC,43.5,%,=,CHEMBL3810211
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)NCc3ccccc3)c(OC)c2)cc1OC,41.3,%,=,CHEMBL3808707
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)NCCc3ccccc3)c(OC)c2)cc1OC,49.0,%,=,CHEMBL3809917
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)N[C@@H](C)c3ccccc3)c(OC)c2)cc1OC,70.8,%,=,CHEMBL3810217
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)N[C@H](C)c3ccccc3)c(OC)c2)cc1OC,45.0,%,=,CHEMBL3809284
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)N(C)c3ccccc3)c(OC)c2)cc1OC,30.0,%,=,CHEMBL3808684
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(NC(=O)Oc2ccc(C[C@H]3C(=O)OC[C@@H]3Cc3ccc(OC)c(OC)c3)cc2OC)cc1,52.9,%,=,CHEMBL3808874
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1cccc(NC(=O)Oc2ccc(C[C@H]3C(=O)OC[C@@H]3Cc3ccc(OC)c(OC)c3)cc2OC)c1,52.8,%,=,CHEMBL3810193
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccccc1NC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,61.7,%,=,CHEMBL3808436
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(Cl)cc3)c(OC)c2)cc1OC,66.9,%,=,CHEMBL3808419
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(Cl)c3)c(OC)c2)cc1OC,78.7,%,=,CHEMBL3808504
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccccc3Cl)c(OC)c2)cc1OC,58.3,%,=,CHEMBL3809580
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(C)c3)c(OC)c2)cc1OC,55.0,%,=,CHEMBL3808719
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(F)c3)c(OC)c2)cc1OC,61.0,%,=,CHEMBL3808626
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc([N+](=O)[O-])c3)c(OC)c2)cc1OC,63.0,%,=,CHEMBL3809632
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(C#N)c3)c(OC)c2)cc1OC,56.0,%,=,CHEMBL3809522
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)N(C)c3cccc(Cl)c3)c(OC)c2)cc1OC,41.0,%,=,CHEMBL3809578
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(Cl)cc1NC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC,42.4,%,=,CHEMBL3808885
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cc(Cl)cc(Cl)c3)c(OC)c2)cc1OC,56.0,%,=,CHEMBL3808655
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(F)c(Cl)c3)c(OC)c2)cc1OC,60.5,%,=,CHEMBL3809295
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(Cl)c3C)c(OC)c2)cc1OC,62.8,%,=,CHEMBL3809701
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 20 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(C)c(Cl)c3)c(OC)c2)cc1OC,53.7,%,=,CHEMBL3809507
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 0.1 uM after 24 hrs by ELISA,Inhibition,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,,%,,CHEMBL435734
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 0.1 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(Cl)cc3)c(OC)c2)cc1OC,,%,,CHEMBL3808419
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 0.1 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(Cl)c3)c(OC)c2)cc1OC,,%,,CHEMBL3808504
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 1 uM after 24 hrs by ELISA,Inhibition,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,,%,,CHEMBL435734
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 1 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(Cl)cc3)c(OC)c2)cc1OC,,%,,CHEMBL3808419
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 1 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(Cl)c3)c(OC)c2)cc1OC,,%,,CHEMBL3808504
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 10 uM after 24 hrs by ELISA,Inhibition,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,,%,,CHEMBL435734
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 10 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3ccc(Cl)cc3)c(OC)c2)cc1OC,,%,,CHEMBL3808419
Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N/M596L Swedish mutant at 10 uM after 24 hrs by ELISA,Inhibition,COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)Nc3cccc(Cl)c3)c(OC)c2)cc1OC,,%,,CHEMBL3808504
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,,%,,CHEMBL3814001
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,,%,,CHEMBL3814125
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,,%,,CHEMBL3814001
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,,%,,CHEMBL3814125
"Potency index, ratio of curcumin IC50 for amyloid beta 42 (unknown origin) aggregation to compound IC50 for amyloid beta 42 (unknown origin) aggregation",Ratio IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1.8,,=,CHEMBL3814001
"Potency index, ratio of curcumin IC50 for amyloid beta 40 (unknown origin) aggregation to compound IC50 for amyloid beta 40 (unknown origin) aggregation",Ratio IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,18.0,,=,CHEMBL3814631
"Potency index, ratio of curcumin IC50 for amyloid beta 40 (unknown origin) aggregation to compound IC50 for amyloid beta 40 (unknown origin) aggregation",Ratio IC50,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,2.4,,=,CHEMBL3813811
Inhibition of amyloid beta 42 (unknown origin) aggregation at 25 uM after 24 hrs by transmission electron microscopy,Inhibition,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,,%,,CHEMBL3814001
Inhibition of amyloid beta 42 (unknown origin) aggregation at 25 uM after 24 hrs by transmission electron microscopy,Inhibition,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,,%,,CHEMBL3814631
Inhibition of amyloid beta 40 (unknown origin) aggregation at 25 uM after 24 hrs by transmission electron microscopy,Inhibition,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,,%,,CHEMBL3814001
Inhibition of amyloid beta 40 (unknown origin) aggregation at 25 uM after 24 hrs by transmission electron microscopy,Inhibition,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,,%,,CHEMBL3814631
Inhibition of amyloid beta 42 (unknown origin) aggregation assessed as time at which fluorescence intensity reaches the midpoint between pre and post aggregation baseline growth phase at 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis (Rvb = 2 hrs),Inhibition,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,,%,,CHEMBL3814001
Inhibition of amyloid beta 42 (unknown origin) aggregation assessed as time at which fluorescence intensity reaches the midpoint between pre and post aggregation baseline growth phase at 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis (Rvb = 2 hrs),TIME,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,6.0,hr,=,CHEMBL3814125
Inhibition of amyloid beta 42 (unknown origin) aggregation assessed as time at which fluorescence intensity reaches the midpoint between pre and post aggregation baseline growth phase at 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis (Rvb = 2 hrs),TIME,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,3.5,hr,=,CHEMBL3814631
Inhibition of amyloid beta 42 (unknown origin) aggregation assessed as time at which fluorescence intensity reaches the midpoint between pre and post aggregation baseline growth phase at 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis (Rvb = 2 hrs),TIME,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,2.6,hr,=,CHEMBL3814270
Inhibition of amyloid beta 40 (unknown origin) aggregation assessed as time at which fluorescence intensity reaches the midpoint between pre and post aggregation baseline growth phase at 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis (Rvb = 12.5 hrs),TIME,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,17.0,hr,=,CHEMBL3814125
Inhibition of nucleation-dependent amyloid beta 40 (unknown origin) aggregation at 1 to 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,,%,,CHEMBL3814631
Inhibition of nucleation-dependent amyloid beta 40 (unknown origin) aggregation at 1 to 25 uM measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Inhibition,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,,%,,CHEMBL3814270
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,4100.0,nM,=,CHEMBL165
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3100.0,nM,=,CHEMBL140
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)nc2ccccc12,25000.0,nM,>,CHEMBL3814397
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)c2ccccc2n1,25000.0,nM,>,CHEMBL3815140
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)c2ccccc2n1,25000.0,nM,>,CHEMBL3814981
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,25000.0,nM,>,CHEMBL3814610
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)nc2ccccc12,25000.0,nM,>,CHEMBL3814189
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,14700.0,nM,=,CHEMBL3813837
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,2700.0,nM,=,CHEMBL3814125
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,8100.0,nM,=,CHEMBL3815148
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,13400.0,nM,=,CHEMBL3814191
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,5300.0,nM,=,CHEMBL3814611
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,13800.0,nM,=,CHEMBL3815150
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,25000.0,nM,>,CHEMBL3814909
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000.0,nM,>,CHEMBL3814324
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,22500.0,nM,=,CHEMBL3813859
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000.0,nM,>,CHEMBL3814103
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],8700.0,nM,=,CHEMBL410263
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)c2ccccc2n1,25000.0,nM,>,CHEMBL3815002
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)nc2ccccc12,,,,CHEMBL3814965
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)nc2ccccc12,,,,CHEMBL3814813
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,25000.0,nM,>,CHEMBL3814123
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,25000.0,nM,>,CHEMBL3357256
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,25000.0,nM,>,CHEMBL3814748
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,14800.0,nM,=,CHEMBL3814631
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,22300.0,nM,=,CHEMBL3814270
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,25000.0,nM,>,CHEMBL3813811
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,25000.0,nM,>,CHEMBL3814383
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,25000.0,nM,>,CHEMBL3814660
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,21000.0,nM,=,CHEMBL3814349
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,25000.0,nM,>,CHEMBL3813788
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)nc3ccccc23)c1,,,,CHEMBL3814429
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,25000.0,nM,>,CHEMBL3813971
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,25000.0,nM,>,CHEMBL3814363
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,25000.0,nM,>,CHEMBL3815078
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,2600.0,nM,=,CHEMBL165
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1500.0,nM,=,CHEMBL140
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)nc2ccccc12,25000.0,nM,>,CHEMBL3814397
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)c2ccccc2n1,25000.0,nM,>,CHEMBL3815140
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)c2ccccc2n1,25000.0,nM,>,CHEMBL3814981
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)nc2ccccc12,25000.0,nM,>,CHEMBL3814189
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,11300.0,nM,=,CHEMBL3813837
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,1500.0,nM,=,CHEMBL3814125
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,930.0,nM,=,CHEMBL3815148
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,5900.0,nM,=,CHEMBL3814191
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,2300.0,nM,=,CHEMBL3814611
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,12500.0,nM,=,CHEMBL3815150
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,6800.0,nM,=,CHEMBL3814909
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000.0,nM,>,CHEMBL3814324
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,13100.0,nM,=,CHEMBL3813859
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000.0,nM,>,CHEMBL3814103
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],3000.0,nM,=,CHEMBL410263
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)c2ccccc2n1,13600.0,nM,=,CHEMBL3815002
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)nc2ccccc12,10200.0,nM,=,CHEMBL3814965
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)nc2ccccc12,14900.0,nM,=,CHEMBL3814813
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,3100.0,nM,=,CHEMBL3357256
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,2800.0,nM,=,CHEMBL3814748
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,80.0,nM,=,CHEMBL3814631
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,580.0,nM,=,CHEMBL3814270
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,620.0,nM,=,CHEMBL3813811
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814383
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814660
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,3500.0,nM,=,CHEMBL3814349
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,1100.0,nM,=,CHEMBL3813788
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)nc3ccccc23)c1,20600.0,nM,=,CHEMBL3814429
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,3900.0,nM,=,CHEMBL3813971
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,3600.0,nM,=,CHEMBL3814363
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078
Induction of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Activity,Nc1nc(N)c2ccccc2n1,,,,CHEMBL268354
Induction of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,Activity,Nc1nc(N)c2ccccc2n1,,,,CHEMBL268354
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300.0,nM,=,CHEMBL429694
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,35000.0,nM,=,CHEMBL3815004
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,17000.0,nM,=,CHEMBL3814529
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,25000.0,nM,=,CHEMBL3814719
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,13000.0,nM,=,CHEMBL3814159
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,240000.0,nM,=,CHEMBL3813916
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,280000.0,nM,=,CHEMBL3814563
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,12.0,%,=,CHEMBL3815004
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(NC)n2)n1,23.0,%,=,CHEMBL3813794
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(NCCc2ccccn2)n1,36.0,%,=,CHEMBL3813898
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,12.0,%,=,CHEMBL3814529
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,12.0,%,=,CHEMBL3814719
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,14.0,%,=,CHEMBL3814159
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,16.0,%,=,CHEMBL3813916
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,23.0,%,=,CHEMBL3813815
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,16.0,%,=,CHEMBL3814563
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CNc2cccc(CCNc3ccccn3)n2)n1,60.0,%,>,CHEMBL3813850
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCCNc2cccc(CCCNc3ccccn3)n2)n1,23.0,%,=,CHEMBL3814513
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(CCCNc3ccccn3)n2)n1,23.0,%,=,CHEMBL3814516
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CCNc2cccc(CNc3ccccn3)n2)n1,53.0,%,=,CHEMBL3814500
Inhibition of Abeta42 (unknown origin) aggregation assessed as ThT fluorescence at 330 uM measured after 24 hrs by ThT fluorescence assay relative to DMSO control,Activity,CNc1cccc(CNc2cccc(CNc3ccccn3)n2)n1,60.0,%,>,CHEMBL3814151
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1c(I)cc(Cl)c2cccnc12,112.03,%,=,CHEMBL497
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,6.51,%,=,CHEMBL3818051
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,9.17,%,=,CHEMBL3819497
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,22.57,%,=,CHEMBL1984884
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,4.34,%,=,CHEMBL1333043
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1cccc(CNc2ccccc2O)c1,8.2,%,=,CHEMBL3818106
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,7.48,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 3 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1c(I)cc(Cl)c2cccnc12,120.26,%,=,CHEMBL497
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1ccc(CNc2ccccc2O)cc1O,3.55,10'5/M,=,CHEMBL3819497
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,2.46,10'5/M,=,CHEMBL3818051
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1ccc(CNc2ccccc2O)cc1,3.27,10'5/M,=,CHEMBL1333043
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1cccc(CNc2ccccc2O)c1,1.55,10'5/M,=,CHEMBL3818106
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,1.91,10'5/M,=,CHEMBL1984884
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1c(I)cc(Cl)c2cccnc12,3.69,10'5/M,=,CHEMBL497
Binding affinity to amyloid beta (1 to 40) (unknown origin) by tyrosine fluorimetric titration assay,Ka,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,1.65,10'5/M,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,4.25,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,3.7,%,=,CHEMBL1333043
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1cccc(CNc2ccccc2O)c1,6.65,%,=,CHEMBL3818106
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,13.91,%,=,CHEMBL1984884
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,7.49,%,=,CHEMBL3819497
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 7 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,6.21,%,=,CHEMBL3818051
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1c(I)cc(Cl)c2cccnc12,170.02,%,=,CHEMBL497
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,100.07,%,=,CHEMBL165
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,8.37,%,=,CHEMBL1333043
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1cccc(CNc2ccccc2O)c1,11.72,%,=,CHEMBL3818106
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,36.21,%,=,CHEMBL1984884
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,12.81,%,=,CHEMBL3819497
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 4 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,14.37,%,=,CHEMBL3818051
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1c(I)cc(Cl)c2cccnc12,310.39,%,=,CHEMBL497
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,24.09,%,=,CHEMBL165
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,10.12,%,=,CHEMBL1333043
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1cccc(CNc2ccccc2O)c1,20.27,%,=,CHEMBL3818106
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,26.63,%,=,CHEMBL1984884
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,9.28,%,=,CHEMBL3819497
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as remaining fibril aggregates at 100 uM after 12 days at pH 6.60 by thioflavin-T fluorescence assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,11.0,%,=,CHEMBL3818051
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,,CHEMBL165
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,,,,CHEMBL1333043
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1cccc(CNc2ccccc2O)c1,,,,CHEMBL3818106
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,,,,CHEMBL1984884
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,,,,CHEMBL3819497
Induction of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 3 days by turbidity assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,,,,CHEMBL3818051
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 7 to 18 days by turbidity assay,Inhibition,Oc1ccc(CNc2ccccc2O)cc1,,%,,CHEMBL1333043
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 7 to 18 days by turbidity assay,Inhibition,Oc1cccc(CNc2ccccc2O)c1,,%,,CHEMBL3818106
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 7 to 18 days by turbidity assay,Inhibition,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,,%,,CHEMBL1984884
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 7 to 18 days by turbidity assay,Inhibition,Oc1ccc(CNc2ccccc2O)cc1O,,%,,CHEMBL3819497
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 7 to 18 days by turbidity assay,Inhibition,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,,%,,CHEMBL3818051
Induction of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 4 days by turbidity assay,Activity,Oc1ccc(CNc2ccccc2O)cc1,,,,CHEMBL1333043
Induction of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 4 days by turbidity assay,Activity,Oc1cccc(CNc2ccccc2O)c1,,,,CHEMBL3818106
Induction of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 4 days by turbidity assay,Activity,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,,,,CHEMBL1984884
Induction of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 4 days by turbidity assay,Activity,Oc1ccc(CNc2ccccc2O)cc1O,,,,CHEMBL3819497
Induction of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 4 days by turbidity assay,Activity,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,,,,CHEMBL3818051
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 12 days by turbidity assay relative to control,Inhibition,Oc1ccc(CNc2ccccc2O)cc1,,%,,CHEMBL1333043
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 12 days by turbidity assay relative to control,Inhibition,Oc1cccc(CNc2ccccc2O)c1,46.0,%,=,CHEMBL3818106
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 12 days by turbidity assay relative to control,Inhibition,Oc1ccccc1/N=C/c1c(O)ccc2ccccc12,25.0,%,=,CHEMBL1984884
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 12 days by turbidity assay relative to control,Inhibition,Oc1ccc(CNc2ccccc2O)cc1O,,%,,CHEMBL3819497
Inhibition of preformed self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation at 100 uM after 12 days by turbidity assay relative to control,Inhibition,Oc1ccc(/N=C/c2c(O)ccc3ccccc23)c(O)c1,,%,,CHEMBL3818051
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,82.2,%,=,CHEMBL3818600
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,53.9,%,=,CHEMBL3818091
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,Cc1ccc(N2CCN(c3ccc(C=C4C(=O)c5ccccc5C4=O)cc3)CC2)c(C)c1,69.9,%,=,CHEMBL3819593
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,Cc1ccc(N2CCN(c3ccc(C=C4C(=O)c5ccccc5C4=O)cc3)CC2)cc1,62.4,%,=,CHEMBL3818518
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ccc(Cl)cc4)CC3)cc2)C(=O)c2ccccc21,60.8,%,=,CHEMBL3819042
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ccc(C(F)(F)F)cc4)CC3)cc2)C(=O)c2ccccc21,74.9,%,=,CHEMBL3819316
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ccc(F)cc4)CC3)cc2)C(=O)c2ccccc21,61.8,%,=,CHEMBL3819571
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ccccc4)CC3)cc2)C(=O)c2ccccc21,57.3,%,=,CHEMBL3818978
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,80.6,%,=,CHEMBL3819454
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(Cc4ccc5c(c4)OCO5)CC3)cc2)C(=O)c2ccccc21,71.8,%,=,CHEMBL3819248
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ccccn4)CC3)cc2)C(=O)c2ccccc21,70.9,%,=,CHEMBL3817925
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,80.9,%,=,CHEMBL3818053
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,53.8,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,9200.0,nM,=,CHEMBL3818600
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,11750.0,nM,=,CHEMBL3819454
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,10110.0,nM,=,CHEMBL3818053
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140
"Potency index, ratio of curcumin IC50 to compound IC50 for self-induced amyloid beta (1 to 42) (unknown origin) aggregation",Ratio IC50,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,1.5,,=,CHEMBL3818600
"Potency index, ratio of curcumin IC50 to compound IC50 for self-induced amyloid beta (1 to 42) (unknown origin) aggregation",Ratio IC50,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,1.5,,=,CHEMBL3819454
"Potency index, ratio of curcumin IC50 to compound IC50 for self-induced amyloid beta (1 to 42) (unknown origin) aggregation",Ratio IC50,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,1.5,,=,CHEMBL3818053
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 72 hrs by transmission electron microscopy,Inhibition,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,,%,,CHEMBL3818600
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 72 hrs by transmission electron microscopy,Inhibition,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,,%,,CHEMBL3818053
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C,,%,,CHEMBL3824349
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)O2,,%,,CHEMBL3823894
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)N[C@H](C(=O)O)C(C)C)O2,,%,,CHEMBL3823765
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)O2,,%,,CHEMBL3824001
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O,40.4,%,=,CHEMBL3822977
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O,17.3,%,=,CHEMBL3822700
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O,5.0,%,=,CHEMBL3822709
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O,6.6,%,=,CHEMBL3823792
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,39.5,%,=,CHEMBL3823952
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,17.7,%,=,CHEMBL3823663
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,4.7,%,=,CHEMBL3823141
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM by ThT-fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C1(C)CCc2c(C)c(O)c(C)c(C)c2O1)C(C)C)C(=O)N[C@@H](C)C(=O)O,2.8,%,=,CHEMBL3824155
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CC1CCN(Cc2ccccc2)CC1)NCCc1c[nH]c2ccccc12,55.2,%,=,CHEMBL3822559
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Cc1ccccc1CN1CCC(CC(=O)NCCc2c[nH]c3ccccc23)CC1,42.1,%,=,CHEMBL3824239
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccccc4C)CC3)c2c1,40.5,%,=,CHEMBL3823317
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Cc1cccc(CN2CCC(CC(=O)NCCc3c[nH]c4ccccc34)CC2)c1,38.1,%,=,CHEMBL3823464
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4cccc(C)c4)CC3)c2c1,40.2,%,=,CHEMBL3823538
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Cc1ccc(CN2CCC(CC(=O)NCCc3c[nH]c4ccccc34)CC2)cc1,42.1,%,=,CHEMBL3822670
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccc(C)cc4)CC3)c2c1,40.5,%,=,CHEMBL3822790
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CC1CCN(Cc2ccccc2Cl)CC1)NCCc1c[nH]c2ccccc12,62.1,%,=,CHEMBL3823858
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccccc4Cl)CC3)c2c1,60.5,%,=,CHEMBL3823598
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CC1CCN(Cc2cccc(Cl)c2)CC1)NCCc1c[nH]c2ccccc12,65.1,%,=,CHEMBL3823309
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4cccc(Cl)c4)CC3)c2c1,60.5,%,=,CHEMBL3823191
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CC1CCN(Cc2ccc(Cl)cc2)CC1)NCCc1c[nH]c2ccccc12,63.5,%,=,CHEMBL3823430
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)CC3CCN(Cc4ccc(Cl)cc4)CC3)c2c1,60.5,%,=,CHEMBL3824237
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2)CC1,50.6,%,=,CHEMBL3824057
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)C3CCN(Cc4ccccc4)CC3)c2c1,46.8,%,=,CHEMBL3824362
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Cc1ccccc1CN1CCC(C(=O)NCCc2c[nH]c3ccccc23)CC1,36.6,%,=,CHEMBL3822890
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)C3CCN(Cc4ccccc4C)CC3)c2c1,32.8,%,=,CHEMBL3823578
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)C1CCN(Cc2ccccc2[N+](=O)[O-])CC1,58.6,%,=,CHEMBL3822921
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(=O)C3CCN(Cc4ccccc4[N+](=O)[O-])CC3)c2c1,52.8,%,=,CHEMBL3823251
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CCc1c[nH]c2ccccc12)NC1CCN(Cc2ccccc2)CC1,56.2,%,=,CHEMBL3823197
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,O=C(CCc1c[nH]c2ccccc12)NCCC1CCN(Cc2ccccc2)CC1,56.3,%,=,CHEMBL3824248
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,45.2,%,=,CHEMBL165
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.5,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM measured after 46 to 48 hrs by ThT-based fluorometric assay,Inhibition,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,,%,,CHEMBL45
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay relative to control,Inhibition,CC(=O)c1cc2ccccc2oc1=O,50.0,%,=,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay relative to control,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,80.0,%,=,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.25 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay relative to control,Inhibition,CC(=O)c1cc2ccccc2oc1=O,40.0,%,=,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.25 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay relative to control,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,53.0,%,=,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.5 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay,Inhibition,CC(=O)c1cc2ccccc2oc1=O,,%,,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.5 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,,%,,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.75 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay,Inhibition,CC(=O)c1cc2ccccc2oc1=O,,%,,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:0.75 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ThT fluorescence assay,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,,%,,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by turbidity assay relative to control,Inhibition,CC(=O)c1cc2ccccc2oc1=O,59.0,%,=,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by turbidity assay relative to control,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,78.0,%,=,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ANS extrinsic fluorescence assay relative to control,Inhibition,CC(=O)c1cc2ccccc2oc1=O,40.0,%,=,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by ANS extrinsic fluorescence assay relative to control,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,86.0,%,=,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by silver staining-based native PAGE assay,Inhibition,CC(=O)c1cc2ccccc2oc1=O,,%,,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by silver staining-based native PAGE assay,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,,%,,CHEMBL497
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation assessed as decrease in levels of higher aggregates at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by silver staining-based native PAGE assay,Inhibition,CC(=O)c1cc2ccccc2oc1=O,,%,,CHEMBL149463
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation assessed as decrease in levels of higher aggregates at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by silver staining-based native PAGE assay,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,,%,,CHEMBL3952071
Inhibition of HFIP-induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:1 protein to compound ratio preincubated for 15 mins followed by HFIP addition measured after 40 mins by silver staining-based native PAGE assay,Inhibition,C/C(=N\NC(N)=S)c1cc2ccccc2oc1=O,,%,,CHEMBL3952071
Inhibition of 3 days aged amyloid beta (25 to 35 residues) (unknown origin) aggregation at 20 uM by intrinsic flavonoid fluorescence assay,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,%,,CHEMBL449317
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 20 uM incubated for 3 days by intrinsic flavonoid fluorescence assay,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,%,,CHEMBL449317
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 20 uM incubated for 3 days by thioflavin T-based fluorescence spectrophotometric method,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,%,,CHEMBL449317
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 10 uM incubated for 3 days by thioflavin T-based fluorescence spectrophotometric method relative to control,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,40.0,%,=,CHEMBL449317
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 100 uM incubated for 7 days by atomic force microscopic method,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,%,,CHEMBL449317
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 20 uM incubated for 3 days by 8-anilino-1-naphthalene-based fluorescence spectrophotometric method,Inhibition,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,,%,,CHEMBL449317
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed at 25 uM after 24 to 48 hrs by transmission electron microscopic analysis,Inhibition,CCOC(=O)c1cnc2c(F)cccc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,,%,,CHEMBL3936155
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed at 25 uM after 24 to 48 hrs by transmission electron microscopic analysis,Inhibition,CCOC(=O)c1cnc2ccc(F)cc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,,%,,CHEMBL3908209
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed at 25 uM after 24 to 48 hrs by transmission electron microscopic analysis,Inhibition,CCOC(=O)c1cnc2ccc(OC)cc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,,%,,CHEMBL3935074
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.79,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,Cc1cc(N2CCN(c3ncccc3C#N)CC2)n2ncnc2n1,46.77,%,=,CHEMBL3974494
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2c(F)cccc2c1N1CCN(c2ncccc2C#N)CC1,47.39,%,=,CHEMBL3944310
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(F)cc2c1N1CCN(c2ncccc2C#N)CC1,54.92,%,=,CHEMBL3957322
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2cc(C(F)(F)F)ccc2c1N1CCN(c2ncccc2C#N)CC1,44.19,%,=,CHEMBL3986008
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(OC)cc2c1N1CCN(c2ncccc2C#N)CC1,39.8,%,=,CHEMBL3968318
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(C)cc2c1N1CCN(c2ncccc2C#N)CC1,27.26,%,=,CHEMBL3897201
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2c(F)cccc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,64.16,%,=,CHEMBL3936155
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(F)cc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,72.86,%,=,CHEMBL3908209
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2cc(C(F)(F)F)ccc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,43.78,%,=,CHEMBL3962563
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(OC)cc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,61.58,%,=,CHEMBL3935074
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay,Inhibition,CCOC(=O)c1cnc2ccc(C)cc2c1N1CCN(c2cc(C)nc3ncnn23)CC1,52.54,%,=,CHEMBL3953816
Effect on self-aggregation of amyloid beta (1 to 42) (unknown origin) at 50 uM measured after 24 hrs by dot blot analysis,Activity,CCCN(CCC)Cc1cn(-c2cc(NC(=S)NCC)ncn2)cn1,,,,CHEMBL3890610
Effect on self-aggregation of amyloid beta (1 to 42) (unknown origin) at 50 uM measured after 24 hrs by dot blot analysis,Activity,CCNC(=S)Nc1cc(-n2cnc(CN3CCCC3)c2)ncn1,,,,CHEMBL3960702
Effect on self-aggregation of amyloid beta (1 to 42) (unknown origin) at 10 uM measured after 24 hrs by ThT fluorescence analysis,Activity,CCCN(CCC)Cc1cn(-c2cc(NC(=S)NCC)ncn2)cn1,,,,CHEMBL3890610
Effect on self-aggregation of amyloid beta (1 to 42) (unknown origin) at 10 uM measured after 24 hrs by ThT fluorescence analysis,Activity,CCNC(=S)Nc1cc(-n2cnc(CN3CCCC3)c2)ncn1,,,,CHEMBL3960702
Binding affinity to amyloid beta (1 to 42) (unknown origin),Activity,CCCN(CCC)Cc1cn(-c2cc(NC(=S)NCC)ncn2)cn1,,,,CHEMBL3890610
Binding affinity to amyloid beta (1 to 42) (unknown origin),Activity,CCNC(=S)Nc1cc(-n2cnc(CN3CCCC3)c2)ncn1,,,,CHEMBL3960702
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccccc2oc1=O,,%,,CHEMBL1543615
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2cc(Br)ccc2oc1=O,,%,,CHEMBL3968400
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,COc1cccc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(=O)oc12,,%,,CHEMBL1366414
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(O)cc2oc1=O,,%,,CHEMBL3968527
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,COc1ccc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(=O)oc2c1,,%,,CHEMBL3938998
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,CCOc1ccc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(=O)oc2c1,,%,,CHEMBL3957520
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,CCCOc1ccc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(=O)oc2c1,,%,,CHEMBL3929967
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccccc3)cc2oc1=O,,%,,CHEMBL3948863
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccccc3Cl)cc2oc1=O,,%,,CHEMBL3921055
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3cccc(Cl)c3Cl)cc2oc1=O,,%,,CHEMBL3940086
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccc(Cl)cc3)cc2oc1=O,,%,,CHEMBL3912096
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2oc1=O,,%,,CHEMBL3905250
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccccc3F)cc2oc1=O,,%,,CHEMBL3976042
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3cccc(F)c3)cc2oc1=O,,%,,CHEMBL3956598
Inhibition of self-mediated HFIP-treated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1cc2ccc(OCc3ccc(F)cc3)cc2oc1=O,,%,,CHEMBL3889532
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)cc1OC,4600.0,nM,=,CHEMBL3942680
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.[Cl-],500.0,nM,=,CHEMBL405110
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/c1cc(/C=C/c2ccc3cc[nH]c3c2)[nH]n1,1200.0,nM,=,CHEMBL3953399
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,470.0,nM,=,CHEMBL3948937
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccc2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,5400.0,nM,=,CHEMBL3901022
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCC2CCCO2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,2500.0,nM,=,CHEMBL3938007
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)c(OC)c1,610.0,nM,=,CHEMBL3965306
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,520.0,nM,=,CHEMBL3911126
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccco2)ccc1O,760.0,nM,=,CHEMBL3981143
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccnc2)ccc1O,10000.0,nM,>,CHEMBL3889997
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccccc2)ccc1O,2200.0,nM,=,CHEMBL3892054
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,420.0,nM,=,CHEMBL3950384
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3ccccc3c2)ccc1O,590.0,nM,=,CHEMBL3922663
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,3700.0,nM,=,CHEMBL3978488
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c(O)c1,930.0,nM,=,CHEMBL3672436
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1100.0,nM,=,CHEMBL3970179
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(O)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1800.0,nM,=,CHEMBL3940632
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2OC)ccc1O,920.0,nM,=,CHEMBL3672401
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2OC)ccc1O,1300.0,nM,=,CHEMBL3969106
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2c(O)cccc2OC)ccc1O,1600.0,nM,=,CHEMBL3672439
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1O,2100.0,nM,=,CHEMBL3958051
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(O)c2OC)ccc1O,1900.0,nM,=,CHEMBL3911667
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(OC)c2O)ccc1O,5400.0,nM,=,CHEMBL3986412
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5400.0,nM,=,CHEMBL140
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,73.8,%,=,CHEMBL3892539
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,48.4,%,=,CHEMBL3931477
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,61.1,%,=,CHEMBL3958981
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,79.3,%,=,CHEMBL3922564
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCN4CCCC4)cc3o2)cc1,65.5,%,=,CHEMBL3913567
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCN4CCCC4)cc3o2)cc1,70.0,%,=,CHEMBL3941548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCN4CCCC4)cc3o2)cc1,75.8,%,=,CHEMBL3904577
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCN4CCCC4)cc3o2)cc1,50.3,%,=,CHEMBL3932576
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)CCNC(=O)COc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,67.1,%,=,CHEMBL3897800
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.6,%,=,CHEMBL95
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,53.1,%,=,CHEMBL140
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,9470.0,nM,=,CHEMBL3922564
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,,%,,CHEMBL3950279
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCCCN4CCCC4)cc3o2)cc1,,%,,CHEMBL3968969
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,Inhibition,CN(C)CCCNC(=O)COc1ccc2c(=O)cc(-c3ccc(N(C)C)cc3)oc2c1,,%,,CHEMBL3975419
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18250.0,nM,=,CHEMBL140
"Potency index, ratio of curcumin IC50 to compound IC50 for self-mediated amyloid beta (1 to 42) (unknown origin) aggregation",Ratio IC50,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,2.0,,=,CHEMBL3922564
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C\c2ccccc2)C(=O)/C(=C/c2ccccc2)C1.O=C(O)C(F)(F)F,10.0,%,<,CHEMBL3895965
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,COc1ccc(/C=C2/CN(C(=O)CCC(=O)NCCCNCCCCNCCCN)C/C(=C\c3ccc(OC)c(OC)c3)C2=O)cc1OC.O=C(O)C(F)(F)F,10.0,%,<,CHEMBL3967235
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2cccc(O)c2)C(=O)/C(=C/c2cccc(O)c2)C1.O=C(O)C(F)(F)F,10.0,%,<,CHEMBL3968185
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C\c2ccc(O)cc2)C(=O)/C(=C/c2ccc(O)cc2)C1.O=C(O)C(F)(F)F,10.0,%,<,CHEMBL3938625
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as residual amyloid beta 42 monomer level at 2 uM after 24 hrs by ESI-IT-MS analysis,Activity,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,27.0,%,=,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as residual amyloid beta 42 monomer level at 50 uM after 24 hrs by ESI-IT-MS analysis,Activity,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,61.9,%,=,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as residual amyloid beta 42 monomer level at 10 uM after 24 hrs by ESI-IT-MS analysis,Activity,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,53.0,%,=,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,COc1cc(/C=C2\CN(C(=O)CCC(=O)NCCCNCCCCNCCCN)C/C(=C\c3ccc(O)c(OC)c3)C2=O)ccc1O.O=C(O)C(F)(F)F,10.0,%,<,CHEMBL3924989
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 50 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCN,,%,,CHEMBL23194
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 50 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,54.1,%,=,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 2 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,12.0,%,=,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level at 10 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,,%,,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level at 50 uM after 24 hrs by ESI-IT-MS analysis relative to control,FC,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,2.79,,=,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level at 50 uM after 24 hrs by ESI-IT-MS analysis relative to control,FC,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,2.56,,=,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level at 2 uM after 24 hrs by ESI-IT-MS analysis relative to control,FC,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,1.46,,=,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level at 10 uM after 24 hrs by ESI-IT-MS analysis relative to control,FC,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,2.14,,=,CHEMBL3976693
Neuroprotective activity against amyloid beta (1 to 42) (unknown origin)-induced neuronal cell death in rat mixed cortical neurons assessed as number of dead neurons at 5 uM incubated for 72 hrs by trypan blue dye based phase contrast microscopic analysis (Rvb = 71.7 +/- 3.1 No_unit),Activity,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,46.5,,=,CHEMBL3976693
Neuroprotective activity against amyloid beta (1 to 42) (unknown origin)-induced neuronal cell death in rat mixed cortical neurons assessed as decrease in number of dead neurons at 5 uM incubated for 72 hrs by trypan blue dye based phase contrast microscopic analysis,Activity,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,,,,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,,%,,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as increase in oxidized amyloid beta 42 monomer level after 24 hrs by ESI-IT-MS analysis,Inhibition,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,,%,,CHEMBL340775
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 50 uM after 24 hrs by ESI-IT-MS analysis,Inhibition,NCCCNCCCCNCCCNC(=O)CCC(=O)N1C/C(=C/c2ccc(O)c(O)c2)C(=O)/C(=C/c2ccc(O)c(O)c2)C1.O=C(O)C(F)(F)F,,%,,CHEMBL3976693
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation assessed as residual amyloid beta 42 monomer level at 10 uM after 24 hrs by ESI-IT-MS analysis,Activity,Cl.O=C1/C(=C/c2ccc(O)c(O)c2)CNC/C1=C\c1ccc(O)c(O)c1,20.5,%,=,CHEMBL340775
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as decrease in size of protein aggregation at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,,%,,CHEMBL3890998
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as decrease in size of protein aggregation at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,,%,,CHEMBL3951337
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as absence of fibrillar branching at equilibrium at 100 uM by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,,%,,CHEMBL3891123
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as absence of fibrillar branching at equilibrium at 100 uM by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,,%,,CHEMBL3890998
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as absence of fibrillar branching at equilibrium at 100 uM by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,,%,,CHEMBL3951337
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in fibrillar aggregates at 100 uM by dot blot analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,72.6,%,=,CHEMBL3891123
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in fibrillar aggregates at 100 uM by dot blot analysis,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,50.5,%,=,CHEMBL3890998
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in fibrillar aggregates at 100 uM by dot blot analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,46.0,%,=,CHEMBL3951337
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation assessed as increase in lag time at 100 uM by dot blot analysis relative to control,FC,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,2.2,,=,CHEMBL3890998
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation assessed as increase in lag time at 100 uM by dot blot analysis relative to control,FC,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,2.7,,=,CHEMBL3951337
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM measured at equilibrium by thioflavin T based fluorometric assay,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,85.6,%,=,CHEMBL3891123
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM measured at equilibrium by thioflavin T based fluorometric assay,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,76.9,%,=,CHEMBL3890998
Inhibition of agitated amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM measured at equilibrium by thioflavin T based fluorometric assay,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,83.1,%,=,CHEMBL3951337
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as decrease in size of protein aggregation at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,,%,,CHEMBL3891123
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as circular/bird-nest like aggregate formation at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,,%,,CHEMBL3891123
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as increase in surface hydrophobicity at equilibrium by nile red dye-based spectroscopic analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,,%,,CHEMBL3951337
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as increase in surface hydrophobicity at equilibrium by nile red dye-based spectroscopic analysis,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,,%,,CHEMBL3890998
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as increase in surface hydrophobicity at equilibrium by nile red dye-based spectroscopic analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,,%,,CHEMBL3891123
Inhibition of agitation-induced amyloid beta (1 to 40) (unknown origin) aggregation at 100 uM measured every 45 mins by thioflavin T based fluorometric assay,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,81.2,%,=,CHEMBL3951337
Inhibition of agitation-induced amyloid beta (1 to 40) (unknown origin) aggregation assessed as decrease in lag time at 100 uM measured every 30 to 45 mins by dot blot analysis relative to control,FC,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,0.31,,<,CHEMBL3951337
Inhibition of agitation-induced amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in fibrillar aggregates at 100 uM measured every 30 to 45 mins by dot blot analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,63.7,%,=,CHEMBL3951337
Inhibition of agitation-induced amyloid beta (1 to 40) (unknown origin) aggregation assessed as decrease in lag time at 100 uM by dot blot analysis relative to control,FC,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,0.5,,<,CHEMBL3951337
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in number aggregates at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)CC)C(=O)CNCCCCN,,%,,CHEMBL3951337
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in number aggregates at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CC[C@H](C)NCC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(N)=O)[C@@H](C)c1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1,,%,,CHEMBL3890998
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation assessed as reduction in number aggregates at equilibrium at 100 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Inhibition,CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(=O)N(CCC)CC(=O)N(CC(=O)N(CC(N)=O)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)C(=O)CNCCCCN,,%,,CHEMBL3891123
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(C)c3)CC1)C2,10.0,%,>,CHEMBL170946
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3F)CC1)C2,10.0,%,>,CHEMBL3943450
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(F)c3)CC1)C2,10.0,%,>,CHEMBL3927363
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ncccc3C)CC1)C2,29.3,%,=,CHEMBL3891369
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(C)n3)CC1)C2,18.5,%,=,CHEMBL3919441
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc4cccc(O)c4n3)CC1)C2,44.8,%,=,CHEMBL3934564
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(O)c4ncccc34)CC1)C2,51.1,%,=,CHEMBL3950063
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,10.0,%,>,CHEMBL502
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM incubated for 46 to 48 hrs by Thioflavin T binding assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,57.4,%,=,CHEMBL140
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc2c(-c3nccc4c3[nH]c3ccccc34)cccc2c1,58.0,%,=,CHEMBL3954861
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc2c(c1)[nH]c1c(C3CCCCC3)nccc12,30.0,%,=,CHEMBL3894654
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(C(=O)c4ccc(F)cc4)nccc3c2c1,82.0,%,=,CHEMBL3947474
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(C(=O)c4ccc(C(F)(F)F)cc4)nccc3c2c1,84.0,%,=,CHEMBL3946448
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccccc1-c1nccc2c1[nH]c1ccccc12,45.0,%,=,CHEMBL3947464
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccc2[nH]c3c(-c4ccc(C(F)(F)F)cc4)nccc3c2c1,82.0,%,=,CHEMBL3928577
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Fc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,22.0,%,=,CHEMBL3956167
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(-c4ccc(C)cc4)nccc3c2c1,63.0,%,=,CHEMBL3929646
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(-c4ccccc4)nccc3c2c1,58.0,%,=,CHEMBL3910719
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccc2[nH]c3c(-c4ccccc4)nccc3c2c1,6.0,%,=,CHEMBL3938663
Inhibition of human amyloid-beta (1 to 42 residues) oligomer at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,79.0,%,=,CHEMBL3975325
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc2c(-c3nccc4c3[nH]c3ccccc34)cccc2c1,39.0,%,=,CHEMBL3954861
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc2c(c1)[nH]c1c(C3CCCCC3)nccc12,-12.0,%,=,CHEMBL3894654
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(C(=O)c4ccc(F)cc4)nccc3c2c1,6.0,%,=,CHEMBL3947474
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(C(=O)c4ccc(C(F)(F)F)cc4)nccc3c2c1,-5.0,%,=,CHEMBL3946448
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,O=C(c1ccc(C(F)(F)F)cc1)c1nccc2c1[nH]c1ccccc12,11.0,%,=,CHEMBL3742387
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,O=C(c1ccccc1)c1nccc2c1[nH]c1ccccc12,20.0,%,=,CHEMBL1682916
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccccc1-c1nccc2c1[nH]c1ccccc12,17.0,%,=,CHEMBL3947464
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccc2[nH]c3c(-c4ccc(C(F)(F)F)cc4)nccc3c2c1,34.0,%,=,CHEMBL3928577
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Fc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,37.0,%,=,CHEMBL3956167
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(-c4ccc(F)cc4)nccc3c2c1,12.0,%,=,CHEMBL3901694
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(-c4ccc(C)cc4)nccc3c2c1,10.0,%,=,CHEMBL3929646
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,COc1ccc2[nH]c3c(-c4ccccc4)nccc3c2c1,19.0,%,=,CHEMBL3910719
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,Cc1ccc2[nH]c3c(-c4ccccc4)nccc3c2c1,-7.0,%,=,CHEMBL3938663
Inhibition of human amyloid-beta (1 to 42 residues) fibril at 1:1 protein to compound ratio after 2 hrs by ELISA,Inhibition,c1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,-4.0,%,=,CHEMBL3975325
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CNC(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3915915
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CN(CCOC)C(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3964515
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CN(CCCOC)C(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3924905
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CNC(=O)c2ccc3ccccc3c2)CC1,10.0,%,<=,CHEMBL3980929
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CN(CCOC)C(=O)c2ccc3ccccc3c2)CC1,23.42,%,=,CHEMBL3952086
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CN(CCCOC)C(=O)c2ccc3ccccc3c2)CC1,10.0,%,<=,CHEMBL3972913
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CNS(=O)(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3943366
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CN(CCOC)S(=O)(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3900751
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCCC(CN(CCCOC)S(=O)(=O)c2ccc3ccccc3c2)C1,10.0,%,<=,CHEMBL3971906
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CNS(=O)(=O)c2ccc3ccccc3c2)CC1,10.0,%,<=,CHEMBL3891772
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CN(CCOC)S(=O)(=O)c2ccc3ccccc3c2)CC1,10.0,%,<=,CHEMBL3960783
Inhibition of HFIP-pretreated recombinant human amyloid beta (1 to 42) self-induced aggregation at 10 uM measured after 20 hrs for every 300 secs by thioflavin-T based fluorometric assay relative to control,Inhibition,C#CCN1CCC(CN(CCCOC)S(=O)(=O)c2ccc3ccccc3c2)CC1,10.0,%,<=,CHEMBL3918754
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cccc(O)c1)CO2,20.1,%,=,CHEMBL3961309
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)C)c(O)c1)CO2,35.2,%,=,CHEMBL3924914
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)Cc1ccc(/C=C2\COc3cc(OC)c(OC)cc3C2=O)cc1O,21.2,%,=,CHEMBL3952627
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCC3)c(O)c1)CO2,37.3,%,=,CHEMBL3915922
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCCC3)c(O)c1)CO2,39.3,%,=,CHEMBL3943883
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCOCC3)c(O)c1)CO2,28.3,%,=,CHEMBL3904918
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCN(C)CC3)c(O)c1)CO2,41.9,%,=,CHEMBL3975706
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)c(O)c1)CO2,7.7,%,=,CHEMBL3913913
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)Cc1ccc(/C=C2\COc3cc(OC)c(OC)cc3C2=O)cc1O,37.8,%,=,CHEMBL3983738
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(/C=C2\COc3cc(OC)c(OC)cc3C2=O)cc1O,32.7,%,=,CHEMBL3984772
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccc(/C=C2\COc3cc(OC)c(OC)cc3C2=O)cc1O)Cc1ccccc1OC,44.0,%,=,CHEMBL3956126
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccc(/C=C2\COc3cc(OC)c(OC)cc3C2=O)cc1O)Cc1ccccc1N(C)C,59.6,%,=,CHEMBL3928434
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)Cc1c(O)cccc1/C=C1\COc2cc(OC)c(OC)cc2C1=O,20.1,%,=,CHEMBL3955220
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cccc(O)c1CN1CCOCC1)CO2,7.8,%,=,CHEMBL3968181
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cccc(O)c1CN1CCN(C)CC1)CO2,26.8,%,=,CHEMBL3938618
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)Cc1c(O)cccc1/C=C1\COc2cc(OC)c(OC)cc2C1=O,35.6,%,=,CHEMBL3965383
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1c(O)cccc1/C=C1\COc2cc(OC)c(OC)cc2C1=O,8.0,%,=,CHEMBL3939153
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(O)c(CN3CCCCC3)c1)CO2,41.4,%,=,CHEMBL3905844
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 24 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(O)cc2O)cc1,77.7,%,=,CHEMBL2263059
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)C(=O)Oc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1,90.8,%,=,CHEMBL3883661
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CCN(CC)C(=O)Oc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1,76.7,%,=,CHEMBL3885433
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCC3)cc2O)cc1,89.5,%,=,CHEMBL3884602
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCCC3)cc2O)cc1,70.2,%,=,CHEMBL3885071
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCOCC3)cc2O)cc1,83.6,%,=,CHEMBL3884796
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1,98.0,%,=,CHEMBL3883374
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN1CCN(C(=O)Oc2ccc(C(=O)/C=C/c3ccc(N(C)C)cc3)c(O)c2)CC1,87.9,%,=,CHEMBL3884870
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CCN1CCN(C(=O)Oc2ccc(C(=O)/C=C/c3ccc(N(C)C)cc3)c(O)c2)CC1,83.2,%,=,CHEMBL3883500
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCN(Cc4ccccc4)CC3)cc2O)cc1,89.4,%,=,CHEMBL3885303
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)C(=O)Oc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(OC(=O)N(C)C)c1,34.7,%,=,CHEMBL3883596
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCC3)cc2OC(=O)N2CCCC2)cc1,48.0,%,=,CHEMBL3883229
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCCC3)cc2OC(=O)N2CCCCC2)cc1,38.0,%,=,CHEMBL3883944
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCOCC3)cc2OC(=O)N2CCOCC2)cc1,33.3,%,=,CHEMBL3885129
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,CCN(CC)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCC3)cc2O)cc1,67.8,%,=,CHEMBL3884004
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,O=C(/C=C/c1ccc(N2CCCC2)cc1)c1ccc(OC(=O)N2CCCC2)cc1O,44.4,%,=,CHEMBL3884263
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,O=C(/C=C/c1ccc(N2CCCCC2)cc1)c1ccc(OC(=O)N2CCCC2)cc1O,57.2,%,=,CHEMBL3883650
Inhibition of self-induced aggregation of amyloid beta (1-42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorimetric method relative to control,Inhibition,O=C(/C=C/c1ccc(N2CCOCC2)cc1)c1ccc(OC(=O)N2CCCC2)cc1O,44.4,%,=,CHEMBL3884558
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs under dark condition by ThT fluorescence assay relative to control,Inhibition,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,80.17,%,=,CHEMBL3883958
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs under dark condition by ThT fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,84.13,%,=,CHEMBL3884327
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs under dark condition by ThT fluorescence assay relative to control,Inhibition,N[C@@H](Cc1c[nH]c2ccccc12)Cn1cc(-c2ccc(Cl)c(Cl)c2)nn1,67.56,%,=,CHEMBL3884069
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs under dark condition by ThT fluorescence assay relative to control,Inhibition,N[C@@H](Cc1c[nH]c2ccccc12)Cn1cc(CNC(=O)/C=C/c2ccc(O)c(O)c2)nn1,81.48,%,=,CHEMBL3885258
Inhibition of human amyloid beta (1 to 42) aggregation incubated for 48 hrs under dark condition by ThT fluorescence assay,IC50,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,66360.0,nM,=,CHEMBL3883958
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,630.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin),IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,7940.0,nM,=,CHEMBL50
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCCCCNCc1ccccc1,22.19,%,=,CHEMBL3922423
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2C(=O)N1CCN1CCN(Cc2ccccc2F)CC1,13.3,%,=,CHEMBL3965700
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCN1CCN(Cc2ccccc2F)CC1,18.6,%,=,CHEMBL3917827
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCN1CCN(CCc2ccccc2F)CC1,15.0,%,=,CHEMBL3941498
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2S(=O)(=O)N1CCN1CCCN(Cc2cc(F)cc(F)c2)C1,13.5,%,=,CHEMBL3919222
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C1c2ccccc2C(=O)N1CCN1CCCC(NCc2cc(F)cc(F)c2)C1,39.0,%,=,CHEMBL3892707
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self-induced aggregation at 10 uM measured every 300 sec up to 28 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,13.8,%,=,CHEMBL502
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccccc4)CC3)cc1)C2,51.1,%,=,CHEMBL3965447
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(Cl)cc4)CC3)cc1)C2,59.5,%,=,CHEMBL3955339
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(F)cc4)CC3)cc1)C2,66.8,%,=,CHEMBL3971579
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C(F)(F)F)cc4)CC3)cc1)C2,64.2,%,=,CHEMBL3893238
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C)cc4)CC3)cc1)C2,63.5,%,=,CHEMBL3930181
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(N2CCN(c3ccc(/C=C4\Cc5cc(OC)c(OC)cc5C4=O)cc3)CC2)cc1,70.5,%,=,CHEMBL3902217
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C)cc4C)CC3)cc1)C2,65.7,%,=,CHEMBL3916256
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,78.2,%,=,CHEMBL3944195
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,83.7,%,=,CHEMBL3925265
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccccc4)CC3)cc1)C2,61.4,%,=,CHEMBL3964617
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(Cc4ccccc4)CC3)cc1)C2,48.5,%,=,CHEMBL3934144
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(Cc4ccc5c(c4)OCO5)CC3)cc1)C2,64.5,%,=,CHEMBL3961645
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,80.4,%,=,CHEMBL3913721
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccccn4)CC3)cc1)C2,73.3,%,=,CHEMBL3972686
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,81.6,%,=,CHEMBL3951861
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,55.7,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccccc4)CC3)cc1)C2,,,,CHEMBL3965447
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(Cl)cc4)CC3)cc1)C2,,,,CHEMBL3955339
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(F)cc4)CC3)cc1)C2,,,,CHEMBL3971579
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C(F)(F)F)cc4)CC3)cc1)C2,,,,CHEMBL3893238
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C)cc4)CC3)cc1)C2,,,,CHEMBL3930181
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1ccc(N2CCN(c3ccc(/C=C4\Cc5cc(OC)c(OC)cc5C4=O)cc3)CC2)cc1,,,,CHEMBL3902217
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccc(C)cc4C)CC3)cc1)C2,,,,CHEMBL3916256
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,12200.0,nM,=,CHEMBL3944195
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,7400.0,nM,=,CHEMBL3925265
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccccc4)CC3)cc1)C2,,,,CHEMBL3964617
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(Cc4ccccc4)CC3)cc1)C2,,,,CHEMBL3934144
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(Cc4ccc5c(c4)OCO5)CC3)cc1)C2,,,,CHEMBL3961645
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,10900.0,nM,=,CHEMBL3913721
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ccccn4)CC3)cc1)C2,,,,CHEMBL3972686
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,9900.0,nM,=,CHEMBL3951861
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140
"Potency index, ratio of compound effect to curcumin effect for inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM",Ratio,COc1ccc(N2CCN(c3ccc(/C=C4\Cc5cc(OC)c(OC)cc5C4=O)cc3)CC2)cc1,1.26,,=,CHEMBL3902217
"Potency index, ratio of curcumin IC50 to compound IC50 for HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation",Ratio IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,2.96,,=,CHEMBL3925265
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 48 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,,%,,CHEMBL3925265
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 48 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,,%,,CHEMBL3951861
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 48 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(NC(=O)/C=C/c2ccc(O)c(O)c2)c1,73.2,%,=,CHEMBL3911965
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(NC(=O)/C=C/c2ccc(O)c(OC)c2)c1,13.2,%,=,CHEMBL3953409
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNC(=O)/C=C/c2ccc(O)c(O)c2)c1,77.6,%,=,CHEMBL3980957
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNC(=O)/C=C/c2ccc(O)c(OC)c2)c1,3.2,%,=,CHEMBL3912985
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CCNC(=O)/C=C/c2ccc(O)c(O)c2)c1,85.3,%,=,CHEMBL3894001
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CCNC(=O)/C=C/c2ccc(O)c(OC)c2)c1,2.2,%,=,CHEMBL3965592
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Nc1cccc(NC(=O)/C=C/c2ccc(O)c(O)c2)c1,82.5,%,=,CHEMBL3902949
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Nc1cccc(NC(=O)/C=C/c2ccc(O)c(OC)c2)c1,2.2,%,=,CHEMBL3973913
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],86.5,%,=,CHEMBL429694
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,1.0,nM,=,CHEMBL1086286
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,14.0,nM,=,CHEMBL1086287
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CC(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,7.0,nM,=,CHEMBL3659993
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCO[C@@H](CCC(O)CO)[C@@H]1COc1c(F)ccc(F)c12,15.0,nM,=,CHEMBL3659994
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C1CC1,8.0,nM,=,CHEMBL1090210
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=C(C[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)NCC(F)(F)F,25.0,nM,=,CHEMBL3659995
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)CC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,10.0,nM,=,CHEMBL3659992
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C(F)(F)F,27.0,nM,=,CHEMBL1090209
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@]2(O)C1)C1CC1,29.0,nM,=,CHEMBL1778349
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,54.0,nM,=,CHEMBL1085076
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)CC(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,210.0,nM,=,CHEMBL3667019
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,440.0,nM,=,CHEMBL3667020
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C)(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,15000.0,nM,>,CHEMBL3667021
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,520.0,nM,=,CHEMBL3667022
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,310.0,nM,=,CHEMBL3667023
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,380.0,nM,=,CHEMBL3667024
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C)(C)OC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,650.0,nM,=,CHEMBL3667025
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,1300.0,nM,=,CHEMBL3667026
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)C(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,140.0,nM,=,CHEMBL3667027
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1.[Na+].[Na+],560.0,nM,=,CHEMBL3667028
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COCOCCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667029
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CN(C)C(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667030
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(CCOCCO)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,700.0,nM,=,CHEMBL3667031
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC,140.0,nM,=,CHEMBL3667032
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OCC(=O)O)c(OC)c2)ccc1O,310.0,nM,=,CHEMBL3667033
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(C(F)(F)F)c2)ccc1O,130.0,nM,=,CHEMBL3639383
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CNc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(NC)c(C(F)(F)F)c2)cc1C(F)(F)F,5800.0,nM,=,CHEMBL3667034
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cncc(C(F)(F)F)c2)ccc1O,100.0,nM,=,CHEMBL3667035
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1,360.0,nM,=,CHEMBL3667036
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,N#CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,300.0,nM,=,CHEMBL3667037
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,320.0,nM,=,CHEMBL3667038
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccco1,650.0,nM,=,CHEMBL3667039
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@]21N=C(C)C(N)=N1,2.0,nM,=,CHEMBL4112651
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@@]21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3893021
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,56.0,nM,=,CHEMBL3959097
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1[C@@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL3898248
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,1.6,nM,=,CHEMBL3672698
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC[C@@H](C)Oc1ccc2c(c1)C1(N=C(C)C(N)=N1)[C@]1(CC[C@H](OC)CC1)C2,16.0,nM,=,CHEMBL3672702
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,2.4,nM,=,CHEMBL3672687
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,96.0,nM,=,CHEMBL3672688
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,2.1,nM,=,CHEMBL3891777
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1C21N=C(C)C(N)=N1,678.0,nM,=,CHEMBL3945110
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL4110988
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,0.6,nM,=,CHEMBL3959097
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(OCCCF)ccc1C[C@]21CC[C@@H](OC(F)F)CC1,1.6,nM,=,CHEMBL3672695
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC(C)F)cc1C21N=C(C)C(N)=N1,2.5,nM,=,CHEMBL3899321
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,216.0,nM,=,CHEMBL3672699
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](O)CC2)C3)c1,1.0,nM,=,CHEMBL3653726
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,[C-]#[N+]c1cc(Cl)cc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,12.0,nM,=,CHEMBL3937729
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,1.7,nM,=,CHEMBL3947671
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@]21N=C(C)C(N)=N1,986.0,nM,=,CHEMBL4113193
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,4.8,nM,=,CHEMBL3943188
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,17.0,nM,=,CHEMBL3913223
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CC1)Cc1cc(F)c(Br)cc1C21N=C(C)C(N)=N1,176.0,nM,=,CHEMBL3672708
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3902640
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cncc(Cl)c3)cc1C21N=C(C)C(N)=N1,3.0,nM,=,CHEMBL3969309
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,7.4,nM,=,CHEMBL3916194
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(C#N)c3)ccc1CCC21CC1,23.0,nM,=,CHEMBL3672718
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(F)c3)ccc1CCC21CC1,118.0,nM,=,CHEMBL3672719
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1CCC21CC1,11.0,nM,=,CHEMBL3672720
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(Br)cc3C23N=C(C)C(N)=N3)CC1,78.0,nM,=,CHEMBL3672721
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,1.0,nM,=,CHEMBL3672723
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,80.0,nM,=,CHEMBL3672724
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,2.5,nM,=,CHEMBL3672725
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,19.0,nM,=,CHEMBL3672726
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,81.0,nM,=,CHEMBL3672727
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,2.4,nM,=,CHEMBL3672728
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1CCC21CC1,16.0,nM,=,CHEMBL3672729
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,3.1,nM,=,CHEMBL3672730
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,92.0,nM,=,CHEMBL3672731
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,4.5,nM,=,CHEMBL3672732
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3(C)CC3)cc1C21N=C(C)C(N)=N1,2.8,nM,=,CHEMBL3915935
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC(F)(F)C3)cc1C21N=C(C)C(N)=N1,8.4,nM,=,CHEMBL3891403
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1C21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3923244
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1[C@@]21N=C(C)C(N)=N1,0.9,nM,=,CHEMBL3937398
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3(F)F)cc1C21N=C(C)C(N)=N1,2.3,nM,=,CHEMBL3905816
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1C21N=C(C)C(N)=N1,1.5,nM,=,CHEMBL3961886
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,1.3,nM,=,CHEMBL3927449
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC3CC3)cc1C21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3939963
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1)c1ccc(C(F)(F)F)cc1,1000.0,nM,=,CHEMBL3692695
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Cc1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,800.0,nM,=,CHEMBL3692696
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCc1cc(C(F)(F)F)ccc1C(F)(F)F)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,630000.0,nM,=,CHEMBL3692697
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCOc1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,20000.0,nM,=,CHEMBL3692698
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,84000.0,nM,=,CHEMBL3692699
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,200000.0,nM,=,CHEMBL3692700
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,CN1C(=O)[C@@H](NCC(=O)Nc2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)c2ccc(Cl)s2)N=C(c2ccccc2)c2ccccc21,800000.0,nM,=,CHEMBL3692701
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,840.0,nM,=,CHEMBL4111029
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)OCC2(F)F)n1,7.0,nM,=,CHEMBL4114267
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)OCC1(F)F,8.0,nM,=,CHEMBL2386720
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC1(C)OC(N)=N[C@](C)(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C1(F)F,7.0,nM,=,CHEMBL2386721
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,49.0,nM,=,CHEMBL2386722
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,10000.0,nM,>,CHEMBL3902027
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,380.0,nM,=,CHEMBL4108431
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,27.0,nM,=,CHEMBL2386723
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,140.0,nM,=,CHEMBL4110279
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)OCC1(F)F,12.0,nM,=,CHEMBL2386724
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,600.0,nM,=,CHEMBL4108635
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,440.0,nM,=,CHEMBL2386725
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,310.0,nM,=,CHEMBL4114995
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(C)c1,82.0,nM,=,CHEMBL4111654
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)c1,540.0,nM,=,CHEMBL4110143
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)nc3N)ccc2F)N=C(N)OCC1(F)F,30.0,nM,=,CHEMBL4110172
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3N)ccc2F)N=C(N)OCC1(F)F,62.0,nM,=,CHEMBL4107314
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(F)cc3N)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4109969
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3N)ccc2F)N=C(N)OCC1(F)F,45.0,nM,=,CHEMBL4115329
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncccc3Cl)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4106556
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,81.0,nM,=,CHEMBL4107875
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,60.0,nM,=,CHEMBL4112705
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCl)nc3N)ccc2F)N=C(N)OCC1(F)F,2900.0,nM,=,CHEMBL4114553
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,250.0,nM,=,CHEMBL4115141
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,480.0,nM,=,CHEMBL4108335
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)cc3Cl)ccc2F)N=C(N)OCC1(F)F,57.0,nM,=,CHEMBL4111699
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,450.0,nM,=,CHEMBL4109860
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCCc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,70.0,nM,=,CHEMBL4110497
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,13.0,nM,=,CHEMBL2386726
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nccnc3N)ccc2F)N=C(N)OCC1(F)F,180.0,nM,=,CHEMBL4110655
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3Cl)ccc2F)N=C(N)OCC1(F)F,19.0,nM,=,CHEMBL4113786
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)cc3N)ccc2F)N=C(N)OCC1(F)F,66.0,nM,=,CHEMBL4112589
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1nc(N)c(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)nc1Cl,6500.0,nM,=,CHEMBL4108644
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)OCC1(F)F,14.0,nM,=,CHEMBL2386719
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,58.0,nM,=,CHEMBL4111183
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,310.0,nM,=,CHEMBL4111103
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,O=c1ccc2nc3ccc(O)cc3oc-2c1,225.0,nM,=,CHEMBL1185321
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,C#COc1ccc2nc3ccc(=O)cc-3oc2c1,828.0,nM,=,CHEMBL3956688
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,O=c1ccc2nc3ccc(OCCF)cc3oc-2c1,800.0,nM,=,CHEMBL3937465
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,O=c1ccc2nc3ccc(OCc4cn(CCF)nn4)cc3oc-2c1,2380.0,nM,=,CHEMBL3940298
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,COc1cccc(COc2ccc3nc4ccc(=O)cc-4oc3c2)c1,537.0,nM,=,CHEMBL3891633
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,O=c1ccc2nc3ccc(OCCBr)cc3oc-2c1,927.0,nM,=,CHEMBL3941825
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Kd,O=c1ccc2nc3ccc(OCc4ccc(I)cc4)cc3oc-2c1,10000.0,nM,>,CHEMBL3961314
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COc1ccc2nc3ccc(=O)cc-3oc2c1,4675.0,nM,=,CHEMBL3943621
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,CCOc1ccc2nc3ccc(=O)cc-3oc2c1,262.0,nM,=,CHEMBL1080002
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,C#COc1ccc2nc3ccc(=O)cc-3oc2c1,4613.0,nM,=,CHEMBL3956688
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COc1ccc(COc2ccc3nc4ccc(=O)cc-4oc3c2)cc1,218.0,nM,=,CHEMBL3950550
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,CC(=O)OCCOc1ccc2nc3ccc(=O)cc-3oc2c1,860.0,nM,=,CHEMBL3926367
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COCCOc1ccc2nc3ccc(=O)cc-3oc2c1,347.0,nM,=,CHEMBL3932977
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COCCOCCOc1ccc2nc3ccc(=O)cc-3oc2c1,407.0,nM,=,CHEMBL3930548
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COc1ccc(OCCOc2ccc3nc4ccc(=O)cc-4oc3c2)cc1,421.0,nM,=,CHEMBL3938185
"In Vitro Competitive Radioligand Binding Assay: To determine the Ki values, fixed brain tissues prepared from 15-month-old Tg2576 mice (N=5) will be incubated for 30 min with 1 uM methoxy-X34 in the presence of a serial dilution of test compounds (10-9-10-6 M, 6 concentrations/compound). Tissue sections (3 sections per reaction) will be then mounted and coverslipped. Photographs of methoxy-X34 binding images will be taken using a Nikon fluorescent microscope. The fluorescent intensity on cerebral amyloid deposits and neuritic plaques will be separately quantified using Image J software.",Ki,COc1ccc(OCCOCCOc2ccc3nc4ccc(=O)cc-4oc3c2)cc1,10000.0,nM,>,CHEMBL3925890
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)CCn1cccn1,1.4,nM,=,CHEMBL3943313
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ccccn1,1.9,nM,=,CHEMBL3934479
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1cccnc1,6.6,nM,=,CHEMBL3961972
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ncon1,1.7,nM,=,CHEMBL3956918
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Cc1nc(CS(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)no1,5.8,nM,=,CHEMBL3957316
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)c[nH]1,18.7,nM,=,CHEMBL3971184
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cccnn1,4.5,nM,=,CHEMBL3948649
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cnccn1,5.5,nM,=,CHEMBL3904071
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccnnc1,10.2,nM,=,CHEMBL3935559
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ncccn1,6.4,nM,=,CHEMBL3928118
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccncn1,2.9,nM,=,CHEMBL3900140
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cncnc1,12.9,nM,=,CHEMBL3909054
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,COc1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)cn1,16.5,nM,=,CHEMBL3905561
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1[nH]cccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,2.8,nM,=,CHEMBL3941787
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Nc1ncccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,18.0,nM,=,CHEMBL3984227
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CC1(C)OCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,66.6,nM,=,CHEMBL3629737
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(COC3)[C@@H]1COc1c(F)ccc(F)c12,10.1,nM,=,CHEMBL3629739
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCC[C@]3(CCOC3)[C@@H]1COc1c(F)ccc(F)c12,13.9,nM,=,CHEMBL3629738
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=C1OCC[C@]12CCC[C@@]1(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]21,228.0,nM,=,CHEMBL3629740
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(CCSCC3)[C@@H]1COc1c(F)ccc(F)c12,26.4,nM,=,CHEMBL3629742
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S1(=O)CCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CC1,57.7,nM,=,CHEMBL3629741
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(N1CC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)C1)C(F)(F)F,23.3,nM,=,CHEMBL3629743
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,9.5,nM,=,CHEMBL3899794
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,421.0,nM,=,CHEMBL3936795
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,397.0,nM,=,CHEMBL3905228
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,79.0,nM,=,CHEMBL3942223
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CP1(=O)OCC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,5.4,nM,=,CHEMBL3629745
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN(CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,40.5,%,=,CHEMBL4101723
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,46.9,%,=,CHEMBL4091504
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1,45.2,%,=,CHEMBL4063688
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1OC,68.2,%,=,CHEMBL4064738
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1N(C)C,46.9,%,=,CHEMBL4086224
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccc(N(C)C)cc1,64.8,%,=,CHEMBL4073325
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN(CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,79.5,%,=,CHEMBL4093991
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,75.8,%,=,CHEMBL4094880
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1,79.9,%,=,CHEMBL4067447
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1OC,89.4,%,=,CHEMBL4101300
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1N(C)C,72.1,%,=,CHEMBL4083301
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccc(N(C)C)cc1,77.1,%,=,CHEMBL4093565
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN(CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,47.5,%,=,CHEMBL4072860
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1,50.6,%,=,CHEMBL4085819
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1,68.0,%,=,CHEMBL4064264
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1OC,78.7,%,=,CHEMBL4077948
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccccc1N(C)C,74.8,%,=,CHEMBL4102209
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCCCOc1cc(O)c2c(=O)c3ccccc3sc2c1)Cc1ccc(N(C)C)cc1,76.3,%,=,CHEMBL4066985
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=c1c2ccccc2sc2cc(O)cc(O)c12,9.5,%,=,CHEMBL2018439
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCOc1ccc(-c2coc3cc(OCCCCN(CC)Cc4ccccc4OC)cc(O)c3c2=O)cc1)Cc1ccccc1OC,35.0,%,=,CHEMBL3127003
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,36.2,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccccc2)[nH]cc1O,38.25,%,=,CHEMBL4077321
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccccc1,21.62,%,=,CHEMBL4072235
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(Cl)cc2)[nH]cc1O,11.55,%,=,CHEMBL4099194
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc(Cl)cc1,14.54,%,=,CHEMBL4075646
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,53.21,%,=,CHEMBL4059796
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,52.44,%,=,CHEMBL4077009
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,49.59,%,=,CHEMBL4092433
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,44.85,%,=,CHEMBL4091301
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc([N+](=O)[O-])cc2)[nH]cc1O,,%,,CHEMBL4069543
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc([N+](=O)[O-])cc1,,%,,CHEMBL4095654
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,51.53,%,=,CHEMBL4074429
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,65.3,%,=,CHEMBL4097746
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,54.88,%,=,CHEMBL4070599
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,56.76,%,=,CHEMBL4086825
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/c2cc(=O)c(O)c[nH]2)cc(OC)c1,35.32,%,=,CHEMBL4065395
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/c2cc(=O)c(O)cn2C)cc(OC)c1,28.27,%,=,CHEMBL4094556
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,58.43,%,=,CHEMBL4074006
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,52.52,%,=,CHEMBL4068105
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,49.31,%,=,CHEMBL4095488
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccccc1O,31.08,%,=,CHEMBL4078980
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2cc(O)cc(O)c2)[nH]cc1O,18.25,%,=,CHEMBL4103241
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1cc(O)cc(O)c1,22.36,%,=,CHEMBL4097928
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,%,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,64.08,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.44,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccccc2)[nH]cc1O,,,,CHEMBL4077321
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccccc1,,,,CHEMBL4072235
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(Cl)cc2)[nH]cc1O,,,,CHEMBL4099194
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(Cl)cc1,,,,CHEMBL4075646
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,18970.0,nM,=,CHEMBL4059796
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,19440.0,nM,=,CHEMBL4077009
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,29220.0,nM,=,CHEMBL4092433
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,,,,CHEMBL4091301
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc([N+](=O)[O-])cc2)[nH]cc1O,,,,CHEMBL4069543
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc([N+](=O)[O-])cc1,,,,CHEMBL4095654
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,23390.0,nM,=,CHEMBL4074429
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,8940.0,nM,=,CHEMBL4097746
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,16500.0,nM,=,CHEMBL4070599
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,12480.0,nM,=,CHEMBL4086825
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1cc(/C=C/c2cc(=O)c(O)c[nH]2)cc(OC)c1,,,,CHEMBL4065395
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1cc(/C=C/c2cc(=O)c(O)cn2C)cc(OC)c1,,,,CHEMBL4094556
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,10720.0,nM,=,CHEMBL4074006
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,15380.0,nM,=,CHEMBL4068105
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,21760.0,nM,=,CHEMBL4095488
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccccc1O,,,,CHEMBL4078980
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2cc(O)cc(O)c2)[nH]cc1O,,,,CHEMBL4103241
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1cc(O)cc(O)c1,,,,CHEMBL4097928
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2ccc(NC3CCNCC3)nc2[nH]1,48.0,%,=,CHEMBL4096497
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc(Nc2ccc3cc[nH]c3n2)nc1,71.0,%,=,CHEMBL4070063
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(Nc2ccc3cc[nH]c3n2)cc1,52.0,%,=,CHEMBL4089491
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1cc(F)cc(Nc2ccc3cc[nH]c3n2)c1,60.0,%,=,CHEMBL4061322
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1cc(F)cc(Nc2cnc3cc[nH]c3c2)c1,52.0,%,=,CHEMBL4097189
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,98.0,%,=,CHEMBL4069995
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2ccc(Nc3ccc4cc[nH]c4n3)nc2[nH]1,71.0,%,=,CHEMBL4071042
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2ccc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,75.0,%,=,CHEMBL4091877
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2ccc(Nc3ccc4cc[nH]c4c3)cc2[nH]1,96.0,%,=,CHEMBL4088069
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2cc(Nc3ccc4cc[nH]c4c3)ccc2[nH]1,94.0,%,=,CHEMBL4065954
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2cc(Nc3ccc4cc[nH]c4n3)ccc2[nH]1,97.0,%,=,CHEMBL4072136
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2cc(Nc3ccc4cc[nH]c4n3)cnc2[nH]1,86.0,%,=,CHEMBL4077396
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,90.0,%,>,CHEMBL4072261
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,90.0,%,>,CHEMBL4066527
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2c1,90.0,%,>,CHEMBL4079970
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,90.0,%,>,CHEMBL4104210
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN1CCC(c2c[nH]c3ccc(Nc4ccc5c(C6CCNCC6)c[nH]c5n4)cc23)CC1,90.0,%,>,CHEMBL4069232
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,90.0,%,>,CHEMBL4096474
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN1CCC(c2c[nH]c3cc(Nc4ccc5c(C6CCN(C)CC6)c[nH]c5c4)ccc23)CC1,90.0,%,>,CHEMBL4060547
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,81.0,%,=,CHEMBL4088780
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,81.0,%,=,CHEMBL4098927
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,81.0,%,=,CHEMBL4104620
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,81.0,%,=,CHEMBL4063009
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,81.0,%,=,CHEMBL4084675
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation at 1:10 protein to compound ratio after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,81.0,%,=,CHEMBL4101130
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,23800.0,nM,=,CHEMBL4069995
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,17800.0,nM,=,CHEMBL4072261
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,26600.0,nM,=,CHEMBL4066527
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,25600.0,nM,=,CHEMBL4104210
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,15300.0,nM,=,CHEMBL4096474
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,24000.0,nM,=,CHEMBL4088780
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,30000.0,nM,=,CHEMBL4098927
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,24000.0,nM,=,CHEMBL4104620
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,48000.0,nM,=,CHEMBL4063009
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,25000.0,nM,=,CHEMBL4084675
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,42000.0,nM,=,CHEMBL4101130
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300.0,nM,=,CHEMBL429694
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cccc(O)c1)O2,33.6,%,=,CHEMBL4075780
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(O)cc1)O2,15.7,%,=,CHEMBL4063760
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)C)c(O)c1)O2,46.9,%,=,CHEMBL4090583
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(CC)Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O,47.5,%,=,CHEMBL4075571
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCC3)c(O)c1)O2,57.2,%,=,CHEMBL4094805
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCCC3)c(O)c1)O2,58.1,%,=,CHEMBL4100760
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCOCC3)c(O)c1)O2,31.5,%,=,CHEMBL4059887
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCN(C)CC3)c(O)c1)O2,38.6,%,=,CHEMBL4081805
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN1CCN(Cc2ccc(/C=C3\Oc4cc(OC)c(OC)cc4C3=O)cc2O)CC1,49.1,%,=,CHEMBL4098196
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCN(Cc4ccccc4)CC3)c(O)c1)O2,41.8,%,=,CHEMBL4071970
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN(C)Cc3ccccc3)c(O)c1)O2,51.5,%,=,CHEMBL4102562
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccccc1CN(C)Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O,55.1,%,=,CHEMBL4076740
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O,72.5,%,=,CHEMBL4064330
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O)Cc1ccccc1OC,74.9,%,=,CHEMBL4092053
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O)Cc1ccccc1N(C)C,78.3,%,=,CHEMBL4072914
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(Cc1ccc(N(C)C)cc1)Cc1ccc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc1O,80.5,%,=,CHEMBL4099799
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(O)c(CN(C)C)c1)O2,40.2,%,=,CHEMBL4069184
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(CC)Cc1cc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)ccc1O,56.4,%,=,CHEMBL4096430
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc(CN(C)C)c(O)c(CN(C)C)c1)O2,38.7,%,=,CHEMBL4095726
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(CC)Cc1cc(/C=C2\Oc3cc(OC)c(OC)cc3C2=O)cc(CN(CC)CC)c1O,75.2,%,=,CHEMBL4068377
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Clc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL118193
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4087140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Clc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4065718
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4070983
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4092601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CCNc2ncnc3ccccc23)cc1,50.0,%,>=,CHEMBL117804
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4089722
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4079415
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4097449
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL3815078
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4071318
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL3814123
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4081859
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Oc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4082825
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4100806
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Oc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4096595
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCc2ccccc2)nc2ccccc12,50.0,%,>=,CHEMBL3814134
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCCc2ccccc2)nc2ccccc12,50.0,%,>=,CHEMBL3814610
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4060687
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4081013
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4099046
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4070380
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4091317
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4061746
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,50.0,%,>=,CHEMBL4083524
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4097374
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4079345
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4105088
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL3262251
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,50.0,%,>=,CHEMBL4067481
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,50.0,%,>=,CHEMBL4094911
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,50.0,%,>=,CHEMBL4078382
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,50.0,%,>=,CHEMBL4102655
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,50.0,%,>=,CHEMBL4086248
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CNc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4064773
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4061837
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4083601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,50.0,%,>=,CHEMBL4070462
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,50.0,%,>=,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCc2ccccc2)c2ccccc2n1,16700.0,nM,=,CHEMBL118193
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,8200.0,nM,=,CHEMBL4087140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4065718
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,2300.0,nM,=,CHEMBL4070983
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,12000.0,nM,=,CHEMBL4092601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2ncnc3ccccc23)cc1,11900.0,nM,=,CHEMBL117804
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,7200.0,nM,=,CHEMBL4089722
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,2600.0,nM,=,CHEMBL4079415
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,8400.0,nM,=,CHEMBL4097449
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,2700.0,nM,=,CHEMBL4071318
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,7800.0,nM,=,CHEMBL4081859
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCc2ccccc2)c2ccccc2n1,270.0,nM,=,CHEMBL4082825
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,10400.0,nM,=,CHEMBL4100806
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCCc2ccccc2)c2ccccc2n1,11200.0,nM,=,CHEMBL4096595
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4060687
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,13300.0,nM,=,CHEMBL4081013
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,14400.0,nM,=,CHEMBL4099046
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,1000.0,nM,=,CHEMBL4070380
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,3100.0,nM,=,CHEMBL4091317
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,1900.0,nM,=,CHEMBL4061746
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,1700.0,nM,=,CHEMBL4083524
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4097374
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCc2ccccc2)c2ccccc2n1,7000.0,nM,=,CHEMBL4079345
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4105088
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL3262251
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,5700.0,nM,=,CHEMBL4067481
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,6600.0,nM,=,CHEMBL4094911
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,2900.0,nM,=,CHEMBL4078382
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,4300.0,nM,=,CHEMBL4102655
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,4900.0,nM,=,CHEMBL4086248
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccccc2)c2ccccc2n1,2000.0,nM,=,CHEMBL4064773
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,1400.0,nM,=,CHEMBL4061837
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL4083601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,3800.0,nM,=,CHEMBL4070462
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,790.0,nM,=,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3300.0,nM,=,CHEMBL140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,1100.0,nM,=,CHEMBL165
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Clc1nc(NCc2ccccc2)c2ccccc2n1,22.0,%,=,CHEMBL118193
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Clc1nc(NCCc2ccccc2)c2ccccc2n1,36.0,%,=,CHEMBL4065718
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,27.0,%,=,CHEMBL4070983
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,36.0,%,=,CHEMBL4092601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CCNc2ncnc3ccccc23)cc1,32.0,%,=,CHEMBL117804
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,10.0,%,<,CHEMBL4089722
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,37.0,%,=,CHEMBL4079415
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,34.0,%,=,CHEMBL4097449
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCc2ccccc2)c2ccccc2n1,10.0,%,<,CHEMBL3815078
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,45.0,%,=,CHEMBL4071318
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCCc2ccccc2)c2ccccc2n1,37.0,%,=,CHEMBL3814123
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,10.0,%,<,CHEMBL4081859
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Oc1nc(NCc2ccccc2)c2ccccc2n1,24.0,%,=,CHEMBL4082825
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,32.0,%,=,CHEMBL4100806
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Oc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4096595
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,Nc1nc(NCCc2ccccc2)nc2ccccc12,50.0,%,=,CHEMBL3814610
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,40.0,%,=,CHEMBL4060687
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,48.0,%,=,CHEMBL4081013
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,33.0,%,=,CHEMBL4099046
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,46.0,%,=,CHEMBL4070380
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,10.0,%,<,CHEMBL4091317
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,31.0,%,=,CHEMBL4061746
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,,%,,CHEMBL4083524
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,20.0,%,=,CHEMBL4097374
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCc2ccccc2)c2ccccc2n1,24.0,%,=,CHEMBL4079345
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,26.0,%,=,CHEMBL4105088
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,13.0,%,=,CHEMBL3262251
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,31.0,%,=,CHEMBL4067481
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,23.1,%,=,CHEMBL4094911
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,41.0,%,=,CHEMBL4078382
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,14.0,%,=,CHEMBL4102655
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,25.0,%,=,CHEMBL4086248
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CNc1nc(NCCc2ccccc2)c2ccccc2n1,40.0,%,=,CHEMBL4064773
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,47.0,%,=,CHEMBL4061837
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,33.0,%,=,CHEMBL4083601
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4070462
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli at 25 uM measured over 24 hrs by ThT-based fluorescence spectroscopic method relative to control,Inhibition,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,22.0,%,=,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,13000.0,nM,=,CHEMBL4087140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9900.0,nM,=,CHEMBL140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15300.0,nM,=,CHEMBL165
"Potency index, ratio of curcumin IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation",Ratio IC50,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,1.3,,=,CHEMBL4070983
"Potency index, ratio of curcumin IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation",Ratio IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,1.2,,=,CHEMBL3814134
"Potency index, ratio of curcumin IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation",Ratio IC50,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,4.1,,=,CHEMBL4091385
"Potency index, ratio of resveratrol IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation",Ratio IC50,Oc1nc(NCc2ccccc2)c2ccccc2n1,4.0,,=,CHEMBL4082825
"Potency index, ratio of resveratrol IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation",Ratio IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,1.8,,=,CHEMBL3814134
"Potency index, ratio of curcumin IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation",Ratio IC50,Oc1nc(NCc2ccccc2)c2ccccc2n1,12.0,,=,CHEMBL4082825
"Potency index, ratio of resveratrol IC50 to test compound IC50 for HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation",Ratio IC50,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,1.4,,=,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,Oc1nc(NCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4082825
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4070380
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4061837
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,,%,,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,Oc1nc(NCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4082825
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4070380
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,,%,,CHEMBL4061837
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,,%,,CHEMBL4091385
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,,%,,CHEMBL4087140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,Nc1nc(NCc2ccccc2)nc2ccccc12,,%,,CHEMBL3814134
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,Nc1nc(NCCc2ccccc2)nc2ccccc12,,%,,CHEMBL3814610
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load measured after 24 hrs by ThT fluorescence assay,Inhibition,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,,%,,CHEMBL4094911
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,,%,,CHEMBL4087140
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,Nc1nc(NCc2ccccc2)nc2ccccc12,,%,,CHEMBL3814134
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,Nc1nc(NCCc2ccccc2)nc2ccccc12,,%,,CHEMBL3814610
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli assessed as reduction in amyloid beta fibril load at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,,%,,CHEMBL4094911
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCC1OC(=O)c2cc(N3N=C(C)CC3=O)ccc21,50.1,%,=,CHEMBL4081930
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCC1OC(=O)c2cc(N3N=C(C)CC3=O)ccc21,50.1,%,=,CHEMBL4099927
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCCC1OC(=O)c2cc(N3N=C(C)CC3=O)ccc21,50.1,%,=,CHEMBL4100880
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCCCC1OC(=O)c2cc(N3N=C(C)CC3=O)ccc21,71.5,%,=,CHEMBL4074119
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCC1OC(=O)c2cc(-n3nc(C(F)(F)F)cc3O)ccc21,50.1,%,=,CHEMBL4062746
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCC1OC(=O)c2cc(-n3nc(C(F)(F)F)cc3O)ccc21,,%,,CHEMBL4104567
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCCC1OC(=O)c2cc(-n3nc(C(F)(F)F)cc3O)ccc21,,%,,CHEMBL4103010
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCCCCC1OC(=O)c2cc(-n3nc(C(F)(F)F)cc3O)ccc21,,%,,CHEMBL4084286
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,39.0,%,=,CHEMBL140
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCCCC1OC(=O)c2ccccc21,1.2,%,=,CHEMBL248594
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CC1=NN(c2ccccc2)C(=O)C1,20.1,%,=,CHEMBL290916
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,30.0,%,=,CHEMBL165
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1ccc2nc3c(c(N)c2c1)CCCC3,5.0,%,<,CHEMBL1256415
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,5.0,%,<,CHEMBL292314
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,Oc1cc(O)cc(/C=C/c2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)c1,31.2,%,=,CHEMBL4081795
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/c2ccc(Nc3c4c(nc5ccc(OC)cc35)CCCC4)cc2)cc(OC)c1,,%,,CHEMBL4063963
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/c2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc(OC)c1,,%,,CHEMBL4075223
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/c2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)cc(OC)c1,21.6,%,=,CHEMBL4075856
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,Oc1cc(O)cc(CCc2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)c1,37.3,%,=,CHEMBL4066309
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(CCc2ccc(Nc3c4c(nc5ccc(OC)cc35)CCCC4)cc2)cc(OC)c1,,%,,CHEMBL4072700
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(CCc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)cc(OC)c1,,%,,CHEMBL4093419
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM by ThT-based fluorometric method relative to control,Inhibition,COc1cc(CCc2ccc(Nc3c4c(nc5cc(Cl)ccc35)CCCC4)cc2)cc(OC)c1,17.6,%,=,CHEMBL4083174
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) fibril formation by thioflavin-T fluorescence based assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1000.0,nM,=,CHEMBL140
Inhibition of recombinant human amyloid beta (1 to 42) aggregation at 100 uM measured every 10 mins for 48 hrs by thioflavin T fluorescence assay,Inhibition,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,%,,CHEMBL4083677
Inhibition of recombinant human amyloid beta (1 to 42) aggregation at 100 uM measured every 10 mins for 48 hrs by thioflavin T fluorescence assay,Inhibition,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,%,,CHEMBL4100115
Inhibition of recombinant human amyloid beta (1 to 42) aggregation at 100 uM measured every 10 mins for 48 hrs by thioflavin T fluorescence assay,Inhibition,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,%,,CHEMBL4073269
Inhibition of recombinant human amyloid beta (1 to 42) aggregation at 100 uM measured every 10 mins for 48 hrs by thioflavin T fluorescence assay,Inhibition,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,%,,CHEMBL4103518
Inhibition of recombinant human amyloid beta (1 to 42) aggregation at 100 uM measured every 10 mins for 48 hrs by thioflavin T fluorescence assay,Inhibition,Cc1cccc(CNC(=O)[C@@H](C)C2CCN(C(=O)c3ccc4oc(-c5ccccc5)nc4c3)CC2)c1,,%,,CHEMBL4079257
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as thinner fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,,,CHEMBL4083677
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as thinner fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4100115
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as thinner fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,,,CHEMBL4073269
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as thinner fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,,,CHEMBL4103518
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as shorter fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,,,CHEMBL4083677
Induction of morphological changes in recombinant human amyloid beta (1 to 42) fibrils assessed as shorter fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4100115
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as loosely attached fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,,,CHEMBL4083677
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as loosely attached fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4100115
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as smoother fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,,,CHEMBL4083677
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of uneven fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4100115
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of uneven fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,,,CHEMBL4073269
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of uneven fibrils at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,,,CHEMBL4103518
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of small mesh-like aggregates at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,,,CHEMBL4073269
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of small mesh-like aggregates at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,,,CHEMBL4103518
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of punctate at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,,,CHEMBL4073269
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as appearance of punctate at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,,,CHEMBL4103518
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as less dense fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,c1ccc(COc2cccc(C3N(Cc4ccccc4)CCN3Cc3ccccc3)c2)cc1,,,,CHEMBL4083677
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as less dense fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,COc1cc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4100115
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as less dense fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cn1c(SCC(=O)Nc2ccccc2)nnc1-c1ccc(N)cc1,,,,CHEMBL4073269
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as less dense fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1ccc(NC(=O)CSc2nnc(-c3ccc(N)cc3)n2C)cc1,,,,CHEMBL4103518
Induction of morphological changes in recombinant human amyloid beta (1 to 42) assessed as less dense fibril at 100 uM measured after 48 hrs by transmission electron microscopic method,Activity,Cc1cccc(CNC(=O)[C@@H](C)C2CCN(C(=O)c3ccc4oc(-c5ccccc5)nc4c3)CC2)c1,,,,CHEMBL4079257
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(Cc2ccccc2)CC1,50.3,%,=,CHEMBL4102156
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCc2ccccc2C1,55.6,%,=,CHEMBL4066362
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(c2ccccn2)CC1,36.3,%,=,CHEMBL4087707
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(c2ncccn2)CC1,46.9,%,=,CHEMBL4074968
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(Cc2ccccc2)CC1,54.6,%,=,CHEMBL4095402
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,50.8,%,=,CHEMBL4085222
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(c2ccccn2)CC1,49.8,%,=,CHEMBL4090419
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(c2ncccn2)CC1,46.0,%,=,CHEMBL4092964
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(Cc2ccccc2)CC1,55.9,%,=,CHEMBL4065298
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCc2ccccc2C1,50.7,%,=,CHEMBL4100686
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(c2ccccn2)CC1,51.5,%,=,CHEMBL4077421
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(c2ncccn2)CC1,39.7,%,=,CHEMBL4071307
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(Cc2ccccc2)CC1,51.1,%,=,CHEMBL4098346
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCc2ccccc2C1,54.7,%,=,CHEMBL4081846
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(c2ccccn2)CC1,49.9,%,=,CHEMBL4059925
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(c2ncccn2)CC1,42.0,%,=,CHEMBL4093828
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,28.3,%,=,CHEMBL32749
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1O,65.9,%,=,CHEMBL4097440
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.8,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 50 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,68.7,%,=,CHEMBL4085222
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 12.5 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,31.2,%,=,CHEMBL4085222
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(Cc2ccccc2)CC1,,,,CHEMBL4102156
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCc2ccccc2C1,,,,CHEMBL4066362
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(c2ccccn2)CC1,,,,CHEMBL4087707
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCN1CCN(c2ncccn2)CC1,,,,CHEMBL4074968
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(Cc2ccccc2)CC1,,,,CHEMBL4095402
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,38.7,%,=,CHEMBL4085222
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(c2ccccn2)CC1,,,,CHEMBL4090419
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCN(c2ncccn2)CC1,,,,CHEMBL4092964
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(Cc2ccccc2)CC1,,,,CHEMBL4065298
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCc2ccccc2C1,,,,CHEMBL4100686
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(c2ccccn2)CC1,,,,CHEMBL4077421
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCN1CCN(c2ncccn2)CC1,,,,CHEMBL4071307
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(Cc2ccccc2)CC1,,,,CHEMBL4098346
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCc2ccccc2C1,,,,CHEMBL4081846
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(c2ccccn2)CC1,,,,CHEMBL4059925
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCCCN1CCN(c2ncccn2)CC1,,,,CHEMBL4093828
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)O)ccc1O,,,,CHEMBL32749
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1O,,,,CHEMBL4097440
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,,,CHEMBL502
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,57.2,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 24 hrs by transmission electron microscopic method,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,,%,,CHEMBL4085222
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,,%,,CHEMBL4085222
Disaggregation of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by transmission electron microscopic method,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OCCCCN1CCc2ccccc2C1,,,,CHEMBL4085222
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) self-aggregation at 10 uM measured every 5 mins by ThT-fluorescence assay,Inhibition,COc1cc2c(cc1OC)C(=O)C(Cc1cc[n+](Cc3cccc(Cl)c3)cc1C(N)=O)C2.[Br-],25.0,%,=,CHEMBL4092048
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM after 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(C(=O)CC(=O)CC2CCN(Cc3ccccc3)CC2)cc1O,45.3,%,=,CHEMBL4083028
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM after 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(C(=O)CC(=O)CC2CCN(Cc3cccc(C)c3)CC2)cc1O,30.4,%,=,CHEMBL4085122
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM after 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(C(=O)CC(=O)CC2CCN(Cc3ccccc3)CC2)cc1OC,22.0,%,=,CHEMBL4063499
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 20 uM after 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,54.9,%,=,CHEMBL140
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,21.5,%,=,CHEMBL4070006
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,C[C@@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)C[C@@H]3O)[C@H](O)[C@H](O)[C@H]1O,77.7,%,=,CHEMBL4071057
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,C[C@@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)C[C@@H]3O)[C@H](O)[C@H](O)[C@H]1O,39.3,%,=,CHEMBL4075399
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,10.3,%,=,CHEMBL506247
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,20.1,%,=,CHEMBL488317
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,COC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6CC(C)(C)C[C@H](OC(C)=O)[C@]6(COC(C)=O)[C@@H](OC(C)=O)C[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H]1O,28.8,%,=,CHEMBL4061337
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,46.5,%,=,CHEMBL4089501
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,42.2,%,=,CHEMBL4088547
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,COC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6CC(C)(C)C[C@H](OC(C)=O)[C@]6(COC(C)=O)[C@@H](OC(C)=O)C[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,40.8,%,=,CHEMBL4067295
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,43.8,%,=,CHEMBL4085271
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](C(=O)O)O[C@@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)[C@@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,65.2,%,=,CHEMBL4103196
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC1(C)C[C@H](O)[C@]2(CO)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,39.2,%,=,CHEMBL4093010
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,64.3,%,=,CHEMBL4065341
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC1(C)CC[C@]2(C(=O)O)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,99.9,%,=,CHEMBL4076297
Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control,Activity,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,100.3,%,=,CHEMBL168
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as cell viability at 6.25 uM after 24 hrs by WST8 assay (Rvb = 63.1 +/- 5.6%),Activity,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,78.8,%,=,CHEMBL506247
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as cell viability at 50 uM after 24 hrs by WST8 assay (Rvb = 63.1 +/- 5.6%),Activity,COC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6CC(C)(C)C[C@H](OC(C)=O)[C@]6(COC(C)=O)[C@@H](OC(C)=O)C[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H]1O,79.2,%,=,CHEMBL4061337
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as cell viability at 50 uM after 24 hrs by WST8 assay (Rvb = 63.1 +/- 5.6%),Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,87.4,%,=,CHEMBL4089501
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as cell viability at 50 uM after 24 hrs by WST8 assay (Rvb = 63.1 +/- 5.6%),Activity,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,83.7,%,=,CHEMBL4088547
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as cell viability at 50 uM after 24 hrs by WST8 assay (Rvb = 63.1 +/- 5.6%),Activity,COC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC=C5[C@@H]6CC(C)(C)C[C@H](OC(C)=O)[C@]6(COC(C)=O)[C@@H](OC(C)=O)C[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,84.3,%,=,CHEMBL4067295
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay,Inhibition,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,,%,,CHEMBL506247
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay,Inhibition,CC1(C)C[C@H](O)[C@]2(CO)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,,%,,CHEMBL4093010
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay,Inhibition,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,,%,,CHEMBL4065341
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay,Inhibition,CC1(C)CC[C@]2(C(=O)O)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,,%,,CHEMBL4076297
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay,Inhibition,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,,%,,CHEMBL168
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 50 uM after 24 hrs by WST8 assay,Inhibition,C[C@@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)C[C@@H]3O)[C@H](O)[C@H](O)[C@H]1O,,%,,CHEMBL4075399
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 50 uM after 24 hrs by WST8 assay,Inhibition,C[C@@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)C[C@@H]3O)[C@H](O)[C@H](O)[C@H]1O,,%,,CHEMBL4071057
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 50 uM after 24 hrs by WST8 assay,Inhibition,CC1(C)CC[C@]2(C(=O)O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,,%,,CHEMBL4070006
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 50 uM after 24 hrs by WST8 assay,Inhibition,CC(=O)OC[C@]12[C@@H](OC(C)=O)CC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(C)=O,,%,,CHEMBL4085271
Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 50 uM after 24 hrs by WST8 assay,Inhibition,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](C(=O)O)O[C@@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)[C@@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,,%,,CHEMBL4103196
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1CN1CCN(Cc2ccc3cccnc3c2O)CC1,44.2,%,=,CHEMBL4082964
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM incubated for 30 mins measured every 5 mins for 14 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1OC,40.0,%,=,CHEMBL4076034
Induction of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) disaggregation after 48 hrs by silver staining-based SDS-PAGE analysis,Activity,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,,,,CHEMBL4066961
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 3.1 to 50 uM after 1 hr by Thioflavin-T fluorescence assay relative to control,Inhibition,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,,%,,CHEMBL4066961
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 3.1 to 50 uM after 1 hr by Thioflavin-T fluorescence assay relative to control,Inhibition,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,50.0,%,<=,CHEMBL4066961
Induction of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) disaggregation at 3.1 to 50 uM after 1 hr by Thioflavin-T fluorescence assay relative to control,Activity,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,40.0,%,=,CHEMBL4066961
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation after 1 hr by transmission electron microscopic method,Inhibition,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,,%,,CHEMBL4066961
Induction of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) disaggregation after 1 hr by transmission electron microscopic method,Activity,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,,,,CHEMBL4066961
Induction of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) disaggregation after 48 hrs by silver staining-based SDS-PAGE analysis,Activity,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],,,,CHEMBL429694
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3)cc1)C2.[Br-],45.6,%,=,CHEMBL4098703
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3F)cc1)C2.[Br-],53.7,%,=,CHEMBL4076580
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(F)c3)cc1)C2.[Br-],43.5,%,=,CHEMBL4095035
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(F)cc3)cc1)C2.[Br-],47.6,%,=,CHEMBL4073287
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3C)cc1)C2.[Br-],38.7,%,=,CHEMBL4099391
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(C)c3)cc1)C2.[Br-],42.6,%,=,CHEMBL4084842
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(C)cc3)cc1)C2.[Br-],49.9,%,=,CHEMBL4076986
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3Br)cc1)C2.[Br-],56.7,%,=,CHEMBL4063583
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc(Br)c3)cc1)C2.[Br-],53.4,%,=,CHEMBL4082048
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc(Br)cc3)cc1)C2.[Br-],50.2,%,=,CHEMBL4083039
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3cccc([N+](=O)[O-])c3)cc1)C2.[Br-],50.8,%,=,CHEMBL4101018
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccc([N+](=O)[O-])cc3)cc1)C2.[Br-],47.2,%,=,CHEMBL4070471
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.6,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as reduction in amyloid beta fibrils by transmission electron microscopic analysis,Inhibition,COc1cc2c(cc1OC)C(=O)/C(=C/c1cc[n+](Cc3ccccc3F)cc1)C2.[Br-],,%,,CHEMBL4076580
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as reduction in amyloid beta fibrils by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of Abeta42 (unknown origin) aggregation at 1.9 mg by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,0.02,%,=,CHEMBL4086058
Inhibition of Abeta42 (unknown origin) aggregation at 2.7 mg by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,0.03,%,=,CHEMBL4073121
Inhibition of Abeta42 (unknown origin) aggregation at 4.8 mg by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,0.06,%,=,CHEMBL4073614
Inhibition of Abeta42 (unknown origin) aggregation at 4.4 mg by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,0.05,%,=,CHEMBL4098015
Inhibition of Abeta42 (unknown origin) aggregation at early stage incubated for 8 hrs by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4086058
Inhibition of Abeta42 (unknown origin) aggregation at early stage incubated for 8 hrs by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4073121
Inhibition of Abeta42 (unknown origin) aggregation at early stage incubated for 8 hrs by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4073614
Inhibition of Abeta42 (unknown origin) aggregation at early stage incubated for 8 hrs by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4098015
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase assessed as time required for nucleation of Abeta42 at 50 uM by Thioflavin-T fluorescence assay,TIME,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,10.0,hr,=,CHEMBL4086058
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase assessed as time required for nucleation of Abeta42 at 50 uM by Thioflavin-T fluorescence assay,TIME,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,10.0,hr,=,CHEMBL4073121
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase assessed as time required for nucleation of Abeta42 at 50 uM by Thioflavin-T fluorescence assay,TIME,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,12.0,hr,=,CHEMBL4073614
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase assessed as time required for nucleation of Abeta42 at 50 uM by Thioflavin-T fluorescence assay,TIME,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,10.0,hr,=,CHEMBL4098015
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase assessed as time delay for Abeta42 aggregation velocity at 50 uM by sedimentation assay,TIME,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,8.0,hr,=,CHEMBL4073614
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4086058
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CCC(C)(C)C[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4073121
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4073614
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C\C(=O)OC[C@@]23CC[C@@]4(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4098015
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,,%,,CHEMBL169
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(CO)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,,%,,CHEMBL524080
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,CC(=O)OC[C@@]12CC[C@@]3(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]3C1=CC[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,,%,,CHEMBL4078166
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(CO)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4070107
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at elongation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(COC(=O)/C=C/c1ccc(O)c(OC)c1)CC2,,%,,CHEMBL4095491
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,,%,,CHEMBL169
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(CO)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,,%,,CHEMBL524080
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,CC(=O)OC[C@@]12CC[C@@]3(C(=O)O)CC[C@@H](C)[C@H](C)[C@H]3C1=CC[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,,%,,CHEMBL4078166
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(COC(=O)/C=C/c1ccc(O)c(OC)c1)CC2,,%,,CHEMBL4095491
Inhibition of HFIP pretreated Abeta42 (unknown origin) aggregation at nucleation phase at 50 uM by Thioflavin-T fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)OC[C@@]23CC[C@@]4(CO)CC[C@@H](C)[C@H](C)[C@H]4C2=CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)ccc1O,,%,,CHEMBL4070107
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4[n+]3C)ccc21.[I-],93.1,%,=,CHEMBL3425895
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2cc3ccccc3[nH]2)ccc2ccccc21.[I-],74.7,%,=,CHEMBL3425894
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2ccc(N3CCOCC3)cc2)ccc2ccccc21.[I-],75.9,%,=,CHEMBL3425893
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1N1CCOCC1.[I-],52.1,%,=,CHEMBL3425892
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2ccccc2)ccc2ccccc21.[I-],25.9,%,=,CHEMBL3425889
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2ccc(O)cc2)ccc2ccccc21.[I-],-8.2,%,=,CHEMBL1303143
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)cc(OC)c1O.[I-],36.7,%,=,CHEMBL3425881
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)cc(OC)c1OC.[I-],3.9,%,=,CHEMBL3425891
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1F.[I-],0.9,%,=,CHEMBL3425890
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2cc([N+](=O)[O-])ccc2O)ccc2ccccc21.[I-],32.0,%,=,CHEMBL3425885
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1.[I-],81.5,%,=,CHEMBL1242180
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(O)c1.[I-],91.3,%,=,CHEMBL4061433
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(OC)c1.[I-],95.1,%,=,CHEMBL4097284
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN1CCN(c2ccc(/C=C/c3ccc4ccccc4[n+]3C)cc2)CC1.[I-],61.5,%,=,CHEMBL4070093
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2ccc3ccccc3[n+]2C)ccc1N1CCN(C)CC1.[I-],50.1,%,=,CHEMBL4093946
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)cc1.[I-],98.7,%,=,CHEMBL4066392
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(Cl)c1.[I-],59.4,%,=,CHEMBL4080358
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2ccc(Cl)cc2)ccc2ccccc21.[I-],0.7,%,=,CHEMBL4104589
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2ccc(F)cc2)ccc2ccccc21.[I-],-3.6,%,=,CHEMBL597863
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(OC)n1.[I-],98.5,%,=,CHEMBL4096862
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ncccc1/C=C/c1ccc2ccccc2[n+]1C.[I-],-12.3,%,=,CHEMBL4060972
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2cccnc2)ccc2ccccc21.[I-],-3.2,%,=,CHEMBL4089155
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN1CCN(c2cc(/C=C/c3ccc(N(C)C)cc3)[n+](C)c3ccccc23)CC1.[I-],78.9,%,=,CHEMBL4099308
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCN(C)CC3)c3ccccc3[n+]2C)c(O)c1.[I-],96.0,%,=,CHEMBL4086152
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCN(C)CC3)c3ccccc3[n+]2C)c(OC)c1.[I-],98.8,%,=,CHEMBL4065910
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN1CCN(c2ccc(/C=C/c3cc(N4CCN(C)CC4)c4ccccc4[n+]3C)cc2)CC1.[I-],58.7,%,=,CHEMBL4093514
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2cc(N3CCN(C)CC3)c3ccccc3[n+]2C)ccc1N1CCN(C)CC1.[I-],49.8,%,=,CHEMBL4086383
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2cc(N3CCOCC3)c3ccccc3[n+]2C)cc1.[I-],75.9,%,=,CHEMBL4064920
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCOCC3)c3ccccc3[n+]2C)c(O)c1.[I-],90.9,%,=,CHEMBL4078528
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCOCC3)c3ccccc3[n+]2C)c(OC)c1.[I-],104.2,%,=,CHEMBL4102810
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2cc3ccccc3[nH]2)cc(N2CCOCC2)c2ccccc21.[I-],76.6,%,=,CHEMBL4067639
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCn1c2ccccc2c2cc(/C=C/c3cc(N4CCOCC4)c4ccccc4[n+]3C)ccc21.[I-],95.7,%,=,CHEMBL4095051
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2cc(N3CCN(CCO)CC3)c3ccccc3[n+]2C)cc1.[I-],79.3,%,=,CHEMBL4105221
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCN(CCO)CC3)c3ccccc3[n+]2C)c(O)c1.[I-],89.4,%,=,CHEMBL4087364
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2cc(N3CCN(CCO)CC3)c3ccccc3[n+]2C)c(OC)c1.[I-],100.8,%,=,CHEMBL4072484
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,C[n+]1c(/C=C/c2cc3ccccc3[nH]2)cc(N2CCN(CCO)CC2)c2ccccc21.[I-],76.8,%,=,CHEMBL4099404
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2cc(N3CCN(CCO)CC3)c3ccccc3[n+]2C)cc(OC)c1O.[I-],41.1,%,=,CHEMBL4065374
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3n2)c(O)c1,50.5,%,=,CHEMBL4086807
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.3,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,80.1,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,33.7,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCn1c2ccccc2c2cc(/C=C/c3ccc4ccccc4n3)ccc21,42.0,%,=,CHEMBL3425908
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as reduction in beta-sheet content at 20 uM measured up to 24 hrs by CD spectroscopic method,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(O)c1.[I-],,%,,CHEMBL4061433
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM measured up to 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CCN(CC)c1ccc(/C=C/c2ccc3ccccc3[n+]2C)c(O)c1.[I-],,%,,CHEMBL4061433
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM measured up to 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM measured up to 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,%,,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM measured up to 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,52.7,%,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,75.4,%,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,124600.0,nM,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,14800.0,nM,=,CHEMBL164
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O,12800.0,nM,=,CHEMBL3348861
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@H]1O,500000.0,nM,>,CHEMBL9323
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,176200.0,nM,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as nucleation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 580.7 10'6/min),K,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,426.4,10'6/min,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as nucleation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 580.7 10'6/min),K,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,496.5,10'6/min,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as apparent elongation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 1657.7 /M/min),Ke(app),O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,3697.7,/M/min,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as apparent elongation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 1657.7 /M/min),Ke(app),O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6829.6,/M/min,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as half life for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 284.7 mins),T1/2,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,5.103,hr,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as half life for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 284.7 mins),T1/2,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,4.883,hr,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 64.4 mins),Tlag,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,81.3,min,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 64.4 mins),Tlag,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,82.7,min,=,CHEMBL50
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as end-time for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 504.9 mins),TIME,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,8.852,hr,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as end-time for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 504.9 mins),TIME,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,8.39,hr,=,CHEMBL50
Displacement of [N-methyl-11C]6-Me-BTA-1 from pre-aggregated amyloid beta (1 to 40) fibrils (unknown origin) after 30 mins by scintillation counting method,Ki,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],890.0,nM,=,CHEMBL224392
Displacement of [3H]PIB from human amyloid beta (1 to 40) fibrils after 3 hrs by liquid scintillation counting,Kd,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,8.4,nM,=,CHEMBL570378
Inhibition of human amyloid beta (1 to 40) aggregation after 1 hr by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL140
Inhibition of human amyloid beta (1 to 42) aggregation after 46 to 48 hrs by Thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,10000.0,nM,=,CHEMBL140
Inhibition of recombinant amyloid beta (1 to 42) fibrils (unknown origin) by thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,23000.0,nM,=,CHEMBL28
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,44.8,%,=,CHEMBL4084943
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,37.5,%,=,CHEMBL4063292
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,29.4,%,=,CHEMBL4092697
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,26.9,%,=,CHEMBL4071918
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,34.2,%,=,CHEMBL4066065
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,25.8,%,=,CHEMBL4072520
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,27.5,%,=,CHEMBL4074677
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,42.4,%,=,CHEMBL4101369
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,29.6,%,=,CHEMBL4096067
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,29.1,%,=,CHEMBL4078020
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,41.2,%,=,CHEMBL4080617
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,44.7,%,=,CHEMBL4098654
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(OCC(=O)NCCCCCCN(C)Cc4ccccc4)cc3)cc(=O)c2c(OC)c1OC,44.3,%,=,CHEMBL4088486
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1,34.4,%,=,CHEMBL4060260
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,36.1,%,=,CHEMBL4096208
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,35.5,%,=,CHEMBL4068935
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,54.7,%,=,CHEMBL4103970
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,59.8,%,=,CHEMBL4079709
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,53.9,%,=,CHEMBL4091828
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,49.1,%,=,CHEMBL4064070
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,56.9,%,=,CHEMBL4073458
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,57.1,%,=,CHEMBL4100298
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,53.3,%,=,CHEMBL4064861
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,56.7,%,=,CHEMBL4092562
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(OC)c1OC,6.7,%,=,CHEMBL74490
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1OC,9.8,%,=,CHEMBL348436
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 12.5 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,43.6,%,=,CHEMBL4100298
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,75.2,%,=,CHEMBL4100298
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by ThT-based fluorometric method,Inhibition,CCN(CCCCNC(=O)COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1)Cc1ccccc1OC,,%,,CHEMBL4100298
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as lag time at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 8.3 +/- 0.7 hrs),Tlag,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,4.4,hr,=,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 11 +/- 1 hrs),T1/2,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,11.0,hr,=,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as fluorescence emission rate constant K at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 1.3 +/- 0.1 No_unit),K,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,2.2,,=,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 52 +/- 7 a.u.),Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,24.0,a.u.,=,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation after 3 hrs by ThT-based fluorometric method,Activity,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,,,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as average assembled nanostructure height at 500 uM after 30 hrs by atomic force microscopic analysis,Activity,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,2.1,nm,=,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in protofibrils formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,%,,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in flat ribbons formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,%,,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as lag time at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 8.3 +/- 0.7 hrs),Tlag,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,2.7,hr,=,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 11 +/- 1 hrs),T1/2,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,4.1,hr,=,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as fluorescence emission rate constant K at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 1.3 +/- 0.1 No_unit),K,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,0.7,,=,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 52 +/- 7 a.u.),Activity,O=C(CCNC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O)N[C@@H](Cc1c[nH]cn1)C(=O)O,6.0,a.u.,=,CHEMBL4080901
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation after 3 hrs by ThT-based fluorometric method,Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as lag time at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 8.3 +/- 0.7 hrs),Tlag,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,4.7,hr,=,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 11 +/- 1 hrs),T1/2,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,8.3,hr,=,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as fluorescence emission rate constant K at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 1.3 +/- 0.1 No_unit),K,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,1.7,,=,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 52 +/- 7 a.u.),Activity,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,37.0,a.u.,=,CHEMBL1236395
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as Tlag at 40 to 5000 uM in presence of trehalose by ThT-based fluorometric method (Rvb = 8.3 +/- 0.7 hrs),Tlag,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,4.3,hr,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM in presence of trehalose by ThT-based fluorometric method (Rvb = 11 +/- 1 hrs),T1/2,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,5.8,hr,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 52 +/- 7 a.u.),Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,33.0,a.u.,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as fluorescence emission rate constant K at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 1.3 +/- 0.1 No_unit),K,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,1.9,,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as time at which amplitude of ThT emission is 50% of difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 11 +/- 1 hrs),T1/2,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,7.8,hr,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as lag time at 40 to 5000 uM after 3 hrs by ThT-based fluorometric method (Rvb = 8.3 +/- 0.7 hrs),Tlag,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,3.9,hr,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in flat ribbons formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,%,,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in protofibrils formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,%,,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation after 3 hrs by ThT-based fluorometric method,Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,,,,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as difference between final and initial fluorescence emission at 40 to 5000 uM after 3 hrs in presence of trehalose by ThT-based fluorometric method (Rvb = 52 +/- 7 a.u.),Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,31.0,a.u.,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as fluorescence emission rate constant K at 40 to 5000 uM after 3 hrs in presence of trehalose by ThT-based fluorometric method (Rvb = 1.3 +/- 0.1 No_unit),K,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,2.7,,=,CHEMBL242948
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in flat ribbons formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as reduction in protofibrils formation at 500 uM after 30 hrs by atomic force microscopic analysis,Inhibition,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation assessed as average assembled nanostructure height at 500 uM after 30 hrs by atomic force microscopic analysis,Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,3.8,nm,=,CHEMBL4105144
Inhibition of amyloid beta (1 to 42) (unknown origin) self induced aggregation after 3 hrs by ThT-based fluorometric method,Activity,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,,,CHEMBL4105144
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ccccc2O)coc2ccccc12,65.2,%,=,CHEMBL4081806
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cccc(Cl)c2O)coc2ccccc12,79.5,%,=,CHEMBL4105296
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ccc(Cl)cc2O)coc2ccccc12,51.5,%,=,CHEMBL4086270
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cc(Cl)ccc2O)coc2ccccc12,68.1,%,=,CHEMBL4063972
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(/N=C/c2coc3ccccc3c2=O)c(O)c1,75.2,%,=,CHEMBL4062159
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(O)c(/N=C/c2coc3ccccc3c2=O)c1,58.1,%,=,CHEMBL4100473
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cc(F)ccc2O)coc2ccccc12,64.5,%,=,CHEMBL4082043
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cccc(Cl)c2O)coc2ccc(Br)cc12,68.1,%,=,CHEMBL4101899
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ccc(Cl)cc2O)coc2ccc(Br)cc12,87.6,%,=,CHEMBL4076993
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cc(Cl)ccc2O)coc2ccc(Br)cc12,72.1,%,=,CHEMBL4105152
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(O)c(/N=C/c2coc3ccc(Br)cc3c2=O)c1,89.5,%,=,CHEMBL4076775
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ccc(F)cc2O)coc2ccc(Br)cc12,71.5,%,=,CHEMBL4077182
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cc(F)ccc2O)coc2ccc(Br)cc12,79.1,%,=,CHEMBL4066518
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc2occ(/C=N/c3cc([N+](=O)[O-])ccc3O)c(=O)c2c1,71.2,%,=,CHEMBL4096448
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc2occ(/C=N/c3ccc(Cl)cc3O)c(=O)c2c1,48.3,%,=,CHEMBL4099570
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc2occ(/C=N/c3cc(Cl)ccc3O)c(=O)c2c1,71.9,%,=,CHEMBL4073506
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc2occ(/C=N/c3cc(F)ccc3O)c(=O)c2c1,87.3,%,=,CHEMBL4090445
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(/N=C/c2coc3ccc(C)cc3c2=O)c(O)c1,45.6,%,=,CHEMBL4062468
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(O)c(/N=C/c2coc3ccc(C)cc3c2=O)c1,75.1,%,=,CHEMBL4082612
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2cc3ccccc3cc2O)coc2ccccc12,66.5,%,=,CHEMBL4100623
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ncccc2O)coc2ccccc12,70.8,%,=,CHEMBL457577
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc2occ(/C=N/c3ncccc3O)c(=O)c2c1,63.4,%,=,CHEMBL4092886
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(/C=N/c2ncccc2O)coc2ccc(Br)cc12,69.8,%,=,CHEMBL4085234
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C#CCN[C@@H]1CCc2ccccc21,,%,,CHEMBL887
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)NNC(=O)c1ccncc1,,%,,CHEMBL92401
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,,%,,CHEMBL45
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,57.2,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,46.5,%,=,CHEMBL140
"Potency index, ratio of compound effect to curcumin effect for inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM",Ratio,Cc1ccc(O)c(/N=C/c2coc3ccc(Br)cc3c2=O)c1,1.9,,=,CHEMBL4076775
Inhibition of human amyloid beta (1 to 42) aggregation assessed as reduction in fibril formation at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,COc1cc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)ccc1O,,%,,CHEMBL487601
Inhibition of human amyloid beta (1 to 42) aggregation at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of human amyloid beta (1 to 42) aggregation assessed as loosely attached/thin fibrils at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) aggregation assessed as loosely attached/thin fibrils at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured up to 16 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC,,%,,CHEMBL76447
Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured up to 16 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1cc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)ccc1O,,%,,CHEMBL487601
Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC,,%,,CHEMBL76447
Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1cc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)ccc1O,,%,,CHEMBL487601
Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured every 10 mins up to 48 hrs by Thioflavin T based fluorescence assay,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured every 10 mins up to 48 hrs by Thioflavin T based fluorescence assay,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured every 10 mins up to 48 hrs by Thioflavin T based fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) aggregation assessed as increase in preponderance of fibril meshwork formation at 100 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC,,%,,CHEMBL76447
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 1 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,COc1cc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)ccc1O,,%,,CHEMBL487601
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 1 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC,,%,,CHEMBL76447
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 10 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 50 to 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity at 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 10 to 50 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity at 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,,%,,CHEMBL3297746
Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity at 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability incubated 15 mins prior to amyloid beta (1 to 42) addition measured after 48 hrs by MTT assay,Inhibition,O=c1cc(-c2ccc(O)c(O)c2O)oc2ccccc12,,%,,CHEMBL3115475
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1cccc2ccc(-c3cc4ccccc4[nH]3)nc12,6.1,%,=,CHEMBL4129430
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1cccc2ccc(-c3cc4cc(F)ccc4[nH]3)nc12,34.2,%,=,CHEMBL4126287
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1cccc2ccc(-c3cc4cc(Cl)ccc4[nH]3)nc12,25.1,%,=,CHEMBL4127662
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc2[nH]c(-c3ccc4cccc(O)c4n3)cc2c1,51.2,%,=,CHEMBL4129804
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2cc(-c3ccc4cccc(O)c4n3)[nH]c2cc1OC,21.5,%,=,CHEMBL4128772
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2[nH]c(-c3ccc4cccc(O)c4n3)cc2cc1O,42.3,%,=,CHEMBL4129996
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1cccc2ccc(-c3cc4ccc5c(c4[nH]3)OCO5)nc12,19.4,%,=,CHEMBL4128631
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4ccccc4[nH]3)nc12,13.6,%,=,CHEMBL4128779
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4cc(F)ccc4[nH]3)nc12,42.9,%,=,CHEMBL4127387
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4cc(Cl)ccc4[nH]3)nc12,35.9,%,=,CHEMBL4127527
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,66.8,%,=,CHEMBL4126151
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2cc(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)[nH]c2cc1OC,32.8,%,=,CHEMBL4126306
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2cc1O,50.3,%,=,CHEMBL4129594
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4cc5c(cc4[nH]3)OCO5)nc12,30.8,%,=,CHEMBL4129735
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc(-c2cc3ccccc3[nH]2)c2cccnc12,43.1,%,=,CHEMBL4128354
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc2[nH]c(-c3ccc(O)c4ncccc34)cc2c1,57.2,%,=,CHEMBL4127320
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc2[nH]c(-c3cc(Cl)c(O)c4ncccc34)cc2c1,68.7,%,=,CHEMBL4128709
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,1.9,%,=,CHEMBL497
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,19.3,%,=,CHEMBL45
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,36.7,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,42.1,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,%,,CHEMBL71
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,%,,CHEMBL389621
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,48.6,%,=,CHEMBL4126151
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4cc5c(cc4[nH]3)OCO5)nc12,48.6,%,=,CHEMBL4129735
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,49.1,%,=,CHEMBL45
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,19.6,%,=,CHEMBL76
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as less dense fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by TEM analysis,Inhibition,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,,%,,CHEMBL4126151
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as thinner fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by TEM analysis,Inhibition,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,,%,,CHEMBL4126151
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) assessed as narrow aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by TEM analysis,Activity,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,,,,CHEMBL4126151
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) assessed as shorter aggregation at compound to amyloid beta ratio of 1:1 after 48 hrs by TEM analysis,Activity,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,,,,CHEMBL4126151
Induction of disaggregation of Cu2+ -associated amyloid beta (1 to 42) (unknown origin) fibrils at compound/amyloid beta/Cu2+ ratio of 2:1:1 after 48 hrs by thioflavin T-based fluorometric assay relative to control,Activity,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,83.3,%,=,CHEMBL4126151
Induction of disaggregation of Cu2+ -associated amyloid beta (1 to 42) (unknown origin) fibrils at compound/amyloid beta/Cu2+ ratio of 2:1:1 after 48 hrs by thioflavin T-based fluorometric assay relative to control,Activity,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,24.0,%,=,CHEMBL45
Induction of disaggregation of Cu2+ -associated amyloid beta (1 to 42) (unknown origin) fibrils at compound/amyloid beta/Cu2+ ratio of 2:1:1 after 48 hrs by thioflavin T-based fluorometric assay relative to control,Activity,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,36.9,%,=,CHEMBL76
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Activity,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,48.55,%,=,CHEMBL4126151
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Activity,Oc1c(Cl)cc(Cl)c2ccc(-c3cc4cc5c(cc4[nH]3)OCO5)nc12,48.55,%,=,CHEMBL4129735
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,44.3,%,=,CHEMBL45
Induction of disaggregation of amyloid beta (1 to 42) (unknown origin) fibrils at compound to amyloid beta ratio of 1:1 after 48 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,13.0,%,=,CHEMBL76
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as reduction in unstructured aggregates at compound to amyloid beta ratio of 1:1 after 48 hrs by TEM analysis,Inhibition,Oc1ccc2[nH]c(-c3ccc4c(Cl)cc(Cl)c(O)c4n3)cc2c1,,%,,CHEMBL4126151
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs in presence of melatonin by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,22.5,%,=,CHEMBL497
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 5 uM after 48 hrs in presence of clioquinol by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,22.5,%,=,CHEMBL45
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL241190
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL4126558
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,,%,,CHEMBL4126715
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)O,,%,,CHEMBL2392127
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL2296789
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL115421
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Inhibition,O=C(CCc1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL4127090
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,5700.0,nM,=,CHEMBL241190
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,100000.0,nM,>,CHEMBL4127947
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,22700.0,nM,=,CHEMBL4126558
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,87800.0,nM,=,CHEMBL4126715
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,100000.0,nM,>,CHEMBL4129983
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,100000.0,nM,>,CHEMBL4125745
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)O,72900.0,nM,=,CHEMBL2392127
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccccc1)C(=O)O,100000.0,nM,>,CHEMBL4129190
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccccc1)C(=O)O,100000.0,nM,>,CHEMBL3276007
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL2296789
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1600.0,nM,=,CHEMBL115421
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COC(=O)[C@H](Cc1ccc(OC)c(OC)c1)NC(=O)/C=C/c1ccc(OC)c(OC)c1,100000.0,nM,>,CHEMBL4126073
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(CCc1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,8700.0,nM,=,CHEMBL4127090
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL4127947
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,,%,,CHEMBL4125745
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccccc1)C(=O)O,,%,,CHEMBL4129190
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccccc1)C(=O)O,,%,,CHEMBL3276007
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,COC(=O)[C@H](Cc1ccc(OC)c(OC)c1)NC(=O)/C=C/c1ccc(OC)c(OC)c1,,%,,CHEMBL4126073
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL241190
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL4126558
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,,%,,CHEMBL4126715
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)O,,%,,CHEMBL2392127
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL2296789
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL115421
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(CCc1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,%,,CHEMBL4127090
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 100 uM after 24 hrs by silicotungstic acid staining based transmission electron microscopic analysis,Inhibition,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,,%,,CHEMBL4129983
Displacement of [125I]IMPY from fibrillar amyloid beta 42 (unknown origin) after 3 hrs,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,138.0,nM,=,CHEMBL181529
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCN3CCN(CCCn4c5ccccc5c5cc(C(=O)OC)nc(C)c54)CC3)c2c(C)n1,,%,,CHEMBL4128308
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCN(C)CCN(C)CCCn3c4ccccc4c4cc(C(=O)OC)nc(C)c43)c2c(C)n1,,%,,CHEMBL4125697
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCCN3CCN(CCCCn4c5ccccc5c5cc(C(=O)OC)nc(C)c54)CC3)c2c(C)n1,,%,,CHEMBL4127073
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCCN(C)CCN(C)CCCCn3c4ccccc4c4cc(C(=O)OC)nc(C)c43)c2c(C)n1,65.5,%,=,CHEMBL4128861
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCN3CCN(CCCn4c5ccccc5c5cc(C(=O)OC)nc(-c6ccccc6)c54)CC3)c2c(-c2ccccc2)n1,,%,,CHEMBL4130223
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCN(C)CCN(C)CCCn3c4ccccc4c4cc(C(=O)OC)nc(-c5ccccc5)c43)c2c(-c2ccccc2)n1,25.4,%,=,CHEMBL4126133
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCCN3CCN(CCCCn4c5ccccc5c5cc(C(=O)OC)nc(-c6ccccc6)c54)CC3)c2c(-c2ccccc2)n1,,%,,CHEMBL4127514
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c3ccccc3n(CCCCN(C)CCN(C)CCCCn3c4ccccc4c4cc(C(=O)OC)nc(-c5ccccc5)c43)c2c(-c2ccccc2)n1,71.5,%,=,CHEMBL4129578
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c([nH]c3ccccc32)c(C)n1,,%,,CHEMBL1209196
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)c1cc2c([nH]c3ccccc32)c(-c2ccccc2)n1,,%,,CHEMBL273491
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,57.8,%,=,CHEMBL165
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)CN1C(=O)CN1CCN(CC(=O)N2Cc3[nH]c4ccccc4c3CC2C(=O)OC)CC1,,%,,CHEMBL4128762
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)CN1C(=O)CCN(C)CCN(C)CCC(=O)N1Cc2[nH]c3ccccc3c2CC1C(=O)OC,59.2,%,=,CHEMBL4125879
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1C(=O)CN1CCN(CC(=O)N2C(C(=O)OC)Cc3c([nH]c4ccccc34)C2C)CC1,50.8,%,=,CHEMBL4127262
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1C(=O)CN(C)CCN(C)CC(=O)N1C(C(=O)OC)Cc2c([nH]c3ccccc23)C1C,72.3,%,=,CHEMBL4128185
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1C(=O)CCN1CCN(CCC(=O)N2C(C(=O)OC)Cc3c([nH]c4ccccc34)C2C)CC1,65.6,%,=,CHEMBL4126804
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1C(=O)CCN(C)CCN(C)CCC(=O)N1C(C(=O)OC)Cc2c([nH]c3ccccc23)C1C,82.7,%,=,CHEMBL4129415
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1C(=O)CCCN1CCN(CCCC(=O)N2C(C(=O)OC)Cc3c([nH]c4ccccc34)C2C)CC1,85.7,%,=,CHEMBL4128035
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccccc2)N1C(=O)CN(C)CCN(C)CC(=O)N1C(C(=O)OC)Cc2c([nH]c3ccccc23)C1c1ccccc1,65.1,%,=,CHEMBL4125969
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccccc2)N1C(=O)CCN1CCN(CCC(=O)N2C(C(=O)OC)Cc3c([nH]c4ccccc34)C2c2ccccc2)CC1,41.9,%,=,CHEMBL4129285
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccccc2)N1C(=O)CCCN1CCN(CCCC(=O)N2C(C(=O)OC)Cc3c([nH]c4ccccc34)C2c2ccccc2)CC1,,%,,CHEMBL4127209
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)CN1,,%,,CHEMBL358326
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(C)N1,,%,,CHEMBL12327
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccccc2)N1,,%,,CHEMBL12578
Inhibition of [125I]2-(3'-Iodo-4'-N-methylaminophenyl) benzothiazole binding to amyloid beta (1 to 40) (unknown origin) after 3 hrs by NaI well counting method,Ki,Oc1ccc(-c2cc3ccccc3s2)cc1,3.04,nM,=,CHEMBL4167943
Inhibition of [125I]2-(3'-Iodo-4'-N-methylaminophenyl) benzothiazole binding to amyloid beta (1 to 40) (unknown origin) after 3 hrs by NaI well counting method,Ki,Nc1ccc(-c2cc3ccccc3s2)cc1,4.31,nM,=,CHEMBL4175800
Inhibition of [125I]2-(3'-Iodo-4'-N-methylaminophenyl) benzothiazole binding to amyloid beta (1 to 42) (unknown origin) after 3 hrs by NaI well counting method,Ki,Oc1ccc(-c2cc3ccccc3s2)cc1,3.72,nM,=,CHEMBL4167943
Inhibition of [125I]2-(3'-Iodo-4'-N-methylaminophenyl) benzothiazole binding to amyloid beta (1 to 42) (unknown origin) after 3 hrs by NaI well counting method,Ki,Nc1ccc(-c2cc3ccccc3s2)cc1,6.5,nM,=,CHEMBL4175800
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as aggregation growth rate at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 0.533 /hr),K,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,0.508,/hr,=,CHEMBL324842
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as change in fluorescence at 5.13 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 6.77 No_unit),Flu intensity,CCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,3.68,,=,CHEMBL496662
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as change in fluorescence at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 6.77 No_unit),Flu intensity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,3.4,,=,CHEMBL324842
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCNC(=O)/C=C/c1ccc(O)c(O)c1,11400.0,nM,=,CHEMBL4162671
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCc1ccc(O)c(O)c1,69000.0,nM,=,CHEMBL68132
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCCC(=O)/C=C/c1ccc(O)c(O)c1,2820.0,nM,=,CHEMBL4165903
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)OCCCCCCO,54800.0,nM,=,CHEMBL4159496
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)OCCCCCO,80100.0,nM,=,CHEMBL4167402
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,9520.0,nM,=,CHEMBL496492
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,10400.0,nM,=,CHEMBL118111
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,5130.0,nM,=,CHEMBL496662
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,2580.0,nM,=,CHEMBL2088769
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCCOC(=O)/C=C/c1ccc(O)c(O)c1,12000.0,nM,=,CHEMBL29489
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,CCCOC(=O)/C=C/c1ccc(O)c(O)c1,24700.0,nM,=,CHEMBL17362
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,C=CCOC(=O)/C=C/c1ccc(O)c(O)c1,23200.0,nM,=,CHEMBL481891
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,COc1ccc(CCOC(=O)CCc2ccccc2)cc1OC,274000.0,nM,=,CHEMBL4166279
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(CCc1ccc(O)c(O)c1)OCCc1ccc(O)c(O)c1,14900.0,nM,=,CHEMBL3357165
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(CCc1ccccc1)OCCc1ccc(O)c(O)c1,5930.0,nM,=,CHEMBL4176478
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(CCc1ccccc1)OCCc1ccccc1,4536000.0,nM,=,CHEMBL4162421
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,8410.0,nM,=,CHEMBL319244
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccc(O)c(O)c1,20600.0,nM,=,CHEMBL1088583
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,COc1ccc(CCOC(=O)/C=C/c2ccc(O)c(O)c2)cc1OC,39500.0,nM,=,CHEMBL4164790
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccccc1)OCCc1ccc(O)c(O)c1,7950.0,nM,=,CHEMBL4169299
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccccc1)OCCc1ccccc1,1040000.0,nM,=,CHEMBL493921
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,COC(=O)/C=C/c1ccc(O)c(O)c1,67700.0,nM,=,CHEMBL17001
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(O)/C=C/c1ccc(O)c(O)c1,216000.0,nM,=,CHEMBL145
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,NC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)/C=C/c1ccc(O)c(O)c1,21900.0,nM,=,CHEMBL4170161
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method,EC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,20300.0,nM,=,CHEMBL324842
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as aggregation growth rate at 5.13 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 0.533 /hr),K,CCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,0.19,/hr,=,CHEMBL496662
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time of aggregation at 20.3 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 4.44 hrs),TIME,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,5.58,hr,=,CHEMBL324842
Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time of aggregation at 5.13 uM after 24 hrs by inverted fluorescence microscopic method (Rvb = 4.44 hrs),TIME,CCCCCCOC(=O)/C=C/c1ccc(O)c(O)c1,1.1,hr,=,CHEMBL496662
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)c2cccnc2)ccc1O,17.5,%,=,CHEMBL4169514
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(/C=C/C(=O)c2cccnc2)ccc1O,18.8,%,=,CHEMBL4177374
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,91.5,%,=,CHEMBL4166095
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)c1cccnc1,21.5,%,=,CHEMBL4174015
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)c1cccnc1,5.8,%,=,CHEMBL1517429
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOC(=O)/C=C/c1ccc(O)c(OC)c1,,%,,CHEMBL286796
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,COc1cc(/C=C/C(=O)c2cccnc2)ccc1O,,,,CHEMBL4169514
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,CCOc1cc(/C=C/C(=O)c2cccnc2)ccc1O,,,,CHEMBL4177374
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,9000.0,nM,=,CHEMBL4166095
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(O)cc1)c1cccnc1,,,,CHEMBL4174015
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1cccc(O)c1)c1cccnc1,,,,CHEMBL1517429
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,CCOC(=O)/C=C/c1ccc(O)c(OC)c1,,,,CHEMBL286796
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,COc1cc(/C=C/C(=O)O)ccc1O,100000.0,nM,>,CHEMBL32749
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(O)/C=C/c1cccc(O)c1,100000.0,nM,>,CHEMBL98521
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400.0,nM,=,CHEMBL32823
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,C=CCOC(=S)/C=C/c1ccc(O)c(O)c1,12500.0,nM,=,CHEMBL4175715
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,20.0,%,=,CHEMBL4166095
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCNCc1ccccc1,26.5,%,=,CHEMBL4164524
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCCNCc1ccccc1,24.6,%,=,CHEMBL4160790
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccccc1CNCCCCCOC(=O)Nc1cc(Cl)nc(Cl)c1,,%,,CHEMBL4168710
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCNCc1c[nH]c2ccccc12,37.7,%,=,CHEMBL4164186
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(Nc1cc(Cl)nc(Cl)c1)OCCCCCNCc1ccc(Oc2ccccc2)cc1,,%,,CHEMBL4172060
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(Nc1ccncc1Br)OCCCCCNCc1ccccc1,,%,,CHEMBL4172510
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(NCCCCCCNCc1ccccc1)c1cc(Cl)nc(Cl)c1,,%,,CHEMBL4161860
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccccc1CNCCCCCCNC(=O)c1cc(Cl)nc(Cl)c1,,%,,CHEMBL4175914
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(NCCCCCCNCc1c[nH]c2ccccc12)c1cc(Cl)nc(Cl)c1,,%,,CHEMBL4165299
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(NCCCCCCNCc1ccc(Oc2ccccc2)cc1)c1cc(Cl)nc(Cl)c1,,%,,CHEMBL4174457
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(NCCCCCCNCc1ccc2ccccc2c1)c1cc(Cl)nc(Cl)c1,,%,,CHEMBL4163781
Inhibition of amyloid beta 42 (unknown origin) self aggregation at 50 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(NC(=O)c2cc(O)c(O)c(O)c2)c1,47.34,%,=,CHEMBL4169826
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNC(=O)c2cc(O)c(O)c(O)c2)c1,51.83,%,=,CHEMBL4159536
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CCNC(=O)c2cc(O)c(O)c(O)c2)c1,27.11,%,=,CHEMBL4170157
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(NC(=O)CCCCC2CCSS2)c1,46.28,%,=,CHEMBL4174650
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNC(=O)CCCCC2CCSS2)c1,51.77,%,=,CHEMBL4166749
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CCNC(=O)CCCCC2CCSS2)c1,49.84,%,=,CHEMBL4166349
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(NC(=O)c2cc(=O)c3ccccc3o2)c1,63.79,%,=,CHEMBL4176974
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNC(=O)c2cc(=O)c3ccccc3o2)c1,55.23,%,=,CHEMBL4162892
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CCNC(=O)c2cc(=O)c3ccccc3o2)c1,67.36,%,=,CHEMBL4173608
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.77,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,75.32,%,=,CHEMBL4176742
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,68.52,%,=,CHEMBL4172159
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,64.53,%,=,CHEMBL4161552
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,65.8,%,=,CHEMBL4168812
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(NC4CC4)n3)CC2)n2ncnc2n1,44.33,%,=,CHEMBL4176666
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1ccc(Nc2nc(Nc3cccc(C(F)(F)F)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,22.45,%,=,CHEMBL4165386
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,61.7,%,=,CHEMBL4173299
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,54.68,%,=,CHEMBL4161947
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,49.33,%,=,CHEMBL4169871
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,58.8,%,=,CHEMBL4167322
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,65.23,%,=,CHEMBL4175196
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,63.01,%,=,CHEMBL4170265
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,64.77,%,=,CHEMBL4162346
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,67.2,%,=,CHEMBL4166865
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1Cl,46.16,%,=,CHEMBL4177486
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,62.52,%,=,CHEMBL4163412
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,60.74,%,=,CHEMBL4174114
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorometric method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,54.32,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,10430.0,nM,=,CHEMBL4176742
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,11550.0,nM,=,CHEMBL4172159
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,15890.0,nM,=,CHEMBL4161552
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,13400.0,nM,=,CHEMBL4168812
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(NC4CC4)n3)CC2)n2ncnc2n1,,,,CHEMBL4176666
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Nc3cccc(C(F)(F)F)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,,,,CHEMBL4165386
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,16290.0,nM,=,CHEMBL4173299
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,18310.0,nM,=,CHEMBL4161947
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,25000.0,nM,=,CHEMBL4169871
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,23540.0,nM,=,CHEMBL4167322
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,17850.0,nM,=,CHEMBL4175196
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,18550.0,nM,=,CHEMBL4170265
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,20720.0,nM,=,CHEMBL4162346
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,17600.0,nM,=,CHEMBL4166865
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1Cl,,,,CHEMBL4177486
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,18050.0,nM,=,CHEMBL4163412
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,23800.0,nM,=,CHEMBL4174114
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,22510.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,,%,,CHEMBL4176742
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,,%,,CHEMBL4172159
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as increase in alpha helix conformation at 10 uM after 12 hrs by CD spectroscopic method,Activity,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,,,,CHEMBL4176742
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as increase in alpha helix conformation at 10 uM after 12 hrs by CD spectroscopic method,Activity,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,,,,CHEMBL4172159
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as decrease in beta sheet and random structure conformation at 10 uM after 12 hrs by CD spectroscopic method,Activity,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,,,,CHEMBL4176742
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as decrease in beta sheet and random structure conformation at 10 uM after 12 hrs by CD spectroscopic method,Activity,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,,,,CHEMBL4172159
Inhibition of AChE-induced amyloid beta (1 to 42 residues) (unknown origin) fibril formation at amyloid beta (1 to 42 residues)/AChE/compound ratio of 100:1:100 after 6 hrs by ThT-based fluorometric method relative to control,Inhibition,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,45.0,%,=,CHEMBL4176742
Inhibition of AChE-induced amyloid beta (1 to 42 residues) (unknown origin) fibril formation at amyloid beta (1 to 42 residues)/AChE/compound ratio of 100:1:100 after 6 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,58.0,%,=,CHEMBL4172159
Inhibition of AChE-induced amyloid beta (1 to 42 residues) (unknown origin) fibril formation at amyloid beta (1 to 42 residues)/AChE/compound ratio of 100:1:100 after 6 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,22.8,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 25 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring late apoptotic cells at 50 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 4.56%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,0.26,%,=,CHEMBL502
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring early apoptotic cells at 50 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 46%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,1.58,%,=,CHEMBL502
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring viable cells at 50 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 48.71%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,96.16,%,=,CHEMBL502
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring necrotic cells at 5 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 0.73%),Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,0.62,%,=,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring late apoptotic cells at 5 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 4.56%),Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,0.31,%,=,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring early apoptotic cells at 5 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 46%),Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,1.32,%,=,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring viable cells at 5 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 48.71%),Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,97.75,%,=,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as increase in cell viability at 50 ug/ml preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs by MTT dye based light microscopic assay (Rvb = 48%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,81.0,%,=,CHEMBL502
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as increase in cell viability at 2 to 10 ug/ml preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs by MTT dye based light microscopic assay (Rvb = 48%),Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,80.0,%,>,CHEMBL1171719
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 50 ug/ml after 96 hrs to 9 days by ThT-based fluorescence spectroscopic method,Activity,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,,,CHEMBL659
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 50 ug/ml after 96 hrs to 9 days by FTIR spectroscopy,Activity,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,,,CHEMBL659
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 50 ug/ml after 24 to 48 hrs by FTIR spectroscopy,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,%,,CHEMBL659
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 5 ug/ml after 96 hrs to 9 days by FTIR spectroscopy,Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,,,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 5 ug/ml after 24 to 48 hrs by FTIR spectroscopy,Inhibition,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,%,,CHEMBL1171719
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 5 ug/ml after 96 hrs to 9 days by phosphotungstic acid staining based transmission electron microscopy,Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,,,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 5 ug/ml after 24 to 48 hrs by phosphotungstic acid staining based transmission electron microscopy,Inhibition,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,%,,CHEMBL1171719
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 50 ug/ml after 96 hrs to 9 days by thioflavin T dye based confocal laser scanning microscopy,Activity,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,,,CHEMBL659
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 50 ug/ml after 24 to 48 hrs by thioflavin T dye based confocal laser scanning microscopy,Inhibition,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,%,,CHEMBL659
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 5 ug/ml after 96 hrs to 9 days by thioflavin T dye based confocal laser scanning microscopy,Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,,,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 5 ug/ml after 24 to 48 hrs by thioflavin T dye based confocal laser scanning microscopy,Inhibition,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,%,,CHEMBL1171719
Disaggregation of amyloid beta (25 to 35 residues) (unknown origin) preformed fibrils at 5 ug/ml after 96 hrs to 9 days by ThT-based fluorescence spectroscopic method,Activity,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,,,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 5 ug/ml after 24 to 48 hrs by ThT-based fluorescence spectroscopic method,Inhibition,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,,%,,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as protection against amyloid beta (25 to 35 residues)-induced apoptosis by measuring necrotic cells at 50 ug/ml by Annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 0.73%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,2.0,%,=,CHEMBL502
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as cell survival at 5 ug/ml after 1 to 3 weeks by clonogenic assay (Rvb = 25%),Survival,CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1,96.0,%,=,CHEMBL1171719
Inhibition of amyloid beta (25 to 35 residues) (unknown origin)-induced toxicity in rat PC12 cells assessed as cell survival at 50 ug/ml after 1 to 3 weeks by clonogenic assay (Rvb = 25%),Survival,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,96.0,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) peptide (unknown origin) self aggregation-induced cytotoxicity in E17 Sprague-Dawley rat primary cortical neurons assessed as neuroprotective activity by measuring increase in cell viability at 1 uM after 24 hrs by MTT assay,Activity,C#CCN(C)Cc1cn(-c2cc(NC(=S)NCC)ncn2)cn1,,,,CHEMBL4162742
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated at 37 degC for 24 hrs by dot immunoblot assay,Inhibition,C#CCN(C)Cc1cn(-c2cc(NC(=S)NCC)ncn2)cn1,,%,,CHEMBL4162742
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,65.9,%,=,CHEMBL4174025
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,67.3,%,=,CHEMBL4163312
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,90.1,%,=,CHEMBL4176630
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,82.5,%,=,CHEMBL4168769
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,85.6,%,=,CHEMBL4173262
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.6,%,=,CHEMBL95
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,53.1,%,=,CHEMBL140
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by uranyl acetate staining based TEM analysis,Inhibition,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)NCCCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc(OC)c3c1OCO3)OCO2,,%,,CHEMBL4168769
Inhibition of human self-induced amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by uranyl acetate staining based TEM analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of STZ induced beta amyloid clearance in human SH-SY5Y cells by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)NC12CC3CC(C)(CC(C)(C3)C1)C2)S(=O)(=O)c1ccccc1,,%,,CHEMBL4163046
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,COc1ccc(C)cc1N(CC(=O)Nc1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1,,%,,CHEMBL4168596
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)Nc1cccc2c3ccccc3n(C)c12)S(=O)(=O)c1ccccc1,,%,,CHEMBL4161356
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,CCn1c2ccccc2c2cc(NC(=O)CN(c3cc(Cl)ccc3OC)S(=O)(=O)c3ccccc3)ccc21,,%,,CHEMBL4167305
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)Nc1ccc(C(F)(F)F)cc1)S(=O)(=O)c1ccccc1,,%,,CHEMBL4161543
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)NC12CC3CC(C)(CC(C)(C3)C1)C2)S(=O)(=O)c1ccccc1,,%,,CHEMBL4163046
Inhibition of STZ induced beta amyloid (unknown origin) deposition in HEK293 cells harboring APPSW mutant at 20 uM by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)N1CCCCC1)S(=O)(=O)c1ccccc1,,%,,CHEMBL4170295
Inhibition of STZ induced beta amyloid clearance in human SH-SY5Y cells by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)Nc1ccc(C(F)(F)F)cc1)S(=O)(=O)c1ccccc1,,%,,CHEMBL4161543
Inhibition of STZ induced beta amyloid clearance in human SH-SY5Y cells by ELISA,Inhibition,CCn1c2ccccc2c2cc(NC(=O)CN(c3cc(Cl)ccc3OC)S(=O)(=O)c3ccccc3)ccc21,,%,,CHEMBL4167305
Inhibition of STZ induced beta amyloid clearance in human SH-SY5Y cells by ELISA,Inhibition,COc1ccc(Cl)cc1N(CC(=O)Nc1cccc2c3ccccc3n(C)c12)S(=O)(=O)c1ccccc1,,%,,CHEMBL4161356
Inhibition of STZ induced beta amyloid clearance in human SH-SY5Y cells by ELISA,Inhibition,COc1ccc(C)cc1N(CC(=O)Nc1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1,,%,,CHEMBL4168596
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cl.O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(Cl)c(Cl)c1,19.41,%,=,CHEMBL4159080
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cl.O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(Cl)c(Cl)c1,26.64,%,=,CHEMBL4159080
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cl.O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(Cl)c(Cl)c1,31.11,%,=,CHEMBL4159080
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cl.O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1cnc(Cl)c(Cl)c1,46.63,%,=,CHEMBL4159080
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N(CCO)CCO)ccc12,16.12,%,=,CHEMBL4171310
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCC(O)CC3)ccc12,17.83,%,=,CHEMBL4171733
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCOCC3)ccc12,20.02,%,=,CHEMBL4161124
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCCCC3)ccc12,37.88,%,=,CHEMBL4175175
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCCC3)ccc12,33.22,%,=,CHEMBL4164540
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CC)C(=S)SCCOc1ccc2c(C)cc(=O)oc2c1,29.08,%,=,CHEMBL4177242
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N(C)C)ccc12,24.55,%,=,CHEMBL4169394
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCN(C)CC3)ccc12,34.02,%,=,CHEMBL4163415
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCN(C(C)C)CC3)ccc12,35.44,%,=,CHEMBL4167973
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCN(C4CC4)CC3)ccc12,34.07,%,=,CHEMBL4160050
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCC(N4CCCCC4)CC3)ccc12,43.53,%,=,CHEMBL4159640
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCSC(=S)N3CCN(c4ncccn4)CC3)ccc12,27.39,%,=,CHEMBL4170269
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCSC(=S)N3CCCCC3)ccc12,37.03,%,=,CHEMBL4159609
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCCSC(=S)N3CCCCC3)ccc12,40.19,%,=,CHEMBL4167524
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCCCSC(=S)N3CCCCC3)ccc12,40.03,%,=,CHEMBL4174729
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCCCCSC(=S)N3CCCCC3)ccc12,33.86,%,=,CHEMBL4164078
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCCCCCCSC(=S)N3CCCCC3)ccc12,10.02,%,=,CHEMBL4166425
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,39.62,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 46 to 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(C)nn1,8.34,%,=,CHEMBL4177201
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCn1cc(CNC(=O)[C@@H](C)CC[C@H]2O[C@H]3C[C@H]4[C@@H]5CC[C@@H]6C[C@@H](OCc7ccccc7)CC[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)nn1,11.81,%,=,CHEMBL4172751
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCCn1cc(CNC(=O)[C@@H](C)CC[C@H]2O[C@H]3C[C@H]4[C@@H]5CC[C@@H]6C[C@@H](OCc7ccccc7)CC[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)nn1,21.77,%,=,CHEMBL4162074
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)n1cc(CNC(=O)[C@@H](C)CC[C@H]2O[C@H]3C[C@H]4[C@@H]5CC[C@@H]6C[C@@H](OCc7ccccc7)CC[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)nn1,52.63,%,=,CHEMBL4176127
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccccc2)nn1,64.21,%,=,CHEMBL4165516
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccc(F)cc2)nn1,37.52,%,=,CHEMBL4161009
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccc(Cl)cc2)nn1,70.49,%,=,CHEMBL4168936
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccc(Br)cc2)nn1,55.82,%,=,CHEMBL4174243
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,71.25,%,=,CHEMBL4163547
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,84.74,%,=,CHEMBL4176559
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)c1,64.77,%,=,CHEMBL4168700
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc(OC)c1,31.54,%,=,CHEMBL4169867
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccc([N+](=O)[O-])cc2)nn1,70.71,%,=,CHEMBL4165290
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2ccncc2)nn1,20.84,%,=,CHEMBL4169768
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,75.06,%,=,CHEMBL4161849
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,16.44,%,=,CHEMBL1171146
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,55.87,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,5840.0,nM,=,CHEMBL4176559
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,8280.0,nM,=,CHEMBL4161849
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,100000.0,nM,>,CHEMBL1171146
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,14990.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,,,CHEMBL153
"Potency index, ratio of IC50 for curcumin to IC50 for test compound for inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay",Ratio IC50,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,2.6,,=,CHEMBL4176559
"Potency index, ratio of IC50 for curcumin to IC50 for test compound for inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay",Ratio IC50,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,1.8,,=,CHEMBL4161849
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCCn3cc(CNC(=O)CCCCC4CCSS4)nn3)ccc12,26.6,%,=,CHEMBL4171465
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(-c2cc3ccc(OCCCn4cc(CNC(=O)CCCCC5CCSS5)nn4)cc3oc2=O)cc1OC,51.2,%,=,CHEMBL4161244
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,27.5,%,=,CHEMBL374478
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,22.0,%,=,CHEMBL502
"Potency index, ratio of compound effect to rifampicin effect for inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM",Ratio,COc1ccc(-c2cc3ccc(OCCCn4cc(CNC(=O)CCCCC5CCSS5)nn4)cc3oc2=O)cc1OC,2.0,,=,CHEMBL4161244
"Potency index, ratio of compound effect to donepezil effect for inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM",Ratio,COc1ccc(-c2cc3ccc(OCCCn4cc(CNC(=O)CCCCC5CCSS5)nn4)cc3oc2=O)cc1OC,2.0,,=,CHEMBL4161244
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N1CC[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)C1)C(C)C,,,,CHEMBL4161195
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N1CC[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)C1)C(C)C,,,,CHEMBL4161195
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N1CC[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)C1)C(C)C,97.0,%,=,CHEMBL4161195
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N1CC[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)C1)C(C)C,90.0,%,=,CHEMBL4161195
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,76.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in water measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,96.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,36.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,66.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in water measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,81.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,38.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 1 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,,,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 1 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,38.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,30.0,%,=,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in water measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,58.0,%,=,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,,,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 1 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,,,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,32.0,%,=,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in water measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,35.0,%,=,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,,,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 1 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,,,CHEMBL4176310
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(N)cc1.Cl.Cl.Cl,56.0,%,=,CHEMBL4167204
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(N)cc1.Cl.Cl.Cl,27.0,%,=,CHEMBL4167204
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(N)cc1.Cl.Cl.Cl,54.0,%,=,CHEMBL4167204
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(N)cc1.Cl.Cl.Cl,,,,CHEMBL4167204
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NC(=O)OC(C)(C)C,29.0,%,=,CHEMBL4159292
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NC(=O)OC(C)(C)C,13.0,%,=,CHEMBL4159292
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NC(=O)OC(C)(C)C,43.0,%,=,CHEMBL4159292
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NC(=O)OC(C)(C)C,,,,CHEMBL4159292
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1N.Cl.Cl.Cl.Cl,,,,CHEMBL4163429
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1N.Cl.Cl.Cl.Cl,,,,CHEMBL4163429
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1N.Cl.Cl.Cl.Cl,18.0,%,=,CHEMBL4163429
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1N.Cl.Cl.Cl.Cl,,,,CHEMBL4163429
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4171327
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4171327
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4171327
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4171327
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,59.0,%,=,CHEMBL4166884
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,23.0,%,=,CHEMBL4166884
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4166884
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,CC(=O)O.COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4166884
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COC(=O)[C@@H]1CCCN1[C@@H]1CNCC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4174784
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as increase in time of half-life of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COC(=O)[C@@H]1CCCN1[C@@H]1CNCC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4174784
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 100 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COC(=O)[C@@H]1CCCN1[C@@H]1CNCC[C@H]1NS(=O)(=O)c1ccc(C)cc1,23.0,%,=,CHEMBL4174784
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in intensity of fluorescence plateau of aggregation at 10 uM using compound dissolved in DMSO measured after 42 hrs by Thioflavin T fluorescence assay relative to control,Activity,COC(=O)[C@@H]1CCCN1[C@@H]1CNCC[C@H]1NS(=O)(=O)c1ccc(C)cc1,,,,CHEMBL4174784
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 1 to 100 uM treated immediately or 3 hrs after fibrillization kinetics by Thioflavin T fluorescence assay,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,%,,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 1 to 100 uM treated at 19 to 44 hrs after fibrillization kinetics by Thioflavin T fluorescence assay,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,%,,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 42 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,%,,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as amyloid beta monomer level at 100 uM after 6 hrs by capillary electrophoresis method (Rvb = 4%),Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,49.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as amyloid beta monomer level at 100 uM after 12 hrs by capillary electrophoresis method (Rvb = 0%),Activity,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,31.0,%,=,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomerization assessed as increase in amyloid beta monomer level at 100 uM up to 2 hrs by capillary electrophoresis method,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(C)cc1.Cl.Cl.Cl,,%,,CHEMBL4165697
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 42 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,COc1ccc(NC(C)=O)cc1C(=O)NNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1[C@@H]1CN(C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CC[C@H]1NS(=O)(=O)c1ccc(N)cc1.Cl.Cl.Cl,,%,,CHEMBL4167204
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(C[n+]2cccc(Cn3c4c(c5ccccc53)CCCC4)c2)cc1.[Cl-],55.7,%,=,CHEMBL4159171
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,16.4,%,=,CHEMBL502
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,7.7,%,=,CHEMBL95
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 10 uM measured every 5 mins by Thioflavin T dye based fluorescence assay relative to control,Inhibition,CN(C)C(=O)Oc1cccc2c1cc(C(=O)NCCOCCOCCN1C(=O)c3ccccc3C1=O)c[n+]2C.O=S(=O)([O-])C(F)(F)F,14.0,%,=,CHEMBL4168520
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cccc(C2NC(=S)Nc3nc4c(c(N)c32)CCCC4)c1,10.0,%,=,CHEMBL4171520
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,Nc1c2c(nc3c1C(c1ccc(Cl)cc1)NC(=S)N3)CCCC2,10.0,%,=,CHEMBL4167753
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,Nc1c2c(nc3c1C(c1cccc(Br)c1)NC(=S)N3)CCCC2,10.0,%,=,CHEMBL4174958
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,272.32,,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,164.75,,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,246.69,,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,272.94,,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,310.48,,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,312.87,,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 3 by thioflavin-T based assay (Rvb = 251.22 +/- 0.35 No_unit),Flu intensity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,343.93,,=,CHEMBL4168528
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,108.4,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,65.58,%,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,98.2,%,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,108.65,%,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,123.59,%,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,124.54,%,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 3 by UV-visible turbidity method (Rvb = 100 +/- 0.14%),Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,136.91,%,=,CHEMBL4168528
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,294.41,,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,224.89,,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,355.78,,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,336.47,,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,367.88,,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,706.94,,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 7 by thioflavin-T based assay (Rvb = 391.27 +/- 8.68 No_unit),Flu intensity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,458.5,,=,CHEMBL4168528
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,75.24,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,57.47,%,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,90.93,%,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,85.99,%,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,94.02,%,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,180.68,%,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 7 by UV-visible turbidity method (Rvb = 100 +/- 2.22%),Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,117.18,%,=,CHEMBL4168528
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,250.97,,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,282.3,,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,367.11,,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,298.32,,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,344.21,,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,767.34,,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as fluorescence emission at 100 uM measured on day 10 by thioflavin-T based assay (Rvb = 408.94 +/- 32 No_unit),Flu intensity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,285.52,,=,CHEMBL4168528
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.37,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,69.03,%,=,CHEMBL4166192
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,89.77,%,=,CHEMBL4166588
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,72.95,%,=,CHEMBL4174503
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,84.17,%,=,CHEMBL4170012
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,187.64,%,=,CHEMBL4159379
Inhibition of self-induced amyloid beta (1 to 40) (unknown origin) fibril aggregation assessed as aggregation level at 100 uM measured on day 10 by UV-visible turbidity method (Rvb = 100 +/- 7.83%),Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,94.27,%,=,CHEMBL4168528
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,229.97,,=,CHEMBL165
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,184.31,,=,CHEMBL4166192
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,246.01,,=,CHEMBL4166588
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,212.55,,=,CHEMBL4174503
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,225.66,,=,CHEMBL4170012
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,289.13,,=,CHEMBL4159379
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 4 days by thioflavin-T based assay (Rvb = 322.95 +/- 17.69 No_unit),Flu intensity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,261.7,,=,CHEMBL4168528
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,90.07,%,=,CHEMBL165
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,72.19,%,=,CHEMBL4166192
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,96.35,%,=,CHEMBL4166588
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,83.25,%,=,CHEMBL4174503
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,88.38,%,=,CHEMBL4170012
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,113.24,%,=,CHEMBL4159379
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 4 days by UV-visible turbidity method (Rvb = 126.49 +/- 6.93%),Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,102.5,%,=,CHEMBL4168528
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,113.6,,=,CHEMBL165
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,159.74,,=,CHEMBL4166192
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,225.75,,=,CHEMBL4166588
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,183.29,,=,CHEMBL4174503
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,219.26,,=,CHEMBL4170012
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,224.06,,=,CHEMBL4159379
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as fluorescence emission at 100 uM after 12 days by thioflavin-T based assay (Rvb = 375.63 +/- 8.38 No_unit),Flu intensity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,229.82,,=,CHEMBL4168528
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,44.49,%,=,CHEMBL165
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,62.57,%,=,CHEMBL4166192
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,88.42,%,=,CHEMBL4166588
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,71.79,%,=,CHEMBL4174503
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,85.88,%,=,CHEMBL4170012
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,O=C(NCCNc1ccnc2cc(Cl)ccc12)c1cnccn1,87.76,%,=,CHEMBL4159379
Disaggregation of self-induced amyloid beta (1 to 40) (unknown origin) preformed fibrils assessed as aggregation level at 100 uM after 12 days by UV-visible turbidity method (Rvb = 147.12 +/- 3.28%),Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,90.01,%,=,CHEMBL4168528
Induction of amyloid beta (1 to 40) (unknown origin) amorphous aggregation at 100 uM after 10 days,Activity,Cl.Oc1ccc(/C=N/CCNCCn2cnc3ccccc32)c(O)c1,6.0,%,=,CHEMBL4166192
Induction of amyloid beta (1 to 40) (unknown origin) amorphous aggregation at 100 uM after 10 days,Activity,Cl.Nc1ncnc2c1ncn2CCNCC/N=C/c1ccc(O)cc1O,6.0,%,=,CHEMBL4166588
Induction of amyloid beta (1 to 40) (unknown origin) amorphous aggregation at 100 uM after 10 days,Activity,Oc1ccc(/C=N/CCn2ccc3ccccc32)c(O)c1,6.0,%,=,CHEMBL4174503
Induction of amyloid beta (1 to 40) (unknown origin) amorphous aggregation at 100 uM after 10 days,Activity,Oc1ccc(/C=N/CCn2ccc3cccnc32)c(O)c1,6.0,%,=,CHEMBL4170012
Induction of amyloid beta (1 to 40) (unknown origin) amorphous aggregation at 100 uM after 10 days,Activity,Oc1ccccc1/C=N/CCNc1ccnc2cc(Cl)ccc12,6.0,%,=,CHEMBL4168528
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccccc1/C=N/c1ccc(OCc2ccccc2)cc1,63.3,%,=,CHEMBL4214391
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1cccc(/C=N/c2ccc(OCc3ccccc3)cc2)c1O,72.5,%,=,CHEMBL4214938
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=N/c2ccc(OCc3ccccc3)cc2)c(O)c1,59.8,%,=,CHEMBL4207498
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(O)c(/C=N/c2ccc(OCc3ccccc3)cc2)c1,49.2,%,=,CHEMBL4202755
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=N/c2ccc(OCc3ccccc3)cc2)c(O)c1O,91.3,%,=,CHEMBL4207619
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1cc(O)c(/C=N/c2ccc(OCc3ccccc3)cc2)c(O)c1,88.5,%,=,CHEMBL4207105
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cc1cccc(/C=N/c2ccc(OCc3ccccc3)cc2)c1O,53.7,%,=,CHEMBL4211982
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cc1ccc(/C=N/c2ccc(OCc3ccccc3)cc2)c(O)c1,60.1,%,=,CHEMBL4209609
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cc1ccc(O)c(/C=N/c2ccc(OCc3ccccc3)cc2)c1,61.9,%,=,CHEMBL4214517
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1cccc(/C=N/c2ccc(OCc3ccccc3)cc2)c1O,53.4,%,=,CHEMBL4210018
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(/C=N/c2ccc(OCc3ccccc3)cc2)c(O)c1,69.5,%,=,CHEMBL4212598
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(O)c(/C=N/c2ccc(OCc3ccccc3)cc2)c1,56.6,%,=,CHEMBL4211040
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(F)cc1/C=N/c1ccc(OCc2ccccc2)cc1,84.4,%,=,CHEMBL4217025
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(Cl)cc1/C=N/c1ccc(OCc2ccccc2)cc1,59.6,%,=,CHEMBL4208742
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(Br)cc1/C=N/c1ccc(OCc2ccccc2)cc1,54.3,%,=,CHEMBL4203861
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1c(Br)cc(Br)cc1/C=N/c1ccc(OCc2ccccc2)cc1,66.7,%,=,CHEMBL4217065
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1ccc(O)c(/C=N/c2ccc(OCc3ccccc3)cc2)c1,70.2,%,=,CHEMBL4208220
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc2ccccc2c1/C=N/c1ccc(OCc2ccccc2)cc1,73.1,%,=,CHEMBL4204543
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,C#CCN(C)Cc1ccccc1,,%,,CHEMBL673
Inhibition of self-induced aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 25 uM incubated for 48 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,65.1,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,65.6,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(O)c(C[C@H](O)Cc2ccc(O)c(OC)c2)c(OC)c1,,%,,CHEMBL4205369
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(O)cc2oc(-c3ccc(O)cc3)cc(=O)c12,,%,,CHEMBL182265
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(-c2cc(=O)c3c(OC)cc(O)cc3o2)ccc1O,,%,,CHEMBL4213477
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,COc1cc(OC)c2c(c1)O[C@H](c1cc(O)c(O)c(OC)c1)[C@@H](O)C2,,%,,CHEMBL4209997
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C(Oc1cc(O)c2c(c1)O[C@@H](c1cc(O)c(O)c(O)c1)CC2)c1cc(O)c(O)c(O)c1,,%,,CHEMBL4215293
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C(Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@@H](O)C2)c1cc(O)c(O)c(O)c1,,%,,CHEMBL4216621
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C(Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2)c1cc(O)c(O)c(O)c1,,%,,CHEMBL4218102
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C1c2ccc(O)c(O)c2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,87.7,%,=,CHEMBL4216216
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,86.1,%,=,CHEMBL297453
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,Oc1cc([C@@H]2CCc3c(O)cccc3O2)cc(O)c1O,59.6,%,=,CHEMBL4216228
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=C(Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c(O)c1)[C@@H](O)C2)c1cc(O)c(O)c(O)c1,56.3,%,=,CHEMBL4216177
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,88.4,%,=,CHEMBL50
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,86.5,%,=,CHEMBL151
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,C[C@@H]1O[C@@H](Oc2c(-c3cc(O)c(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,62.2,%,=,CHEMBL522983
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,C[C@H]1O[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@@H](O)[C@@H]1O,70.7,%,=,CHEMBL2262641
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control,Inhibition,C[C@@H]1Oc2cccc(O)c2C(=O)[C@@H]1O,,%,,CHEMBL4207335
Inhibition of self-mediated aggregation of amyloid beta (1 to 42 residues) (unknown origin) at 10 uM by Thioflavin T based assay relative to control,Inhibition,COc1cc(/C=C/C(=O)Nc2ccc(-c3ccc(NC(=O)/C=C/c4ccc(O)c(OC)c4)cc3)cc2)ccc1O,83.7,%,=,CHEMBL4218403
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3cccs3)c2)c(F)c1,16.6,%,=,CHEMBL4204790
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(C)cc3)c2)c(F)c1,23.6,%,=,CHEMBL4216891
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccccc3OC)c2)c(F)c1,25.1,%,=,CHEMBL4207163
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(OC)cc3)c2)c(F)c1,32.9,%,=,CHEMBL4214580
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccccc3O)c2)c(F)c1,23.1,%,=,CHEMBL4209667
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(O)cc3)c2)c(F)c1,18.7,%,=,CHEMBL4218980
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(OC)cc3OC)c2)c(F)c1,18.8,%,=,CHEMBL4214057
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3cccc(OC)c3O)c2)c(F)c1,29.0,%,=,CHEMBL4206726
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3cc(OC)ccc3O)c2)c(F)c1,38.1,%,=,CHEMBL4215639
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(OC)c(O)c3)c2)c(F)c1,31.0,%,=,CHEMBL4218016
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(N(C)C)cc3)c2)c(F)c1,60.0,%,=,CHEMBL4205278
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccccc3N(C)C)c2)c(F)c1,36.8,%,=,CHEMBL4214570
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,CCN(CC)c1ccc(/C=C/C(=O)c2cc(-c3ccc(C(C)C(=O)OC)cc3F)ccc2O)cc1,78.2,%,=,CHEMBL4209656
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(N4CCCCC4)cc3)c2)c(F)c1,31.5,%,=,CHEMBL4213098
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(N4CCOCC4)cc3)c2)c(F)c1,51.3,%,=,CHEMBL4213106
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccc(OC)c(OC)c3)c2)c(F)c1,14.2,%,=,CHEMBL4209642
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3cccnc3)c2)c(F)c1,8.3,%,=,CHEMBL4214556
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(C(=O)/C=C/c3ccncc3)c2)c(F)c1,18.2,%,=,CHEMBL4205262
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,12.3,%,=,CHEMBL563
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,40.6,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,C#CCN(C)CCCOc1ccc(Cl)cc1Cl,,%,,CHEMBL8706
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,C#CCN[C@@H]1CCc2ccccc21,,%,,CHEMBL887
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,CC(C)NNC(=O)c1ccncc1,,%,,CHEMBL92401
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,47.7,%,=,CHEMBL140
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1ccccc1,30.6,%,=,CHEMBL4211297
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1ccc(C)cc1,50.0,%,=,CHEMBL4216262
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1ccc(C(C)C)cc1,30.6,%,=,CHEMBL4206927
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1ccc(OC)cc1,49.1,%,=,CHEMBL4211814
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(OC)c1,38.2,%,=,CHEMBL4202569
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1cccc(F)c1,30.6,%,=,CHEMBL4207453
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(CCCCOc1ccc2ccc(=O)oc2c1)Cc1ccc(F)c(F)c1,30.6,%,=,CHEMBL4214760
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(C)CCOc1ccc2ccc(=O)oc2c1,36.4,%,=,CHEMBL4203107
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(C)CCCOc1ccc2ccc(=O)oc2c1,59.3,%,=,CHEMBL4210358
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,C#CCN(C)CCCCOc1ccc2ccc(=O)oc2c1,54.0,%,=,CHEMBL4215298
Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.3,%,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,c1ccc2c(NCCCCC[Se][Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,65.8,%,=,CHEMBL4204315
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,c1ccc2c(NCCCCCSSCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,61.8,%,=,CHEMBL4208641
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,c1ccc2c(NCCCCC[Se]CCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,48.1,%,=,CHEMBL4213042
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM relative to control,Inhibition,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,71.1,%,=,CHEMBL32823
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM relative to control,Inhibition,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,66.3,%,=,CHEMBL3235503
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4)cc3)ccc12.[Br-],39.3,%,=,CHEMBL4217466
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4F)cc3)ccc12.[Br-],53.7,%,=,CHEMBL4205764
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc(F)c4)cc3)ccc12.[Br-],50.8,%,=,CHEMBL4206041
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc(F)cc4)cc3)ccc12.[Br-],49.1,%,=,CHEMBL4217755
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1ccccc1C[n+]1ccc(COc2ccc3c(C)cc(=O)oc3c2)cc1.[Br-],55.2,%,=,CHEMBL4210401
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cccc(C[n+]2ccc(COc3ccc4c(C)cc(=O)oc4c3)cc2)c1.[Br-],62.1,%,=,CHEMBL4205520
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1ccc(C[n+]2ccc(COc3ccc4c(C)cc(=O)oc4c3)cc2)cc1.[Br-],58.5,%,=,CHEMBL4213874
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccccc4Br)cc3)ccc12.[Br-],63.7,%,=,CHEMBL4208961
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc(Br)c4)cc3)ccc12.[Br-],62.7,%,=,CHEMBL4218281
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc(Br)cc4)cc3)ccc12.[Br-],67.6,%,=,CHEMBL4213345
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4cccc([N+](=O)[O-])c4)cc3)ccc12.[Br-],42.8,%,=,CHEMBL4205110
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,Cc1cc(=O)oc2cc(OCc3cc[n+](Cc4ccc([N+](=O)[O-])cc4)cc3)ccc12.[Br-],37.7,%,=,CHEMBL4216807
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,65.2,%,=,CHEMBL140
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)c2ccccc2)cc1,35.2,%,=,CHEMBL4204899
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)c2ccccc2)cc1,37.1,%,=,CHEMBL4207272
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccccc2)cc1,33.5,%,=,CHEMBL4218997
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccccc2)cc1,38.1,%,=,CHEMBL4215728
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)CCc2ccccc2)cc1,35.2,%,=,CHEMBL4204053
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)CCc2ccccc2)cc1,36.1,%,=,CHEMBL4203519
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)cc2)cc1,38.5,%,=,CHEMBL4208392
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)cc2)cc1,42.1,%,=,CHEMBL4207876
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)c(O)c2)cc1,40.5,%,=,CHEMBL4214951
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(O)c(O)c2)cc1,42.1,%,=,CHEMBL4212229
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CC(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1O,42.5,%,=,CHEMBL4217212
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(OC)c(O)c2)cc1,43.5,%,=,CHEMBL4214755
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(CC(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,38.5,%,=,CHEMBL4203538
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1ccc(NC(=O)Cc2ccc(OC)c(OC)c2)cc1,40.6,%,=,CHEMBL4203653
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccccc2)cc1,56.8,%,=,CHEMBL4215324
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccc(O)cc2)cc1,56.6,%,=,CHEMBL3970226
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1,57.8,%,=,CHEMBL3978533
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccc(Cl)cc2)cc1,58.6,%,=,CHEMBL4212579
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])cc2)cc1,52.8,%,=,CHEMBL4207482
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)Cc1ccc(NC(=O)/C=C/c2ccc(O)c(O)c2)cc1,56.2,%,=,CHEMBL4216806
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)ccc1O,56.8,%,=,CHEMBL3891025
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)Nc2ccc(CN(C)Cc3ccccc3)cc2)cc1OC,56.6,%,=,CHEMBL3917990
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2cc(-c3ccc(CN(C)Cc4ccccc4)cc3)c(=O)oc2cc1OC,,%,,CHEMBL75121
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,,%,,CHEMBL32749
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,48.2,%,=,CHEMBL165
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,42.5,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self -induced aggregation at 10 uM after 48 hrs by ThT-based fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,15.4,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self -induced aggregation at 10 uM after 48 hrs by ThT-based fluorescence method relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self -induced aggregation at 10 uM after 48 hrs by ThT-based fluorescence method relative to control,Inhibition,COc1ccccc1C1c2c(nc3c(c2N)CCCC3)-n2c(=O)c3ccccc3c(=O)n21,25.5,%,=,CHEMBL4218303
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,6.46,%,=,CHEMBL4209420
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,7.38,%,=,CHEMBL4213147
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,10.5,%,=,CHEMBL4208322
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,22.9,%,=,CHEMBL4217746
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,17.6,%,=,CHEMBL4203988
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,22.1,%,=,CHEMBL4208869
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,26.0,%,=,CHEMBL4217139
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CCCCCCCCCCCCCCCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,39.6,%,=,CHEMBL4205426
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,C=CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,37.9,%,=,CHEMBL4212713
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,C=CCCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,42.2,%,=,CHEMBL4217666
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,CC(C)=CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,31.0,%,=,CHEMBL4207386
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,C#CCNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,52.3,%,=,CHEMBL4212275
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(CNCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,30.5,%,=,CHEMBL4214932
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(CNCCCc1ccccc1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,43.3,%,=,CHEMBL4210020
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,Cc1ccccc1CNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,25.0,%,=,CHEMBL4210517
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(CNCc1ccccc1F)Nc1ccc2nc3n(c(=O)c2c1)CCC3,43.5,%,=,CHEMBL4205651
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(CNCc1cc(F)cc(F)c1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,63.9,%,=,CHEMBL4207101
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(CNCc1ccccc1[N+](=O)[O-])Nc1ccc2nc3n(c(=O)c2c1)CCC3,29.9,%,=,CHEMBL4218829
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,N#Cc1ccccc1CNCC(=O)Nc1ccc2nc3n(c(=O)c2c1)CCC3,40.2,%,=,CHEMBL4202749
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,4.03,%,=,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,O=c1c2ccccc2nc2n1CCC2,2.53,%,=,CHEMBL456881
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM incubated for 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.9,%,=,CHEMBL140
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,43600.0,nM,=,CHEMBL4217978
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,85500.0,nM,=,CHEMBL4207221
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%),Inhibition,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,16.0,%,=,CHEMBL9509
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,73.0,%,=,CHEMBL4217978
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,52.7,%,=,CHEMBL4207221
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)OC(c2ccc(O)c(OC)c2)C(CO)O4)[C@@H](O)C3=O)ccc1O,54.4,%,=,CHEMBL4218169
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%),Inhibition,COc1cc(C2Oc3cc([C@H]4Oc5cc(OC(=O)/C=C/c6ccccc6)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,61.1,%,=,CHEMBL4205406
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%),Inhibition,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,4.8,%,=,CHEMBL9509
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,14.2,%,=,CHEMBL4217978
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,13.2,%,=,CHEMBL4207221
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%),Inhibition,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)OC(c2ccc(O)c(OC)c2)C(CO)O4)[C@@H](O)C3=O)ccc1O,16.8,%,=,CHEMBL4218169
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%),Inhibition,COc1cc(C2Oc3cc([C@H]4Oc5cc(OC(=O)/C=C/c6ccccc6)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,17.1,%,=,CHEMBL4205406
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 0.1 mM measured after 4 days by atomic force microscopic method,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OCc1nc(C)c(C)nc1C,,%,,CHEMBL4209795
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation up to 100 uM measured after 24 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OCc1nc(C)c(C)nc1C,,%,,CHEMBL4209795
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 0.1 mM measured after 4 days by atomic force microscopic method,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1O,,%,,CHEMBL4216066
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1O,,%,,CHEMBL4216066
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1O,48.0,%,=,CHEMBL4216066
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)NCCCCCCNc2c3c(nc4ccccc24)CCCC3)cc(OC)c1O,47.0,%,=,CHEMBL4216066
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 0.1 mM measured after 4 days by atomic force microscopic method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 40 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,21.9,%,=,CHEMBL4218085
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,20.0,%,=,CHEMBL95
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCC(O)CNc1c2c(nc3ccccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,70.9,%,=,CHEMBL4210268
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,56.8,%,=,CHEMBL4207096
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,50.8,%,=,CHEMBL4214328
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,39.4,%,=,CHEMBL4218085
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,57.4,%,=,CHEMBL4214695
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,74.6,%,=,CHEMBL4211149
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 80 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,O=C(NCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,40.6,%,=,CHEMBL4206668
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 24 hrs by uranyl acetate staining based TEM analysis,Inhibition,O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1ccc2[nH]c(-c3ccccc3O)nc2c1,,%,,CHEMBL4211149
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,%,,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 0.25 to 50 uM after 48 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,%,,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM by Thioflavin-T fluorescence assay,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,%,,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM by Thioflavin-T fluorescence assay,Inhibition,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,,%,,CHEMBL4068121
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM in presence of reductant TCEP by Thioflavin-T fluorescence assay,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,%,,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,50.0,%,>,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 5 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,50.0,%,>,CHEMBL4068121
Binding affinity to HFIP pretreated 15-N labeled amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation in His14/Arg5/Gln15/Lys16/Leu17/Phe19 region at 335 uM after 1 hr 1H-15N SOFAST-HMQC NMR analysis,Activity,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,,,CHEMBL53
Binding affinity to HFIP pretreated 15-N labeled amyloid beta (1 to 42) (unknown origin) assessed as chemical shift perturbation in Arg5/His14/Gln15 region at 335 uM after 1 hr 1H-15N SOFAST-HMQC NMR analysis,Activity,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,,,,CHEMBL4068121
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as retention time for amyloid beta (1 to 42) (Lys16)-compound adduct at 250 uM after 1 hr by LC/Q Tof-MS analysis,Retention_time,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,6.4,min,=,CHEMBL53
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as retention time for amyloid beta (1 to 42) (Lys28)-compound adduct at 250 uM after 1 hr by LC/Q Tof-MS analysis,Retention_time,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,6.9,min,=,CHEMBL53
"Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as retention time for amyloid beta (1 to 42) - 6-methyl-5,6-dihydro-4H-dibenzo[de,g]quinoline-10,11-dione adduct at 250 uM after 1 hr by LC/Q Tof-MS analysis",Activity,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,,,CHEMBL53
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as retention time for amyloid beta (1 to 42)-compound adduct formation at 250 uM after 1 hr by LC/Q Tof-MS analysis,Activity,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,,,,CHEMBL4068121
Binding affinity to amyloid beta (9 to 35) E22P M35ox mutant (unknown origin) oxidized at M35 residue assessed as E22P M35ox(Lys16/Lys28)-compound adduct formation at 250 uM after 1 hr by LC/Q Tof-MS analysis,Activity,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,,,CHEMBL53
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) aggregation assessed as time for nucleation phase of aggregation at 5 uM by Thioflavin-T fluorescence assay (Rvb = 4 to 5 hrs),TIME,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,6.0,hr,=,CHEMBL53
Inhibition of HFIP pretreated amyloid beta (1 to 42) (unknown origin) aggregation assessed as time for nucleation phase of aggregation at 5 uM by Thioflavin-T fluorescence assay (Rvb = 4 to 5 hrs),TIME,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,6.0,hr,=,CHEMBL4068121
Inhibition of amyloid beta (1 to 42) (unknown origin)-mediated toxicity in human SH-SY5Y cells at 500 uM preincubated with amyloid beta (1 to 42) for 30 mins followed by addition to cells measured after 24 hrs by MTT assay,Inhibition,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,%,,CHEMBL53
Inhibition of amyloid beta (1 to 42) (unknown origin)-mediated toxicity in human SH-SY5Y cells at 500 uM preincubated with amyloid beta (1 to 42) for 30 mins followed by addition to cells measured after 24 hrs by MTT assay,Inhibition,CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O,,%,,CHEMBL4068121
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc2s[nH]c(=O)c2cc1OC,12.2,%,=,CHEMBL4226892
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc2sn(CCCN(C)Cc3ccccc3)c(=O)c2cc1OC,7.6,%,=,CHEMBL4226044
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1,19.6,%,=,CHEMBL4228740
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCn1sc2cc(OC)c(OC)cc2c1=O,21.8,%,=,CHEMBL4226830
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1OC,12.4,%,=,CHEMBL4226509
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1N(C)C,19.8,%,=,CHEMBL4227361
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccc(N(C)C)cc1,13.4,%,=,CHEMBL4226769
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc2sn(CCCCN(C)Cc3ccccc3)c(=O)c2cc1OC,17.3,%,=,CHEMBL4227620
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1,9.4,%,=,CHEMBL4225991
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCn1sc2cc(OC)c(OC)cc2c1=O,11.7,%,=,CHEMBL4226833
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1OC,21.1,%,=,CHEMBL4226245
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1N(C)C,11.7,%,=,CHEMBL4227093
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccc(N(C)C)cc1,32.5,%,=,CHEMBL4227568
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc2sn(CCCCCCN(C)Cc3ccccc3)c(=O)c2cc1OC,4.3,%,=,CHEMBL4228401
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1,35.4,%,=,CHEMBL4224820
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCn1sc2cc(OC)c(OC)cc2c1=O,20.2,%,=,CHEMBL4228676
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1OC,48.0,%,=,CHEMBL4226503
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccccc1N(C)C,31.2,%,=,CHEMBL4228589
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCn1sc2cc(OC)c(OC)cc2c1=O)Cc1ccc(N(C)C)cc1,33.4,%,=,CHEMBL4228361
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCn1c(=O)c2cc(OC)c(OC)cc2[s+]1[O-])Cc1ccccc1,29.2,%,=,CHEMBL4225699
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCn1c(=O)c2cc(OC)c(OC)cc2[s+]1[O-],38.0,%,=,CHEMBL4228099
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,CCN(CCCCCCN1C(=O)c2cc(OC)c(OC)cc2S1(=O)=O)Cc1ccccc1,6.0,%,=,CHEMBL4227127
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCN1C(=O)c2cc(OC)c(OC)cc2S1(=O)=O,23.9,%,=,CHEMBL4228882
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM after 24 hrs by thioflavin T fluorescence-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,7000.0,nM,=,CHEMBL76
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,4000.0,nM,=,CHEMBL682
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,4500.0,nM,=,CHEMBL138623
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1500.0,nM,=,CHEMBL317760
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,10000.0,nM,=,CHEMBL451753
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,3100.0,nM,=,CHEMBL94521
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,2500.0,nM,=,CHEMBL4227472
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1700.0,nM,=,CHEMBL97247
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2000.0,nM,=,CHEMBL319756
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,5100.0,nM,=,CHEMBL167970
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,2300.0,nM,=,CHEMBL4226945
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4100.0,nM,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCOCC2)cc(C(=O)NCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226684
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(Cc2ccccc2Nc2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4225384
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,8200.0,nM,=,CHEMBL4225842
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,4600.0,nM,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,6600.0,nM,=,CHEMBL4225563
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(Cc2ccccc2Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226959
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1Nc1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226332
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,6200.0,nM,=,CHEMBL4228998
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCOCC2)c1,10000.0,nM,>,CHEMBL4226906
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(Cc2ccccc2-c2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226598
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1-c1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226641
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,10000.0,nM,>,CHEMBL4227708
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,10000.0,nM,>,CHEMBL4227244
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(Cc2ccccc2-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226530
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1-c1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4227963
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,12800.0,nM,=,CHEMBL76
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,5400.0,nM,=,CHEMBL682
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,10400.0,nM,=,CHEMBL138623
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2800.0,nM,=,CHEMBL317760
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,13800.0,nM,=,CHEMBL451753
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,7100.0,nM,=,CHEMBL94521
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,4900.0,nM,=,CHEMBL4227472
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2900.0,nM,=,CHEMBL97247
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2100.0,nM,=,CHEMBL319756
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,11200.0,nM,=,CHEMBL167970
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1900.0,nM,=,CHEMBL4226945
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4700.0,nM,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCOCC2)cc(C(=O)NCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226684
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(Cc2ccccc2Nc2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4225384
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4225842
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,6000.0,nM,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,7900.0,nM,=,CHEMBL4225563
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(Cc2ccccc2Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226959
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)Cc1ccccc1Nc1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226332
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,9400.0,nM,=,CHEMBL4228998
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCOCC2)c1,10000.0,nM,>,CHEMBL4226906
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(Cc2ccccc2-c2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226598
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)Cc1ccccc1-c1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4226641
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,10000.0,nM,>,CHEMBL4227708
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,10000.0,nM,>,CHEMBL4227244
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(Cc2ccccc2-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000.0,nM,>,CHEMBL4226530
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)Cc1ccccc1-c1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000.0,nM,>,CHEMBL4227963
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,1.0,,=,CHEMBL76
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,0.5,,=,CHEMBL682
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,0.6,,=,CHEMBL138623
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1.6,,=,CHEMBL317760
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,0.5,,=,CHEMBL451753
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,0.7,,=,CHEMBL94521
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,1.2,,=,CHEMBL4227472
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2.1,,=,CHEMBL97247
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1.7,,=,CHEMBL319756
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,0.5,,=,CHEMBL167970
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1.4,,=,CHEMBL4226945
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,2.8,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,1.0,,=,CHEMBL4225842
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,2.6,,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,0.9,,=,CHEMBL4225563
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,1.4,,=,CHEMBL4228998
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,1.0,,=,CHEMBL76
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,0.4,,=,CHEMBL682
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,0.5,,=,CHEMBL138623
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,0.9,,=,CHEMBL317760
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,0.4,,=,CHEMBL451753
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,0.5,,=,CHEMBL94521
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,1.2,,=,CHEMBL4227472
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,3.4,,=,CHEMBL97247
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2.3,,=,CHEMBL319756
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,0.6,,=,CHEMBL167970
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1.1,,=,CHEMBL4226945
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,2.3,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,3.0,,=,CHEMBL4225842
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,4.0,,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,1.3,,=,CHEMBL4225563
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in AICD level at 3 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,1.9,,=,CHEMBL4228998
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 10 uM measured after 24 hrs by Western blot analysis relative to chloroquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,3.0,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 10 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,3.0,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in ACID level at 10 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,10.0,,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,5.6,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,5.6,,=,CHEMBL4226025
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in ACID level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,3.2,,=,CHEMBL4226951
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in ACID level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine,FC,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,3.2,,=,CHEMBL4226025
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,51.74,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(O)/C=C/c1ccccc1,,%,,CHEMBL27246
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,25.72,%,=,CHEMBL497
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(O)CCc1ccccc1,,%,,CHEMBL851
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,%,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,54.98,%,=,CHEMBL4228823
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,12.34,%,=,CHEMBL4228719
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,29.43,%,=,CHEMBL4226059
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc([N+](=O)[O-])cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,13.18,%,=,CHEMBL4226115
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,49.86,%,=,CHEMBL4227890
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,8.65,%,=,CHEMBL4228621
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,73.41,%,=,CHEMBL4227615
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,27.76,%,=,CHEMBL4226505
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,61.91,%,=,CHEMBL4227357
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,26.12,%,=,CHEMBL4228027
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,25.68,%,=,CHEMBL4225226
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,28.15,%,=,CHEMBL4225986
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,65.82,%,=,CHEMBL4226827
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CCc1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,15.55,%,=,CHEMBL4226121
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,18.31,%,=,CHEMBL4225721
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,34.3,%,=,CHEMBL4226831
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,32.46,%,=,CHEMBL4225989
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,,,,CHEMBL497
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,12430.0,nM,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(O)/C=C/c1ccccc1,,,,CHEMBL27246
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(O)CCc1ccccc1,,,,CHEMBL851
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,8860.0,nM,=,CHEMBL4228823
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,,,,CHEMBL4228719
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,18940.0,nM,=,CHEMBL4226059
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc([N+](=O)[O-])cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,,,,CHEMBL4226115
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,11440.0,nM,=,CHEMBL4227890
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(Br)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,,,,CHEMBL4228621
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5050.0,nM,=,CHEMBL4227615
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,16810.0,nM,=,CHEMBL4226505
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,7350.0,nM,=,CHEMBL4227357
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,17330.0,nM,=,CHEMBL4228027
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,22550.0,nM,=,CHEMBL4225226
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,19740.0,nM,=,CHEMBL4225986
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5640.0,nM,=,CHEMBL4226827
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,,,,CHEMBL4226121
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,,,,CHEMBL4225721
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,18280.0,nM,=,CHEMBL4226831
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,20610.0,nM,=,CHEMBL4225989
Inhibition of beta amyloid (unknown origin) deposition,IC50,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,45000.0,nM,=,CHEMBL194823
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,,,,CHEMBL180239
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,,,,CHEMBL180239
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by atomic force microscopic method,Activity,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by atomic force microscopic method,Activity,O=C(/C=C(O)/C=C/c1ccccc1)/C=C/c1ccccc1,,,,CHEMBL129913
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by atomic force microscopic method,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(OC(C)=O)c(OC)c3)[nH]n2)ccc1OC(C)=O,0.65,uM,=,CHEMBL4245718
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,0.14,uM,=,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC(C)=O)c(OC)c2)ccc1OC(C)=O,1.0,uM,=,CHEMBL4244099
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 2 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,0.73,uM,=,CHEMBL140
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C=C(/C)O)ccc1O,,,,CHEMBL4243190
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/c2cc(C)[nH]n2)ccc1O,38.8,uM,=,CHEMBL481599
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,C(=C/c1cc(/C=C/c2ccccc2)[nH]n1)\c1ccccc1,,,,CHEMBL4248284
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(OC(C)=O)c(OC)c3)[nH]n2)ccc1OC(C)=O,0.31,uM,=,CHEMBL4245718
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,1.47,uM,=,CHEMBL180239
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,O=C(/C=C/c1ccccc1)/C(CCCC1C(=O)c2ccccc2C1=O)=C(O)/C=C/c1ccccc1,,,,CHEMBL4239967
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C(CCCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1.16,uM,=,CHEMBL4250078
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1.11,uM,=,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,O=C(/C=C(O)/C=C/c1ccccc1)/C=C/c1ccccc1,,,,CHEMBL129913
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cccc(/C=C/C(=O)/C=C(O)/C=C/c2cccc(OC)c2)c1,,,,CHEMBL492977
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC(C)=O)c(OC)c2)ccc1OC(C)=O,1.95,uM,=,CHEMBL4244099
Disruption of recombinant human amyloid beta (1 to 40) fibrils after 24 hrs by ThT fluorescence assay,DC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,0.78,uM,=,CHEMBL140
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)/C=C(/C)O)ccc1O,,,,CHEMBL4243190
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/c2cc(C)[nH]n2)ccc1O,,,,CHEMBL481599
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,C(=C/c1cc(/C=C/c2ccccc2)[nH]n1)\c1ccccc1,,,,CHEMBL4248284
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/c2cc(/C=C/c3ccc(OC(C)=O)c(OC)c3)[nH]n2)ccc1OC(C)=O,75.0,%,>,CHEMBL4245718
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,75.0,%,>,CHEMBL180239
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(/C=C/c1ccccc1)/C(CCCC1C(=O)c2ccccc2C1=O)=C(O)/C=C/c1ccccc1,,,,CHEMBL4239967
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)/C(CCCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,75.0,%,>,CHEMBL4250078
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)/C(CCC2C(=O)c3ccccc3C2=O)=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,75.0,%,>,CHEMBL4244532
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(/C=C(O)/C=C/c1ccccc1)/C=C/c1ccccc1,,,,CHEMBL129913
Disruption of recombinant human amyloid beta (1 to 40) fibrils at 10 uM after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,75.0,%,>,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1cccs1)CC2.[I-],94.9,%,=,CHEMBL4247204
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1cccc([N+](=O)[O-])c1)CC2.[I-],94.4,%,=,CHEMBL4238440
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1cccc(Cl)c1)CC2.[I-],104.6,%,=,CHEMBL4242600
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1cccc(F)c1)CC2.[I-],89.1,%,=,CHEMBL4248914
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1ccccc1)CC2.[I-],97.6,%,=,CHEMBL4238865
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1cccc3ccccc13)C2=O,-6.8,%,=,CHEMBL4245954
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1cccs1)C2=O,-11.1,%,=,CHEMBL4250204
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1cccc([N+](=O)[O-])c1)C2=O,-42.6,%,=,CHEMBL4242137
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1cccc(Cl)c1)C2=O,-26.5,%,=,CHEMBL4246404
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1cccc(F)c1)C2=O,-27.7,%,=,CHEMBL4248148
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C/c1ccccc1)C2=O,-18.9,%,=,CHEMBL4243904
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCC(Cc1ccccc1)C2=O,-4.0,%,=,CHEMBL4250765
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\C=C\c1ccccc1)C2=O,2.0,%,=,CHEMBL4240972
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc3ccccc13)CC2.[I-],86.7,%,=,CHEMBL4241414
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccs1)CC2.[I-],99.5,%,=,CHEMBL4237231
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc([N+](=O)[O-])c1)CC2.[I-],86.4,%,=,CHEMBL4244745
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc(Cl)c1)CC2.[I-],91.9,%,=,CHEMBL4248516
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc(F)c1)CC2.[I-],98.7,%,=,CHEMBL4248969
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1ccccc1)CC2.[I-],84.7,%,=,CHEMBL4239680
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Cc1c2c(nc3ccccc13)CC/C(=C\c1ccccc1)C2=O,16.6,%,=,CHEMBL4245933
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CCc2nc3ccccc3cc21,2.7,%,=,CHEMBL4250186
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2cccc(Cl)c2)CCc2nc3ccccc3cc21,46.2,%,=,CHEMBL4250568
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2ccccc2Cl)CCc2nc3ccccc3cc21,3.5,%,=,CHEMBL4243255
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2cccc(F)c2)CCc2nc3ccccc3cc21,7.2,%,=,CHEMBL4239981
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2ccccc2F)CCc2nc3ccccc3cc21,-0.5,%,=,CHEMBL4244204
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,O=C1/C(=C/c2ccccc2)CCc2nc3ccccc3cc21,-3.2,%,=,CHEMBL4242956
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1cccc3ccccc13)C2=O,7.8,%,=,CHEMBL4247186
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1cccs1)C2=O,14.5,%,=,CHEMBL4246758
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccco1)C2=O,15.2,%,=,CHEMBL4240236
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,COc1ccc(/C=C2\CCc3nc4ccccc4c(N)c3C2=O)cc1,-2.0,%,=,CHEMBL4248805
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,COc1cccc(/C=C2\CCc3nc4ccccc4c(N)c3C2=O)c1,7.9,%,=,CHEMBL4244529
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccc([N+](=O)[O-])cc1)C2=O,2.4,%,=,CHEMBL4239087
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1cccc([N+](=O)[O-])c1)C2=O,8.2,%,=,CHEMBL4237663
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccc(Cl)cc1)C2=O,24.8,%,=,CHEMBL4242851
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1cccc(Cl)c1)C2=O,34.2,%,=,CHEMBL4239739
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccccc1Cl)C2=O,14.1,%,=,CHEMBL4245831
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1cccc(F)c1)C2=O,20.3,%,=,CHEMBL4241585
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccccc1F)C2=O,37.0,%,=,CHEMBL4249633
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CC/C(=C\c1ccccc1)C2=O,7.7,%,=,CHEMBL4245373
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,78.9,%,=,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.[Cl-],,%,,CHEMBL405110
Binding affinity to amyloid beta (1 to 42) (unknown origin) by surface plasmon resonance assay,Kd,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc3ccccc13)CC2.[I-],16000.0,nM,=,CHEMBL4241414
Binding affinity to amyloid beta (1 to 42) (unknown origin) by surface plasmon resonance assay,Kd,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,38500.0,nM,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) beta-sheet formation at 20 uM after 24 hrs by CD spectroscopic method,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc3ccccc13)CC2.[I-],,%,,CHEMBL4241414
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM after 24 hrs by uranyl acetate staining-based transmission electron microscopic method,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C/c1cccc3ccccc13)CC2.[I-],,%,,CHEMBL4241414
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) fibril formation at 20 uM after 24 hrs by uranyl acetate staining-based transmission electron microscopic method,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,%,,CHEMBL165
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 72 hrs by thioflavin T assay relative to control,Inhibition,C[n+]1c2c(c(N)c3ccccc31)C(=O)/C(=C\c1cccc3ccccc13)CC2.[I-],91.2,%,=,CHEMBL4245008
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,7.7,%,=,CHEMBL95
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,16.4,%,=,CHEMBL502
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 10 uM after 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Clc1ccc(C[n+]2cccc(Cn3c4ccccc4c4ccccc43)c2)cc1.[Cl-],49.9,%,=,CHEMBL4241164
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3ccccc13)CCCC2,40.0,%,=,CHEMBL4286601
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,47.0,%,=,CHEMBL4278164
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,15.0,%,=,CHEMBL4288850
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,O=C(O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,25.0,%,=,CHEMBL4293305
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,CCOC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2,30.0,%,=,CHEMBL4285481
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2,46.0,%,=,CHEMBL4278686
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,39.0,%,=,CHEMBL4290039
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,40.0,%,=,CHEMBL4282154
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,42.0,%,=,CHEMBL4293418
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3,47.0,%,=,CHEMBL4285581
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3,45.0,%,=,CHEMBL4278287
Inhibition of self-induced aggregation of HFIP-treated human amyloid beta (1 to 42 residues) at 20 uM by thioflavin T-based fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM measured for 300 secs by thioflavin T fluorometric assay relative to control,Inhibition,Cn1c2nc3ccccc3c-2c(NCCCCCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,26.5,%,=,CHEMBL4294640
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM measured for 300 secs by thioflavin T fluorometric assay relative to control,Inhibition,Cn1c2nc3ccccc3c-2c(NCCCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,25.9,%,=,CHEMBL4284047
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM measured for 300 secs by thioflavin T fluorometric assay relative to control,Inhibition,Cn1c2nc3ccccc3c-2c(NCCCCNc2c3c(nc4ccccc24)CCCC3)c2ccccc21,19.7,%,=,CHEMBL4281440
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 10 uM measured for 300 secs by thioflavin T fluorometric assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 50 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,68.0,%,=,CHEMBL4287929
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 75 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,58.0,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2cc(=O)c(O)co2)cc(OC)c1,18.64,%,=,CHEMBL4289536
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,68.46,%,=,CHEMBL4287929
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2ccccc2O)occ1O,63.56,%,=,CHEMBL4284208
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,56.93,%,=,CHEMBL4294830
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,%,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,63.83,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.23,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccccc2)occ1O,,,,CHEMBL2283266
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccc(Cl)cc2)occ1O,,,,CHEMBL4292488
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)occ1O,17680.0,nM,=,CHEMBL4282190
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,5920.0,nM,=,CHEMBL4294375
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccc([N+](=O)[O-])cc2)occ1O,,,,CHEMBL4284114
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,,,,CHEMBL4286108
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)co1,7930.0,nM,=,CHEMBL4286002
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/c2cc(=O)c(O)co2)cc(OC)c1,,,,CHEMBL4289536
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7200.0,nM,=,CHEMBL4287929
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccccc2O)occ1O,8290.0,nM,=,CHEMBL4284208
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,17950.0,nM,=,CHEMBL4294830
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,,,CHEMBL153
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,,,,CHEMBL4287929
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccccc2O)occ1O,,,,CHEMBL4284208
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,,CHEMBL165
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 75 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,,,,CHEMBL4287929
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 75 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccccc2O)occ1O,,,,CHEMBL4284208
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 75 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,,CHEMBL165
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,,,,CHEMBL4287929
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccccc2O)occ1O,,,,CHEMBL4284208
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 50 uM after 24 hrs by uranyl acetate staining based transmission electron microscopic analysis,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,,CHEMBL165
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 75 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,14.0,%,=,CHEMBL4287929
Disaggregation of Fe3+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 75 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,O=c1cc(/C=C/c2ccccc2O)occ1O,17.0,%,=,CHEMBL4284208
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 50 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,O=c1cc(/C=C/c2ccccc2O)occ1O,62.0,%,=,CHEMBL4284208
Disaggregation of Cu2+-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as remaining amyloid beta aggregation level at 50 mM after 24 hrs by thioflavin-T fluorescence assay,Activity,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,78.0,%,=,CHEMBL165
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1/C=C/c1cc(=O)c(O)co1,61.1,%,=,CHEMBL4286002
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,38.22,%,=,CHEMBL4286108
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc([N+](=O)[O-])cc2)occ1O,,%,,CHEMBL4284114
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,61.19,%,=,CHEMBL4294375
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2cccc(F)c2)occ1O,58.01,%,=,CHEMBL4282190
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(Cl)cc2)occ1O,18.03,%,=,CHEMBL4292488
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2ccccc2)occ1O,42.5,%,=,CHEMBL2283266
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils at 100 uM measured on day 14 by transmission electron microscopy,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,,,CHEMBL197478
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils at 100 uM measured immediately by transmission electron microscopy,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,,,CHEMBL197478
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils up to 100 uM measured on day 14 by Western blot analysis,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,,,CHEMBL197478
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils up to 100 uM measured immediately by Western blot analysis,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,,,CHEMBL197478
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4200.0,nM,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 100 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,1.0,%,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,8.0,%,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 3.1 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,60.0,%,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation up to 100 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL197478
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL145
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL4292496
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL4287993
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL4277351
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL4292519
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) at 12.5 to 25 uM incubated with agitation for 1 min every hr measured over 80 hrs by transmission electron microscopy,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL197478
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,15600.0,nM,=,CHEMBL145
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3400.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,C#CCNC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)/C=C/c1ccc(O)c(O)c1,107.0,%,=,CHEMBL4277767
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,79.1,%,=,CHEMBL324842
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,C#CCCCCNC(=O)/C=C/c1ccc(O)c(O)c1,67.6,%,=,CHEMBL4287999
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,C#CCCCNC(=O)/C=C/c1ccc(O)c(O)c1,135.3,%,=,CHEMBL4292498
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,C#CCNC(=O)/C=C/c1ccc(O)c(O)c1,79.4,%,=,CHEMBL4284618
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(O)/C=C/c1ccc(O)c(O)c1,91.2,%,=,CHEMBL145
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)NCc1cn(Cc2ccc(-c3ccc(Cn4cc(CNC(=O)[C@@H](Cc5ccc(O)c(O)c5)OC(=O)/C=C/c5ccc(O)c(O)c5)nn4)cc3)cc2)nn1,65.1,%,=,CHEMBL4291397
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCCc1cn(Cc2ccc(-c3ccc(Cn4cc(CCCCNC(=O)/C=C/c5ccc(O)c(O)c5)nn4)cc3)cc2)nn1,61.8,%,=,CHEMBL4280746
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCc1cn(Cc2ccc(-c3ccc(Cn4cc(CCCNC(=O)/C=C/c5ccc(O)c(O)c5)nn4)cc3)cc2)nn1,111.8,%,=,CHEMBL4294805
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCc1cn(Cc2ccc(-c3ccc(Cn4cc(CNC(=O)/C=C/c5ccc(O)c(O)c5)nn4)cc3)cc2)nn1,88.2,%,=,CHEMBL4284183
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCc1cn(Cc2ccc(Cn3cc(CNC(=O)/C=C/c4ccc(O)c(O)c4)nn3)cc2)nn1,76.5,%,=,CHEMBL4284615
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,67.6,%,=,CHEMBL4292496
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,61.8,%,=,CHEMBL4287993
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,79.4,%,=,CHEMBL4277351
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCOCCOCCNC(=O)/C=C/c1ccc(O)c(O)c1,64.7,%,=,CHEMBL4292519
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,52.9,%,=,CHEMBL197478
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as fibril formation at 10 uM incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay relative to control,Activity,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1ccc(O)c(O)c1,11.5,%,=,CHEMBL319488
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL197478
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Inhibition,O=C(O)/C=C/c1ccc(O)c(O)c1,,%,,CHEMBL145
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Activity,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,,,,CHEMBL197478
Inhibition of recombinant human HFIP-pretreated amyloid beta (1 to 42) self aggregation at 10 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,CN(CCCCCN1C(=O)c2ccccc2S1(=O)=O)Cc1ccccc1,22.19,%,=,CHEMBL4276675
Binding affinity to brain acid soluble protein 1 in human Hela cells lysates assessed as protein enrichment by measuring normalized heavy/light ratio at by nano-LC-ESIMS/MS analysis,Ratio,C/C=C(\C)C(=O)O[C@H]1[C@H](O)[C@]2(COC(C)=O)[C@@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,0.744,,=,CHEMBL4294164
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,43.5,%,=,CHEMBL4283390
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3F)CC2)cc(C(C)(C)C)c1O,43.5,%,=,CHEMBL4292766
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 20 uM incubated for 46 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.6,%,=,CHEMBL140
Inhibition of AChE-induced amyloid beta 40 (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3)CC2)cc(C(C)(C)C)c1O,38.4,%,=,CHEMBL4283390
Inhibition of AChE-induced amyloid beta 40 (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,28.7,%,=,CHEMBL502
Inhibition of AChE-induced amyloid beta 40 (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cc(/C=C/C(=O)NCCC2CCN(Cc3ccccc3F)CC2)cc(C(C)(C)C)c1O,40.1,%,=,CHEMBL4292766
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,CC12CC3CC(C)(C1)CC(N)(C3)C2,,%,,CHEMBL807
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,NC12CC3CC(F)(CC(C1)c1ccccc13)C2,,%,,CHEMBL3259988
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,5.0,%,<,CHEMBL292314
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,O=C(CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NC12CC3CC(F)(CC(C1)c1ccccc13)C2,5.0,%,<,CHEMBL4438626
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,O=C(CCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NC12CC3CC(F)(CC(C1)c1ccccc13)C2,9.0,%,=,CHEMBL4462369
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,FC12CC3CC(NCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)(CC(C1)c1ccccc13)C2,8.4,%,=,CHEMBL4469343
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,FC12CC3CC(NCCCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)(CC(C1)c1ccccc13)C2,12.3,%,=,CHEMBL4558495
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,NC12CC3CC(F)(CC(C1)c1cc(NC(=O)CCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)ccc13)C2,5.0,%,<,CHEMBL4471659
Inhibition of human recombinant amyloid beta (1 to 42) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM by Thioflavin S steady state fluorescence assay relative to control,Inhibition,NC12CC3CC(F)(CC(C1)c1cc(NC(=O)CCCCNc4c5c(nc6cc(Cl)ccc46)CCCC5)ccc13)C2,5.0,%,<,CHEMBL4591167
Inhibition of APP (unknown origin),IC50,O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1,199.53,nM,=,CHEMBL289556
Inhibition of APP (unknown origin),IC50,CCOc1nc(CC)c(CNC(=O)[C@@H](S)CC(C)C)n1Cc1ccc(-c2ccccc2C(=O)O)cc1F,10000.0,nM,>,CHEMBL4435800
Inhibition of APP (unknown origin),pIC50,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,,,,CHEMBL1069
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCN2CCC(Cc3ccccc3)CC2)cc1)c1ccc(OCCN2CCC(Cc3ccccc3)CC2)cc1O,53.5,%,=,CHEMBL4476735
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCN2CCCCC2)cc1)c1ccc(OCCN2CCCCC2)cc1O,59.8,%,=,CHEMBL4575664
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCN2CCCC2)cc1)c1ccc(OCCN2CCCC2)cc1O,61.3,%,=,CHEMBL4556096
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,CCN(CC)CCOc1ccc(/C=C/C(=O)c2ccc(OCCN(CC)CC)cc2O)cc1,63.1,%,=,CHEMBL4451613
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCN2CCC(Cc3ccccc3)CC2)cc1)c1ccc(OCCCN2CCC(Cc3ccccc3)CC2)cc1O,61.8,%,=,CHEMBL4538061
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCN2CCCCC2)cc1)c1ccc(OCCCN2CCCCC2)cc1O,65.7,%,=,CHEMBL4461873
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCN2CCCC2)cc1)c1ccc(OCCCN2CCCC2)cc1O,60.9,%,=,CHEMBL4466366
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,CCN(CC)CCCOc1ccc(/C=C/C(=O)c2ccc(OCCCN(CC)CC)cc2O)cc1,64.7,%,=,CHEMBL4540199
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1)c1ccc(OCCCCN2CCC(Cc3ccccc3)CC2)cc1O,62.7,%,=,CHEMBL4473461
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCN2CCCCC2)cc1)c1ccc(OCCCCN2CCCCC2)cc1O,71.8,%,=,CHEMBL4456071
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCN2CCCC2)cc1)c1ccc(OCCCCN2CCCC2)cc1O,63.1,%,=,CHEMBL4437622
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,CCN(CC)CCCCOc1ccc(/C=C/C(=O)c2ccc(OCCCCN(CC)CC)cc2O)cc1,62.7,%,=,CHEMBL4454906
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCCCN2CCC(Cc3ccccc3)CC2)cc1)c1ccc(OCCCCCCN2CCC(Cc3ccccc3)CC2)cc1O,51.3,%,=,CHEMBL4552080
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCCCN2CCCCC2)cc1)c1ccc(OCCCCCCN2CCCCC2)cc1O,61.8,%,=,CHEMBL4474824
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,O=C(/C=C/c1ccc(OCCCCCCN2CCCC2)cc1)c1ccc(OCCCCCCN2CCCC2)cc1O,68.3,%,=,CHEMBL4537240
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,CCN(CC)CCCCCCOc1ccc(/C=C/C(=O)c2ccc(OCCCCCCN(CC)CC)cc2O)cc1,63.7,%,=,CHEMBL4543178
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 24 hrs by ThT-based fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,47.3,%,=,CHEMBL140
Inhibition of self-induced amyloid beta ( 1 to 42 residues) (unknown origin) aggregation relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OC(=O)N3CCCC3)cc2O)cc1,89.5,%,=,CHEMBL3884602
Inhibition of self-induced amyloid beta ( 1 to 42 residues) (unknown origin) aggregation relative to control,Inhibition,CCN(CC)Cc1ccc(/C=C/C(=O)c2ccc(OC)c(OC)c2)cc1O,55.0,%,=,CHEMBL4455506
Inhibition of self-induced amyloid beta ( 1 to 42 residues) (unknown origin) aggregation relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2O)c1,63.9,%,=,CHEMBL4466019
Inhibition of self-induced amyloid beta ( 1 to 42 residues) (unknown origin) aggregation relative to control,Inhibition,CCN(CC)c1ccc(/C=C/C(=O)c2cc(-c3ccc(C(C)C(=O)OC)cc3F)ccc2O)cc1,78.2,%,=,CHEMBL4209656
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation,INH,COc1cc(O)c(O)cc1/C=C/C(=O)c1ccc(O)cc1,2.16,uM,=,CHEMBL4524154
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,52.9,%,=,CHEMBL297453
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,51.4,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,Cc1cccc(/C=C/C(=O)c2cccc(O)c2)c1,,%,,CHEMBL4579361
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COc1ccc(/C=C/C(=O)c2cccc(O)c2)cc1OC,,%,,CHEMBL4087479
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,Cc1cccc(/C=C/C(=O)c2cc(O)cc(O)c2)c1,27.2,%,=,CHEMBL4448876
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COc1ccc(/C=C/C(=O)c2cc(O)cc(O)c2)cc1,19.0,%,=,CHEMBL4571653
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COCOc1ccc(C(=O)/C=C/c2cccc(C)c2)c(O)c1OCOC,16.4,%,=,CHEMBL4461280
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COCOc1ccc(C(=O)/C=C/c2ccc(OC)cc2)c(O)c1OCOC,16.4,%,=,CHEMBL4470408
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COCOc1ccc(C(=O)/C=C/c2cccc(Cl)c2)c(O)c1OCOC,16.4,%,=,CHEMBL4473149
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,Cc1cccc(/C=C/C(=O)c2ccc(O)c(O)c2O)c1,70.3,%,=,CHEMBL4474954
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,COc1ccc(/C=C/C(=O)c2ccc(O)c(O)c2O)cc1,70.3,%,=,CHEMBL4535330
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control,Inhibition,O=C(/C=C/c1cccc(Cl)c1)c1ccc(O)c(O)c1O,70.3,%,=,CHEMBL4470087
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,,%,,CHEMBL362378
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,53.74,%,=,CHEMBL362378
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(OC)c(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311038
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311040
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc3c2OC(c2ccc(O)cc2)CC3=O)O1,50.93,%,=,CHEMBL4550657
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 40 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,65.7,%,=,CHEMBL362378
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 40 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(OC)c(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311038
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 40 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311040
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 40 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc3c2OC(c2ccc(O)cc2)CC3=O)O1,63.48,%,=,CHEMBL4550657
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 40 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 80 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(O)cc3)c2O)O1,73.35,%,=,CHEMBL362378
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 80 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(OC)c(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311038
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 80 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc(-c2coc3c4c(ccc3c2=O)OC(C)(C)C=C4)cc1OC,,%,,CHEMBL3311040
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 80 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,CC1(C)C=Cc2c(ccc3c2OC(c2ccc(O)cc2)CC3=O)O1,73.47,%,=,CHEMBL4550657
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 80 uM incubated for 48 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) incubated for 24 hrs by TEM analysis,IC50,CCN(CC)CCCOc1ccc(-n2ccc(=O)c(O)c2C)cc1,17230.0,nM,=,CHEMBL4462662
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation,IC50,CCN(CC)CCCCC(C)Nc1c2ccccc2nc2c(C(=O)NCCCO/N=C/C(=O)NCCCC[C@@H]3NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C3=O)cccc12,2000.0,nM,=,CHEMBL4465480
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(Cc5ccccc5)CC4)cc3)C2)cc1OC,89.8,%,=,CHEMBL4465544
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(Cc5ccccc5)CC4)cc3)C2)cc1OC,86.4,%,=,CHEMBL4576193
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCN(C)CC4)cc3)C2)cc1OC,72.6,%,=,CHEMBL4582736
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,CCN1CCN(c2ccc(C3CC(c4ccc(OC)c(OC)c4)=NN3C(C)=O)cc2)CC1,83.4,%,=,CHEMBL4594199
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(C)CC4)cc3)C2)cc1OC,63.4,%,=,CHEMBL4445377
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,83.4,%,=,CHEMBL502
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 100 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,48.4,%,=,CHEMBL374478
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 10 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(Cc5ccccc5)CC4)cc3)C2)cc1OC,82.2,%,=,CHEMBL4576193
Inhibition of human amyloid beta (1 to 42) self-induced aggregation assessed as Amyloid beta (1 to 42) aggregation at 10 uM incubated for 48 hrs by thioflavin T-based fluorescence assay (Rvb = 100%),Activity,COc1ccc(C2=NN(C(C)=O)C(c3ccc(N4CCC(C)CC4)cc3)C2)cc1OC,80.6,%,=,CHEMBL4445377
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 10 uM ThT-based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCCCCCNC(=S)NC45CC6CC(CC(C6)C4)C5)c2c1)CCCC3,77.0,%,=,CHEMBL4566976
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 10 uM ThT-based fluorescence assay relative to control,Inhibition,COc1ccccc1CN1CCN(CCCCCOc2cccc3[nH]c4ccccc4c23)CC1,34.0,%,=,CHEMBL4591636
Inhibition of human HFIP-pretreated amyloid beta (1 to 42) self aggregation at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,Nc1ncccc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,%,,CHEMBL4467668
Inhibition of human HFIP-pretreated amyloid beta (1 to 42) self aggregation at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,Nc1ncc(-c2ccccc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,%,,CHEMBL4559169
Inhibition of human HFIP-pretreated amyloid beta (1 to 42) self aggregation at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,Nc1ncc(-c2ccncc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,%,,CHEMBL4454448
Inhibition of human HFIP-pretreated amyloid beta (1 to 42) self aggregation at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.0,%,=,CHEMBL140
Disaggregation of HFIP-pretreated human amyloid beta (1 to 42) preformed fibrils at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Activity,Nc1ncccc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,,,CHEMBL4467668
Disaggregation of HFIP-pretreated human amyloid beta (1 to 42) preformed fibrils at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Activity,Nc1ncc(-c2ccccc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,,,CHEMBL4559169
Disaggregation of HFIP-pretreated human amyloid beta (1 to 42) preformed fibrils at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Activity,Nc1ncc(-c2ccncc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1,,,,CHEMBL4454448
Disaggregation of HFIP-pretreated human amyloid beta (1 to 42) preformed fibrils at 40 uM after 24 hrs by ThT-based fluorometric method relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.0,%,=,CHEMBL140
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 10 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,c1ccc2c(NCc3ccc(-c4ccc(CNc5c6c(nc7ccccc57)CCCC6)cc4)cc3)c3c(nc2c1)CCCC3,75.5,%,=,CHEMBL4456928
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)c3ncccc3c2)cc1,71.69,%,=,CHEMBL4466820
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation by thioflavin T based fluorescence assay,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation,IC50,Cl.O=c1c2c(F)cccc2[se]n1-c1cc(Cl)c(O)c2ncccc12,9600.0,nM,=,CHEMBL4438040
Inhibition of beta amyloid (unknown origin) self-induced aggregation at 10 uM relative to control,Inhibition,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,47.8,%,=,CHEMBL1929421
Inhibition of beta amyloid (unknown origin) self-induced aggregation at 20 uM relative to control,Inhibition,Cc1cc(=O)oc2cc(OCCN3CCN(CC(=O)Nc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,67.8,%,=,CHEMBL2391486
Inhibition of beta amyloid (unknown origin) self-induced aggregation relative to control,Inhibition,Cc1ccc2[nH]c3c(c2c1)CN(CCCCCN1CCc2[nH]c4ccc(C)cc4c2C1)CC3,67.0,%,=,CHEMBL4467520
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12,11.25,%,=,CHEMBL85139
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c2cc(NS(=O)(=O)c3ccccc3OC(F)(F)F)ccc2nc2n1CCc1c-2[nH]c2ccccc12,58.95,%,=,CHEMBL4473175
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,33.78,%,=,CHEMBL502
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated for 48 hrs by transmission electron microscopic method,Inhibition,O=c1c2cc(NS(=O)(=O)c3ccccc3OC(F)(F)F)ccc2nc2n1CCc1c-2[nH]c2ccccc12,,%,,CHEMBL4473175
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation assessed as short and thin fibril formation at 100 uM incubated for 48 hrs by transmission electron microscopic method,Inhibition,O=c1c2cc(NS(=O)(=O)c3ccccc3OC(F)(F)F)ccc2nc2n1CCc1c-2[nH]c2ccccc12,,%,,CHEMBL4473175
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated for 48 hrs by transmission electron microscopic method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin F fluorescence method relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,=,CHEMBL95
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin F fluorescence method relative to control,Inhibition,CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,81.5,%,=,CHEMBL4456083
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin F fluorescence method relative to control,Inhibition,CCOc1ccc(Cc2nc3cc(C(=O)NCCCNc4c5c(nc6ccccc46)CCCC5)ccc3n2CCC(C)C)cc1,16.4,%,=,CHEMBL4441666
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin F fluorescence method relative to control,Inhibition,CCOc1ccc(Cc2nc3cc(C(=O)NCCSSCCNc4c5c(nc6ccccc46)CCCC5)ccc3n2CCC(C)C)cc1,83.4,%,=,CHEMBL4447210
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,63.5,%,=,CHEMBL4475228
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1OC,63.8,%,=,CHEMBL4555120
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2)cc1,70.0,%,=,CHEMBL4588525
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,c1ccc(COc2ccc(CCOCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2OCc2ccccc2)cc1,75.3,%,=,CHEMBL4545701
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,Oc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1,54.4,%,=,CHEMBL4531167
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,Oc1ccc(CCOCCCCCNc2c3c(nc4ccccc24)CCCC3)cc1O,,%,,CHEMBL4589250
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,71.1,%,=,CHEMBL32823
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as increase in blue shift in maximum absorption at 0.2 uM by fluorescence based assay,FC,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,22.0,,=,CHEMBL4475538
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as increase in blue shift in maximum absorption at 0.2 uM by fluorescence based assay,FC,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC(O)CO)C3=O)ccc21,9.5,,=,CHEMBL4453231
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as increase in blue shift in maximum absorption at 0.2 uM by fluorescence based assay,FC,CCOC(=O)CN(CC(=O)OCC)C(=O)CN1C(=O)/C(=C\c2ccc3c(c2)Sc2ccccc2N3C)SC1=S,38.3,,=,CHEMBL4570231
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as increase in red shift in maximum absorption at 0.2 uM by fluorescence based assay,FC,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)N(CC(=O)O)CC(=O)O)C3=O)ccc21,2.4,,=,CHEMBL4524664
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as binding constant by fluorescence based assay,Kd,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,24.5,nM,=,CHEMBL4475538
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as binding constant by fluorescence based assay,Kd,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC(O)CO)C3=O)ccc21,34.9,nM,=,CHEMBL4453231
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as binding constant by fluorescence based assay,Kd,CCOC(=O)CN(CC(=O)OCC)C(=O)CN1C(=O)/C(=C\c2ccc3c(c2)Sc2ccccc2N3C)SC1=S,46.3,nM,=,CHEMBL4570231
Binding affinity to amyloid beta 1 to 42 (unknown origin) in PBS buffer at pH 7.4 assessed as binding constant by fluorescence based assay,Kd,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)N(CC(=O)O)CC(=O)O)C3=O)ccc21,76.5,nM,=,CHEMBL4524664
Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells incubated for 48 hrs by fluorescence microscopy,Inhibition,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,,%,,CHEMBL4475538
Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells incubated for 48 hrs by fluorescence microscopy,IC50,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,60.0,nM,=,CHEMBL4475538
Inhibition of amyloid beta 1 to 42 (unknown origin)-induced cytotoxicity in human SH-SY5Y cells at 1 to 5 uM incubated for 24 hrs by MTT assay,Activity,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC(O)CO)C3=O)ccc21,,,,CHEMBL4453231
Inhibition of amyloid beta 1 to 42 (unknown origin)-induced cytotoxicity in human SH-SY5Y cells at 1 to 5 uM incubated for 24 hrs by MTT assay,Activity,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)N(CC(=O)O)CC(=O)O)C3=O)ccc21,,,,CHEMBL4524664
Inhibition of amyloid beta 1 to 42 (unknown origin)-induced ROS production in human SH-SY5Y cells at 1 and 5 uM incubated for 24 hrs by DCFH-DA staining based fluorescence assay,Activity,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC(O)CO)C3=O)ccc21,,,,CHEMBL4453231
Inhibition of amyloid beta 1 to 42 (unknown origin)-induced ROS production in human SH-SY5Y cells at 1 and 5 uM incubated for 24 hrs by DCFH-DA staining based fluorescence assay,Activity,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)N(CC(=O)O)CC(=O)O)C3=O)ccc21,,,,CHEMBL4524664
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CN(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2O)c1,60.2,%,=,CHEMBL4446815
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2O)c1,63.9,%,=,CHEMBL4466019
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CON(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2O)c1,61.4,%,=,CHEMBL4579723
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2O)c1,,%,,CHEMBL4448344
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OC(=O)N(c2ccccc2)c2ccccc2)c1)c1ccccc1O,,%,,CHEMBL4565177
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OC(=O)N2CCOCC2)c1)c1ccccc1O,,%,,CHEMBL4591934
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CN(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2OC(=O)N(C)C)c1,,%,,CHEMBL4454576
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2OC(=O)N(C)CC)c1,53.1,%,=,CHEMBL4563460
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CON(C)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2OC(=O)N(C)OC)c1,49.9,%,=,CHEMBL4454566
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)Oc1cccc(/C=C/C(=O)c2ccccc2OC(=O)N(CC)CC)c1,51.5,%,=,CHEMBL4460825
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OC(=O)N(c2ccccc2)c2ccccc2)c1)c1ccccc1OC(=O)N(c1ccccc1)c1ccccc1,,%,,CHEMBL4448924
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OC(=O)N2CCOCC2)c1)c1ccccc1OC(=O)N1CCOCC1,49.2,%,=,CHEMBL4468771
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)c1ccccc1O,70.6,%,=,CHEMBL3823220
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,CC(C)NNC(=O)c1ccncc1,,%,,CHEMBL92401
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,C#CCN[C@@H]1CCc2ccccc21,,%,,CHEMBL887
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin-T based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,45.7,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OCCCN2CCc3ccccc3C2)c1)c1ccccc1O,65.9,%,=,CHEMBL4574317
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OCCCCN2CCc3ccccc3C2)c1)c1ccccc1O,70.2,%,=,CHEMBL4456222
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OCCCCCN2CCc3ccccc3C2)c1)c1ccccc1O,69.7,%,=,CHEMBL4538762
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OCCCCCCN2CCc3ccccc3C2)c1)c1ccccc1O,65.6,%,=,CHEMBL4434713
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(OCCCCN2CCC(Cc3ccccc3)CC2)c1)c1ccccc1O,71.4,%,=,CHEMBL4567417
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(F)cc1)c1ccc(OCCCN2CCc3ccccc3C2)cc1O,72.4,%,=,CHEMBL4457588
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1/C=C/C(=O)c1ccc(OCCCCN2CCc3ccccc3C2)cc1O,83.1,%,=,CHEMBL4573947
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(OCCCCCCN3CCc4ccccc4C3)cc2O)cc1,97.5,%,=,CHEMBL4441838
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CCc1cccc(OCCCCN2CCc3ccccc3C2)c1)c1ccccc1O,,%,,CHEMBL4473943
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 25 uM incubated for 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation relative to control,Inhibition,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,96.89,%,=,CHEMBL4522050
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,95.14,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,8065.0,nM,=,CHEMBL4522050
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,6385.0,nM,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,46420.0,nM,=,CHEMBL4568384
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,44520.0,nM,=,CHEMBL4439214
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 75 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,6.89,%,=,CHEMBL4568384
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 75 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,3.37,%,=,CHEMBL4439214
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,26.72,%,=,CHEMBL4568384
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 25 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,37.11,%,=,CHEMBL4439214
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.77,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,53.72,%,=,CHEMBL4568384
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccc(F)cc2F)ccc1Oc1ccnc2cc(Cl)ccc12,27.76,%,=,CHEMBL4437174
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2cccc(C(F)(F)F)c2)ccc1Oc1ccnc2cc(Cl)ccc12,30.03,%,=,CHEMBL4513315
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccccn2)ccc1Oc1ccnc2cc(Cl)ccc12,41.45,%,=,CHEMBL4516318
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2cccc(C)n2)ccc1Oc1ccnc2cc(Cl)ccc12,41.59,%,=,CHEMBL4448850
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccc(C)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,46.79,%,=,CHEMBL4449663
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM after 48 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,53.62,%,=,CHEMBL4439214
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) assessed as appearance of sparse fibrils at 50 uM after 48 hrs by transmission electron microscopic analysis,Activity,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,,,,CHEMBL4439214
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) assessed as appearance of sparse fibrils at 50 uM after 48 hrs by transmission electron microscopic analysis,Activity,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,,,,CHEMBL4568384
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccccc3c2C=C1c1cc(O)cc(O)c1,67.3,%,=,CHEMBL4588767
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1cc(O)cc(O)c1)=C3,32.4,%,=,CHEMBL4456050
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3cc(O)ccc3c2C=C1c1cc(O)cc(O)c1,70.3,%,=,CHEMBL4552863
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccc(O)cc3c2C=C1c1cc(O)cc(O)c1,78.7,%,=,CHEMBL4455417
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccccc3c2C=C1c1ccc(O)c(O)c1,43.7,%,=,CHEMBL4534352
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1ccc(O)c(O)c1)=C3,49.5,%,=,CHEMBL4441642
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)c(O)c1,80.5,%,=,CHEMBL4476718
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)c(O)c1,82.8,%,=,CHEMBL4444573
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccccc3c2C=C1c1ccc(O)cc1,0.0,%,=,CHEMBL4455722
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1ccc(O)cc1)=C3,0.0,%,=,CHEMBL4542361
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)cc1,12.3,%,=,CHEMBL4446882
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)cc1,20.5,%,=,CHEMBL4472062
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2cc(O)ccc2C=C1c1cc(O)cc(O)c1,50.2,%,=,CHEMBL4466197
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,OB1Oc2ccc(O)cc2C=C1c1ccc(O)c(O)c1,58.8,%,=,CHEMBL4468824
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,61.2,%,=,CHEMBL165
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,53.9,%,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,,%,,CHEMBL32749
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) at 20 uM after 48 hrs by thioflavin T-based fluorescence method relative to control,Inhibition,COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1,,%,,CHEMBL296411
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccccc3c2C=C1c1cc(O)cc(O)c1,12600.0,nM,=,CHEMBL4588767
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1cc(O)cc(O)c1)=C3,,,,CHEMBL4456050
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3cc(O)ccc3c2C=C1c1cc(O)cc(O)c1,8900.0,nM,=,CHEMBL4552863
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1cc(O)cc(O)c1,4900.0,nM,=,CHEMBL4455417
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccccc3c2C=C1c1ccc(O)c(O)c1,,,,CHEMBL4534352
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1ccc(O)c(O)c1)=C3,,,,CHEMBL4441642
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)c(O)c1,4600.0,nM,=,CHEMBL4476718
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)c(O)c1,3400.0,nM,=,CHEMBL4444573
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccccc3c2C=C1c1ccc(O)cc1,,,,CHEMBL4455722
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,CN(C)c1ccc2c3c(ccc2c1)OB(O)C(c1ccc(O)cc1)=C3,,,,CHEMBL4542361
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)cc1,,,,CHEMBL4446882
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)cc1,,,,CHEMBL4472062
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2cc(O)ccc2C=C1c1cc(O)cc(O)c1,21700.0,nM,=,CHEMBL4466197
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,OB1Oc2ccc(O)cc2C=C1c1ccc(O)c(O)c1,17500.0,nM,=,CHEMBL4468824
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,16800.0,nM,=,CHEMBL165
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,13700.0,nM,=,CHEMBL140
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,COc1cc(/C=C/C(=O)O)ccc1O,,,,CHEMBL32749
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1,,,,CHEMBL296411
"Potency index, ratio of curcumin IC50 to test compound IC50 for self-induced aggregation of amyloid beta (1 to 42) (unknown origin)",Ratio IC50,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)c(O)c1,4.0,,=,CHEMBL4444573
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at 2 uM after 2 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,C/C=C1C(=C\c2[nH]c(/C=C3/N=C(/C=C4/NC(=O)C(CC)=C4C)C(C)=C3CCC(=O)O)c(CCC(=O)O)c2C)/NC(=O)C/1C,,%,,CHEMBL4472349
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at 2 uM after 25 hrs by uranyl acetate staining based transmission electron microscopic method,Inhibition,C/C=C1C(=C\c2[nH]c(/C=C3/N=C(/C=C4/NC(=O)C(CC)=C4C)C(C)=C3CCC(=O)O)c(CCC(=O)O)c2C)/NC(=O)C/1C,,%,,CHEMBL4472349
Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at protein to compound ratio of 5:1 after 100 hrs by ThT fluorescence assay,Inhibition,C/C=C1C(=C\c2[nH]c(/C=C3/N=C(/C=C4/NC(=O)C(CC)=C4C)C(C)=C3CCC(=O)O)c(CCC(=O)O)c2C)/NC(=O)C/1C,,%,,CHEMBL4472349
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation at protein to compound ratio of 5:1 after 100 hrs by ThT fluorescence assay,Inhibition,C/C=C1C(=C\c2[nH]c(/C=C3/N=C(/C=C4/NC(=O)C(CC)=C4C)C(C)=C3CCC(=O)O)c(CCC(=O)O)c2C)/NC(=O)C/1C,,%,,CHEMBL4472349
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(CNCCCN2C(=O)c3cccc4cccc(c34)C2=O)ccc1O,30.4,%,=,CHEMBL4441923
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(CNCCCN2C(=O)c3cccc4cccc(c34)C2=O)cc(OC)c1O,33.2,%,=,CHEMBL4441916
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(CNc2ccc(Nc3c4c(nc5ccccc35)CCCC4)cc2)ccc1O,77.1,%,=,CHEMBL4447264
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,75.9,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1cc(/C=N/CCCN2C(=O)c3cccc4cccc(c34)C2=O)ccc1O,,%,,CHEMBL4476323
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 10 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,,%,,CHEMBL95
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 48 hrs measured every 3 mins by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCN(CCNC3CCN(Cc4ccccc4)C3)CC2)cc1,19.2,%,=,CHEMBL4450323
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 48 hrs measured every 3 mins by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2)cc1,27.7,%,=,CHEMBL4583271
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 48 hrs measured every 3 mins by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,22.1,%,=,CHEMBL4538208
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 48 hrs measured every 3 mins by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(C(c2ccccc2)c2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,35.3,%,=,CHEMBL4516189
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCN(c2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,34.5,%,=,CHEMBL4446516
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCN(c4ccccc4)CC3)C2)cc1,38.5,%,=,CHEMBL4437584
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCN(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,37.4,%,=,CHEMBL4542622
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCN(CCNC3CCN(Cc4ccccc4)C3)CC2)cc1,37.9,%,=,CHEMBL4450323
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCN(CCc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,15.2,%,=,CHEMBL4454326
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CCN2CCN(CCNC3CCN(Cc4ccccc4)C3)CC2)cc1,34.7,%,=,CHEMBL4549465
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCN(C(c2ccccc2)c2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,27.9,%,=,CHEMBL4449308
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2)cc1,31.6,%,=,CHEMBL4583271
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(c2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,43.7,%,=,CHEMBL4455544
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCC(c4ccccc4)CC3)C2)cc1,37.4,%,=,CHEMBL4440199
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,35.0,%,=,CHEMBL4538208
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CC2CCN(CCNC3CCN(Cc4ccccc4)C3)CC2)cc1,36.6,%,=,CHEMBL4546340
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(CCc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,48.3,%,=,CHEMBL4444817
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CCC2CCN(CCNC3CCN(Cc4ccccc4)C3)CC2)cc1,41.0,%,=,CHEMBL4441721
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCC(C(c2ccccc2)c2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,53.3,%,=,CHEMBL4516189
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCC(C(c4ccccc4)c4ccccc4)CC3)C2)cc1,31.7,%,=,CHEMBL4548789
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CCN1CCC(CCc2ccccc2)CC1)NC1CCN(Cc2ccccc2)C1,47.8,%,=,CHEMBL4441798
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CCC2CCN(CCCNC3CCN(Cc4ccccc4)C3)CC2)cc1,36.3,%,=,CHEMBL4463530
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCCC(c2ccccc2)C1)NC1CCN(Cc2ccccc2)C1,38.8,%,=,CHEMBL4534311
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CN2CCC(NCCN3CCCC(c4ccccc4)C3)C2)cc1,44.9,%,=,CHEMBL4552890
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCCC(Cc2ccccc2)C1)NC1CCN(Cc2ccccc2)C1,45.1,%,=,CHEMBL4441374
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CC2CCCN(CCNC3CCN(Cc4ccccc4)C3)C2)cc1,49.2,%,=,CHEMBL4591651
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,O=C(CN1CCCC(CCc2ccccc2)C1)NC1CCN(Cc2ccccc2)C1,58.2,%,=,CHEMBL4467074
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM expressed in Escherichia coli BL21 (DE3) incubated for 24 hrs by thioflavin T-based fluorometric assay relative to control,Inhibition,c1ccc(CCC2CCCN(CCNC3CCN(Cc4ccccc4)C3)C2)cc1,41.3,%,=,CHEMBL4528953
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCOC(=O)c1cc(O)c(C(=O)OCC)cc1O,6.5,%,=,CHEMBL4532056
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=C(O)c1cc(O)c(C(=O)O)cc1O,4.7,%,=,CHEMBL4464247
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,85.0,%,=,CHEMBL4524631
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,81.0,%,=,CHEMBL4516540
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,93.5,%,=,CHEMBL4439936
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,98.2,%,=,CHEMBL4562198
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,90.0,%,=,CHEMBL4440350
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,88.0,%,=,CHEMBL4527242
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,98.6,%,=,CHEMBL4474151
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,96.2,%,=,CHEMBL4553651
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,99.7,%,=,CHEMBL4554367
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,99.9,%,=,CHEMBL4463164
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,71.6,%,=,CHEMBL4467746
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,99.8,%,=,CHEMBL4552250
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,91.4,%,=,CHEMBL4520323
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,99.7,%,=,CHEMBL4475678
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,99.6,%,=,CHEMBL4451935
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,40.2,%,=,CHEMBL140
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCOC(=O)c1cc(O)c(C(=O)OCC)cc1O,,,,CHEMBL4532056
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,O=C(O)c1cc(O)c(C(=O)O)cc1O,,,,CHEMBL4464247
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3980.0,nM,=,CHEMBL4524631
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,4200.0,nM,=,CHEMBL4516540
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,3630.0,nM,=,CHEMBL4439936
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,2410.0,nM,=,CHEMBL4562198
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3550.0,nM,=,CHEMBL4440350
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,3860.0,nM,=,CHEMBL4527242
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,3450.0,nM,=,CHEMBL4474151
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3050.0,nM,=,CHEMBL4553651
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,3710.0,nM,=,CHEMBL4554367
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,3160.0,nM,=,CHEMBL4463164
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,5470.0,nM,=,CHEMBL4467746
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,2370.0,nM,=,CHEMBL4552250
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,2800.0,nM,=,CHEMBL4520323
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,2310.0,nM,=,CHEMBL4475678
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3310.0,nM,=,CHEMBL4451935
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,68.5,%,=,CHEMBL4524631
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,62.7,%,=,CHEMBL4516540
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,70.1,%,=,CHEMBL4439936
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,77.3,%,=,CHEMBL4562198
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,67.7,%,=,CHEMBL4440350
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,81.1,%,=,CHEMBL4527242
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,80.3,%,=,CHEMBL4474151
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,75.2,%,=,CHEMBL4553651
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,64.4,%,=,CHEMBL4554367
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,60.4,%,=,CHEMBL4463164
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,67.4,%,=,CHEMBL4467746
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,80.9,%,=,CHEMBL4552250
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,83.5,%,=,CHEMBL4520323
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,76.3,%,=,CHEMBL4475678
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,83.8,%,=,CHEMBL4451935
Disaggregation of self-induced preformed fibrils of human amyloid beta (1 to 42) at 25 uM after 24 hrs by Thioflavin T based fluorometric assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation,EC50,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,25000000.0,nM,=,CHEMBL589390
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM,Inhibition,CC[C@@H](CN1CCCC1=O)C(=O)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)C[C@H]1C=C(C)C[C@@H]2C1,36.0,%,=,CHEMBL4569343
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation at 1 uM incubated for 1 hr by thioflavin T fluorescence spectroscopic method relative to control,Inhibition,O=C(Cc1cc(=O)oc2cc(O)ccc12)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,82.0,%,=,CHEMBL4575800
Inhibition of Amyloid beta (1 to 42) (unknown origin) fibril formation assessed as reduction in thickness of fibrils at 20 uM incubated for 48 hrs by transmission-type electron microscopy,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin) fibril formation assessed as reduction in number of fibrils at 20 uM incubated for 48 hrs by transmission-type electron microscopy,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation assessed as decrease in negative maximum of CD spectrum of amyloid beta (1-42) incubated for 4 hrs by CD spectroscopy,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 12 hrs by thioflavin T assay,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 12 hrs by thioflavin T assay,Inhibition,CC1(C)O[C@H]2Cc3c(O)cc(O)c([C@@H]4c5c(O)cc(O)cc5O[C@H](c5ccc(O)c(O)c5)[C@H]4O)c3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4095454
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 12 hrs by thioflavin T assay,Inhibition,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,,%,,CHEMBL501490
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 12 hrs by thioflavin T assay,Inhibition,CC1(C)O[C@H]2Cc3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL2269091
Inhibition of Amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 12 hrs by thioflavin T assay,Inhibition,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,,%,,CHEMBL311498
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 20 uM incubated for 48 hrs by WST8 assay,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,100.0,%,=,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 40 uM incubated for 48 hrs by WST8 assay,Inhibition,CC1(C)O[C@H]2Cc3c(O)cc(O)c([C@@H]4c5c(O)cc(O)cc5O[C@H](c5ccc(O)c(O)c5)[C@H]4O)c3O[C@@H]2c2cc(O)c(O)cc21,100.0,%,=,CHEMBL4095454
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 40 uM incubated for 48 hrs by WST8 assay,Inhibition,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,100.0,%,=,CHEMBL501490
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability incubated for 48 hrs by WST8 assay,Inhibition,CC1(C)O[C@H]2[C@H](c3c(O)cc(O)c4c3O[C@@H]3c5cc(O)c(O)cc5C(C)(C)O[C@H]3C4)c3c(O)cc(O)cc3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4205284
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability incubated for 48 hrs by WST8 assay,Inhibition,CC1(C)O[C@H]2Cc3c(O)cc(O)c([C@@H]4c5c(O)cc(O)cc5O[C@H](c5ccc(O)c(O)c5)[C@H]4O)c3O[C@@H]2c2cc(O)c(O)cc21,,%,,CHEMBL4095454
Inhibition of Amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability incubated for 48 hrs by WST8 assay,Inhibition,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,,%,,CHEMBL501490
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)c(Oc4ccc(-c5cc(=O)c6c(O)cc(O)cc6o5)cc4)c(O)cc3o2)cc1,50000.0,nM,>,CHEMBL4589690
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1Oc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,50000.0,nM,>,CHEMBL3589108
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,9500.0,nM,=,CHEMBL291426
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(OC)cc6)oc45)c3o2)cc1,50000.0,nM,>,CHEMBL3589106
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3o2)cc1,45600.0,nM,=,CHEMBL4513568
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,17300.0,nM,=,CHEMBL4463033
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,50000.0,nM,>,CHEMBL4536141
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,15900.0,nM,=,CHEMBL4554693
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,32800.0,nM,=,CHEMBL4545404
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,13000.0,nM,=,CHEMBL4449738
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,21300.0,nM,=,CHEMBL3589107
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O,50000.0,nM,>,CHEMBL451902
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,50000.0,nM,>,CHEMBL378516
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,50000.0,nM,>,CHEMBL453479
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4O)c3o2)cc1,50000.0,nM,>,CHEMBL1208904
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,50000.0,nM,>,CHEMBL208908
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,50000.0,nM,>,CHEMBL208578
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,20100.0,nM,=,CHEMBL374055
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,10100.0,nM,=,CHEMBL1208903
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,50000.0,nM,>,CHEMBL208988
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,13200.0,nM,=,CHEMBL377324
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,4900.0,nM,=,CHEMBL220745
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,50000.0,nM,>,CHEMBL450522
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,4700.0,nM,=,CHEMBL378188
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,4900.0,nM,=,CHEMBL255493
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,4800.0,nM,=,CHEMBL63354
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)c(Oc4ccc(-c5cc(=O)c6c(O)cc(O)cc6o5)cc4)c(OC)cc3o2)cc1,50000.0,nM,>,CHEMBL4522982
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,50000.0,nM,>,CHEMBL28
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,4100.0,nM,=,CHEMBL164
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in aggregation at 50 uM by ThT fluorescence assay,Inhibition,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,44.0,%,=,CHEMBL208908
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM for 48 hrs by TEM analysis,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,,%,,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM for 48 hrs by TEM analysis,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,,%,,CHEMBL4444043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,17440.0,nM,=,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,3870.0,nM,=,CHEMBL4444043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,91.41,%,=,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,95.42,%,=,CHEMBL4444043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 75 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,85.77,%,=,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 75 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,87.5,%,=,CHEMBL4444043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,59.31,%,=,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,82.41,%,=,CHEMBL4444043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 12.5 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,42.03,%,=,CHEMBL4436866
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 12.5 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,70.42,%,=,CHEMBL4444043
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,58.8,%,=,CHEMBL4436866
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,62.64,%,=,CHEMBL4444043
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,COc1ccc(OC)c(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,47.94,%,=,CHEMBL4435306
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,CN(C)c1ccc(-c2cc(-c3cccc4ccccc34)nc3nncn23)cc1,54.51,%,=,CHEMBL4578090
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.7,%,=,CHEMBL140
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,72.77,%,=,CHEMBL4436866
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,85.46,%,=,CHEMBL4444043
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(OC)c(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,42.14,%,=,CHEMBL4435306
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Clc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,,%,,CHEMBL4456307
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,Clc1ccccc1C1C=C(c2cccc3ccccc23)Nc2nncn21,40.39,%,=,CHEMBL4438613
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,31.23,%,=,CHEMBL4590912
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1coc(-c2cc(-c3cccc4ccccc34)nc3nncn23)c1,12.07,%,=,CHEMBL4584649
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,CN(C)c1ccc(-c2cc(-c3cccc4ccccc34)nc3nncn23)cc1,43.12,%,=,CHEMBL4578090
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccc(-c2cc(-c3cccc4ccccc34)nc3nncn23)cc1OC,36.62,%,=,CHEMBL4473126
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc(-c2cc(-c3cccc4ccccc34)nc3nncn23)cc1,,%,,CHEMBL4444113
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM for 48 hrs by TEM analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,40.0,%,=,CHEMBL140
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C(O)/C=C/c1ccccc1O)/C=C/c1ccc(O)c(O)c1,62.0,%,=,CHEMBL3103052
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1O)CC(=O)/C=C/c1cccc(O)c1O,93.0,%,=,CHEMBL4465224
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)/C=C/c1cccc(O)c1O,92.0,%,=,CHEMBL4465205
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1cc(O)ccc1O,57.0,%,=,CHEMBL4536281
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)/C=C/c1cccc(O)c1O,100.0,%,=,CHEMBL4438864
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)/C=C/c1cc(O)ccc1O,80.0,%,=,CHEMBL4460553
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1cc(O)ccc1O,56.0,%,=,CHEMBL4446261
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1cc(O)ccc1O,53.0,%,=,CHEMBL3672403
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)/C=C/c1cc(O)ccc1O,99.0,%,=,CHEMBL4442693
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)/C=C/c1ccccc1O,100.0,%,=,CHEMBL4573289
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)/C=C/c1ccc(O)c(O)c1,100.0,%,=,CHEMBL4587853
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)/C=C/c1ccc(O)c(O)c1,75.0,%,=,CHEMBL4525599
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)/C=C/c1cc(O)ccc1O,100.0,%,=,CHEMBL4447188
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)/C=C/c1cccc(O)c1O,98.0,%,=,CHEMBL4550028
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)/C=C/c1cccc(O)c1O,90.0,%,=,CHEMBL4582302
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)/C=C/c1cccc(O)c1O,96.0,%,=,CHEMBL4438975
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)/C=C/c1cccc(O)c1O,100.0,%,=,CHEMBL4575348
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)c1ccc(O)c(O)c1,90.0,%,=,CHEMBL4451204
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)c1ccc(O)c(O)c1,85.0,%,=,CHEMBL4460460
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)c1ccc(O)c(O)c1,98.0,%,=,CHEMBL4586524
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)c1cccc(O)c1O,100.0,%,=,CHEMBL4551077
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 10 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,80.0,%,=,CHEMBL140
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 10 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1cccc(O)c1O,98.0,%,=,CHEMBL4562928
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 10 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1cccc(O)c1O,100.0,%,=,CHEMBL4561007
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 10 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1cccc(O)c1O,100.0,%,=,CHEMBL4540886
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4562928
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1O)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4465224
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4465205
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4561007
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4540886
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)CC(=O)/C=C/c1cc(O)ccc1O,95.0,%,=,CHEMBL4536281
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)/C=C/c1cccc(O)c1O,95.0,%,=,CHEMBL4438864
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccccc1O)CC(=O)/C=C/c1cc(O)ccc1O,95.0,%,=,CHEMBL4460553
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1)CC(=O)/C=C/c1cc(O)ccc1O,95.0,%,=,CHEMBL4446261
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)cc1)CC(=O)/C=C/c1cc(O)ccc1O,95.0,%,=,CHEMBL3672403
Inhibition of self-induced amyloid beta 42 (unknown origin) fibril formation at 10 uM incubated for 6 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)CC(=O)/C=C/c1cc(O)ccc1O,95.0,%,=,CHEMBL4442693
Disaggregation of self-induced amyloid beta 42 (unknown origin) preformed fibrils assessed as length of nanorod-like fragment by TEM analysis,Activity,O=C(/C=C/c1cc(O)ccc1O)/C=C/c1cccc(O)c1O,50.0,nm,=,CHEMBL4575348
Disaggregation of self-induced amyloid beta 42 (unknown origin) preformed fibrils assessed as appearance of nanorod-like fragment by CD spectra analysis,Activity,O=C(/C=C/c1cc(O)ccc1O)/C=C/c1cccc(O)c1O,,,,CHEMBL4575348
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1cccc(O)c1O)c1cc(O)ccc1O,98.0,%,=,CHEMBL4551547
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation at 1 uM incubated for 20 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(/C=C/c1ccc(O)c(O)c1)c1cc(O)ccc1O,85.0,%,=,CHEMBL125800
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,O=C(CCCCCCNc1c2c(nc3cccc(Cl)c13)CCCC2)NCCc1c[nH]c2ccccc12,,%,,CHEMBL4589980
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,O=C(CCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)NCCc1cc2ccccc2[nH]1,,%,,CHEMBL4448188
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,5.0,%,<,CHEMBL292314
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(N)c2c1)CCCC3,5.0,%,<,CHEMBL1256415
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.NC(Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,57.2,%,=,CHEMBL4559593
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,60.7,%,=,CHEMBL4449083
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,54.7,%,=,CHEMBL4538398
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,51.6,%,=,CHEMBL4556372
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,47.0,%,=,CHEMBL4475391
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,51.9,%,=,CHEMBL4472570
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,58.0,%,=,CHEMBL4467355
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,57.9,%,=,CHEMBL4586157
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc2nc3c(c(NCCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl,54.5,%,=,CHEMBL4582203
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,18.7,%,=,CHEMBL4444822
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,19.9,%,=,CHEMBL4541558
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,28.9,%,=,CHEMBL4552440
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,50.6,%,=,CHEMBL4563209
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,58.6,%,=,CHEMBL4556281
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,59.0,%,=,CHEMBL4555818
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,59.4,%,=,CHEMBL4466307
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCNc1c2c(nc3ccccc13)CCCC2,44.0,%,=,CHEMBL4459500
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2,46.4,%,=,CHEMBL4438120
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCNc1c2c(nc3ccccc13)CCCC2,59.1,%,=,CHEMBL4459416
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCNc1c2c(nc3ccccc13)CCCC2,54.3,%,=,CHEMBL4556575
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2,55.5,%,=,CHEMBL4540429
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCNc1c2c(nc3ccccc13)CCCC2,60.9,%,=,CHEMBL4559477
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Cl.Cl.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCCCCCCCNc1c2c(nc3ccccc13)CCCC2,63.6,%,=,CHEMBL4456435
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,5.0,%,<,CHEMBL95
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 10 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,O=C1C(NCCNc2c3c(nc4cc(Cl)ccc24)CCCC3)=CC(=O)c2c(O)cccc21,37.5,%,=,CHEMBL3356536
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,O=C1C=C(NC(Cc2c[nH]c3ccccc23)C(=O)O)C(=O)c2ccccc21,25.4,%,=,CHEMBL4580660
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation at 50 uM incubated for 24 hrs by thioflavin T based fluorescence assay relative to control,Inhibition,O=C1C=C(N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)C(=O)c2ccccc21,28.5,%,=,CHEMBL3957176
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) fibril formation assessed as appearance of sparse fibrils at 25 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,58.04,%,=,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,84.1,%,=,CHEMBL4453548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 15 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,39.85,%,=,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 15 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,43.79,%,=,CHEMBL4453548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,3.9,%,=,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,28.62,%,=,CHEMBL4453548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) fibril formation assessed as appearance of sparse fibrils at 25 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,,%,,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) fibril formation assessed as appearance of sparse fibrils at 25 uM after 48 hrs by transmission electron microscopic analysis,Inhibition,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,,%,,CHEMBL4453548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,17890.0,nM,=,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,15720.0,nM,=,CHEMBL4453548
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,,,,CHEMBL4560049
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(CN1CCOCC1)Nc1n[nH]c2ncccc12,47.36,%,=,CHEMBL4437109
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(CN1CCCCC1)Nc1n[nH]c2ncccc12,,,,CHEMBL4451095
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,N#Cc1cccnc1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,,,,CHEMBL4569884
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)Nc1n[nH]c2ncccc12,,,,CHEMBL4437847
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,Cc1cc(N2CCN(CC(=O)Nc3n[nH]c4ncccc34)CC2)n2ncnc2n1,,,,CHEMBL4474224
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,53.8,%,=,CHEMBL4444093
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,CCOC(=O)c1cnc2ccc(C)cc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,52.13,%,=,CHEMBL4439198
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils measured after 24 hrs by ThT fluorescence assay relative to control,Activity,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,61.59,%,=,CHEMBL4453548
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.7,%,=,CHEMBL140
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,50.85,%,=,CHEMBL4560049
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCOCC1)Nc1n[nH]c2ncccc12,74.62,%,=,CHEMBL4437109
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCCCC1)Nc1n[nH]c2ncccc12,50.61,%,=,CHEMBL4451095
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,N#Cc1cccnc1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,39.98,%,=,CHEMBL4569884
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)Nc1n[nH]c2ncccc12,23.6,%,=,CHEMBL4437847
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Cc1cc(N2CCN(CC(=O)Nc3n[nH]c4ncccc34)CC2)n2ncnc2n1,43.43,%,=,CHEMBL4474224
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,79.47,%,=,CHEMBL4444093
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOC(=O)c1cnc2ccc(C)cc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,69.31,%,=,CHEMBL4439198
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM incubated for 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,81.65,%,=,CHEMBL4453548
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 72 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2cccnc12,,%,,CHEMBL4571835
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 72 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 72 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(c1cc(O)c2ncccc2c1)N(C)C,,%,,CHEMBL4537123
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2cccnc12,31.34,%,=,CHEMBL4571835
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin-T fluorescence assay (Rvb =0%),Inhibition,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2cccnc12,55.88,%,=,CHEMBL4571835
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin-T fluorescence assay (Rvb =0%),Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,50.19,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 20 uM after 48 hrs by thioflavin-T fluorescence assay (Rvb =0%),Inhibition,CC(c1cc(O)c2ncccc2c1)N(C)C,44.05,%,=,CHEMBL4537123
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self- aggregation at 20 uM after 72 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2cccnc12,66.09,%,=,CHEMBL4571835
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay,Inhibition,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL50
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cl.c1ccc(CN2CCCc3[nH]c4ccccc4c3C2)cc1,38.0,%,=,CHEMBL4436327
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cl.c1ccc(CCN2CCCc3[nH]c4ccccc4c3C2)cc1,38.0,%,=,CHEMBL4453569
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cl.Cn1c2c(c3ccccc31)CN(CCc1ccccc1)CCC2,38.0,%,=,CHEMBL4452751
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cl.c1ccc(CCCN2CCCc3[nH]c4ccccc4c3C2)cc1,38.0,%,=,CHEMBL4570863
Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay relative to control,Inhibition,Cl.c1ccc(CCCCN2CCCc3[nH]c4ccccc4c3C2)cc1,38.0,%,=,CHEMBL4538834
Inhibition of beta amyloid in human SH-SY5Y cells,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,300000.0,nM,=,CHEMBL6246
Inhibition of beta amyloid (unknown origin) after 12 to 24 hrs,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,100000.0,nM,=,CHEMBL6246
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 5 to 20 uM after 48 hrs by Thioflavin T based fluorometric assay,Inhibition,Nc1ccc2oc(N3CCN(C(=O)c4ccc(Br)cc4)CC3)nc2c1,,%,,CHEMBL4536953
Displacement of [125I]IMPY from human amyloid beta(1-42) aggregates incubated for 3 hrs by gamma counting analysis,Ki,CN(C)c1ccc(-c2nc3cc([125I])ccc3o2)cn1,6.9,nM,=,CHEMBL4470128
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN(C)C)c2)c(F)c1,42.71,%,=,CHEMBL4439405
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)Cc1cc(-c2ccc(C(C)C(=O)OC)cc2F)ccc1O,8.3,%,=,CHEMBL4458428
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN3CCCC3)c2)c(F)c1,15.83,%,=,CHEMBL4546572
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN3CCCCC3)c2)c(F)c1,15.46,%,=,CHEMBL4472615
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN3CCOCC3)c2)c(F)c1,12.92,%,=,CHEMBL4473849
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN3CCN(C)CC3)c2)c(F)c1,34.14,%,=,CHEMBL4445282
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN1CCN(Cc2cc(-c3ccc(C(C)C(=O)OC)cc3F)ccc2O)CC1,28.86,%,=,CHEMBL4439838
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN3CCN(Cc4ccccc4)CC3)c2)c(F)c1,28.43,%,=,CHEMBL4438735
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN(C)Cc3ccccc3)c2)c(F)c1,36.72,%,=,CHEMBL4474981
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(Cc1ccccc1)Cc1cc(-c2ccc(C(C)C(=O)OC)cc2F)ccc1O,36.76,%,=,CHEMBL4552280
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(O)c(CN(C)Cc3ccccc3OC)c2)c(F)c1,60.61,%,=,CHEMBL4579095
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(Cc1cc(-c2ccc(C(C)C(=O)OC)cc2F)ccc1O)Cc1ccccc1OC,60.45,%,=,CHEMBL4542573
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(Cc1cc(-c2ccc(C(C)C(=O)OC)cc2F)ccc1O)Cc1ccccc1N(C)C,60.56,%,=,CHEMBL4578805
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCN(Cc1ccc(N(C)C)cc1)Cc1cc(-c2ccc(C(C)C(=O)OC)cc2F)ccc1O,65.03,%,=,CHEMBL4443679
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,12.84,%,=,CHEMBL563
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,41.3,%,=,CHEMBL140
Inhibition of HFIP-pretreated human amyloid beta (1 to 42) self-induced aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of amyloid beta 1 to 42 (unknown origin) self aggregation up to 20 uM after 48 hrs by thioflavin T-based fluorometric assay relative to donepezil,Inhibition,O=[N+]([O-])c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,18.5,%,=,CHEMBL4442580
Inhibition of amyloid beta 1 to 42 (unknown origin) self aggregation up to 20 uM after 48 hrs by thioflavin T-based fluorometric assay relative to donepezil,Inhibition,FC(F)(F)c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,26.1,%,=,CHEMBL4583534
Inhibition of amyloid beta 1 to 42 (unknown origin) self aggregation up to 20 uM after 48 hrs by thioflavin T-based fluorometric assay relative to donepezil,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,16.7,%,=,CHEMBL502
Inhibition of amyloid beta 1 to 42 (unknown origin) aggregation assessed as oligomer height at 10 uM incubated for 7 days by AFM analysis,Activity,FC(F)(F)c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,44.46,nm,=,CHEMBL4583534
Inhibition of amyloid beta 1 to 42 (unknown origin) aggregation assessed as roughness index at 10 uM incubated for 7 days by AFM analysis,Activity,FC(F)(F)c1ccc(CNC2CCN(Cc3ccccc3)CC2)cc1,1.7,nm,=,CHEMBL4583534
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CCC1(C)C=Cc2c(O)cc(C)cc2O1,68000.0,nM,=,CHEMBL4645437
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)c(O)c1O,16700.0,nM,=,CHEMBL4640668
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc(C)c(C(=O)O)c2O)O1,24700.0,nM,=,CHEMBL1171643
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,62700.0,nM,=,CHEMBL2012313
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c1O,221000.0,nM,=,CHEMBL4643713
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,7400.0,nM,=,CHEMBL164
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)cc(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,29300.0,nM,=,CHEMBL4646459
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,150800.0,nM,=,CHEMBL4644047
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)c(-c2c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c2O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,12300.0,nM,=,CHEMBL4638539
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)cc1O,19900.0,nM,=,CHEMBL4641877
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCCNc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,44.13,%,=,CHEMBL4641208
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCNc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,36.61,%,=,CHEMBL4634179
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation assessed as reduction in number of amyloid beta aggregates at 20 uM measured after 48 hrs by TEM analysis,Inhibition,c1ccc2c(N3CCCC3)cc(-c3ccc4c(c3)OCO4)nc2c1,,%,,CHEMBL4641481
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCCCCNc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,39.37,%,=,CHEMBL4646479
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc2c(NCCCN3CCCCC3)cc(-c3ccc4c(c3)OCO4)nc2c1,65.59,%,=,CHEMBL4642757
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc2c(NCCCN3CCOCC3)cc(-c3ccc4c(c3)OCO4)nc2c1,61.64,%,=,CHEMBL4634509
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc2c(N3CCCC3)cc(-c3ccc4c(c3)OCO4)nc2c1,62.52,%,=,CHEMBL4641481
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc2c(N3CCCCC3)cc(-c3ccc4c(c3)OCO4)nc2c1,48.55,%,=,CHEMBL4642522
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,CCCCNc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,30.63,%,=,CHEMBL4634689
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCNc1cc(-c2ccccc2)nc2ccccc12,36.8,%,=,CHEMBL327412
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCCNc1cc(-c2ccccc2)nc2ccccc12,40.71,%,=,CHEMBL4642989
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,OCCCCCCNc1cc(-c2ccccc2)nc2ccccc12,29.16,%,=,CHEMBL4638069
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc(-c2cc(NCCCN3CCCCC3)c3ccccc3n2)cc1,60.31,%,=,CHEMBL3580417
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc(-c2cc(NCCCN3CCOCC3)c3ccccc3n2)cc1,55.51,%,=,CHEMBL3559961
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,c1ccc(-c2cc(N3CCCC3)c3ccccc3n2)cc1,57.68,%,=,CHEMBL4639799
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(-c2ccc3c(c2)OCO3)nc2ccccc12,26.92,%,=,CHEMBL2205100
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation at 20 uM measured after 48 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.26,%,=,CHEMBL140
Inhibition of self-induced human amyloid beta (1 to 42) peptide aggregation assessed as reduction in number of amyloid beta aggregates at 20 uM measured after 48 hrs by TEM analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C=CCSCC(NC(=O)CCCCCNc1c2c(nc3ccccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,78.2,%,=,CHEMBL4642573
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C=CCSCC(NC(=O)CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,31.6,%,=,CHEMBL4635342
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs in presence of copper by ThT fluorescence assay relative to control,Inhibition,C=CCSCC(NC(=O)CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,56.6,%,=,CHEMBL4635342
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C#CCSCC(NC(=O)CCCNc1c2c(nc3ccccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,77.2,%,=,CHEMBL4637185
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C#CCSCC(NC(=O)CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,24.1,%,=,CHEMBL4633417
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM after 24 hrs in presence of copper by ThT fluorescence assay relative to control,Inhibition,C#CCSCC(NC(=O)CCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)C(=O)Nc1nc2ccccc2s1,37.6,%,=,CHEMBL4633417
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/CCCN(C)Cc1ccccc1)OC2=O,11.7,%,=,CHEMBL4634341
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1,17.0,%,=,CHEMBL4648720
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21,15.1,%,=,CHEMBL4645281
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1OC,23.8,%,=,CHEMBL4646770
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,15.4,%,=,CHEMBL4648295
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21)Cc1ccc(N(C)C)cc1,22.0,%,=,CHEMBL4643131
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/CCCN1CCCCC1)OC2=O,4.9,%,=,CHEMBL4633809
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/CCCCCN(C)Cc1ccccc1)OC2=O,19.45,%,=,CHEMBL4646581
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC/C=C1\OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,16.3,%,=,CHEMBL4641295
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\CCCN(C)Cc1ccccc1)OC2=O,8.6,%,=,CHEMBL4641476
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1,30.3,%,=,CHEMBL4633220
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21,19.1,%,=,CHEMBL4636967
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1OC,19.0,%,=,CHEMBL4641547
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,8.2,%,=,CHEMBL4644774
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21)Cc1ccc(N(C)C)cc1,21.7,%,=,CHEMBL4643023
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\CCCN1CCCCC1)OC2=O,11.3,%,=,CHEMBL4633903
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CC)CCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21,15.1,%,=,CHEMBL4643022
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\CCCCCN(C)Cc1ccccc1)OC2=O,12.36,%,=,CHEMBL4643866
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC/C=C1/OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,13.0,%,=,CHEMBL4638217
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(CCCCN(C)Cc1ccccc1)OC2=O,8.9,%,=,CHEMBL4646362
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC1OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1,15.6,%,=,CHEMBL4638512
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1ccccc1CN(C)CCCCC1OC(=O)c2cc(OC)c(OC)cc21,14.4,%,=,CHEMBL4639305
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC1OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1OC,13.8,%,=,CHEMBL4637525
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC1OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,15.3,%,=,CHEMBL4646713
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCC1OC(=O)c2cc(OC)c(OC)cc21)Cc1ccc(N(C)C)cc1,5.0,%,<,CHEMBL4638405
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(CCCCN1CCCCC1)OC2=O,5.0,%,<,CHEMBL4641163
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CC)CCCCC1OC(=O)c2cc(OC)c(OC)cc21,15.0,%,=,CHEMBL4638936
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(CCCCCCN(C)Cc1ccccc1)OC2=O,12.98,%,=,CHEMBL4645926
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCN(CCCCCCC1OC(=O)c2cc(OC)c(OC)cc21)Cc1ccccc1N(C)C,7.66,%,=,CHEMBL4645834
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,5.0,%,<,CHEMBL502
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CCCCC1OC(=O)c2ccccc21,5.0,%,<,CHEMBL248594
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,39.0,%,=,CHEMBL140
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C#CCN(C)CCCOc1ccc(Cl)cc1Cl,,%,,CHEMBL8706
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,C#CCN[C@@H]1CCc2ccccc21,,%,,CHEMBL887
Inhibition of HFIP-pretreated self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,CC(C)NNC(=O)c1ccncc1,,%,,CHEMBL92401
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccc3O)cc2)c(F)c1,24.69,%,=,CHEMBL4642602
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Cl)ccc3O)cc2)c(F)c1,48.32,%,=,CHEMBL4636591
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)ccc3O)cc2)c(F)c1,36.96,%,=,CHEMBL4639929
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)cc(Br)c3O)cc2)c(F)c1,57.85,%,=,CHEMBL4644589
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(C)ccc3O)cc2)c(F)c1,58.46,%,=,CHEMBL4637910
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(OC)ccc3O)cc2)c(F)c1,73.61,%,=,CHEMBL4636947
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(OC)c3O)cc2)c(F)c1,46.21,%,=,CHEMBL4638329
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccc(OC)cc3O)cc2)c(F)c1,32.79,%,=,CHEMBL4636375
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(N(C)C)ccc3O)cc2)c(F)c1,96.33,%,=,CHEMBL4647293
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(NC(C)=O)ccc3O)cc2)c(F)c1,39.19,%,=,CHEMBL4643921
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)ccc3O)cc2)c(F)c1,43.05,%,=,CHEMBL4648088
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN(C)C)c3O)cc2)c(F)c1,68.6,%,=,CHEMBL4633431
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)cc(OC)c3O)cc2)c(F)c1,58.25,%,=,CHEMBL4637268
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN4CCCCC4)ccc3O)cc2)c(F)c1,29.39,%,=,CHEMBL4634583
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN4CCCCC4)c3O)cc2)c(F)c1,48.81,%,=,CHEMBL4646741
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccn3)cc2)c(F)c1,48.28,%,=,CHEMBL4648532
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3nc(C)c(C)nc3C)cc2)c(F)c1,27.53,%,=,CHEMBL4636637
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccccc2NCc2cc(N(C)C)ccc2O)c(F)c1,96.09,%,=,CHEMBL4635615
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,12.57,%,=,CHEMBL563
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,62.36,%,=,CHEMBL497
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,32.55,%,=,CHEMBL140
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccc3O)cc2)c(F)c1,42.91,%,=,CHEMBL4642602
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Cl)ccc3O)cc2)c(F)c1,41.87,%,=,CHEMBL4636591
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)ccc3O)cc2)c(F)c1,32.01,%,=,CHEMBL4639929
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)cc(Br)c3O)cc2)c(F)c1,38.26,%,=,CHEMBL4644589
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(C)ccc3O)cc2)c(F)c1,49.67,%,=,CHEMBL4637910
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(OC)ccc3O)cc2)c(F)c1,43.64,%,=,CHEMBL4636947
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(OC)c3O)cc2)c(F)c1,39.92,%,=,CHEMBL4638329
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccc(OC)cc3O)cc2)c(F)c1,30.56,%,=,CHEMBL4636375
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(N(C)C)ccc3O)cc2)c(F)c1,84.33,%,=,CHEMBL4647293
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(NC(C)=O)ccc3O)cc2)c(F)c1,23.99,%,=,CHEMBL4643921
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)ccc3O)cc2)c(F)c1,43.68,%,=,CHEMBL4648088
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN(C)C)c3O)cc2)c(F)c1,41.85,%,=,CHEMBL4633431
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)cc(OC)c3O)cc2)c(F)c1,38.29,%,=,CHEMBL4637268
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN4CCCCC4)ccc3O)cc2)c(F)c1,29.38,%,=,CHEMBL4634583
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN4CCCCC4)c3O)cc2)c(F)c1,42.4,%,=,CHEMBL4646741
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccn3)cc2)c(F)c1,37.82,%,=,CHEMBL4648532
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccc(NCc3nc(C)c(C)nc3C)cc2)c(F)c1,22.46,%,=,CHEMBL4636637
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COC(=O)C(C)c1ccc(-c2ccccc2NCc2cc(N(C)C)ccc2O)c(F)c1,87.3,%,=,CHEMBL4635615
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,7.29,%,=,CHEMBL563
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,Oc1c(I)cc(Cl)c2cccnc12,40.14,%,=,CHEMBL497
Inhibition of Cu2+-induced HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,32.46,%,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccc3O)cc2)c(F)c1,44.08,%,=,CHEMBL4642602
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Cl)ccc3O)cc2)c(F)c1,41.87,%,=,CHEMBL4636591
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)ccc3O)cc2)c(F)c1,36.59,%,=,CHEMBL4639929
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(Br)cc(Br)c3O)cc2)c(F)c1,35.89,%,=,CHEMBL4644589
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(C)ccc3O)cc2)c(F)c1,42.62,%,=,CHEMBL4637910
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(OC)ccc3O)cc2)c(F)c1,53.28,%,=,CHEMBL4636947
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(OC)c3O)cc2)c(F)c1,41.69,%,=,CHEMBL4638329
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccc(OC)cc3O)cc2)c(F)c1,25.62,%,=,CHEMBL4636375
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(N(C)C)ccc3O)cc2)c(F)c1,91.12,%,=,CHEMBL4647293
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(NC(C)=O)ccc3O)cc2)c(F)c1,27.11,%,=,CHEMBL4643921
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)ccc3O)cc2)c(F)c1,51.19,%,=,CHEMBL4648088
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN(C)C)c3O)cc2)c(F)c1,45.06,%,=,CHEMBL4633431
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN(C)C)cc(OC)c3O)cc2)c(F)c1,49.28,%,=,CHEMBL4637268
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cc(CN4CCCCC4)ccc3O)cc2)c(F)c1,30.2,%,=,CHEMBL4634583
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3cccc(CN4CCCCC4)c3O)cc2)c(F)c1,43.27,%,=,CHEMBL4646741
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3ccccn3)cc2)c(F)c1,35.54,%,=,CHEMBL4648532
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccc(NCc3nc(C)c(C)nc3C)cc2)c(F)c1,18.29,%,=,CHEMBL4636637
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COC(=O)C(C)c1ccc(-c2ccccc2NCc2cc(N(C)C)ccc2O)c(F)c1,91.07,%,=,CHEMBL4635615
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,9.28,%,=,CHEMBL563
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,Oc1c(I)cc(Cl)c2cccnc12,51.14,%,=,CHEMBL497
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.77,%,=,CHEMBL140
Inhibition of self-induced aggregation amyloid beta (1 to 42) (unknown origin) assessed as reduction in fibril formation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],12530.0,nM,=,CHEMBL4776150
Inhibition of self-induced aggregation amyloid beta (1 to 42) (unknown origin) assessed as reduction in fibril formation incubated for 24 hrs by Thioflavin T based fluorometric assay,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],,%,,CHEMBL4776150
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as decrease in negative band ellipticity and shift around 230 nm resulting in inhibition of beta-sheets formation at 80 uM incubated for 24 hrs by circular dichroism spectroscopy,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],,%,,CHEMBL4776150
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as decrease in negative band ellipticity and shift around 230 nm resulting in modulation of amyloid beta (1 to 42) conformation at 80 uM incubated for 24 hrs by circular dichroism spectroscopy,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],,%,,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 50 uM treated for 49 hrs at 25 degreeC by microscopic analysis (Rvb = 87 %),Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],74.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 100 uM treated for 49 hrs at 25 degreeC by microscopic analysis (Rvb = 87 %),Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],66.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 200 uM treated for 49 hrs at 25 degreeC by microscopic analysis (Rvb = 87 %),Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],35.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans GMC101 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 50 uM measured after 92 hrs by microscopic analysis relative to control,Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],74.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans GMC101 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 100 uM measured after 92 hrs by microscopic analysis relative to control,Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],66.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans GMC101 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 200 uM measured after 92 hrs by microscopic analysis relative to control,Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],35.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 L3 expressing human amyloid beta (1 to 42) assessed as roller movement of worms by microscopic analysis,Activity,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],,,,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans GMC101 L3 expressing human amyloid beta (1 to 42) assessed as reduction in fluorescence intensity at 50 uM incubated for 2 days by fluorescence based confocal microscopic analysis relative to control,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],43.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans GMC101 L3 expressing human amyloid beta (1 to 42) assessed as reduction in fluorescence intensity at 100 uM incubated for 2 days by fluorescence based confocal microscopic analysis relative to control,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],20.0,%,=,CHEMBL4776150
Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 L3 expressing human amyloid beta (1 to 42) assessed as reduction in fluorescence intensity at 50 to 200 uM incubated for 2 days by thiofavin-T based fluorescence microscopic analysis,Inhibition,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],,%,,CHEMBL4776150
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM after 48 hrs by Thioflavin T based fluorometric assay,Flu intensity,Brc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)cc1,0.42,,=,CHEMBL4779999
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM after 48 hrs by Thioflavin T based fluorometric assay,Flu intensity,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(F)c1,0.3,,=,CHEMBL4759108
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM after 48 hrs by Thioflavin T based fluorometric assay,Flu intensity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,0.31,,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by Thioflavin T based fluorometric assay,Inhibition,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(F)c1,,%,,CHEMBL4759108
Inhibition of amyloid beta (unknown origin) self aggregation assessed as maximum peak height at 10 uM after 10 days by atomic force microscopy,Activity,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(F)c1,44.23,nm,=,CHEMBL4759108
Inhibition of amyloid beta (unknown origin) self aggregation assessed as roughness index at 10 uM after 10 days by atomic force microscopy,Activity,Fc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)o2)c(F)c1,1.84,nm,=,CHEMBL4759108
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,COC[C@H]1O[C@@H](c2ccc(O)c(O)c2)[C@H](OC)[C@@H](OC)[C@@H]1OC,,%,,CHEMBL4752579
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,COC[C@H]1O[C@@H](c2c(O)cc(O)c(C(C)=O)c2O)[C@H](OC)[C@@H](OC)[C@@H]1OC,,%,,CHEMBL4741397
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,COC[C@H]1O[C@@H](c2cc(O)ccc2O)[C@H](OC)[C@@H](OC)[C@@H]1OC,,%,,CHEMBL4751502
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,O=C(Oc1ccc(O)c([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1)c1ccccc1,,%,,CHEMBL4747911
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,OC[C@H]1O[C@@H](c2c(O)ccc3ccccc23)[C@H](O)[C@@H](O)[C@@H]1O,,%,,CHEMBL4743792
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,COC[C@H]1O[C@@H](c2ccc(OC(=O)c3ccccc3)c(OC(=O)c3ccccc3)c2)[C@H](OC)[C@@H](OC)[C@@H]1OC,,%,,CHEMBL4776773
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,O=C(Oc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1OC(=O)c1ccccc1)c1ccccc1,,%,,CHEMBL4755414
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,O=C(Oc1ccccc1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,,%,,CHEMBL4789916
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,Oc1ccc(OC2O[C@H](COCc3ccccc3)[C@@H](OCc3ccccc3)[C@H](OCc3ccccc3)[C@H]2OCc2ccccc2)cc1,,%,,CHEMBL4741846
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,O=C(Cc1ccccc1)c1c(O)cc(O)cc1O,,%,,CHEMBL560920
Inhibition of human amyloid beta (1 to 42) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay,Inhibition,O=C(Cc1ccccc1)Oc1cc(O)cc(O)c1,,%,,CHEMBL4743135
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 1 uM and measured after 48 hrs by thiazine red staining method,Inhibition,CSC(=S)NCCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4798103
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 1 nM and measured after 48 hrs by thiazine red staining method,Inhibition,O=C(O)CCCCCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4753672
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 1 nM and measured after 48 hrs by thiazine red staining method,Inhibition,O=C(O)CCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4742037
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 0.001 to 50 micromol/L and measured after 48 hrs by thiazine red staining method,Inhibition,CSC(=S)NCCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4798103
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 0.001 to 50 micromol/L and measured after 48 hrs by thiazine red staining method,Inhibition,O=C(O)CCCCCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4753672
Inhibition of Abeta(1 to 42) peptide aggregation in immortalized human microglia with SV40 assessed as reduction in fluorescence intensity at 0.001 to 50 micromol/L and measured after 48 hrs by thiazine red staining method,Inhibition,O=C(O)CCNC(=O)CCC(=O)Nc1cccc2ccccc12,,%,,CHEMBL4742037
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,3000.0,nM,=,CHEMBL4762873
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCCC(=O)Nc1ccccc1)NO,20000.0,nM,>,CHEMBL98
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(F)cc23)cc1,20000.0,nM,>,CHEMBL4757035
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,1100.0,nM,=,CHEMBL4796066
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,3500.0,nM,=,CHEMBL4751082
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,3000.0,nM,=,CHEMBL4761847
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,13000.0,nM,=,CHEMBL4753795
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,34900.0,nM,=,CHEMBL4750838
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1,20000.0,nM,>,CHEMBL4799871
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2ccnc3ccccc23)cc1,20000.0,nM,>,CHEMBL4752558
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,8500.0,nM,=,CHEMBL28626
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,41.0,%,=,CHEMBL4762873
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CCCCCCC(=O)Nc1ccccc1)NO,0.0,%,=,CHEMBL98
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(F)cc23)cc1,38.0,%,=,CHEMBL4757035
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,70.0,%,=,CHEMBL4796066
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,53.0,%,=,CHEMBL4751082
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,57.0,%,=,CHEMBL4761847
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,42.0,%,=,CHEMBL4753795
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,53.0,%,=,CHEMBL4750838
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1,0.0,%,=,CHEMBL4799871
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(NO)c1ccc(Nc2ccnc3ccccc23)cc1,0.0,%,=,CHEMBL4752558
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,,%,,CHEMBL28626
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,,,,CHEMBL4761179
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,,,,CHEMBL4787165
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,,,,CHEMBL4792013
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,,,CHEMBL4759355
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,,,,CHEMBL4779514
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,43.3,%,=,CHEMBL4793075
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)C,,,,CHEMBL4759959
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,,,CHEMBL4745075
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)OC,,,,CHEMBL4741070
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1OC,,,,CHEMBL4740081
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,,,,CHEMBL4756176
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,,,CHEMBL4762653
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCCCC2)cc1OC,,,,CHEMBL4747710
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(C)C,,,,CHEMBL4748948
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,,,CHEMBL4756054
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N(CC)Cc2ccccc2)cc1OC,,,,CHEMBL4800310
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(Cc1ccccc1)C(=O)/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)c(OC)c1,,,,CHEMBL4762548
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)C(=O)/C=C/c1ccc(OC(=O)N(C)C)c(OC)c1,,,,CHEMBL4789995
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1,,,,CHEMBL4776936
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1,,,,CHEMBL4777412
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1,,,,CHEMBL4750360
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)O)ccc1O,,,,CHEMBL32749
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,C#CCN(C)CCCOc1ccc(Cl)cc1Cl,,,,CHEMBL8706
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,C#CCN[C@@H]1CCc2ccccc21,,,,CHEMBL887
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,58.3,%,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by transmission electron microscopic analysis,Activity,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,,,,CHEMBL4793075
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,49.7,%,=,CHEMBL4761179
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1OC,53.7,%,=,CHEMBL4787165
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,56.6,%,=,CHEMBL4792013
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,%,,CHEMBL4759355
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,,%,,CHEMBL4779514
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1OC,58.2,%,=,CHEMBL4793075
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)C,,%,,CHEMBL4759959
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,%,,CHEMBL4745075
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCc3ccccc3C2)ccc1OC(=O)N(C)OC,,%,,CHEMBL4741070
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(CC)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1OC,,%,,CHEMBL4740081
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(C)C,,%,,CHEMBL4756176
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,%,,CHEMBL4762653
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCCCC2)cc1OC,,%,,CHEMBL4747710
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(C)C,,%,,CHEMBL4748948
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OC(=O)N(c1ccccc1)c1ccccc1,,%,,CHEMBL4756054
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N(CC)Cc2ccccc2)cc1OC,50.7,%,=,CHEMBL4800310
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(Cc1ccccc1)C(=O)/C=C/c1ccc(OC(=O)N(c2ccccc2)c2ccccc2)c(OC)c1,,%,,CHEMBL4762548
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(OC(=O)N(C)C)c(OC)c1,,%,,CHEMBL4789995
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCC(Cc3ccccc3)CC2)cc1,48.1,%,=,CHEMBL4776936
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCc3ccccc3C2)cc1,52.9,%,=,CHEMBL4777412
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1,,%,,CHEMBL4750360
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,28.3,%,=,CHEMBL32749
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,C#CCN(C)CCCOc1ccc(Cl)cc1Cl,,%,,CHEMBL8706
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,C#CCN[C@@H]1CCc2ccccc21,,%,,CHEMBL887
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM measured after 24 hrs by thioflavin T-based fluorimetric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,55.1,%,=,CHEMBL140
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1,25.6,%,=,CHEMBL4747992
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2cccc(F)c2)CC1,19.3,%,=,CHEMBL4776811
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2F)CC1,11.4,%,=,CHEMBL4748993
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2)CC1,22.8,%,=,CHEMBL4794823
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)c(F)c2)CC1,21.6,%,=,CHEMBL4756451
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2c(F)cccc2F)CC1,15.6,%,=,CHEMBL4755445
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)cc2)CC1,13.7,%,=,CHEMBL4764558
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2cccc(F)c2)CC1,23.2,%,=,CHEMBL4795876
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2Cl)CC1,21.8,%,=,CHEMBL4742138
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccn2)CC1,12.1,%,=,CHEMBL4749550
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2F)CC1,18.8,%,=,CHEMBL4759253
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2)CC1,21.4,%,=,CHEMBL4796437
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2)CC1,22.1,%,=,CHEMBL4753478
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1O,,%,,CHEMBL4787873
Inhibition of self-induced human amyloid beta (1 to 42) aggregation at 25 uM incubated for 24 hrs by thioflavin T-based fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,180.0,nM,=,CHEMBL81379
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,180.0,nM,=,CHEMBL986
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)CCCC1,180.0,nM,=,CHEMBL4787961
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,180.0,nM,=,CHEMBL38
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,FC(F)(F)Oc1ccc(CNC2CCN(Cc3ccccc3)C2)cc1,37.3,%,=,CHEMBL4793341
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,Fc1ccc(CNC2CCN(Cc3ccccc3)C2)c(F)c1,30.3,%,=,CHEMBL4752715
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,31.0,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,19710.0,nM,=,CHEMBL4755968
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,2050.0,nM,=,CHEMBL4791642
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,15120.0,nM,=,CHEMBL4750451
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,18300.0,nM,=,CHEMBL4763981
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,Nc1c2c(nc3ccccc13)CCCC2,,,,CHEMBL95
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,,,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,13430.0,nM,=,CHEMBL165
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,16250.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,38.8,%,=,CHEMBL4776843
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,41.5,%,=,CHEMBL4742248
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,37.5,%,=,CHEMBL4798157
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,31.6,%,=,CHEMBL4757466
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,21.2,%,=,CHEMBL4800679
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(CCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,27.9,%,=,CHEMBL4781157
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=c1c2ccccc2nc2n1CCC2,20.7,%,=,CHEMBL456881
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM incubated for 48 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(O)C1NCCC2c3ccccc3NC12,20.7,%,=,CHEMBL4794842
"Potency index, ratio of resveratrol IC50 to test compound IC50 for inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation",Ratio IC50,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,6.0,,=,CHEMBL4791642
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)C)cc3o2)cc1,79.2,%,=,CHEMBL4762284
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(CC)CC)cc3o2)cc1,77.8,%,=,CHEMBL4792211
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(c4ccccc4)c4ccccc4)cc3o2)cc1)N(c1ccccc1)c1ccccc1,70.9,%,=,CHEMBL4745591
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,77.9,%,=,CHEMBL4762069
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)OC)cc3o2)cc1,76.8,%,=,CHEMBL4789142
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N4CCCC4)cc3o2)cc1)N1CCCC1,73.7,%,=,CHEMBL4776074
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N4CCOCC4)cc3o2)cc1)N1CCOCC1,71.5,%,=,CHEMBL4800458
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)C)cc(OC(=O)N(C)C)cc3o2)cc1,38.3,%,=,CHEMBL4784106
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,35.1,%,=,CHEMBL4787451
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)OC)cc(OC(=O)N(C)OC)cc3o2)cc1,36.0,%,=,CHEMBL4795422
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,O=C(Oc1ccc(-c2cc(=O)c3c(OC(=O)N4CCOCC4)cc(OC(=O)N4CCOCC4)cc3o2)cc1)N1CCOCC1,31.2,%,=,CHEMBL4763103
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.8,%,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)C)cc3o2)cc1,,,,CHEMBL4762284
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CCN(CC)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(CC)CC)cc3o2)cc1,,,,CHEMBL4792211
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(c4ccccc4)c4ccccc4)cc3o2)cc1)N(c1ccccc1)c1ccccc1,,,,CHEMBL4745591
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,66.2,%,=,CHEMBL4762069
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)OC)cc3o2)cc1,,,,CHEMBL4789142
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N4CCCC4)cc3o2)cc1)N1CCCC1,,,,CHEMBL4776074
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,O=C(Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N4CCOCC4)cc3o2)cc1)N1CCOCC1,,,,CHEMBL4800458
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)C)cc(OC(=O)N(C)C)cc3o2)cc1,,,,CHEMBL4784106
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,40.6,%,=,CHEMBL4787451
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,CON(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)OC)cc(OC(=O)N(C)OC)cc3o2)cc1,,,,CHEMBL4795422
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,O=C(Oc1ccc(-c2cc(=O)c3c(OC(=O)N4CCOCC4)cc(OC(=O)N4CCOCC4)cc3o2)cc1)N1CCOCC1,,,,CHEMBL4763103
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,,,CHEMBL502
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM by ThT fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,57.2,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by TEM analysis,Inhibition,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,,%,,CHEMBL4762069
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM measured after 24 hrs by TEM analysis,Inhibition,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,,%,,CHEMBL4787451
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 48 hrs by TEM analysis,Activity,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)N(C)CC)cc3o2)cc1,,,,CHEMBL4762069
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 48 hrs by TEM analysis,Activity,CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1,,,,CHEMBL4787451
Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],70.5,%,=,CHEMBL12089
Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc2cc3[n+](cc2c1OCc1ccc(C)cc1)CCc1cc2c(cc1-3)OCO2.[Br-],82.6,%,=,CHEMBL4745802
Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc2cc3[n+](cc2c1OCc1ccc2ccccc2c1)CCc1cc2c(cc1-3)OCO2.[Br-],97.2,%,=,CHEMBL4747577
Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc2cc3[n+](cc2c1OC(C)c1ccccc1)CCc1cc2c(cc1-3)OCO2.[Br-],86.7,%,=,CHEMBL4752813
Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,Inhibition,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,100.0,%,=,CHEMBL1433
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1c(OCc2ccccc2)c(=O)ccn1-c1ccc(CC(=O)NCc2ccc(-c3nc4ccccc4s3)cc2)cc1,68.9,%,=,CHEMBL4743941
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1c(O)c(=O)ccn1CCCC(=O)N1CCCC1c1nc2ccccc2s1,59.3,%,=,CHEMBL4797501
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1c(O)c(=O)ccn1CC(=O)NCC(O)CNc1c2c(nc3ccccc13)CCCC2,86.0,%,=,CHEMBL4758784
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay relative to control,Inhibition,Cc1c(O)c(=O)ccn1CC(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,95.2,%,=,CHEMBL4778798
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,7050.0,nM,=,CHEMBL4755924
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,5060.0,nM,=,CHEMBL4744947
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,64.95,%,=,CHEMBL4755924
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay relative to control,Inhibition,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,78.26,%,=,CHEMBL4744947
Inhibition of human amyloid beta (1 to 42) aggregation incubated for 24 hrs by ThT fluorescence assay,Inhibition,COc1cccc2cc(C(=O)NCCn3ccc(=O)c(OCc4ccccc4)c3C)oc12,36.1,%,=,CHEMBL4763495
Inhibition of human amyloid beta (1 to 42) aggregation incubated for 24 hrs by ThT fluorescence assay,Inhibition,COc1cccc2cc(C(=O)NCCn3ccc(=O)c(O)c3C)oc12,49.8,%,=,CHEMBL4777813
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThT fluorescence assay,IC50,C#CCN(C)CCCn1ccc(=O)c(O)c1C,2850.0,nM,=,CHEMBL4740154
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM incubated for 24 hrs by ThT fluorescence assay relative to control,Inhibition,C#CCN(C)CCCn1ccc(=O)c(O)c1C,80.12,%,=,CHEMBL4740154
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,Cn1c(=O)sc2cc(NC(=O)CCCCN3CCC(c4ccccc4)CC3)ccc21,55.6,%,=,CHEMBL4760122
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,Cn1c(=O)sc2cc(C(=O)CCN3CCN(Cc4ccccc4)CC3)ccc21,57.5,%,=,CHEMBL4795992
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,57.1,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay relative to control,Inhibition,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,32.2,%,=,CHEMBL258921
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CC)c1ccc(/C=C2\OC(=O)c3cc(OC)c(OC)cc32)cc1O,28.6,%,=,CHEMBL4746533
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CC)c1ccc(/C=C2/OC(=O)c3cc(OC)c(OC)cc32)cc1O,26.1,%,=,CHEMBL4780953
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCCC3)c(O)c1)OC2=O,23.0,%,=,CHEMBL4788648
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCCC3)c(O)c1)OC2=O,30.6,%,=,CHEMBL4762169
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCCCC3)c(O)c1)OC2=O,24.6,%,=,CHEMBL4780148
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCCCC3)c(O)c1)OC2=O,22.5,%,=,CHEMBL4778409
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCOCC3)c(O)c1)OC2=O,26.7,%,=,CHEMBL4782916
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCOCC3)c(O)c1)OC2=O,24.9,%,=,CHEMBL4750877
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CC)c1cc(/C=C2\OC(=O)c3cc(OC)c(OC)cc32)ccc1O,25.9,%,=,CHEMBL4761887
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CC)c1cc(/C=C2/OC(=O)c3cc(OC)c(OC)cc32)ccc1O,33.6,%,=,CHEMBL4778167
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C/c1ccc(O)c(N3CCCCC3)c1)OC2=O,34.2,%,=,CHEMBL4792421
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)/C(=C\c1ccc(O)c(N3CCCCC3)c1)OC2=O,15.8,%,=,CHEMBL4757683
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CC)c1ccc(CC2OC(=O)c3cc(OC)c(OC)cc32)cc1O,30.1,%,=,CHEMBL4752902
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(N3CCCC3)c(O)c1)OC2=O,31.1,%,=,CHEMBL4765003
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(N3CCCCC3)c(O)c1)OC2=O,28.9,%,=,CHEMBL4754258
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(Cc1ccc(N3CCOCC3)c(O)c1)OC2=O,29.5,%,=,CHEMBL4798284
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCCCC1OC(=O)c2ccccc21,5.0,%,<,CHEMBL248594
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CC(=O)Oc1ccccc1C(=O)O,,%,,CHEMBL25
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,,%,,CHEMBL799
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)c1ccc(/C=C2\OC(=O)c3cc(OC)c(OC)cc32)cc1O,,,,CHEMBL4746533
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)c1ccc(/C=C2/OC(=O)c3cc(OC)c(OC)cc32)cc1O,,,,CHEMBL4780953
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCCC3)c(O)c1)OC2=O,,,,CHEMBL4788648
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCCC3)c(O)c1)OC2=O,,,,CHEMBL4762169
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCCCC3)c(O)c1)OC2=O,,,,CHEMBL4780148
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCCCC3)c(O)c1)OC2=O,,,,CHEMBL4778409
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C/c1ccc(N3CCOCC3)c(O)c1)OC2=O,,,,CHEMBL4782916
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C\c1ccc(N3CCOCC3)c(O)c1)OC2=O,,,,CHEMBL4750877
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)c1cc(/C=C2\OC(=O)c3cc(OC)c(OC)cc32)ccc1O,19.9,%,=,CHEMBL4761887
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)c1cc(/C=C2/OC(=O)c3cc(OC)c(OC)cc32)ccc1O,,,,CHEMBL4778167
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C/c1ccc(O)c(N3CCCCC3)c1)OC2=O,11.8,%,=,CHEMBL4792421
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)/C(=C\c1ccc(O)c(N3CCCCC3)c1)OC2=O,,,,CHEMBL4757683
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCN(CC)c1ccc(CC2OC(=O)c3cc(OC)c(OC)cc32)cc1O,,,,CHEMBL4752902
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)C(Cc1ccc(N3CCCC3)c(O)c1)OC2=O,,,,CHEMBL4765003
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)C(Cc1ccc(N3CCCCC3)c(O)c1)OC2=O,,,,CHEMBL4754258
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc2c(cc1OC)C(Cc1ccc(N3CCOCC3)c(O)c1)OC2=O,,,,CHEMBL4798284
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CCCCC1OC(=O)c2ccccc21,5.0,%,<,CHEMBL248594
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,24.3,%,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,CC(=O)Oc1ccccc1C(=O)O,,,,CHEMBL25
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 25 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,,,,CHEMBL799
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloid beta42 fibrils at <50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloid beta42 fibrils at <50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloid beta42 fibrils at <50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloid beta42 fibrils at <50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloidbeta42 fibrils at 50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloidbeta42 fibrils at 50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloidbeta42 fibrils at 50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular assembly assessed as elongation of amyloidbeta42 fibrils at 50 mM measured for 10 days by ThT dye based fluorescence spectrophotometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in 6E10 epitope binding site structure at 1 mM measured for 1 to 5 days by Western blot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in 6E10 epitope binding site structure at 1 mM measured for 1 to 5 days by Western blot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in antiparallel beta-sheets characteristic of cytotoxic Abeta42 aggregates at 1 mM measured for 5 days by CD spectrometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in antiparallel beta-sheets characteristic of cytotoxic Abeta42 aggregates at 1 mM measured for 5 days by CD spectrometry,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in antiparallel beta-sheets characteristic of cytotoxic Abeta42 aggregates at 1 mM measured for 5 days by CD spectrometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in antiparallel beta-sheets characteristic of cytotoxic Abeta42 aggregates at 1 mM measured for 5 days by CD spectrometry,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as inhibition of Abeta42-induced disruption of cell membrane by measuring reduction in Ca2+ influx at 1 mM incubated for 24 hrs by Fluo-3AM dye based scanning confocal fluorescence microscopy relative to control,Inhibition,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,41.0,%,=,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as inhibition of Abeta42-induced disruption of cell membrane by measuring reduction in Ca2+ influx at 1 mM incubated for 24 hrs by Fluo-3AM dye based scanning confocal fluorescence microscopy relative to control,Inhibition,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,%,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as inhibition of Abeta42-induced disruption of cell membrane by measuring reduction in Ca2+ influx at 1 mM incubated for 24 hrs by Calcein-AM dye based scanning confocal fluorescence microscopy relative to control,Inhibition,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,60.0,%,=,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as inhibition of Abeta42-induced disruption of cell membrane by measuring reduction in Ca2+ influx at 1 mM incubated for 24 hrs by Calcein-AM dye based scanning confocal fluorescence microscopy relative to control,Inhibition,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,%,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in AChE activity at 1 mM incubated for 1 day,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring increase in AKT1 phosphorylation phosphorylation at Ser473 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring increase in AKT1 phosphorylation phosphorylation at Ser473 residue at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in inflammation by measuring decrease in Abeta-42-induced ANXA1 expression at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in inflammation by measuring decrease in Abeta-42-induced ANXA1 expression at 1 mM incubated for 1 hr by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr in presence of insulin by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in insulin resistance by measuring reduction in Abeta-42-induced IRS1 phosphorylation at Ser612 residue at 1 mM incubated for 1 hr in presence of insulin by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in inflammation by measuring decrease in Abeta-42-induced ANXA1 expression at 1 mM incubated for 1 hr in presence of insulin by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of amyloid beta (1 to 42) supramolecular organization in human SH-SY5Y cells assessed as reduction in inflammation by measuring decrease in Abeta-42-induced ANXA1 expression at 1 mM incubated for 1 hr in presence of insulin by immunoblot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as reduction in amount of cytotoxic Abeta42 oligomers at 1 mM measured for 1 to 5 days by Western blot analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular organization at 0.4 mM by dynamic light scattering based analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of human amyloid beta (1 to 42) supramolecular organization at 0.4 mM by dynamic light scattering based analysis,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of human amyloid beta (1 to 42) supramolecular organization at 0.4 mM by dynamic light scattering based analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular organization at 0.4 mM by dynamic light scattering based analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as prevalence of Abeta42 fibrils with parallel beta-sheets at 16 mM incubated for 5 days by ATR-FITR analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O,,,,CHEMBL234432
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as prevalence of Abeta42 fibrils with parallel beta-sheets at 16 mM incubated for 5 days by ATR-FITR analysis,Activity,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,,CHEMBL240524
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as prevalence of Abeta42 fibrils with parallel beta-sheets at 16 mM incubated for 5 days by ATR-FITR analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O[C@H]1O,,,,CHEMBL1162001
Modulation of human amyloid beta (1 to 42) supramolecular organization assessed as prevalence of Abeta42 fibrils with parallel beta-sheets at 16 mM incubated for 5 days by ATR-FITR analysis,Activity,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1O,,,,CHEMBL2448885
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4798535
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,7.0,%,=,CHEMBL4787579
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,11.2,%,=,CHEMBL4797814
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCOCCOCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4758624
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4762419
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4797177
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,11.0,%,=,CHEMBL4794645
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,17.9,%,=,CHEMBL4796461
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,27.9,%,=,CHEMBL4751100
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCNCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,34.0,%,=,CHEMBL4785201
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCNCCOCCOCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4787251
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,10.0,%,<,CHEMBL4747041
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,24.4,%,=,CHEMBL4747836
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,41.8,%,=,CHEMBL4789620
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1OCc1ccccc1)CCC(C)(CC(=O)NCCCCCCNc1c3c(nc4cc(Cl)ccc14)CCCC3)O2,4.4,%,=,CHEMBL4789172
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,10.0,%,<,CHEMBL4794549
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,17.4,%,=,CHEMBL4792460
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,16.4,%,=,CHEMBL4757922
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)NCCCCCCNc1c3c(nc4ccccc14)CCCC3)O2,10.0,%,<,CHEMBL4749077
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(C)O2,,%,,CHEMBL4755403
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CC(=O)O)O2,10.0,%,<,CHEMBL4747354
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,COc1cc2c(cc1O)CCC(C)(CCN)O2,10.0,%,<,CHEMBL4796696
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,Nc1c2c(nc3ccccc13)CCCC2,10.0,%,<,CHEMBL95
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,Nc1c2c(nc3cc(Cl)ccc13)CCCC2,10.0,%,<,CHEMBL292314
Inhibition of self-induced Amyloid beta (1 to 42 residues) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM measured after overnight incubation by thioflavin-S based spectrophotometric method relative to control,Inhibition,O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,68.2,%,=,CHEMBL3545559
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCn2cc(COn3nnc4ccccc43)nn2)c2ccccc2o1,16.22,%,=,CHEMBL4778582
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCn2cc(COn3nnc4ccccc43)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4755707
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCn2cc(COn3nnc4ccccc43)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4753776
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCn2cc(COn3nnc4ccccc43)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4777793
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCCn2cc(COn3nnc4ccccc43)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4757272
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCn3cc(Cn4nnc5ccccc54)nn3)cc2o1,29.36,%,=,CHEMBL4758696
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCn3cc(Cn4nnc5ccccc54)nn3)cc2o1,15.86,%,=,CHEMBL4758084
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCn3cc(Cn4nnc5ccccc54)nn3)cc2o1,11.36,%,=,CHEMBL4747633
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCn3cc(Cn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4784930
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCCn3cc(Cn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4791291
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCn2cc(Cn3nc4ccccc4n3)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4778639
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCn2cc(Cn3nc4ccccc4n3)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4764253
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCn2cc(Cn3nc4ccccc4n3)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4761822
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCn2cc(Cn3nc4ccccc4n3)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4761402
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCCn2cc(Cn3nc4ccccc4n3)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4798200
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCn3cc(COn4nnc5ccccc54)nn3)cc2o1,11.38,%,=,CHEMBL4782518
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCn3cc(COn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4782774
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCn3cc(COn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4743747
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCn3cc(COn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4788572
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCCn3cc(COn4nnc5ccccc54)nn3)cc2o1,10.0,%,<=,CHEMBL4754009
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCn2cc(Cn3nnc4ccccc43)nn2)c2ccccc2o1,36.68,%,=,CHEMBL4762795
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCn2cc(Cn3nnc4ccccc43)nn2)c2ccccc2o1,34.26,%,=,CHEMBL4749763
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCn2cc(Cn3nnc4ccccc43)nn2)c2ccccc2o1,22.36,%,=,CHEMBL4756123
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCn2cc(Cn3nnc4ccccc43)nn2)c2ccccc2o1,11.36,%,=,CHEMBL4758921
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1cc(OCCCCCCn2cc(Cn3nnc4ccccc43)nn2)c2ccccc2o1,10.0,%,<=,CHEMBL4781507
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCn3cc(Cn4nc5ccccc5n4)nn3)cc2o1,10.0,%,<=,CHEMBL4741410
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCn3cc(Cn4nc5ccccc5n4)nn3)cc2o1,10.0,%,<=,CHEMBL4750478
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCn3cc(Cn4nc5ccccc5n4)nn3)cc2o1,10.0,%,<=,CHEMBL4796953
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCn3cc(Cn4nc5ccccc5n4)nn3)cc2o1,10.0,%,<=,CHEMBL4746553
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,O=c1ccc2ccc(OCCCCCCn3cc(Cn4nc5ccccc5n4)nn3)cc2o1,10.0,%,<=,CHEMBL4762724
Inhibition of copper-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM by thioflavin T based fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,62.26,%,=,CHEMBL140
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4793331
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1C/C=C/COc2ccc(cc2)C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4785668
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4757967
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,C[C@H](NC(=O)[C@@H]1C/C=C/COc2ccc(cc2)C[C@H](NC(=O)[C@@H]2CCCN2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)O,,%,,CHEMBL4759267
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,O=C(O)C[C@H](NC(=O)[C@@H]1C/C=C/COc2ccc(cc2)C[C@H](NC(=O)[C@@H]2CCCN2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)O,,%,,CHEMBL4746437
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)[C@@H]1NC(=O)[C@@H](N)C/C=C/COc2ccc(cc2)C[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)O)NC1=O,,%,,CHEMBL4776675
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O)C(C)C,,%,,CHEMBL4783338
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,COC(=O)[C@@H]1C/C=C/COc2ccc(cc2)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1,,%,,CHEMBL4743949
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 at 40 uM incubated for 48 hrs by thioflavin-T fluorescence assay,Inhibition,CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,,%,,CHEMBL4762384
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4793331
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4757967
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,C[C@H](NC(=O)[C@@H]1C/C=C/COc2ccc(cc2)C[C@H](NC(=O)[C@@H]2CCCN2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)O,,%,,CHEMBL4759267
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,O=C(O)C[C@H](NC(=O)[C@@H]1C/C=C/COc2ccc(cc2)C[C@H](NC(=O)[C@@H]2CCCN2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)O,,%,,CHEMBL4746437
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(C)[C@@H]1NC(=O)[C@@H](N)C/C=C/COc2ccc(cc2)C[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)O)NC1=O,,%,,CHEMBL4776675
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H]1C/C=C/COc2ccc(cc2)C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O,,%,,CHEMBL4785668
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation in PBS buffer at pH 7.4 assessed as effect on fibril formation at 40 uM after 48 hrs by uranyl acetate staining based transmission electron microscopy,Inhibition,CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@H]1Cc2ccc(cc2)OC/C=C/C[C@@H](C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O)C(C)C,,%,,CHEMBL4783338
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,80.5,%,=,CHEMBL4746962
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCCCC3)cc2)ccc1=O,80.4,%,=,CHEMBL4790750
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCOCC3)cc2)ccc1=O,69.8,%,=,CHEMBL4765168
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCN(C)CC3)cc2)ccc1=O,76.1,%,=,CHEMBL4742244
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCN3CCCC3)cc2)ccc1=O,51.6,%,=,CHEMBL4750326
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCCN3CCCC3)cc2)ccc1=O,77.3,%,=,CHEMBL4764747
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCc1c(OC)c(=O)ccn1-c1ccc(OCCCN2CCCC2)cc1,64.9,%,=,CHEMBL4744905
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)c(C)cc1=O,60.1,%,=,CHEMBL4741097
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,56.0,%,=,CHEMBL4748265
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCOc1c(C)n(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,52.7,%,=,CHEMBL4742309
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C(C)C)CC3)cc2)ccc1=O,54.4,%,=,CHEMBL4789311
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C(C)C)CC3)cc2)ccc1=O,58.5,%,=,CHEMBL4740932
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)ccc1=O,59.6,%,=,CHEMBL4790392
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)ccc1=O,52.5,%,=,CHEMBL4763867
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)ccc1=O,57.9,%,=,CHEMBL4753961
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)ccc1=O,50.7,%,=,CHEMBL4752329
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C(C)C)CC3)cc2)ccc1=O,28.5,%,=,CHEMBL4764966
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C4CCC4)CC3)cc2)ccc1=O,43.6,%,=,CHEMBL4749796
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C4CCCC4)CC3)cc2)ccc1=O,49.0,%,=,CHEMBL4748967
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C(C)C)CC3)cc2)ccc1=O,21.2,%,=,CHEMBL4782278
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C4CCC4)CC3)cc2)ccc1=O,51.5,%,=,CHEMBL4753396
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C4CCCC4)CC3)cc2)ccc1=O,54.6,%,=,CHEMBL4751577
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,54.8,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,52.4,%,=,CHEMBL4746962
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCCCC3)cc2)ccc1=O,45.1,%,=,CHEMBL4790750
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCOCC3)cc2)ccc1=O,56.6,%,=,CHEMBL4765168
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCN3CCN(C)CC3)cc2)ccc1=O,67.0,%,=,CHEMBL4742244
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCN3CCCC3)cc2)ccc1=O,59.1,%,=,CHEMBL4750326
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OCCCCN3CCCC3)cc2)ccc1=O,26.9,%,=,CHEMBL4764747
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCc1c(OC)c(=O)ccn1-c1ccc(OCCCN2CCCC2)cc1,62.4,%,=,CHEMBL4744905
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)c(C)cc1=O,55.2,%,=,CHEMBL4741097
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,63.4,%,=,CHEMBL4748265
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCOc1c(C)n(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,67.5,%,=,CHEMBL4742309
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C(C)C)CC3)cc2)ccc1=O,63.5,%,=,CHEMBL4789311
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C(C)C)CC3)cc2)ccc1=O,41.4,%,=,CHEMBL4740932
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)ccc1=O,7.5,%,=,CHEMBL4790392
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)ccc1=O,9.3,%,=,CHEMBL4763867
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)ccc1=O,1.5,%,=,CHEMBL4753961
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cn(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)ccc1=O,,%,,CHEMBL4752329
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C(C)C)CC3)cc2)ccc1=O,50.9,%,=,CHEMBL4764966
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C4CCC4)CC3)cc2)ccc1=O,44.3,%,=,CHEMBL4749796
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(C(=O)N3CCN(C4CCCC4)CC3)cc2)ccc1=O,23.9,%,=,CHEMBL4748967
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C(C)C)CC3)cc2)ccc1=O,64.0,%,=,CHEMBL4782278
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C4CCC4)CC3)cc2)ccc1=O,54.4,%,=,CHEMBL4753396
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(C)n(-c2ccc(S(=O)(=O)N3CCN(C4CCCC4)CC3)cc2)ccc1=O,,%,,CHEMBL4751577
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,65.7,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as reduction in fibril formation after 24 hrs by TEM analysis,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,,%,,CHEMBL4748265
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as reduction in fibril formation after 24 hrs by TEM analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation assessed as reduction in fibril formation after 24 hrs by TEM analysis,Inhibition,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,,%,,CHEMBL4748265
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation assessed as reduction in fibril formation after 24 hrs by TEM analysis,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,%,,CHEMBL140
Disaggregation of self-induced pre-formed amyloid beta (1 to 42) (unknown origin) fibrils assessed as disassembly of fibril after 24 hrs by TEM analysis,Activity,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,,,,CHEMBL4748265
Disaggregation of self-induced pre-formed amyloid beta (1 to 42) (unknown origin) fibrils assessed as disassembly of fibril after 24 hrs by TEM analysis,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Disaggregation of self-induced pre-formed amyloid beta (1 to 40) (unknown origin) fibrils assessed as disassembly of fibril after 24 hrs by TEM analysis,Activity,COc1cn(-c2ccc(OCCCN3CCCC3)cc2)ccc1=O,,,,CHEMBL4748265
Disaggregation of self-induced pre-formed amyloid beta (1 to 40) (unknown origin) fibrils assessed as disassembly of fibril after 24 hrs by TEM analysis,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,,,,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,66.2,%,=,CHEMBL1926943
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,50.4,%,=,CHEMBL4776214
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(F)(F)F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,4.5,%,=,CHEMBL4740165
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(Cl)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,75.8,%,=,CHEMBL4754814
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,91.7,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(-c2ccccc2)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,12.9,%,=,CHEMBL4800590
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(C)(C)C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,42.0,%,=,CHEMBL4787836
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,26.8,%,=,CHEMBL4781193
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(N)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,77.4,%,=,CHEMBL4741741
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccncc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,46.0,%,=,CHEMBL4753722
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,29.1,%,=,CHEMBL4794858
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4776108
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](N)c1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,67.3,%,=,CHEMBL4751915
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C1(NC(=O)[C@@H](N)C(C)C)CCCC1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4785370
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4743633
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4745736
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,24.1,%,=,CHEMBL4746449
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)NC[C@@H]1CCCN1[C@@H](C)C(=O)O)C(C)C,11.9,%,=,CHEMBL4751899
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,46.4,%,=,CHEMBL4741565
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,4.4,%,=,CHEMBL4781619
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)(C)C)C(C)C,0.0,%,=,CHEMBL4792386
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C1CCCC1)C(C)C,47.8,%,=,CHEMBL4759453
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC1CC1)C(=O)N[C@@H](C)C(=O)O)C(C)C,0.0,%,=,CHEMBL4797717
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,100.0,%,=,CHEMBL4779724
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,61.0,%,=,CHEMBL4778058
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCC[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,40.8,%,=,CHEMBL4798708
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)NCCC(=O)O,13.0,%,=,CHEMBL4796634
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)O,32.5,%,=,CHEMBL4743678
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O,100.0,%,=,CHEMBL4762367
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,65.1,%,=,CHEMBL4749752
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O,71.5,%,=,CHEMBL4743198
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O,23.4,%,=,CHEMBL4745340
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)C[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4786819
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H]1CC2CCCCC2N1)C(=O)N[C@@H](C)C(=O)O,91.5,%,=,CHEMBL4776339
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](C)C(=O)O,98.3,%,=,CHEMBL4798457
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,88.7,%,=,CHEMBL4790001
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,95.3,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4792357
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,60.6,%,=,CHEMBL1926943
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,78.4,%,=,CHEMBL4776214
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(F)(F)F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,20.4,%,=,CHEMBL4740165
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(Cl)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,57.4,%,=,CHEMBL4754814
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,97.5,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(-c2ccccc2)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,34.7,%,=,CHEMBL4800590
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(C)(C)C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,57.4,%,=,CHEMBL4787836
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,3.2,%,=,CHEMBL4781193
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(N)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,68.4,%,=,CHEMBL4741741
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccncc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,44.2,%,=,CHEMBL4753722
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,23.8,%,=,CHEMBL4794858
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC)C(C)C)C(=O)N[C@@H](C)C(=O)O,94.3,%,=,CHEMBL4776108
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](N)c1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,58.2,%,=,CHEMBL4751915
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C1(NC(=O)[C@@H](N)C(C)C)CCCC1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4785370
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,99.2,%,=,CHEMBL4743633
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4745736
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,5.3,%,=,CHEMBL4746449
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)NC[C@@H]1CCCN1[C@@H](C)C(=O)O)C(C)C,0.0,%,=,CHEMBL4751899
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,19.3,%,=,CHEMBL4741565
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,0.0,%,=,CHEMBL4781619
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)(C)C)C(C)C,0.0,%,=,CHEMBL4792386
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C1CCCC1)C(C)C,40.3,%,=,CHEMBL4759453
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC1CC1)C(=O)N[C@@H](C)C(=O)O)C(C)C,0.0,%,=,CHEMBL4797717
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,83.4,%,=,CHEMBL4779724
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,44.1,%,=,CHEMBL4778058
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCC[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,34.9,%,=,CHEMBL4798708
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)NCCC(=O)O,0.0,%,=,CHEMBL4796634
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)O,2.0,%,=,CHEMBL4743678
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O,100.0,%,=,CHEMBL4762367
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,39.3,%,=,CHEMBL4749752
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O,59.9,%,=,CHEMBL4743198
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O,26.5,%,=,CHEMBL4745340
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)C[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)O,89.7,%,=,CHEMBL4786819
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H]1CC2CCCCC2N1)C(=O)N[C@@H](C)C(=O)O,99.1,%,=,CHEMBL4776339
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](C)C(=O)O,95.2,%,=,CHEMBL4798457
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,90.2,%,=,CHEMBL4790001
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,97.4,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,97.2,%,=,CHEMBL4792357
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,33.9,%,=,CHEMBL1926943
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,94.8,%,=,CHEMBL4776214
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(F)(F)F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,41.8,%,=,CHEMBL4740165
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(Cl)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,46.4,%,=,CHEMBL4754814
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(-c2ccccc2)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,26.4,%,=,CHEMBL4800590
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C(C)(C)C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,78.6,%,=,CHEMBL4787836
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(C)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,0.0,%,=,CHEMBL4781193
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(N)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,59.2,%,=,CHEMBL4741741
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccncc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,42.7,%,=,CHEMBL4753722
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,34.0,%,=,CHEMBL4794858
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC)C(C)C)C(=O)N[C@@H](C)C(=O)O,84.8,%,=,CHEMBL4776108
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](N)c1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,50.1,%,=,CHEMBL4751915
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C1(NC(=O)[C@@H](N)C(C)C)CCCC1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4785370
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,96.1,%,=,CHEMBL4743633
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4745736
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,0.0,%,=,CHEMBL4746449
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)NC[C@@H]1CCCN1[C@@H](C)C(=O)O)C(C)C,0.0,%,=,CHEMBL4751899
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N1C2CCCCC2C[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,37.2,%,=,CHEMBL4741565
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O,0.0,%,=,CHEMBL4781619
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)(C)C)C(C)C,0.0,%,=,CHEMBL4792386
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C1CCCC1)C(C)C,17.1,%,=,CHEMBL4759453
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC1CC1)C(=O)N[C@@H](C)C(=O)O)C(C)C,0.0,%,=,CHEMBL4797717
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,80.6,%,=,CHEMBL4779724
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)C[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,31.6,%,=,CHEMBL4778058
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CCC[C@@H](C(=O)N[C@@H](C)C(=O)O)N(C)C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C,22.2,%,=,CHEMBL4798708
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)NCCC(=O)O,0.0,%,=,CHEMBL4796634
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)O,2.8,%,=,CHEMBL4743678
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O,82.0,%,=,CHEMBL4762367
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,38.8,%,=,CHEMBL4749752
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O,38.6,%,=,CHEMBL4743198
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O,24.2,%,=,CHEMBL4745340
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)C[C@@H]1CCCN1C(=O)C[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)O,78.9,%,=,CHEMBL4786819
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H]1CC2CCCCC2N1)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4776339
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](C)C(=O)O,93.6,%,=,CHEMBL4798457
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](NC(=O)[C@@H](N)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC,97.7,%,=,CHEMBL4790001
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,100.0,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,92.2,%,=,CHEMBL4792357
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,57.2,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,53.2,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 10 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,55.5,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,54.5,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,53.3,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 4 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,54.5,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,53.1,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,53.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as relative fluorescence unit at 2 uM measured after 24 hrs by thioflavin-T fluorescence assay (Rvb = 100%),RFU,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,51.2,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,83.1,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,74.8,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,51.8,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.5 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,81.0,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.5 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,68.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.5 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,41.3,%,=,CHEMBL4791621
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,79.9,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,61.2,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.1 uM measured after 24 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)(C)C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O,34.4,%,=,CHEMBL4791621
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured at 24 hrs interval for 120 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,61.0,%,=,CHEMBL4786388
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 1 uM measured at 24 hrs interval for 120 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,42.5,%,=,CHEMBL4786388
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 0.5 uM measured at 24 hrs interval for 120 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,32.1,%,=,CHEMBL4786388
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM by thioflavin-T fluorescence assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM by thioflavin-T fluorescence assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.5 to 2 uM measured at 24 hrs interval for 198 hrs by thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) assessed as reduction in peptide aggregation at 0.5 to 2 uM measured at 24 hrs interval for 198 hrs by thioflavin-T fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs by ANS dye based fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs by ANS dye based fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4776473
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs by ANS dye based fluorescence assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Disaggregation of preformed amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs by ANS dye based fluorescence assay,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs in presence of giant unilamellar vesicles by ANS dye based fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 2 uM measured after 24 hrs in presence of giant unilamellar vesicles by ANS dye based fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by tyrosine fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by tyrosine fluorescence assay,Inhibition,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,%,,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with beta sheet conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 66.4%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,13.6,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with beta sheet conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 66.4%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,18.7,%,=,CHEMBL4794858
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with beta sheet conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 66.4%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,14.2,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with random coil conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 5%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,97.6,%,=,CHEMBL4786388
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with random coil conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 5%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,31.6,%,=,CHEMBL4794858
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with random coil conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 5%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,60.0,%,=,CHEMBL4776473
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as protein with turn conformation at 10 uM measured after 24 hrs by circular dichroism analysis (Rvb = 11.6%),Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,45.3,%,=,CHEMBL4794858
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as amyloid beta (25 to 42)-adduct formation at 10 uM measured after 24 hrs by ESI-HRMS analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as amyloid beta (2 to 42)-adduct formation at 10 uM measured after 24 hrs by ESI-HRMS analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Binding affinity to amyloid beta (1 to 42) (unknown origin) at 10 uM measured after 24 hrs by ESI-HRMS analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as amyloid beta (27 to 42)-adduct formation at 10 uM measured after 24 hrs by ESI-HRMS analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by HR-TEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by HR-TEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4794858
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by HR-TEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by STEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(F)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4786388
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by STEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1cccc2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4794858
Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as absence of fibrillar assembly at 10 uM measured after 24 hrs by STEM analysis,Activity,CC[C@H](C)[C@H](NC(=O)[C@@H]1CC2CCCCC2N1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O,,,,CHEMBL4776473
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduced particle size at 10 uM measured after 48 hrs by Dynamic light scattering analysis,Inhibition,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,,%,,CHEMBL4790766
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduced particle size at 10 uM measured after 48 hrs by Dynamic light scattering analysis,Inhibition,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,,%,,CHEMBL4800002
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 22 uM measured after 24 hrs by Transmission electron microscopy method,Inhibition,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(NC(C)=O)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,,%,,CHEMBL4790766
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 22 uM measured after 24 hrs by Transmission electron microscopy method,Inhibition,CCOC(=O)c1c(C)nc(N2CCN(S(=O)(=O)c3ccc(N)c(Cl)c3)CC2)nc1-c1ccc(OC)c(OC)c1,,%,,CHEMBL4800002
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 22 uM measured after 24 hrs by Transmission electron microscopy method,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,80.0,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(/C=C/c1cc(O)ccc1O)/C=C/c1cccc(O)c1O,100.0,%,=,CHEMBL4575348
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C1C=C(c2ccc(O)c(O)c2)OC(c2cc(O)ccc2O)C1,100.0,%,=,CHEMBL4757185
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],32.0,%,=,CHEMBL12089
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2cc3n(c(=O)c2c1OC)CCc1cc2c(cc1-3)OCO2,-79.0,%,=,CHEMBL11531
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2ccn(CCc3cc4c(cc3Br)OCO4)c(=O)c2c1OC,-63.0,%,=,CHEMBL4763402
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2cc[nH]c(=O)c2c1OC,-34.0,%,=,CHEMBL4746880
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CCOC(CNC(=O)c1cccc(OC)c1OC)OCC,-49.0,%,=,CHEMBL4748293
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2cc3[n+](cc2c1OC)CCc1cc(O)c(O)cc1-3.[Cl-],27.0,%,=,CHEMBL575979
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(O)ccc2cc3[n+](cc12)CCc1cc(O)c(O)cc1-3.[Cl-],39.0,%,=,CHEMBL4744986
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,Oc1cc2c(cc1O)-c1cc3ccc(O)c(O)c3c[n+]1CC2.[Cl-],72.0,%,=,CHEMBL572918
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4,-28.0,%,=,CHEMBL275097
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1c(O)ccc2c1CN1CCc3cc(O)c(O)cc3C1C2,61.0,%,=,CHEMBL4757763
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,Inhibition,Oc1cc2c(cc1O)C1Cc3ccc(O)c(O)c3CN1CC2,78.0,%,=,CHEMBL1197464
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation assessed as decrease in diameter of aggregate after 20 hrs by dynamic light scattering analysis (Rvb = 4.6 micrometer),Activity,Oc1cc2c(cc1O)C1Cc3ccc(O)c(O)c3CN1CC2,1.3,nm,=,CHEMBL1197464
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation assessed as decrease in size of amyloid beta fibrils after 20 hrs by TEM analysis (Rvb = 1 micrometer),Activity,Oc1cc2c(cc1O)-c1cc3ccc(O)c(O)c3c[n+]1CC2.[Cl-],50.0,nm,=,CHEMBL572918
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation assessed as decrease in size of amyloid beta fibrils after 20 hrs by TEM analysis (Rvb = 1 micrometer),Activity,Oc1cc2c(cc1O)C1Cc3ccc(O)c(O)c3CN1CC2,50.0,nm,=,CHEMBL1197464
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation assessed as appearance of nano-rod like amyloid beta fragments after 20 hrs by CD spectroscopic method,Inhibition,Oc1cc2c(cc1O)-c1cc3ccc(O)c(O)c3c[n+]1CC2.[Cl-],,%,,CHEMBL572918
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation assessed as appearance of nano-rod like amyloid beta fragments after 20 hrs by CD spectroscopic method,Inhibition,Oc1cc2c(cc1O)C1Cc3ccc(O)c(O)c3CN1CC2,,%,,CHEMBL1197464
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2[nH]1,2160.0,nM,=,CHEMBL4874567
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3ccc4nc5n(c(=O)c4c3)CCC5)cc2c1,1210.0,nM,=,CHEMBL4861956
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(F)ccc2[nH]1,1560.0,nM,=,CHEMBL4854341
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(Cl)ccc2[nH]1,1690.0,nM,=,CHEMBL4871461
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2o1,3260.0,nM,=,CHEMBL4864253
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2s1,2300.0,nM,=,CHEMBL4871713
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Cc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,1620.0,nM,=,CHEMBL4878452
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,3090.0,nM,=,CHEMBL4853181
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(CCCc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,5270.0,nM,=,CHEMBL4870177
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3cc4c(=O)n5c(nc4cc3C)CCC5)cc2c1,6100.0,nM,=,CHEMBL4861631
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(F)ccc2[nH]1)CCC3,3270.0,nM,=,CHEMBL4856921
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(Cl)ccc2[nH]1)CCC3,5100.0,nM,=,CHEMBL4854859
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=c1c2ccccc2nc2n1CCC2,,,,CHEMBL456881
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Nc1c2c(nc3ccccc13)CCCC2,,,,CHEMBL95
Inhibition of amyloid beta (unknown origin) aggregation assessed as fibril formation at 10 uM incubated for 30 mins by negative staining TEM imaging analysis,Inhibition,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1C(F)(F)F,,%,,CHEMBL4870888
Inhibition of amyloid beta (unknown origin) aggregation assessed as increase in generation of amyloid beta oligomers at 10 uM incubated for 30 mins by negative staining TEM imaging analysis,Inhibition,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1C(F)(F)F,,%,,CHEMBL4870888
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)O)ccc1O,226230.0,nM,=,CHEMBL32749
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,24600.0,nM,=,CHEMBL4864402
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,39270.0,nM,=,CHEMBL4860315
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,34930.0,nM,=,CHEMBL4848839
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,119160.0,nM,=,CHEMBL68672
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=S)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,,,,CHEMBL4854646
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,12380.0,nM,=,CHEMBL4876981
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)OC)ccc1OCc1ccccc1,79870.0,nM,=,CHEMBL4878181
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(F)(F)C2)ccc1OCc1ccccc1,106820.0,nM,=,CHEMBL4847323
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCC2)ccc1OCc1ccccc1,65090.0,nM,=,CHEMBL4849442
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,27940.0,nM,=,CHEMBL4862182
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3850.0,nM,=,CHEMBL140
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,10640.0,nM,=,CHEMBL4846673
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,18650.0,nM,=,CHEMBL4873786
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,45780.0,nM,=,CHEMBL4867164
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCOCC2)ccc1OCc1ccccc1,78070.0,nM,=,CHEMBL1511811
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4852764
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCN(c3ccccc3)CC2)ccc1OCc1ccccc1,,,,CHEMBL4855849
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCc2ccco2)ccc1OCc1ccccc1,,,,CHEMBL4865544
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4875170
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,17080.0,nM,=,CHEMBL4846812
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,18720.0,nM,=,CHEMBL4878858
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,17750.0,nM,=,CHEMBL4868950
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,19240.0,nM,=,CHEMBL4856483
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,16830.0,nM,=,CHEMBL4877271
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,8590.0,nM,=,CHEMBL4877129
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)C1CN(C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)C1,12780.0,nM,=,CHEMBL4877193
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CC(F)(F)C3)C2)ccc1OCc1ccccc1,21830.0,nM,=,CHEMBL4876605
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCCCC3)C2)ccc1OCc1ccccc1,10550.0,nM,=,CHEMBL4868565
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCOCC3)C2)ccc1OCc1ccccc1,35670.0,nM,=,CHEMBL4874507
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,3130.0,nM,=,CHEMBL4850421
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)N2CCCCC2)ccc1OCc1ccccc1,8170.0,nM,=,CHEMBL4872439
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCc2ccccc2)ccc1OCc1ccccc1,81560.0,nM,=,CHEMBL4869616
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccc(F)cc3)C2)ccc1OCc1ccccc1,3350.0,nM,=,CHEMBL4849121
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)C2CN(C(=O)/C=C/c3ccc(OCc4ccccc4)c(OC)c3)C2)cc1,4780.0,nM,=,CHEMBL4863966
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccco3)C2)ccc1OCc1ccccc1,3610.0,nM,=,CHEMBL4859895
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,1800.0,nM,=,CHEMBL4863296
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)CCNC(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,54210.0,nM,=,CHEMBL4876813
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,17910.0,nM,=,CHEMBL4863014
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/c2nnn[nH]2)ccc1OCc1ccccc1,,,,CHEMBL4872883
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,98460.0,nM,=,CHEMBL4846539
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/c2cnco2)ccc1OCc1ccccc1,,,,CHEMBL4855922
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(O)C(F)(F)F)ccc1OCc1ccccc1,,,,CHEMBL4847523
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2Cc2ccccc2)ccc1OCc1ccccc1,,,,CHEMBL4871639
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,7760.0,nM,=,CHEMBL4872213
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,9910.0,nM,=,CHEMBL4845958
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(OC)c1,205460.0,nM,=,CHEMBL4458591
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,10640.0,nM,=,CHEMBL4865997
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(O)c(OC)c1,98790.0,nM,=,CHEMBL4850411
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OC)c(OC)c1,45310.0,nM,=,CHEMBL4873939
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OCc2cscn2)c(OC)c1,,,,CHEMBL4860973
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OCc2cccnc2)c(OC)c1,,,,CHEMBL4877974
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2cc(OC)cc(OC)c2)c(OC)c1,,,,CHEMBL4860963
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2cc(F)cc(F)c2)c(OC)c1,,,,CHEMBL4863922
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCCCOc2ccccc2)c(OC)c1,,,,CHEMBL4845995
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,3.62,%,=,CHEMBL4865997
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,36.83,%,=,CHEMBL32749
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,0.0,%,=,CHEMBL4864402
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,0.0,%,=,CHEMBL4860315
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,6.49,%,=,CHEMBL4848839
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,91.88,%,=,CHEMBL68672
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,16.96,%,=,CHEMBL4876981
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,13.42,%,=,CHEMBL4862182
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,78.15,%,=,CHEMBL140
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,22.31,%,=,CHEMBL4846673
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,13.26,%,=,CHEMBL4873786
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,8.81,%,=,CHEMBL4867164
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,48.23,%,=,CHEMBL4850421
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,20.57,%,=,CHEMBL4863296
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/c2nnn[nH]2)ccc1OCc1ccccc1,9.56,%,=,CHEMBL4872883
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,0.0,%,=,CHEMBL4846539
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(O)C(F)(F)F)ccc1OCc1ccccc1,44.11,%,=,CHEMBL4847523
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(-c2cncn2Cc2ccccc2)ccc1OCc1ccccc1,27.53,%,=,CHEMBL4871639
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,13.82,%,=,CHEMBL4872213
Inhibition of human amyloid beta (1 to 40) fibrillization at 100 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,0.0,%,=,CHEMBL4845958
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)O)ccc1O,9.75,%,=,CHEMBL32749
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,73.08,%,=,CHEMBL68672
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,9.35,%,=,CHEMBL4876981
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,7.28,%,=,CHEMBL4862182
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,65.48,%,=,CHEMBL140
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,0.29,%,=,CHEMBL4846673
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,0.0,%,=,CHEMBL4873786
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,14.85,%,=,CHEMBL4850421
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,5.5,%,=,CHEMBL4863296
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(O)C(F)(F)F)ccc1OCc1ccccc1,0.0,%,=,CHEMBL4847523
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(-c2cncn2Cc2ccccc2)ccc1OCc1ccccc1,2.21,%,=,CHEMBL4871639
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,5.98,%,=,CHEMBL4872213
Inhibition of human amyloid beta (1 to 40) fibrillization at 20 uM measured every 15 mins for 100 hrs by Thioflavin-T fluorescence assay relative to control,Inhibition,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,1.95,%,=,CHEMBL4865997
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,2240.0,nM,=,CHEMBL4868743
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,3260.0,nM,=,CHEMBL4852639
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,4120.0,nM,=,CHEMBL4862604
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,5540.0,nM,=,CHEMBL4876778
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,3950.0,nM,=,CHEMBL4857779
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,4510.0,nM,=,CHEMBL4848375
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,7010.0,nM,=,CHEMBL4870117
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,6260.0,nM,=,CHEMBL4859825
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,3290.0,nM,=,CHEMBL4856094
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,2570.0,nM,=,CHEMBL4846443
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,5320.0,nM,=,CHEMBL4872910
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,6020.0,nM,=,CHEMBL4848524
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,5380.0,nM,=,CHEMBL4853496
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,6180.0,nM,=,CHEMBL4852674
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,2070.0,nM,=,CHEMBL4876429
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,3050.0,nM,=,CHEMBL4878762
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Oc1cccc2ccc(/C=C/c3ccc(OCCCN4CCCC4)cc3)nc12,,,,CHEMBL4858290
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Oc1cccc2ccc(/C=C/c3ccc(OCCCN4CCCCC4)cc3)nc12,,,,CHEMBL4847024
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7120.0,nM,=,CHEMBL4287929
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,8270.0,nM,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,,,CHEMBL153
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,N=C(NCc1ccc(Cl)cc1)SCCCc1c[nH]cn1,,,,CHEMBL14690
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,91.4,%,=,CHEMBL4868743
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,90.76,%,=,CHEMBL4852639
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,93.29,%,=,CHEMBL4862604
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,89.8,%,=,CHEMBL4876778
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,94.59,%,=,CHEMBL4857779
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,76.66,%,=,CHEMBL4848375
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,74.67,%,=,CHEMBL4870117
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,74.85,%,=,CHEMBL4859825
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,85.41,%,=,CHEMBL4856094
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,86.96,%,=,CHEMBL4846443
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,71.89,%,=,CHEMBL4872910
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,75.69,%,=,CHEMBL4848524
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,84.98,%,=,CHEMBL4853496
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,70.4,%,=,CHEMBL4852674
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,97.62,%,=,CHEMBL4876429
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,86.84,%,=,CHEMBL4878762
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Oc1cccc2ccc(/C=C/c3ccc(OCCCN4CCCC4)cc3)nc12,17.58,%,=,CHEMBL4858290
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Oc1cccc2ccc(/C=C/c3ccc(OCCCN4CCCCC4)cc3)nc12,15.71,%,=,CHEMBL4847024
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,65.76,%,=,CHEMBL4287929
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.1,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2,,%,,CHEMBL153
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by Thioflavin T based fluorometric assay relative to control,Inhibition,N=C(NCc1ccc(Cl)cc1)SCCCc1c[nH]cn1,,%,,CHEMBL14690
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by transmission electron microscopic analysis,Inhibition,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,,%,,CHEMBL4868743
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs by transmission electron microscopic analysis,Inhibition,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,,%,,CHEMBL4852639
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as reduction in fluorescence intensity at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,35.1,%,=,CHEMBL4868743
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as reduction in fluorescence intensity at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,29.42,%,=,CHEMBL4852639
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils assessed as reduction in fluorescence intensity at 20 uM after 24 hrs by thioflavin-T fluorescence assay relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,52.46,%,=,CHEMBL140
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 20 uM measured after 24 hrs by transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,,,,CHEMBL4868743
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) preformed fibrils at 20 uM measured after 24 hrs by transmission electron microscopic analysis,Activity,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,,,,CHEMBL4852639
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,98.1,%,=,CHEMBL4863690
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,99.7,%,=,CHEMBL4873761
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,92.6,%,=,CHEMBL4854597
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,96.6,%,=,CHEMBL4861145
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,95.1,%,=,CHEMBL4865817
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,87.9,%,=,CHEMBL4876641
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,73.7,%,=,CHEMBL4857021
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,91.6,%,=,CHEMBL4858987
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,95.0,%,=,CHEMBL4874405
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,97.5,%,=,CHEMBL4854252
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,97.2,%,=,CHEMBL4850978
Disaggregation of self-induced amyloid beta (1 to 42) (unknown origin) at 25 uM measured by Thioflavin T based fluorometric assay relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,84.4,%,=,CHEMBL4872327
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,3560.0,nM,=,CHEMBL4863690
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1480.0,nM,=,CHEMBL4873761
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1490.0,nM,=,CHEMBL4854597
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1270.0,nM,=,CHEMBL4861145
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,880.0,nM,=,CHEMBL4865817
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1030.0,nM,=,CHEMBL4876641
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1320.0,nM,=,CHEMBL4857021
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,2100.0,nM,=,CHEMBL4858987
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1380.0,nM,=,CHEMBL4874405
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,1680.0,nM,=,CHEMBL4854252
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3780.0,nM,=,CHEMBL4850978
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3170.0,nM,=,CHEMBL4872327
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,,,CHEMBL502
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) assessed as reduction in fibril formation incubated for 24 hrs by transmission electron microscopy,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,,,,CHEMBL4865817
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,81.0,%,=,CHEMBL140
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,95.2,%,=,CHEMBL4863690
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,91.9,%,=,CHEMBL4873761
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,93.2,%,=,CHEMBL4854597
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,94.8,%,=,CHEMBL4861145
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,95.3,%,=,CHEMBL4865817
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,96.5,%,=,CHEMBL4876641
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,95.0,%,=,CHEMBL4857021
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,91.7,%,=,CHEMBL4858987
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,95.6,%,=,CHEMBL4874405
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,91.9,%,=,CHEMBL4854252
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,93.9,%,=,CHEMBL4850978
Inhibition of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Inhibition,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,91.0,%,=,CHEMBL4872327
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,56.5,%,=,CHEMBL140
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,74.8,%,=,CHEMBL4863690
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,73.0,%,=,CHEMBL4873761
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,85.6,%,=,CHEMBL4854597
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,89.5,%,=,CHEMBL4861145
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,88.1,%,=,CHEMBL4865817
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,83.4,%,=,CHEMBL4876641
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,77.6,%,=,CHEMBL4857021
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,78.8,%,=,CHEMBL4858987
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,84.4,%,=,CHEMBL4874405
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,73.8,%,=,CHEMBL4854252
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,82.1,%,=,CHEMBL4850978
Disaggregation of Cu2+ induced amyloid beta (1 to 42 residues) (unknown origin) aggregation at 25 uM by thioflavin-T fluorescence method relative to control,Activity,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,88.3,%,=,CHEMBL4872327
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,CCN(CC)CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1,64.1,%,=,CHEMBL4852191
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,CCN(CCCCOc1ccc(/C=C/C(=O)c2ccc(N(C)C)cc2O)cc1)Cc1ccccc1OC,70.1,%,=,CHEMBL4857775
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,CCN(CCCOc1ccc(C(=O)/C=C/c2ccccc2)c(O)c1)Cc1ccccc1N(C)C,23.0,%,=,CHEMBL4849646
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,43.1,%,=,CHEMBL140
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,CCN(CCCCOc1ccc(/C=C/C(=O)c2ccc(N(C)C)cc2O)cc1)Cc1ccccc1N(C)C,75.8,%,=,CHEMBL4868157
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,CN(C)c1ccc(/C=C/C(=O)c2ccc(N(C)C)cc2O)cc1,64.3,%,=,CHEMBL4868189
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,COc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1,59.7,%,=,CHEMBL4854334
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by T-fluorescence assay relative to control,Inhibition,COc1ccc(/C=C/C(=O)c2ccc(N(C)C)cc2O)cc1,36.1,%,=,CHEMBL4863869
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCN(C)C1=CC(=O)c2ccccc2C1=O,67.4,%,=,CHEMBL4858292
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=CC(=O)c2ccccc2C1=O,24.0,%,=,CHEMBL2334460
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCN(C)C1=C(Cl)C(=O)c2ccccc2C1=O,40.5,%,=,CHEMBL4862113
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=C(Cl)C(=O)c2ccccc2C1=O,18.4,%,=,CHEMBL4866391
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=CC(=O)c2cccc(OCC)c2C1=O,11.2,%,=,CHEMBL4878660
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=CC(=O)c2cccc(OCc3ccccc3)c2C1=O,17.5,%,=,CHEMBL4868518
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=CC(=O)c2cccc(OC)c2C1=O,15.5,%,=,CHEMBL4866040
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C#CCNC1=CC(=O)c2c(O)ccc(O)c2C1=O,21.7,%,=,CHEMBL4872400
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,92.7,%,=,CHEMBL164
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation at 50 uM measured every 10 mins for 72 hrs by Thioflavin T flourimetric assay relative to control,Inhibition,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,93.1,%,=,CHEMBL1433
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O[C@H](CNCc1ccccc1)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4850659
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O[C@@H](CNCc1ccccc1)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4866859
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1CNC[C@H](O)[C@H](Cc1ccccc1)NCC(c1ccccc1)c1ccccc1,81.4,%,=,CHEMBL4867049
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1CNC[C@H](O)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4878052
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NCCC(c2ccccc2)c2ccccc2)c1,34.7,%,=,CHEMBL4862223
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)c1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NCCC(c2ccccc2)c2ccccc2)c1,34.7,%,=,CHEMBL4861746
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NCC(c1ccccc1)c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4858536
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4862581
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(NC[C@@H](O)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4875470
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)NC[C@H](O)[C@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4868522
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)CNC[C@@H](O)[C@H](Cc1ccccc1)NCC(c1ccccc1)c1ccccc1,34.7,%,=,CHEMBL4862200
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1ccccc1,20.5,%,=,CHEMBL4869613
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)[C@@H](O)CNCc1ccccc1,20.5,%,=,CHEMBL4845832
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1CNC[C@H](O)[C@H](Cc1ccccc1)NC(=O)C(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4870994
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccccc1CNC[C@H](O)[C@H](Cc1ccccc1)NC(=O)CC(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4847981
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4873295
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CC(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4877962
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4874266
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CC(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4858894
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)c1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4851264
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)c1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CC(c2ccccc2)c2ccccc2)c1,20.5,%,=,CHEMBL4876288
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)[C@@H](O)CNCc1cccc(C(F)(F)F)c1,20.5,%,=,CHEMBL4877574
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1ccc(CNC[C@H](O)[C@H](Cc2ccccc2)NC(=O)C(c2ccccc2)c2ccccc2)cc1,20.5,%,=,CHEMBL4857933
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)c1ccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CC(c2ccccc2)c2ccccc2)cc1,20.5,%,=,CHEMBL4851448
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4857510
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CC(c1ccccc1)c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4869848
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4874214
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CC(c1ccccc1)c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4873410
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)NC[C@H](O)[C@H](Cc1ccccc1)NC(=O)C(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4861616
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)NC[C@H](O)[C@H](Cc1ccccc1)NC(=O)CC(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4857439
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,CC(C)(C)CNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4855794
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(N[C@@H](Cc1ccccc1)[C@H](O)CNCC(F)(F)F)C(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4857355
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)[C@H](O)CNCC(F)(F)F,20.5,%,=,CHEMBL4850475
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(N[C@@H](Cc1ccccc1)[C@H](O)CNCC1CC1)C(c1ccccc1)c1ccccc1,20.5,%,=,CHEMBL4856275
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation at 10 uM after 36 to 48 hrs by thioflavin-T fluorescence assay relative to control,Inhibition,O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)[C@H](O)CNCC1CC1,20.5,%,=,CHEMBL4865539
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,,%,,CHEMBL4878996
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,Cc1ccc(NC(=O)c2cn(-c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,,%,,CHEMBL4870606
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,COc1ccc(-n2cc(CNc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1OC,,%,,CHEMBL4853246
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,Cc1ccc(-n2cc(CNc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,,%,,CHEMBL4877181
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM after 24 hrs by thioflavin-T fluorescence method,Inhibition,O=C(Nc1ccccc1)c1cn(-c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)nn1,,%,,CHEMBL4850224
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM measured after 24 hrs in presence of copper ion by thioflavin-T fluorescence method,Inhibition,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,50.0,%,<=,CHEMBL4878996
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation at 40 uM measured after 24 hrs in presence of copper ion by thioflavin-T fluorescence method,Inhibition,COc1ccc(-n2cc(CNc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1OC,50.0,%,<=,CHEMBL4853246
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 24 hrs by thioflavin-T fluorescence method,IC50,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,4600.0,nM,=,CHEMBL4878996
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation upto 10 uM by ThT fluorescence assay,Inhibition,NC(=O)c1ccc2c(c1)N(Cc1ccc(C(=O)NO)cc1)c1ccccc1S2,,%,,CHEMBL4862510
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2.Cl,33.34,%,=,CHEMBL536047
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,73.74,%,=,CHEMBL4874244
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,85.04,%,=,CHEMBL4856400
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c3C(C1)C2.Cl.Cl,78.04,%,=,CHEMBL4878434
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,COc1ccc2nc3c(c(N)c2c1)C1CC(C)=CC(C3)C1.Cl,37.21,%,=,CHEMBL4850590
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 100 uM by Thioflavin T based fluorometric assay,Inhibition,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,94.68,%,=,CHEMBL164
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL35
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NC2CC2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4851753
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,53010.0,nM,=,CHEMBL4850080
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NCc2ccccc2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4846222
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,68500.0,nM,=,CHEMBL4860892
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,41160.0,nM,=,CHEMBL4879194
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,21920.0,nM,=,CHEMBL4861569
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,41150.0,nM,=,CHEMBL4871443
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NCCc2ccccc2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4863308
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,137390.0,nM,=,CHEMBL4877793
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,113130.0,nM,=,CHEMBL4846727
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,COc1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,,,,CHEMBL4846970
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,47810.0,nM,=,CHEMBL4848103
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,Cc1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,,,,CHEMBL4872394
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,167530.0,nM,=,CHEMBL4852897
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,115520.0,nM,=,CHEMBL4848555
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)N2CCCCC2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4846378
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,136390.0,nM,=,CHEMBL4867846
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,NC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL4852754
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL4854685
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCNC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL4861036
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(C)C(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL4862956
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(C(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4858520
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(C(=O)N2CCCCC2)c(Cl)cc1NCc1ccco1,,,,CHEMBL4871063
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(Nc1ccccc1)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,,CHEMBL4852794
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,117490.0,nM,=,CHEMBL4850077
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(O)C(F)(F)F)c(NCc2ccco2)cc1Cl,,,,CHEMBL4875841
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,55950.0,nM,=,CHEMBL4851224
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,82410.0,nM,=,CHEMBL4863425
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,102590.0,nM,=,CHEMBL4850840
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,6560.0,nM,=,CHEMBL4870723
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,70480.0,nM,=,CHEMBL4874275
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(-c2noc(=O)[nH]2)c(NCc2ccco2)cc1Cl,,,,CHEMBL4874912
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(F)cc1NCc1ccco1,129540.0,nM,=,CHEMBL4864237
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(Cl)cc1NCc1ccco1,,,,CHEMBL4847254
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(Br)cc1NCc1ccco1,154420.0,nM,=,CHEMBL4858866
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,153050.0,nM,=,CHEMBL4858198
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(Cl)cc1NCc1ccco1)C(F)(F)F,,,,CHEMBL4852293
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(Br)cc1NCc1ccco1)C(F)(F)F,,,,CHEMBL4863817
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,COc1ccc(C(O)C(F)(F)F)c(NCc2ccco2)c1,,,,CHEMBL4875224
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(Cl)cc1NCc1cscn1)C(F)(F)F,,,,CHEMBL4856901
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(Br)cc1NCc1cscn1)C(F)(F)F,,,,CHEMBL4857258
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,129690.0,nM,=,CHEMBL4848389
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,8.56,%,=,CHEMBL35
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)NC2CC2)c(Cl)cc1NCc1ccco1,29.18,%,=,CHEMBL4851753
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,%,,CHEMBL4850080
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)NCc2ccccc2)c(Cl)cc1NCc1ccco1,11.81,%,=,CHEMBL4846222
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,,%,,CHEMBL4860892
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,,%,,CHEMBL4879194
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,%,,CHEMBL4861569
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,17.63,%,=,CHEMBL4871443
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)NCCc2ccccc2)c(Cl)cc1NCc1ccco1,,%,,CHEMBL4863308
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,21.29,%,=,CHEMBL4877793
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,%,,CHEMBL4846727
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,27.83,%,=,CHEMBL4846970
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,39.24,%,=,CHEMBL4848103
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,Cc1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,,%,,CHEMBL4872394
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,17.42,%,=,CHEMBL4852897
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,11.3,%,=,CHEMBL4848555
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(S(=O)(=O)N2CCCCC2)c(Cl)cc1NCc1ccco1,19.08,%,=,CHEMBL4846378
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,17.49,%,=,CHEMBL4867846
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,NC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,32.37,%,=,CHEMBL4852754
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,19.07,%,=,CHEMBL4854685
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CCNC(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,24.64,%,=,CHEMBL4861036
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CN(C)C(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,18.35,%,=,CHEMBL4862956
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(C(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,34.05,%,=,CHEMBL4858520
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1cc(C(=O)N2CCCCC2)c(Cl)cc1NCc1ccco1,11.03,%,=,CHEMBL4871063
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(Nc1ccccc1)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,29.43,%,=,CHEMBL4852794
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,15.03,%,=,CHEMBL4850077
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,27.14,%,=,CHEMBL4851224
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,,%,,CHEMBL4863425
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,,%,,CHEMBL4850840
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,25.17,%,=,CHEMBL4870723
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,14.06,%,=,CHEMBL4874275
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,CNS(=O)(=O)c1cc(-c2noc(=O)[nH]2)c(NCc2ccco2)cc1Cl,20.22,%,=,CHEMBL4874912
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1ccc(F)cc1NCc1ccco1,12.39,%,=,CHEMBL4864237
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1ccc(Cl)cc1NCc1ccco1,20.18,%,=,CHEMBL4847254
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,O=C(O)c1ccc(Br)cc1NCc1ccco1,6.13,%,=,CHEMBL4858866
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,6.13,%,=,CHEMBL4858198
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,OC(c1ccc(Cl)cc1NCc1ccco1)C(F)(F)F,60.72,%,=,CHEMBL4852293
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,OC(c1ccc(Br)cc1NCc1ccco1)C(F)(F)F,81.32,%,=,CHEMBL4863817
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(C(O)C(F)(F)F)c(NCc2ccco2)c1,36.8,%,=,CHEMBL4875224
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,OC(c1ccc(Cl)cc1NCc1cscn1)C(F)(F)F,27.88,%,=,CHEMBL4856901
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,OC(c1ccc(Br)cc1NCc1cscn1)C(F)(F)F,33.03,%,=,CHEMBL4857258
Inhibition of human amyloid beta (1 to 42) fibrillization at 100 uM measured every 15 mins by Thioflavin-T fluorescence assay relative to control,Inhibition,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,6.49,%,=,CHEMBL4848389
Photo-degradation of Amyloid beta (1 to 42) (unknown origin) assessed as disruption of Co2 induced aggregation at 66.7 uM irradiated with UVA-LED for 1 hr by immunoblotting analysis,Inhibition,CC[n+]1ccc(-c2ccc(-c3nc4ccccc4s3)cc2)cc1.[Br-],,%,,CHEMBL4857230
Photo-degradation of Amyloid beta (1 to 42) (unknown origin) assessed as disruption of Co2 induced aggregation at 66.7 uM irradiated with UVA-LED measured after 5 mins by immunoblotting analysis,Inhibition,CC[n+]1ccc(-c2ccc(-c3nc4ccccc4s3)cc2)cc1.[Br-],,%,,CHEMBL4857230
Photo-degradation of Amyloid beta (1 to 42) (unknown origin) assessed as disruption of Co2 induced aggregation irradiated with UVA-LED measured after 30 mins by immunoblotting analysis,Activity,Cc1ccc2c(c1)sc(-c1ccc(N(C)C)cc1)[n+]2C.[Cl-],,,,CHEMBL224392
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,c1ccc2oc(C3CCNCC3)cc2c1,45.45,%,=,CHEMBL4863598
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,55.4,%,=,CHEMBL4855388
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,Oc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,48.28,%,=,CHEMBL4873119
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1OC,14.67,%,=,CHEMBL4863754
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,8.04,%,=,CHEMBL4871752
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(OC)c(CN2CCC(c3cc4ccccc4o3)CC2)c1,51.8,%,=,CHEMBL4875660
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,CCc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,19.9,%,=,CHEMBL4855139
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,Clc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,24.4,%,=,CHEMBL4878578
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,Fc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,57.71,%,=,CHEMBL4875517
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12,61.91,%,=,CHEMBL4865381
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(C(=O)c2c(C3CCN(Cc4ccccc4)CC3)oc3ccccc23)cc1,47.43,%,=,CHEMBL4849087
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)cc1OC,42.93,%,=,CHEMBL4848309
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)c(OC)c3)CC2)cc1OC,54.37,%,=,CHEMBL4874487
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(OC)c(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)c1,39.41,%,=,CHEMBL4858801
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(OC)c(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)c(OC)c3)CC2)c1,37.41,%,=,CHEMBL4848809
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(C(=O)c2c(C3CCN(Cc4cc(OC)ccc4OC)CC3)oc3ccccc23)cc1,45.95,%,=,CHEMBL4857748
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccccc3)CC2)cc1,42.22,%,=,CHEMBL4853093
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1ccc(CN2CCC(c3oc4ccccc4c3C(=O)c3ccc(OC)cc3)CC2)cc1,45.03,%,=,CHEMBL4845972
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,49.9,%,=,CHEMBL140
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of human amyloid beta (25 to 35) self-induced aggregation at 100 uM after 48 hrs by thioflavin-T fluorescence relative to control,Inhibition,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,,%,,CHEMBL636
Inhibition of amyloid beta(25 to 35) (unknown origin) binding to human SH-SY5Y cell plasma membrane at 10 uM measured after 20 mins by UV-vis microplate reader assay,Inhibition,c1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,,%,,CHEMBL4855388
Inhibition of amyloid beta(25 to 35) (unknown origin) binding to human SH-SY5Y cell plasma membrane at 10 uM measured after 20 mins by UV-vis microplate reader assay,Inhibition,Fc1ccc(CN2CCC(c3cc4ccccc4o3)CC2)cc1,,%,,CHEMBL4875517
Inhibition of amyloid beta(25 to 35) (unknown origin) binding to human SH-SY5Y cell plasma membrane at 10 uM measured after 20 mins by UV-vis microplate reader assay,Inhibition,O=C(c1ccccc1)c1c(C2CCN(Cc3ccccc3)CC2)oc2ccccc12,,%,,CHEMBL4865381
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,[11CH3]Oc1ccc(NC(=O)c2ccn3c(n2)nc2ccccc23)cn1,,,,CHEMBL4863383
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,CNc1ccc(-c2cn3c(n2)sc2cc(OCCF)ccc23)cc1,130.0,%,=,CHEMBL2068862
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,FCCC1CCN(c2ccn3c(n2)nc2ccccc23)CC1,34.0,%,=,CHEMBL3546238
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)sc1nc(C(=O)Nc3cccnc3)cn12,100.0,%,=,CHEMBL4860410
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)Nc3cccnc3)ccn12,17.0,%,=,CHEMBL4869785
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,O=C(Nc1cccnc1)c1ccn2c(n1)nc1ccccc12,-12.0,%,=,CHEMBL4868771
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,O=C(Nc1ccccn1)c1ccn2c(n1)nc1ccccc12,24.0,%,=,CHEMBL4870456
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)Nc3ccccn3)ccn12,41.0,%,=,CHEMBL4856369
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)Nc3ccc(OC)nc3)ccn12,13.0,%,=,CHEMBL4874428
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1cncc(NC(=O)c2ccn3c(n2)nc2ccccc23)c1,25.0,%,=,CHEMBL4872211
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1cncc(NC(=O)c2ccn3c(n2)nc2cc(OC)ccc23)c1,5.0,%,=,CHEMBL4873557
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1cc(NC(=O)c2ccn3c(n2)nc2ccccc23)cnc1OC,21.0,%,=,CHEMBL4869137
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ncc(NC(=O)c2ccn3c(n2)nc2ccccc23)cc1C,-29.0,%,=,CHEMBL4873333
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,Cc1cc(NC(=O)c2ccn3c(n2)nc2ccccc23)cnc1C,21.0,%,=,CHEMBL4867379
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,Cn1nc(NC(=O)c2ccn3c(n2)nc2ccccc23)ccc1=O,12.0,%,=,CHEMBL4877913
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)Nc3ccncn3)ccn12,30.0,%,=,CHEMBL4851076
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)N3Cc4cccnc4C3)ccn12,0.0,%,=,CHEMBL4846194
"Displacement of [3]10-methoxy-N-(pyridin-3-yl-7-thia-2,5-diazatricyclo(6.4.0.0 2.6)-dodeca-1(12),3,5,8,10-pentaene-4-carboxamide from human Amyloid beta plaques using AD postmortem patient brain homogenates at 1 uM incubated for 2 hr by radio ligand binding assay relative to control",Activity,COc1ccc2c(c1)nc1nc(C(=O)NC3CCCc4cccnc43)ccn12,8.0,%,=,CHEMBL4849438
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,O=C1CC(c2ccc(O)cc2)Oc2cc(OC(=O)N3CCCCC3)cc(O)c21,36.11,%,=,CHEMBL4872071
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,O=C1CC(c2ccc(O)cc2)Oc2cc(OC(=O)N3CCOCC3)cc(O)c21,62.3,%,=,CHEMBL4848543
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,CCN(C)C(=O)Oc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O,66.49,%,=,CHEMBL4852914
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,CN(C)C(=O)Oc1ccc(C2CC(=O)c3c(O)cc(OC(=O)N(C)C)cc3O2)cc1,62.39,%,=,CHEMBL4850938
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,44.91,%,=,CHEMBL9352
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 25 uM by Thioflavin T based fluorometric assay,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,31.75,%,=,CHEMBL140
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccccc3)cccc21,45.9,%,=,CHEMBL368698
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,33.3,%,=,CHEMBL4849477
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccc(F)cc3)cccc21,40.5,%,=,CHEMBL4863101
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=[N+]([O-])c1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,35.1,%,=,CHEMBL4850275
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,COc1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,27.6,%,=,CHEMBL4871357
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,COc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,54.2,%,=,CHEMBL4864854
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,COc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1OC,36.8,%,=,CHEMBL4866390
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCC3CCCCC3)cccc21,53.5,%,=,CHEMBL4854460
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCC3CCCNC3)cccc21,27.3,%,=,CHEMBL4865076
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)C1,59.2,%,=,CHEMBL4852840
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCC(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,69.7,%,=,CHEMBL4854568
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1cccc2ccccc12)n1ccc2c(OCCNCc3ccccc3)cccc21,20.5,%,=,CHEMBL4872486
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2cccc3ccccc23)c1,23.6,%,=,CHEMBL4874512
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,c1ccc(CNCCOc2cccc3c2ccn3Cc2ccccc2)cc1,71.3,%,=,CHEMBL4862516
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2ccn3Cc2ccccc2)C1,79.4,%,=,CHEMBL4859019
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,c1ccc(CNCCOc2cccc3c2CCN3Cc2ccccc2)cc1,72.5,%,=,CHEMBL4855189
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2CCN3Cc2ccccc2)c1,72.6,%,=,CHEMBL4856695
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2CCN3Cc2ccccc2)C1,79.7,%,=,CHEMBL4866550
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=C1Cc2c(OCCNCc3ccccc3)cccc2N1Cc1ccccc1,42.4,%,=,CHEMBL4874675
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2CC(=O)N3Cc2ccccc2)c1,58.5,%,=,CHEMBL4873096
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2CC(=O)N3Cc2ccccc2)C1,65.2,%,=,CHEMBL4870158
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=c1[nH]c2c(OCCNCc3ccccc3)cccc2n1Cc1ccccc1,32.9,%,=,CHEMBL4849430
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2[nH]c(=O)n3Cc2ccccc2)c1,64.3,%,=,CHEMBL4866962
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2[nH]c(=O)n3Cc2ccccc2)C1,43.9,%,=,CHEMBL4858014
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CN(CCOc1cccc2c1ccn2S(=O)(=O)c1ccccc1)Cc1ccccc1,20.0,%,<,CHEMBL4872905
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccccc3Cl)cccc21,20.0,%,<,CHEMBL4863079
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3cccc(Cl)c3)cccc21,20.0,%,<,CHEMBL4849917
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccc(Cl)cc3)cccc21,20.0,%,<,CHEMBL4862131
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3cc(Cl)cc(Cl)c3)cccc21,20.0,%,<,CHEMBL4845762
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3cccc(C(F)(F)F)c3)cccc21,20.0,%,<,CHEMBL4849702
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CN(C)c1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,20.0,%,<,CHEMBL4850764
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CN(C)c1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4871678
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccc4c(c3)OCCO4)cccc21,20.0,%,<,CHEMBL4871652
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CCOc1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,20.0,%,<,CHEMBL4862752
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CCOc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4879036
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(=O)Oc1cccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,20.0,%,<,CHEMBL4867606
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(=O)Oc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4846931
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,COC(=O)c1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4849680
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(=O)Nc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4855991
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(Cc4ccccc4)CC3)cccc21,20.0,%,<,CHEMBL4851655
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCC3CCCC3)cccc21,20.0,%,<,CHEMBL4853545
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCC3CC3)cccc21,20.0,%,<,CHEMBL4873700
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CNCCOc1cccc2c1ccn2S(=O)(=O)c1ccccc1,20.0,%,<,CHEMBL178254
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccccn3)cccc21,20.0,%,<,CHEMBL4850738
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCc3ccncc3)cccc21,20.0,%,<,CHEMBL4863037
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)o1,20.0,%,<,CHEMBL4862289
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,O=S(=O)(c1ccccc1)N1CCc2c(OCCNCc3ccccc3)cccc21,20.0,%,<,CHEMBL4860124
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2CCN3S(=O)(=O)c2ccccc2)c1,20.0,%,<,CHEMBL4872078
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2CCN3S(=O)(=O)c2ccccc2)C1,20.0,%,<,CHEMBL4845699
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(=O)Oc1ccc(CNCCOc2cccc3c2CCN3S(=O)(=O)c2ccccc2)cc1,20.0,%,<,CHEMBL4863967
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(C)(C)OC(=O)N1CCCC(CNCCOc2cccc3c2ccn3S(=O)(=O)c2cccc3ccccc23)C1,20.0,%,<,CHEMBL4861756
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,CC(=O)Oc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2cccc3ccccc23)cc1,20.0,%,<,CHEMBL4874372
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation at 10 uM incubated for 24 to 48 hrs by Thioflavin-T based fluorometric assay,Inhibition,Cc1cccc(CNCCOc2cccc3c2ccn3Cc2ccccc2)c1,,%,,CHEMBL4857018
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) expressed in Escherichia coli BL21(DE3) at 10 uM incubated for 60 mins by fluorescence based analysis,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCCNc4c5c(nc6ccccc46)CCCC5)CC3)cccc21,30.0,%,=,CHEMBL3885186
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccccc3O)ccc2nc2n1CCC2,4690.0,nM,=,CHEMBL4846102
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cccc(Br)c3O)ccc2nc2n1CCC2,8340.0,nM,=,CHEMBL4871074
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccc(Cl)cc3O)ccc2nc2n1CCC2,7020.0,nM,=,CHEMBL4876164
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c1O,4200.0,nM,=,CHEMBL4874834
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(Br)ccc3O)ccc2nc2n1CCC2,7630.0,nM,=,CHEMBL4871454
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(F)ccc3O)ccc2nc2n1CCC2,6300.0,nM,=,CHEMBL4861468
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c(O)c1,3910.0,nM,=,CHEMBL4852660
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccccc1O)CCC3,5090.0,nM,=,CHEMBL4849288
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cccc(Br)c1O)CCC3,9270.0,nM,=,CHEMBL4879281
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccc(Cl)cc1O)CCC3,6100.0,nM,=,CHEMBL4875354
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c1O,4260.0,nM,=,CHEMBL4870217
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(Br)ccc1O)CCC3,7370.0,nM,=,CHEMBL4853059
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(F)ccc1O)CCC3,6330.0,nM,=,CHEMBL4856085
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c(O)c1,3220.0,nM,=,CHEMBL4860689
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2ccccc2nc2n1CCC2,,,,CHEMBL456881
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1c(O)c(O)c(C(=O)O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,6600.0,nM,=,CHEMBL4845912
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CCCC2=C/C(=C\C(C)(C)O)OC2=O)c1O,40700.0,nM,=,CHEMBL4847749
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CCCC1=C/C(=C\C(C)(C)O)OC1=O,51400.0,nM,=,CHEMBL4846858
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CC/C=C(\C)CC[C@H](O)C(C)(C)O,53300.0,nM,=,CHEMBL4871044
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c1O,50300.0,nM,=,CHEMBL4877566
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,9900.0,nM,=,CHEMBL164
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,100000.0,nM,>,CHEMBL378225
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4ccc[nH]c4=O)c3C(C1)C2,42.3,%,=,CHEMBL4866930
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNS(=O)(=O)c4cn[nH]c4)c3C(C1)C2,35.3,%,=,CHEMBL4862716
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)cc(O)c4)c3C(C1)C2,49.5,%,=,CHEMBL4859103
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)Nc4cn[nH]c4)c3C(C1)C2,32.6,%,=,CHEMBL4863615
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)N4CCNC(=O)C4)c3C(C1)C2,9.7,%,=,CHEMBL4854913
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCC(=O)NCc4cc[nH]c(=O)c4)c3C(C1)C2,19.9,%,=,CHEMBL4848527
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,COc1cc(CNC(=O)CCCCCCCCNc2c3c(nc4cc(Cl)ccc24)CC2C=C(C)CC3C2)ccn1,29.4,%,=,CHEMBL4872514
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(NCCCCCCCCCNC(=O)c4cc(O)c5c(c4)C(=O)c4cccc(O)c4C5=O)c3C(C1)C2,47.9,%,=,CHEMBL3304306
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC1=CC2Cc3nc4cc(Cl)ccc4c(N)c3C(C1)C2,8.9,%,=,CHEMBL140476
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,,%,,CHEMBL164
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,,%,,CHEMBL502
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],39.2,%,=,CHEMBL345124
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control,Inhibition,O=C(NCCCCCCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)NCCC3,68.2,%,=,CHEMBL3545559
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,74.8,%,=,CHEMBL4850546
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCNc3c4c(nc5ccccc35)CCCC4)cccc21,61.1,%,=,CHEMBL4850051
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCNc3c4c(nc5ccccc35)CCCC4)cccc21,77.4,%,=,CHEMBL4874513
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCCNc3c4c(nc5ccccc35)CCCC4)cccc21,73.2,%,=,CHEMBL4848231
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCCCNc3c4c(nc5ccccc35)CCCC4)cccc21,69.2,%,=,CHEMBL4877482
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccccc3)cccc21,55.0,%,=,CHEMBL4878361
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCNCc3ccccc3)cccc21,53.2,%,=,CHEMBL4866788
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCNCc3ccccc3)cccc21,41.8,%,=,CHEMBL4850488
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCCNCc3ccccc3)cccc21,62.5,%,=,CHEMBL4871964
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccccc3Cl)cccc21,57.0,%,=,CHEMBL4878383
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cccc(Cl)c3)cccc21,64.3,%,=,CHEMBL4847532
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccc(Cl)cc3)cccc21,60.6,%,=,CHEMBL4863218
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cc(Cl)cc(Cl)c3)cccc21,57.2,%,=,CHEMBL4847373
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccc(F)cc3)cccc21,73.4,%,=,CHEMBL4852099
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=[N+]([O-])c1ccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,57.7,%,=,CHEMBL4851595
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,COc1ccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,63.8,%,=,CHEMBL4868597
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,Cc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,57.4,%,=,CHEMBL4864206
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cccc(C(F)(F)F)c3)cccc21,,%,,CHEMBL4854972
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,68.1,%,=,CHEMBL4845823
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation at 10 uM incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,86.6,%,=,CHEMBL636
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,1100.0,nM,=,CHEMBL4850546
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,1380.0,nM,=,CHEMBL4845823
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccccc3)cccc21,26.9,%,=,CHEMBL4878361
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCCCCNCc3ccccc3)cccc21,36.5,%,=,CHEMBL4871964
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccccc3Cl)cccc21,27.5,%,=,CHEMBL4878383
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cccc(Cl)c3)cccc21,25.7,%,=,CHEMBL4847532
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccc(Cl)cc3)cccc21,31.9,%,=,CHEMBL4863218
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cc(Cl)cc(Cl)c3)cccc21,40.9,%,=,CHEMBL4847373
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3ccc(F)cc3)cccc21,23.7,%,=,CHEMBL4852099
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=[N+]([O-])c1ccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,31.6,%,=,CHEMBL4851595
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,COc1ccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)cc1,41.4,%,=,CHEMBL4868597
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,Cc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,48.5,%,=,CHEMBL4864206
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNCc3cccc(C(F)(F)F)c3)cccc21,37.1,%,=,CHEMBL4854972
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 24 hrs by microplate reader assay relative to control,Inhibition,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,77.5,%,=,CHEMBL4845823
Aβ42 inhibition assay,IC50,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.5,nM,<,CHEMBL1091513
Aβ40 inhibition assay,IC50,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.5,nM,<,CHEMBL1091513
Radioligand Binding Assay,IC50,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.65,nM,,CHEMBL1091513
Aβ40 inhibition assay,IC50,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,1600.0,nM,,CHEMBL4558518
Aβ42 inhibition assay,IC50,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,31.0,nM,,CHEMBL3609637
Aβ40 inhibition assay,IC50,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,131.0,nM,,CHEMBL3609637
Aβ42 inhibition assay,IC50,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,10.0,µM,>,CHEMBL4534005
Aβ40 inhibition assay,IC50,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,10.0,µM,>,CHEMBL4534005
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,Cc1c2c(nc3ccccc13)CC[C@@]1(C)C2=CC[C@H]2[C@@H]3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@@H]21,,,,CHEMBL5092884
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccccc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5091327
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5085391
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5Cl)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5093879
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,Cc1c2c(nc3ccccc13)CC1=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]1(C)C2,,,,CHEMBL5088779
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccccc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5094512
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5080437
Disaggregation of aggregated human amyloid beta (1 to 42) preformed fibrils in human SH-SY5Y cells assessed as decrease the number of foci to basal levels at 50 uM for 12 hrs by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6Cl)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5074590
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,Cc1c2c(nc3ccccc13)CC[C@@]1(C)C2=CC[C@H]2[C@@H]3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@@H]21,,%,,CHEMBL5092884
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccccc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5091327
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5085391
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5Cl)CC[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5093879
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,Cc1c2c(nc3ccccc13)CC1=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]1(C)C2,,%,,CHEMBL5088779
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccccc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5094512
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5080437
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction in fluorescence intensity at 20 uM measured upto 30 h by thioflavin-T fluorescence assay,Inhibition,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6Cl)c5C[C@]4(C)[C@H]3CC[C@]12C,,%,,CHEMBL5074590
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,Cc1c2c(nc3ccccc13)CC[C@@]1(C)C2=CC[C@H]2[C@@H]3CC[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@@H]21,,,,CHEMBL5092884
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccccc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5091327
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5085391
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4c5c(nc6ccc(Cl)cc6c5-c5ccccc5Cl)CC[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5093879
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,Cc1c2c(nc3ccccc13)CC1=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]1(C)C2,,,,CHEMBL5088779
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccccc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5094512
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5080437
Disaggregation of aggregated huamn amyloid beta (1 to 42) fibrils in human SH-SY5Y cells assessed as decrease the area of foci to basal levels at 50 uM for 12 hour by confocal microscopy relative to control,Activity,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4Cc5nc6ccc(Cl)cc6c(-c6ccccc6Cl)c5C[C@]4(C)[C@H]3CC[C@]12C,,,,CHEMBL5074590
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.3,nM,=,CHEMBL2152899
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2cc(C#N)nc2C(N)=N1,8.5,nM,=,CHEMBL5085521
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,12.6,nM,=,CHEMBL5088449
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.6,nM,=,CHEMBL5075933
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4c(C#N)cnc4C(N)=N3)c2)cn1,6.3,nM,=,CHEMBL5073381
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5084378
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.6,nM,=,CHEMBL5085412
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5093303
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,Cc1nc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)co1,4.8,nM,=,CHEMBL5093195
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.5,nM,=,CHEMBL5077699
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.2,nM,=,CHEMBL5082406
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1,1.3,nM,=,CHEMBL5074068
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 20 umol/L incubated for 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,27.65,%,=,CHEMBL502
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 20 umol/L incubated for 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=C(NCCc1c[nH]c2ccccc12)c1ccccc1O,19.6,%,=,CHEMBL1512476
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 20 umol/L incubated for 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,CON(C)C(=O)Oc1ccccc1C(=O)NCCc1c[nH]c2ccccc12,40.26,%,=,CHEMBL5071046
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 20 umol/L incubated for 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21,34.81,%,=,CHEMBL258921
Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 20 umol/L incubated for 24 hrs by thioflavin-T fluorescence method relative to control,Inhibition,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,60.28,%,=,CHEMBL140
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,98.0,nM,=,CHEMBL3261067
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1,3.0,nM,=,CHEMBL3261069
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1,98.0,nM,=,CHEMBL3261068
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670365
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3670368
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3670371
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,10.0,nM,=,CHEMBL3670372
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,30.0,nM,=,CHEMBL5070669
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,26.0,nM,=,CHEMBL3670385
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,284.0,nM,=,CHEMBL3670367
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,263.0,nM,=,CHEMBL5089745
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1,23.0,nM,=,CHEMBL5080033
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta42 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta40 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL3670375
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta(1 to 40 residues) level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375
Inhibition of APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CCSC(N)=N1,4.0,nM,=,CHEMBL5093426
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in soluble APP beta level incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,4.0,nM,=,CHEMBL3261067
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1,17.0,nM,=,CHEMBL3653341
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1,3.0,nM,=,CHEMBL3653393
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N,1160.0,nM,=,CHEMBL4128145
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1,32.0,nM,=,CHEMBL3653399
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3653404
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3653403
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL3653405
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,105.0,nM,=,CHEMBL5077684
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5073160
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5090563
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1,17.0,nM,=,CHEMBL5075177
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,6.0,nM,=,CHEMBL5086270
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL5074449
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL5085959
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 40 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 42 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=C1CNC(=O)[C@H](Cc2ccc(OCCCN3CCCCC3)cc2)N1,,,,CHEMBL5081279
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=C1CNC(=O)[C@@H](Cc2ccc(OCCCN3CCCCC3)cc2)N1,,,,CHEMBL5078493
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,C[C@@H]1NC(=O)[C@H](Cc2ccc(OCCCN3CCCCC3)cc2)NC1=O,,,,CHEMBL5085646
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccc(OCCCN3CCCCC3)cc2)NC1=O,,,,CHEMBL5083150
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=C1N[C@@H](Cc2ccc(OCCCN3CCCCC3)cc2)C(=O)N[C@H]1Cc1ccccc1,,,,CHEMBL5092830
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,c1cc(OCCCN2CCCCC2)ccc1C[C@H]1CNCCN1,,,,CHEMBL5082819
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,c1ccc(C[C@H]2CN[C@@H](Cc3ccc(OCCCN4CCCCC4)cc3)CN2)cc1,,,,CHEMBL5090291
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,CC(=O)N1CC(=O)N/C(=C\c2ccc(OCCCN3CCCCC3)cc2)C1=O,,,,CHEMBL5092036
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=C1CNC(=O)/C(=C/c2ccc(OCCCN3CCCCC3)cc2)N1,,,,CHEMBL5087354
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=c1[nH]/c(=C\c2ccc(OCCCN3CCCCC3)cc2)c(=O)[nH]/c1=C\c1ccccc1,,,,CHEMBL5079959
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,CC(=O)N1C(=O)/C(=C/c2ccc(OCCCN3CCCCC3)cc2)NC(=O)[C@@H]1Cc1ccccc1,,,,CHEMBL5086337
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) at 200 uM by SPR analysis,Activity,O=C1N[C@@H](Cc2ccccc2)C(=O)N/C1=C\c1ccc(OCCCN2CCCCC2)cc1,,,,CHEMBL5092241
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) assessed as dissociation constant by SPR analysis,Kd,O=C1N[C@@H](Cc2ccc(OCCCN3CCCCC3)cc2)C(=O)N[C@H]1Cc1ccccc1,12000000.0,nM,=,CHEMBL5092830
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) assessed as dissociation constant by SPR analysis,Kd,O=C1CN(Cc2ccc(OCCCN3CCCCC3)cc2)C(=O)CN1,1547000.0,nM,=,CHEMBL5077020
Binding affinity to CM-5 sensor chip immobilized beta-amyloid monomer (1 to 42) (unknown origin) assessed as dissociation constant by SPR analysis,Kd,O=C1CN(Cc2ccc(OCCCN3CCCCC3)cc2)CCN1Cc1ccccc1,51620.0,nM,=,CHEMBL5094225
